Thyroid Adenocarcinoma: PARADIGM pathway analysis of mRNASeq expression and copy number data
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 54 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
IL4-mediated signaling events 74
Ephrin A reverse signaling 63
Syndecan-1-mediated signaling events 56
Wnt signaling 56
Syndecan-4-mediated signaling events 56
IL23-mediated signaling events 56
Signaling mediated by p38-alpha and p38-beta 55
TCR signaling in naïve CD8+ T cells 55
Glucocorticoid receptor regulatory network 51
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 50
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
IL4-mediated signaling events 74 6738 91 -0.68 0.6 1000 -1000 -0.084 -1000
Ephrin A reverse signaling 63 445 7 -0.098 0 1000 -1000 -0.008 -1000
Syndecan-1-mediated signaling events 56 1925 34 -0.19 0.029 1000 -1000 -0.039 -1000
Wnt signaling 56 398 7 -0.1 -0.009 1000 -1000 -0.021 -1000
Syndecan-4-mediated signaling events 56 3779 67 -0.24 0.054 1000 -1000 -0.026 -1000
IL23-mediated signaling events 56 3413 60 -0.6 0.028 1000 -1000 -0.1 -1000
Signaling mediated by p38-alpha and p38-beta 55 2438 44 -0.19 0.029 1000 -1000 -0.036 -1000
TCR signaling in naïve CD8+ T cells 55 5128 93 -0.19 0.041 1000 -1000 -0.051 -1000
Glucocorticoid receptor regulatory network 51 5829 114 -0.52 0.38 1000 -1000 -0.057 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 50 3418 68 -0.44 0.15 1000 -1000 -0.075 -1000
Signaling events regulated by Ret tyrosine kinase 48 4002 82 -0.15 0.029 1000 -1000 -0.061 -1000
IL12-mediated signaling events 47 4165 87 -0.3 0.067 1000 -1000 -0.073 -1000
Calcium signaling in the CD4+ TCR pathway 46 1433 31 -0.3 0.029 1000 -1000 -0.041 -1000
amb2 Integrin signaling 43 3596 82 -0.23 0.037 1000 -1000 -0.035 -1000
PDGFR-alpha signaling pathway 42 1871 44 -0.16 0.035 1000 -1000 -0.039 -1000
Glypican 2 network 42 168 4 -0.034 -0.013 1000 -1000 0.009 -1000
Endothelins 41 4014 96 -0.22 0.029 1000 -1000 -0.051 -1000
Class IB PI3K non-lipid kinase events 38 114 3 -0.011 -1000 1000 -1000 -0.004 -1000
Fc-epsilon receptor I signaling in mast cells 36 3551 97 -0.12 0.031 1000 -1000 -0.053 -1000
p75(NTR)-mediated signaling 35 4458 125 -0.16 0.075 1000 -1000 -0.058 -1000
Noncanonical Wnt signaling pathway 33 860 26 -0.1 0.029 1000 -1000 -0.043 -1000
Thromboxane A2 receptor signaling 33 3523 105 -0.12 0.076 1000 -1000 -0.049 -1000
HIF-1-alpha transcription factor network 31 2415 76 -0.18 0.07 1000 -1000 -0.058 -1000
FOXA2 and FOXA3 transcription factor networks 31 1437 46 -0.38 0.033 1000 -1000 -0.064 -1000
Arf6 downstream pathway 30 1296 43 -0.14 0.041 1000 -1000 -0.022 -1000
Glypican 1 network 30 1485 48 -0.17 0.044 1000 -1000 -0.025 -1000
Osteopontin-mediated events 29 1127 38 -0.2 0.029 1000 -1000 -0.04 -1000
IL6-mediated signaling events 29 2212 75 -0.2 0.053 1000 -1000 -0.045 -1000
Ras signaling in the CD4+ TCR pathway 29 497 17 -0.11 0.048 1000 -1000 -0.02 -1000
Effects of Botulinum toxin 28 744 26 -0.18 0.047 1000 -1000 -0.007 -1000
TCGA08_retinoblastoma 28 229 8 -0.041 0.028 1000 -1000 -0.005 -1000
ErbB2/ErbB3 signaling events 27 1811 65 -0.13 0.04 1000 -1000 -0.053 -1000
IL27-mediated signaling events 27 1400 51 -0.13 0.069 1000 -1000 -0.046 -1000
BCR signaling pathway 27 2741 99 -0.17 0.034 1000 -1000 -0.061 -1000
Reelin signaling pathway 26 1483 56 -0.13 0.069 1000 -1000 -0.037 -1000
JNK signaling in the CD4+ TCR pathway 25 431 17 -0.038 0.028 1000 -1000 -0.035 -1000
Nongenotropic Androgen signaling 24 1279 52 -0.093 0.061 1000 -1000 -0.036 -1000
IL1-mediated signaling events 23 1464 62 -0.12 0.066 1000 -1000 -0.057 -1000
Plasma membrane estrogen receptor signaling 23 1988 86 -0.091 0.053 1000 -1000 -0.061 -1000
Caspase cascade in apoptosis 22 1667 74 -0.07 0.041 1000 -1000 -0.037 -1000
Syndecan-2-mediated signaling events 22 1535 69 -0.15 0.054 1000 -1000 -0.042 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 22 1716 78 -0.087 0.043 1000 -1000 -0.055 -1000
a4b1 and a4b7 Integrin signaling 21 106 5 -0.024 0.02 1000 -1000 0.003 -1000
Arf6 signaling events 21 1341 62 -0.12 0.064 1000 -1000 -0.036 -1000
Signaling events mediated by PTP1B 21 1619 76 -0.12 0.035 1000 -1000 -0.045 -1000
BMP receptor signaling 21 1716 81 -0.16 0.054 1000 -1000 -0.045 -1000
Angiopoietin receptor Tie2-mediated signaling 21 1850 88 -0.15 0.04 1000 -1000 -0.062 -1000
FOXM1 transcription factor network 21 1084 51 -0.083 0.055 1000 -1000 -0.077 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 20 1728 85 -0.058 0.13 1000 -1000 -0.042 -1000
S1P1 pathway 20 724 36 -0.16 0.029 1000 -1000 -0.038 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 20 920 45 -0.11 0.065 1000 -1000 -0.045 -1000
IL2 signaling events mediated by STAT5 20 449 22 -0.088 0.031 1000 -1000 -0.03 -1000
Visual signal transduction: Rods 20 1084 52 -0.073 0.029 1000 -1000 -0.018 -1000
IL2 signaling events mediated by PI3K 19 1114 58 -0.078 0.054 1000 -1000 -0.035 -1000
LPA4-mediated signaling events 18 217 12 -0.11 0.008 1000 -1000 -0.017 -1000
Coregulation of Androgen receptor activity 18 1437 76 -0.21 0.055 1000 -1000 -0.022 -1000
Nephrin/Neph1 signaling in the kidney podocyte 18 622 34 -0.02 0.029 1000 -1000 -0.035 -1000
Visual signal transduction: Cones 18 718 38 -0.036 0.027 1000 -1000 -0.017 -1000
FAS signaling pathway (CD95) 18 848 47 -0.2 0.045 1000 -1000 -0.04 -1000
Integrins in angiogenesis 18 1584 84 -0.15 0.051 1000 -1000 -0.051 -1000
LPA receptor mediated events 18 1847 102 -0.13 0.04 1000 -1000 -0.071 -1000
EGFR-dependent Endothelin signaling events 18 380 21 -0.033 0.041 1000 -1000 -0.043 -1000
TCGA08_p53 17 119 7 -0.038 0.027 1000 -1000 -0.014 -1000
Neurotrophic factor-mediated Trk receptor signaling 17 2150 120 -0.12 0.08 1000 -1000 -0.05 -1000
Aurora B signaling 17 1158 67 -0.12 0.029 1000 -1000 -0.045 -1000
Signaling events mediated by the Hedgehog family 16 836 52 -0.056 0.039 1000 -1000 -0.037 -1000
Regulation of p38-alpha and p38-beta 16 867 54 -0.12 0.069 1000 -1000 -0.05 -1000
Circadian rhythm pathway 15 340 22 -0.093 0.029 1000 -1000 -0.023 -1000
ceramide signaling pathway 15 760 49 -0.07 0.041 1000 -1000 -0.042 -1000
RXR and RAR heterodimerization with other nuclear receptor 15 801 52 -0.12 0.07 1000 -1000 -0.049 -1000
EPHB forward signaling 15 1294 85 -0.083 0.061 1000 -1000 -0.058 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 14 799 54 -0.13 0.042 1000 -1000 -0.051 -1000
Aurora C signaling 14 98 7 -0.018 0.003 1000 -1000 -0.014 -1000
Ceramide signaling pathway 14 1105 76 -0.17 0.079 1000 -1000 -0.038 -1000
Regulation of nuclear SMAD2/3 signaling 13 1828 136 -0.12 0.067 1000 -1000 -0.045 -1000
IFN-gamma pathway 13 895 68 -0.16 0.044 1000 -1000 -0.046 -1000
Ephrin B reverse signaling 13 658 48 -0.035 0.036 1000 -1000 -0.027 -1000
Class I PI3K signaling events 13 1004 73 -0.12 0.052 1000 -1000 -0.039 -1000
ErbB4 signaling events 12 865 69 -0.15 0.038 1000 -1000 -0.039 -1000
Signaling events mediated by VEGFR1 and VEGFR2 12 1534 125 -0.056 0.064 1000 -1000 -0.048 -1000
IGF1 pathway 12 738 57 -0.057 0.055 1000 -1000 -0.045 -1000
Cellular roles of Anthrax toxin 11 467 39 -0.07 0.029 1000 -1000 -0.023 -1000
Hedgehog signaling events mediated by Gli proteins 11 750 65 -0.26 0.067 1000 -1000 -0.038 -1000
Presenilin action in Notch and Wnt signaling 11 699 61 -0.066 0.076 1000 -1000 -0.052 -1000
S1P5 pathway 11 193 17 -0.028 0.029 1000 -1000 -0.025 -1000
TCGA08_rtk_signaling 11 290 26 -0.1 0.053 1000 -1000 -0.004 -1000
PDGFR-beta signaling pathway 11 1119 97 -0.076 0.071 1000 -1000 -0.047 -1000
Regulation of Androgen receptor activity 11 826 70 -0.15 0.033 1000 -1000 -0.046 -1000
Paxillin-independent events mediated by a4b1 and a4b7 10 401 37 -0.024 0.049 1000 -1000 -0.031 -1000
Syndecan-3-mediated signaling events 10 370 35 -0.11 0.075 1000 -1000 -0.031 -1000
Canonical Wnt signaling pathway 10 516 51 -0.066 0.055 1000 -1000 -0.059 -1000
VEGFR1 specific signals 10 606 56 -0.046 0.045 1000 -1000 -0.045 -1000
BARD1 signaling events 9 562 57 -0.042 0.056 1000 -1000 -0.038 -1000
Sphingosine 1-phosphate (S1P) pathway 9 271 28 -0.028 0.052 1000 -1000 -0.027 -1000
PLK1 signaling events 9 839 85 -0.019 0.049 1000 -1000 -0.026 -1000
Insulin-mediated glucose transport 9 294 32 -0.13 0.054 1000 -1000 -0.029 -1000
Stabilization and expansion of the E-cadherin adherens junction 9 722 74 -0.058 0.071 1000 -1000 -0.073 -1000
S1P3 pathway 9 403 42 -0.028 0.05 1000 -1000 -0.04 -1000
Nectin adhesion pathway 8 531 63 -0.039 0.075 1000 -1000 -0.042 -1000
Regulation of Telomerase 8 820 102 -0.06 0.078 1000 -1000 -0.036 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 8 288 33 -0.067 0.06 1000 -1000 -0.033 -1000
Rapid glucocorticoid signaling 8 162 20 -0.01 0.036 1000 -1000 -0.006 -1000
S1P4 pathway 8 209 25 -0.028 0.043 1000 -1000 -0.033 -1000
Canonical NF-kappaB pathway 7 292 39 -0.07 0.065 1000 -1000 -0.028 -1000
Signaling events mediated by HDAC Class III 7 314 40 -0.087 0.051 1000 -1000 -0.024 -1000
HIF-2-alpha transcription factor network 7 332 43 -0.089 0.09 1000 -1000 -0.047 -1000
FoxO family signaling 6 434 64 -0.14 0.095 1000 -1000 -0.035 -1000
Retinoic acid receptors-mediated signaling 6 367 58 -0.031 0.058 1000 -1000 -0.025 -1000
Paxillin-dependent events mediated by a4b1 6 236 36 -0.041 0.051 1000 -1000 -0.031 -1000
Signaling events mediated by PRL 6 230 34 -0.063 0.042 1000 -1000 -0.038 -1000
TRAIL signaling pathway 5 283 48 0 0.074 1000 -1000 -0.038 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 5 476 83 -0.13 0.058 1000 -1000 -0.035 -1000
Atypical NF-kappaB pathway 5 160 31 -0.034 0.039 1000 -1000 -0.029 -1000
p38 MAPK signaling pathway 5 263 44 -0.02 0.052 1000 -1000 -0.024 -1000
Aurora A signaling 4 272 60 -0.042 0.06 1000 -1000 -0.021 -1000
mTOR signaling pathway 4 262 53 -0.007 0.046 1000 -1000 -0.038 -1000
Class I PI3K signaling events mediated by Akt 4 284 68 -0.13 0.054 1000 -1000 -0.033 -1000
Signaling mediated by p38-gamma and p38-delta 4 60 15 0 0.027 1000 -1000 -0.027 -1000
Insulin Pathway 4 311 74 -0.074 0.068 1000 -1000 -0.044 -1000
Signaling events mediated by HDAC Class II 3 227 75 -0.056 0.079 1000 -1000 -0.025 -1000
EPO signaling pathway 3 183 55 -0.005 0.072 1000 -1000 -0.043 -1000
Signaling events mediated by HDAC Class I 3 403 104 -0.07 0.066 1000 -1000 -0.028 -1000
E-cadherin signaling in the nascent adherens junction 3 293 76 -0.035 0.07 1000 -1000 -0.061 -1000
E-cadherin signaling in keratinocytes 3 147 43 -0.031 0.053 1000 -1000 -0.035 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 2 52 23 -0.013 0.052 1000 -1000 -0.021 -1000
PLK2 and PLK4 events 2 6 3 0.015 0.027 1000 -1000 -0.009 -1000
Arf6 trafficking events 1 106 71 -0.05 0.053 1000 -1000 -0.031 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0 18 27 0 0.071 1000 -1000 -0.033 -1000
E-cadherin signaling events 0 0 5 0.028 0.054 1000 -1000 0.005 -1000
Arf1 pathway 0 35 54 -0.001 0.046 1000 -1000 -0.018 -1000
Alternative NF-kappaB pathway 0 11 13 0 0.075 1000 -1000 0 -1000
Total 2567 150855 7203 -15 -990 131000 -131000 -4.9 -131000
IL4-mediated signaling events

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.52 0.56 -10000 0 -1.3 104 104
STAT6 (cleaved dimer) -0.58 0.61 -10000 0 -1.3 134 134
IGHG1 -0.15 0.16 -10000 0 -0.38 38 38
IGHG3 -0.5 0.54 -10000 0 -1.1 133 133
AKT1 -0.35 0.44 -10000 0 -0.96 102 102
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.37 0.54 -10000 0 -1.2 97 97
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.35 0.47 -10000 0 -1 91 91
THY1 -0.53 0.57 -10000 0 -1.3 105 105
MYB -0.019 0.15 -10000 0 -0.46 36 36
HMGA1 0 0.13 -10000 0 -0.58 18 18
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.48 0.61 -10000 0 -1.1 128 128
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.35 0.48 -10000 0 -1 95 95
SP1 0.022 0.029 -10000 0 -10000 0 0
INPP5D 0.017 0.064 -10000 0 -0.31 12 12
SOCS5 0.037 0.022 -10000 0 -10000 0 0
STAT6 (dimer)/ETS1 -0.57 0.61 -10000 0 -1.3 131 131
SOCS1 -0.35 0.35 -10000 0 -0.77 119 119
SOCS3 -0.37 0.44 -10000 0 -1 90 90
FCER2 -0.52 0.56 -10000 0 -1.2 128 128
PARP14 0.02 0.063 -10000 0 -0.58 4 4
CCL17 -0.67 0.7 -10000 0 -1.5 139 139
GRB2 0.028 0.007 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.27 0.35 -10000 0 -0.78 87 87
T cell proliferation -0.55 0.6 -10000 0 -1.3 124 124
IL4R/JAK1 -0.52 0.56 -10000 0 -1.3 110 110
EGR2 -0.58 0.62 -10000 0 -1.4 113 113
JAK2 -0.02 0.042 -10000 0 -10000 0 0
JAK3 -0.051 0.2 -10000 0 -0.54 50 50
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
JAK1 0.009 0.022 -10000 0 -10000 0 0
COL1A2 -0.19 0.31 -10000 0 -1.5 15 15
CCL26 -0.59 0.64 -10000 0 -1.4 121 121
IL4R -0.56 0.61 -10000 0 -1.4 110 110
PTPN6 0.037 0.02 -10000 0 -0.25 1 1
IL13RA2 -0.58 0.62 -10000 0 -1.4 116 116
IL13RA1 -0.018 0.042 -10000 0 -10000 0 0
IRF4 -0.4 0.63 -10000 0 -1.5 82 82
ARG1 -0.14 0.22 -10000 0 -0.81 23 23
CBL -0.44 0.53 -10000 0 -1.1 122 122
GTF3A 0.006 0.046 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
IL13RA1/JAK2 -0.02 0.058 -10000 0 -10000 0 0
IRF4/BCL6 -0.35 0.58 -10000 0 -1.4 82 82
CD40LG -0.077 0.18 -10000 0 -0.38 86 86
MAPK14 -0.45 0.56 -10000 0 -1.1 113 113
mitosis -0.32 0.4 -10000 0 -0.87 102 102
STAT6 -0.64 0.78 -10000 0 -1.5 122 122
SPI1 -0.006 0.13 -10000 0 -0.43 29 29
RPS6KB1 -0.3 0.37 0.49 1 -0.84 96 97
STAT6 (dimer) -0.64 0.79 -10000 0 -1.5 123 123
STAT6 (dimer)/PARP14 -0.58 0.64 -10000 0 -1.3 126 126
mast cell activation 0.013 0.012 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.42 0.57 -10000 0 -1.2 100 100
FRAP1 -0.35 0.44 -10000 0 -0.96 102 102
LTA -0.62 0.65 -10000 0 -1.4 129 129
FES 0.029 0.004 -10000 0 -10000 0 0
T-helper 1 cell differentiation 0.6 0.68 1.4 126 -10000 0 126
CCL11 -0.5 0.54 -10000 0 -1.2 105 105
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.4 0.56 -10000 0 -1.2 98 98
IL2RG -0.066 0.18 -10000 0 -0.37 85 85
IL10 -0.56 0.61 -10000 0 -1.4 107 107
IRS1 0.019 0.069 -10000 0 -0.42 8 8
IRS2 0.012 0.098 -10000 0 -0.58 10 10
IL4 -0.11 0.11 -10000 0 -0.24 89 89
IL5 -0.52 0.56 -10000 0 -1.2 133 133
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.43 0.49 -10000 0 -1 117 117
COL1A1 -0.37 0.56 -10000 0 -1.5 64 64
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.53 0.59 -10000 0 -1.3 106 106
IL2R gamma/JAK3 -0.089 0.21 -10000 0 -0.39 98 98
TFF3 -0.68 0.67 -10000 0 -1.4 146 146
ALOX15 -0.52 0.56 -10000 0 -1.3 104 104
MYBL1 0.025 0.033 -10000 0 -0.26 5 5
T-helper 2 cell differentiation -0.48 0.54 -10000 0 -1.1 128 128
SHC1 0.027 0.008 -10000 0 -10000 0 0
CEBPB 0.03 0.012 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.35 0.47 -10000 0 -1 90 90
mol:PI-3-4-5-P3 -0.35 0.44 -10000 0 -0.96 102 102
PI3K -0.38 0.5 -10000 0 -1.1 102 102
DOK2 -0.027 0.16 -10000 0 -0.46 43 43
ETS1 0.035 0.038 -10000 0 -0.38 2 2
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.25 0.32 -10000 0 -0.74 82 82
ITGB3 -0.54 0.6 -10000 0 -1.3 109 109
PIGR -0.59 0.64 -10000 0 -1.4 121 121
IGHE 0.032 0.059 0.27 6 -0.44 1 7
MAPKKK cascade -0.24 0.31 -10000 0 -0.72 82 82
BCL6 0.028 0.032 -10000 0 -0.57 1 1
OPRM1 -0.52 0.56 -10000 0 -1.2 133 133
RETNLB -0.52 0.56 -10000 0 -1.2 133 133
SELP -0.53 0.6 -10000 0 -1.4 104 104
AICDA -0.51 0.53 -10000 0 -1.2 107 107
Ephrin A reverse signaling

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade -0.078 0.17 -9999 0 -0.38 71 71
EFNA5 -0.033 0.17 -9999 0 -0.46 47 47
FYN -0.079 0.15 -9999 0 -0.36 69 69
neuron projection morphogenesis -0.078 0.17 -9999 0 -0.38 71 71
cell-cell signaling 0 0 -9999 0 -10000 0 0
Ephrin A5/EPHA5 -0.078 0.17 -9999 0 -0.38 71 71
EPHA5 -0.098 0.2 -9999 0 -0.38 116 116
Syndecan-1-mediated signaling events

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.023 0.054 -9999 0 -0.58 3 3
CCL5 -0.049 0.16 -9999 0 -0.35 76 76
SDCBP 0.029 0.004 -9999 0 -10000 0 0
FGFR/FGF2/Syndecan-1 -0.16 0.27 -9999 0 -0.59 82 82
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
Syndecan-1/Laminin-5 -0.15 0.27 -9999 0 -0.62 74 74
Syndecan-1/Syntenin -0.16 0.27 -9999 0 -0.62 74 74
MAPK3 -0.14 0.24 -9999 0 -0.58 67 67
HGF/MET -0.047 0.18 -9999 0 -0.44 61 61
TGFB1/TGF beta receptor Type II 0.023 0.054 -9999 0 -0.58 3 3
BSG 0.026 0.017 -9999 0 -0.26 1 1
keratinocyte migration -0.15 0.26 -9999 0 -0.6 74 74
Syndecan-1/RANTES -0.18 0.29 -9999 0 -0.63 86 86
Syndecan-1/CD147 -0.14 0.26 -9999 0 -0.62 69 69
Syndecan-1/Syntenin/PIP2 -0.15 0.26 -9999 0 -0.6 74 74
LAMA5 0.028 0.006 -9999 0 -10000 0 0
positive regulation of cell-cell adhesion -0.15 0.25 -9999 0 -0.58 74 74
MMP7 -0.16 0.25 -9999 0 -0.43 155 155
HGF -0.031 0.16 -9999 0 -0.44 47 47
Syndecan-1/CASK -0.16 0.26 -9999 0 -0.59 81 81
Syndecan-1/HGF/MET -0.19 0.31 -9999 0 -0.66 89 89
regulation of cell adhesion -0.13 0.23 -9999 0 -0.56 67 67
HPSE -0.044 0.19 -9999 0 -0.54 48 48
positive regulation of cell migration -0.16 0.27 -9999 0 -0.59 82 82
SDC1 -0.16 0.27 -9999 0 -0.6 82 82
Syndecan-1/Collagen -0.16 0.27 -9999 0 -0.59 82 82
PPIB 0.028 0.015 -9999 0 -0.26 1 1
MET -0.03 0.18 -9999 0 -0.58 36 36
PRKACA 0.027 0.008 -9999 0 -10000 0 0
MMP9 -0.087 0.22 -9999 0 -0.45 91 91
MAPK1 -0.14 0.24 -9999 0 -0.58 69 69
homophilic cell adhesion -0.16 0.27 -9999 0 -0.61 80 80
MMP1 -0.085 0.21 -9999 0 -0.41 97 97
Wnt signaling

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.094 0.17 -9999 0 -0.33 109 109
FZD6 0.028 0.005 -9999 0 -10000 0 0
WNT6 -0.026 0.16 -9999 0 -0.46 41 41
WNT4 -0.1 0.2 -9999 0 -0.37 120 120
FZD3 0.029 0.004 -9999 0 -10000 0 0
WNT5A -0.009 0.15 -9999 0 -0.56 24 24
WNT11 -0.088 0.2 -9999 0 -0.39 104 104
Syndecan-4-mediated signaling events

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.16 0.31 -10000 0 -0.62 107 107
Syndecan-4/Syndesmos -0.18 0.36 -10000 0 -0.78 86 86
positive regulation of JNK cascade -0.18 0.33 -10000 0 -0.7 91 91
Syndecan-4/ADAM12 -0.21 0.37 -10000 0 -0.79 91 91
CCL5 -0.049 0.16 -10000 0 -0.35 76 76
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
DNM2 0.027 0.008 -10000 0 -10000 0 0
ITGA5 0.026 0.032 -10000 0 -0.58 1 1
SDCBP 0.029 0.004 -10000 0 -10000 0 0
PLG 0.004 0.016 0.041 24 -0.066 6 30
ADAM12 -0.042 0.15 -10000 0 -0.31 78 78
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.028 0.007 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha -0.041 0.031 -10000 0 -0.094 54 54
Syndecan-4/Laminin alpha1 -0.22 0.4 -10000 0 -0.78 107 107
Syndecan-4/CXCL12/CXCR4 -0.2 0.36 -10000 0 -0.77 91 91
Syndecan-4/Laminin alpha3 -0.21 0.37 -10000 0 -0.74 102 102
MDK -0.034 0.18 -10000 0 -0.54 41 41
Syndecan-4/FZD7 -0.19 0.37 -10000 0 -0.79 90 90
Syndecan-4/Midkine -0.21 0.4 -10000 0 -0.82 94 94
FZD7 0.016 0.083 -10000 0 -0.54 8 8
Syndecan-4/FGFR1/FGF -0.17 0.34 -10000 0 -0.73 87 87
THBS1 -0.032 0.16 -10000 0 -0.37 57 57
integrin-mediated signaling pathway -0.23 0.38 -10000 0 -0.77 107 107
positive regulation of MAPKKK cascade -0.18 0.33 -10000 0 -0.7 91 91
Syndecan-4/TACI -0.24 0.37 -10000 0 -0.76 99 99
CXCR4 0.001 0.098 -10000 0 -0.31 30 30
cell adhesion -0.063 0.15 0.2 3 -0.32 88 91
Syndecan-4/Dynamin -0.18 0.36 -10000 0 -0.77 88 88
Syndecan-4/TSP1 -0.21 0.38 -10000 0 -0.78 95 95
Syndecan-4/GIPC -0.18 0.36 -10000 0 -0.77 88 88
Syndecan-4/RANTES -0.21 0.38 -10000 0 -0.8 92 92
ITGB1 0.029 0.005 -10000 0 -10000 0 0
LAMA1 -0.059 0.21 -10000 0 -0.56 55 55
LAMA3 -0.032 0.16 -10000 0 -0.39 54 54
RAC1 0.028 0.007 -10000 0 -10000 0 0
PRKCA 0.054 0.19 0.9 15 -0.47 2 17
Syndecan-4/alpha-Actinin -0.18 0.37 -10000 0 -0.8 83 83
TFPI 0.018 0.066 -10000 0 -0.35 10 10
F2 0 0.012 0.048 4 -0.064 6 10
alpha5/beta1 Integrin 0.04 0.026 -10000 0 -0.42 1 1
positive regulation of cell adhesion -0.24 0.38 -10000 0 -0.74 115 115
ACTN1 0.026 0.035 -10000 0 -0.42 2 2
TNC -0.12 0.24 -10000 0 -0.49 102 102
Syndecan-4/CXCL12 -0.2 0.37 -10000 0 -0.78 92 92
FGF6 0 0 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
CXCL12 -0.015 0.15 -10000 0 -0.5 31 31
TNFRSF13B -0.1 0.2 -10000 0 -0.37 118 118
FGF2 0.013 0.098 -10000 0 -0.58 10 10
FGFR1 0.019 0.076 -10000 0 -0.58 6 6
Syndecan-4/PI-4-5-P2 -0.2 0.36 -10000 0 -0.78 88 88
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.15 0.26 -10000 0 -0.49 127 127
cell migration -0.01 0.016 -10000 0 -10000 0 0
PRKCD 0.032 0.018 -10000 0 -10000 0 0
vasculogenesis -0.2 0.35 0.26 1 -0.72 95 96
SDC4 -0.21 0.4 -10000 0 -0.86 85 85
Syndecan-4/Tenascin C -0.24 0.42 -10000 0 -0.83 107 107
Syndecan-4/PI-4-5-P2/PKC alpha -0.033 0.024 -10000 0 -0.075 54 54
Syndecan-4/Syntenin -0.18 0.37 -10000 0 -0.78 87 87
MMP9 -0.086 0.22 -10000 0 -0.44 91 91
Rac1/GTP -0.065 0.15 0.2 3 -0.33 88 91
cytoskeleton organization -0.17 0.34 -10000 0 -0.73 86 86
GIPC1 0.027 0.008 -10000 0 -10000 0 0
Syndecan-4/TFPI -0.19 0.37 0.26 1 -0.78 88 89
IL23-mediated signaling events

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.43 0.56 -9999 0 -1.4 77 77
IL23A -0.46 0.58 -9999 0 -1.4 87 87
NF kappa B1 p50/RelA/I kappa B alpha -0.43 0.58 -9999 0 -1.4 84 84
positive regulation of T cell mediated cytotoxicity -0.51 0.68 -9999 0 -1.6 84 84
ITGA3 -0.43 0.54 -9999 0 -1.3 77 77
IL17F -0.28 0.33 -9999 0 -0.76 83 83
IL12B -0.053 0.13 -9999 0 -0.36 45 45
STAT1 (dimer) -0.48 0.64 -9999 0 -1.5 84 84
CD4 -0.42 0.53 -9999 0 -1.3 77 77
IL23 -0.45 0.55 -9999 0 -1.3 87 87
IL23R -0.053 0.13 -9999 0 -1.1 3 3
IL1B -0.48 0.6 -9999 0 -1.5 84 84
T-helper cell lineage commitment 0 0 -9999 0 -10000 0 0
IL24 -0.45 0.56 -9999 0 -1.3 91 91
TYK2 -0.004 0.034 -9999 0 -10000 0 0
STAT4 -0.056 0.19 -9999 0 -0.45 66 66
STAT3 0.028 0.007 -9999 0 -10000 0 0
IL18RAP -0.025 0.15 -9999 0 -0.44 40 40
IL12RB1 -0.058 0.15 -9999 0 -0.37 57 57
PIK3CA 0.026 0.044 -9999 0 -0.58 2 2
IL12Rbeta1/TYK2 -0.042 0.12 -9999 0 -0.45 17 17
IL23R/JAK2 -0.058 0.14 -9999 0 -0.98 3 3
positive regulation of chronic inflammatory response -0.51 0.68 -9999 0 -1.6 84 84
natural killer cell activation 0.006 0.008 -9999 0 -10000 0 0
JAK2 -0.008 0.042 -9999 0 -10000 0 0
PIK3R1 0.028 0.006 -9999 0 -10000 0 0
NFKB1 0.027 0.005 -9999 0 -10000 0 0
RELA 0.027 0.006 -9999 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.42 0.51 -9999 0 -1.2 87 87
ALOX12B -0.47 0.57 -9999 0 -1.3 97 97
CXCL1 -0.51 0.61 -9999 0 -1.4 105 105
T cell proliferation -0.51 0.68 -9999 0 -1.6 84 84
NFKBIA 0.026 0.006 -9999 0 -10000 0 0
IL17A -0.2 0.26 -9999 0 -0.59 75 75
PI3K -0.45 0.59 -9999 0 -1.4 84 84
IFNG -0.031 0.045 -9999 0 -0.13 31 31
STAT3 (dimer) -0.42 0.55 -9999 0 -1.3 83 83
IL18R1 -0.067 0.2 -9999 0 -0.43 75 75
IL23/IL23R/JAK2/TYK2/SOCS3 -0.26 0.36 -9999 0 -0.95 48 48
IL18/IL18R -0.099 0.23 -9999 0 -0.44 98 98
macrophage activation -0.02 0.021 -9999 0 -0.046 60 60
TNF -0.49 0.61 -9999 0 -1.4 94 94
STAT3/STAT4 -0.47 0.6 -9999 0 -1.4 92 92
STAT4 (dimer) -0.5 0.65 -9999 0 -1.5 93 93
IL18 -0.059 0.2 -9999 0 -0.49 61 61
IL19 -0.42 0.53 -9999 0 -1.3 81 81
STAT5A (dimer) -0.48 0.63 -9999 0 -1.5 83 83
STAT1 0.017 0.077 -9999 0 -0.42 10 10
SOCS3 -0.003 0.12 -9999 0 -0.41 26 26
CXCL9 -0.49 0.59 -9999 0 -1.4 93 93
MPO -0.45 0.56 -9999 0 -1.3 92 92
positive regulation of humoral immune response -0.51 0.68 -9999 0 -1.6 84 84
IL23/IL23R/JAK2/TYK2 -0.6 0.91 -9999 0 -2 83 83
IL6 -0.49 0.6 -9999 0 -1.4 94 94
STAT5A 0.028 0.007 -9999 0 -10000 0 0
IL2 0.004 0.051 -9999 0 -0.26 10 10
positive regulation of tyrosine phosphorylation of STAT protein 0.006 0.008 -9999 0 -10000 0 0
CD3E -0.45 0.56 -9999 0 -1.4 79 79
keratinocyte proliferation -0.51 0.68 -9999 0 -1.6 84 84
NOS2 -0.46 0.57 -9999 0 -1.3 95 95
Signaling mediated by p38-alpha and p38-beta

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.19 0.42 -10000 0 -1.1 61 61
MKNK1 0.028 0.006 -10000 0 -10000 0 0
MAPK14 -0.045 0.15 -10000 0 -0.34 62 62
ATF2/c-Jun -0.079 0.18 -10000 0 -0.64 22 22
MAPK11 -0.036 0.14 -10000 0 -0.34 58 58
MITF -0.064 0.18 -10000 0 -0.4 77 77
MAPKAPK5 -0.057 0.17 -10000 0 -0.39 72 72
KRT8 -0.057 0.17 -10000 0 -0.39 72 72
MAPKAPK3 0.029 0.004 -10000 0 -10000 0 0
MAPKAPK2 0.027 0.008 -10000 0 -10000 0 0
p38alpha-beta/CK2 -0.072 0.22 -10000 0 -0.51 62 62
CEBPB -0.06 0.18 -10000 0 -0.39 74 74
SLC9A1 -0.062 0.18 -10000 0 -0.4 75 75
mol:GDP 0 0 -10000 0 -10000 0 0
ATF2 -0.073 0.2 -10000 0 -0.42 82 82
p38alpha-beta/MNK1 -0.044 0.19 -10000 0 -0.42 59 59
JUN -0.079 0.18 -10000 0 -0.63 22 22
PPARGC1A -0.13 0.23 -10000 0 -0.43 121 121
USF1 -0.062 0.18 -10000 0 -0.4 74 74
RAB5/GDP/GDI1 -0.058 0.14 -10000 0 -0.37 31 31
NOS2 -0.12 0.33 -10000 0 -1.1 31 31
DDIT3 -0.062 0.17 -10000 0 -0.39 74 74
RAB5A 0.029 0.004 -10000 0 -10000 0 0
HSPB1 -0.046 0.14 0.33 3 -0.41 20 23
p38alpha-beta/HBP1 -0.039 0.18 -10000 0 -0.42 56 56
CREB1 -0.063 0.19 -10000 0 -0.42 73 73
RAB5/GDP 0.021 0.003 -10000 0 -10000 0 0
EIF4E -0.053 0.16 -10000 0 -0.38 54 54
RPS6KA4 -0.063 0.18 -10000 0 -0.4 76 76
PLA2G4A -0.075 0.19 -10000 0 -0.44 65 65
GDI1 -0.058 0.18 -10000 0 -0.41 69 69
TP53 -0.079 0.2 -10000 0 -0.5 60 60
RPS6KA5 -0.062 0.18 -10000 0 -0.4 75 75
ESR1 -0.12 0.26 -10000 0 -0.5 99 99
HBP1 0.028 0.007 -10000 0 -10000 0 0
MEF2C -0.057 0.17 -10000 0 -0.39 71 71
MEF2A -0.065 0.18 -10000 0 -0.4 77 77
EIF4EBP1 -0.064 0.19 -10000 0 -0.42 75 75
KRT19 -0.13 0.28 -10000 0 -0.56 98 98
ELK4 -0.062 0.18 -10000 0 -0.4 74 74
ATF6 -0.063 0.18 -10000 0 -0.4 74 74
ATF1 -0.059 0.18 -10000 0 -0.41 72 72
p38alpha-beta/MAPKAPK2 -0.045 0.18 -10000 0 -0.42 58 58
p38alpha-beta/MAPKAPK3 -0.044 0.19 -10000 0 -0.42 60 60
TCR signaling in naïve CD8+ T cells

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC -0.094 0.25 0.29 9 -0.57 64 73
FYN -0.15 0.34 0.64 2 -0.69 82 84
LAT/GRAP2/SLP76 -0.13 0.26 -10000 0 -0.56 84 84
IKBKB 0.029 0.004 -10000 0 -10000 0 0
AKT1 -0.096 0.23 0.64 7 -0.44 82 89
B2M 0.019 0.072 -10000 0 -0.52 6 6
IKBKG -0.034 0.068 0.1 1 -0.16 54 55
MAP3K8 0.026 0.035 -10000 0 -0.42 2 2
mol:Ca2+ -0.031 0.04 0.12 5 -0.092 70 75
integrin-mediated signaling pathway 0.032 0.042 -10000 0 -0.36 4 4
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.16 0.32 0.62 3 -0.67 87 90
TRPV6 -0.073 0.3 0.94 16 -0.57 51 67
CD28 -0.045 0.17 -10000 0 -0.38 66 66
SHC1 -0.14 0.33 0.3 11 -0.68 82 93
receptor internalization -0.16 0.35 -10000 0 -0.71 86 86
PRF1 -0.14 0.35 0.47 1 -0.9 53 54
KRAS 0.028 0.006 -10000 0 -10000 0 0
GRB2 0.028 0.007 -10000 0 -10000 0 0
COT/AKT1 -0.071 0.18 0.65 4 -0.35 78 82
LAT -0.15 0.33 0.3 2 -0.68 85 87
EntrezGene:6955 -0.001 0.004 -10000 0 -10000 0 0
CD3D -0.097 0.21 -10000 0 -0.4 108 108
CD3E -0.061 0.18 -10000 0 -0.38 82 82
CD3G -0.082 0.2 -10000 0 -0.4 95 95
RASGRP2 -0.009 0.036 0.11 3 -0.18 10 13
RASGRP1 -0.1 0.26 0.59 9 -0.48 89 98
HLA-A 0.025 0.028 -10000 0 -0.26 3 3
RASSF5 0.021 0.063 -10000 0 -0.58 4 4
RAP1A/GTP/RAPL 0.032 0.042 -10000 0 -0.36 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.003 0.15 0.43 18 -0.14 44 62
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.08 0.1 -10000 0 -0.25 86 86
PRKCA -0.059 0.13 -10000 0 -0.28 69 69
GRAP2 -0.031 0.14 -10000 0 -0.35 52 52
mol:IP3 -0.083 0.22 0.24 32 -0.42 87 119
EntrezGene:6957 -0.001 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.15 0.34 -10000 0 -0.71 77 77
ORAI1 0.041 0.19 0.47 3 -0.8 11 14
CSK -0.16 0.33 -10000 0 -0.69 83 83
B7 family/CD28 -0.17 0.37 -10000 0 -0.68 101 101
CHUK 0.029 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.18 0.39 -10000 0 -0.8 86 86
PTPN6 -0.16 0.33 0.25 1 -0.69 83 84
VAV1 -0.17 0.34 -10000 0 -0.68 95 95
Monovalent TCR/CD3 -0.14 0.31 -10000 0 -0.5 109 109
CBL 0.028 0.006 -10000 0 -10000 0 0
LCK -0.16 0.36 0.85 1 -0.72 84 85
PAG1 -0.16 0.33 -10000 0 -0.69 84 84
RAP1A 0.028 0.006 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK -0.18 0.39 -10000 0 -0.79 86 86
CD80 -0.07 0.2 -10000 0 -0.42 83 83
CD86 -0.025 0.16 -10000 0 -0.46 41 41
PDK1/CARD11/BCL10/MALT1 -0.082 0.14 -10000 0 -0.3 89 89
HRAS 0.027 0.022 -10000 0 -0.26 2 2
GO:0035030 -0.16 0.28 -10000 0 -0.55 102 102
CD8A -0.017 0.12 -10000 0 -0.32 47 47
CD8B -0.08 0.21 -10000 0 -0.42 91 91
PTPRC -0.036 0.16 -10000 0 -0.38 57 57
PDK1/PKC theta -0.12 0.29 0.65 10 -0.54 85 95
CSK/PAG1 -0.15 0.32 -10000 0 -0.7 77 77
SOS1 0.028 0.006 -10000 0 -10000 0 0
peptide-MHC class I 0.032 0.059 -10000 0 -0.36 7 7
GRAP2/SLP76 -0.15 0.31 -10000 0 -0.64 90 90
STIM1 0.014 0.16 1.1 2 -0.83 8 10
RAS family/GTP -0.008 0.12 0.32 14 -0.19 45 59
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.18 0.4 -10000 0 -0.78 86 86
mol:DAG -0.1 0.17 0.14 3 -0.37 93 96
RAP1A/GDP 0.004 0.082 0.36 9 -0.067 2 11
PLCG1 0.029 0.005 -10000 0 -10000 0 0
CD247 -0.045 0.17 -10000 0 -0.39 65 65
cytotoxic T cell degranulation -0.13 0.33 0.46 1 -0.84 53 54
RAP1A/GTP -0.003 0.013 -10000 0 -0.068 8 8
mol:PI-3-4-5-P3 -0.12 0.27 0.64 6 -0.53 87 93
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.11 0.28 0.27 28 -0.55 88 116
NRAS 0.028 0.005 -10000 0 -10000 0 0
ZAP70 -0.039 0.16 -10000 0 -0.36 65 65
GRB2/SOS1 0.041 0.011 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 -0.14 0.26 -10000 0 -0.54 94 94
MALT1 0.029 0.005 -10000 0 -10000 0 0
TRAF6 0.027 0.032 -10000 0 -0.58 1 1
CD8 heterodimer -0.071 0.19 -10000 0 -0.42 79 79
CARD11 -0.085 0.22 -10000 0 -0.44 90 90
PRKCB -0.07 0.14 -10000 0 -0.3 87 87
PRKCE -0.057 0.13 -10000 0 -0.27 78 78
PRKCQ -0.14 0.32 0.68 7 -0.63 86 93
LCP2 0.018 0.058 -10000 0 -0.28 12 12
BCL10 0.028 0.006 -10000 0 -10000 0 0
regulation of survival gene product expression -0.078 0.2 0.56 8 -0.37 82 90
IKK complex 0.009 0.15 0.53 15 -0.12 24 39
RAS family/GDP -0.008 0.013 -10000 0 -10000 0 0
MAP3K14 -0.057 0.13 0.23 2 -0.29 59 61
PDPK1 -0.089 0.23 0.55 10 -0.42 83 93
TCR/CD3/MHC I/CD8/Fyn -0.19 0.42 -10000 0 -0.94 71 71
Glucocorticoid receptor regulatory network

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.11 0.094 0.36 4 -10000 0 4
SMARCC2 0.027 0.018 -10000 0 -0.18 1 1
SMARCC1 0.028 0.016 -10000 0 -10000 0 0
TBX21 -0.19 0.25 -10000 0 -0.62 66 66
SUMO2 0.03 0.016 -10000 0 -10000 0 0
STAT1 (dimer) 0.021 0.08 -10000 0 -0.43 10 10
FKBP4 0.027 0.016 -10000 0 -0.26 1 1
FKBP5 0.012 0.082 -10000 0 -0.33 18 18
GR alpha/HSP90/FKBP51/HSP90 0.16 0.12 0.34 57 -0.3 1 58
PRL -0.1 0.12 -10000 0 -0.31 74 74
cortisol/GR alpha (dimer)/TIF2 0.27 0.28 0.58 136 -0.38 7 143
RELA -0.037 0.11 -10000 0 -0.27 31 31
FGG 0.25 0.21 0.46 153 -10000 0 153
GR beta/TIF2 0.12 0.19 0.34 77 -0.37 26 103
IFNG -0.4 0.4 -10000 0 -0.89 114 114
apoptosis 0.042 0.2 0.53 28 -0.51 6 34
CREB1 0.027 0.022 -10000 0 -10000 0 0
histone acetylation -0.066 0.15 0.31 7 -0.39 39 46
BGLAP -0.13 0.16 -10000 0 -0.58 15 15
GR/PKAc 0.14 0.1 0.32 61 -10000 0 61
NF kappa B1 p50/RelA -0.069 0.19 -10000 0 -0.46 40 40
SMARCD1 0.028 0.017 -10000 0 -10000 0 0
MDM2 0.13 0.12 0.28 118 -10000 0 118
GATA3 -0.019 0.16 -10000 0 -0.54 31 31
AKT1 0.022 0.006 -10000 0 -10000 0 0
CSF2 -0.28 0.48 -10000 0 -1.3 63 63
GSK3B 0.03 0.016 -10000 0 -10000 0 0
NR1I3 0.048 0.22 0.55 22 -0.77 7 29
CSN2 0.2 0.17 0.38 150 -10000 0 150
BRG1/BAF155/BAF170/BAF60A 0.068 0.048 -10000 0 -0.31 3 3
NFATC1 0.02 0.066 -10000 0 -0.47 6 6
POU2F1 0.022 0.049 -10000 0 -0.42 4 4
CDKN1A -0.01 0.24 -10000 0 -1.5 9 9
response to stress 0 0 -10000 0 -10000 0 0
response to UV 0.002 0.011 -10000 0 -10000 0 0
SFN -0.13 0.25 -10000 0 -0.47 123 123
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.067 0.18 0.34 28 -0.35 10 38
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 0.026 0.25 0.5 27 -0.84 15 42
JUN -0.25 0.22 -10000 0 -0.5 122 122
IL4 -0.15 0.16 -10000 0 -0.34 128 128
CDK5R1 0.022 0.045 -10000 0 -0.26 9 9
PRKACA 0.027 0.008 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.2 0.22 0.22 15 -0.45 115 130
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.16 0.11 0.35 50 -0.27 1 51
cortisol/GR alpha (monomer) 0.38 0.32 0.7 156 -10000 0 156
NCOA2 -0.028 0.18 -10000 0 -0.58 35 35
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.12 0.18 -10000 0 -0.49 61 61
AP-1/NFAT1-c-4 -0.4 0.33 -10000 0 -0.75 142 142
AFP -0.18 0.17 -10000 0 -0.39 103 103
SUV420H1 0.028 0.005 -10000 0 -10000 0 0
IRF1 0.18 0.17 0.47 57 -10000 0 57
TP53 0.033 0.084 -10000 0 -0.52 8 8
PPP5C 0.028 0.007 -10000 0 -10000 0 0
KRT17 -0.52 0.55 -10000 0 -1.2 119 119
KRT14 -0.32 0.49 -10000 0 -1.2 71 71
TBP 0.035 0.021 -10000 0 -0.32 1 1
CREBBP 0.088 0.11 0.33 49 -0.25 3 52
HDAC1 0.028 0.006 -10000 0 -10000 0 0
HDAC2 0.045 0.044 0.28 6 -10000 0 6
AP-1 -0.4 0.33 -10000 0 -0.75 142 142
MAPK14 0.031 0.012 -10000 0 -10000 0 0
MAPK10 0.029 0.034 -10000 0 -0.58 1 1
MAPK11 0.022 0.024 -10000 0 -0.26 1 1
KRT5 -0.49 0.5 -10000 0 -1.1 118 118
interleukin-1 receptor activity 0.017 0.045 0.25 7 -10000 0 7
NCOA1 0.031 0.008 -10000 0 -10000 0 0
STAT1 0.021 0.08 -10000 0 -0.43 10 10
CGA -0.15 0.16 -10000 0 -0.58 14 14
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.21 0.28 0.59 100 -0.47 1 101
MAPK3 0.03 0.014 -10000 0 -10000 0 0
MAPK1 0.023 0.016 -10000 0 -10000 0 0
ICAM1 -0.31 0.45 -10000 0 -1 86 86
NFKB1 -0.034 0.11 0.38 1 -0.26 28 29
MAPK8 -0.21 0.19 -10000 0 -0.44 124 124
MAPK9 0.03 0.012 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) 0.043 0.2 0.53 28 -0.53 6 34
BAX 0.028 0.12 0.84 5 -0.66 2 7
POMC -0.3 0.48 -10000 0 -1.6 41 41
EP300 0.068 0.11 0.32 40 -0.36 3 43
cortisol/GR alpha (dimer)/p53 0.31 0.25 0.59 136 -10000 0 136
proteasomal ubiquitin-dependent protein catabolic process 0.12 0.15 0.32 108 -10000 0 108
SGK1 0.091 0.23 0.6 10 -1.2 6 16
IL13 -0.3 0.3 -10000 0 -0.8 68 68
IL6 -0.34 0.48 -10000 0 -1.1 88 88
PRKACG 0 0 -10000 0 -10000 0 0
IL5 -0.26 0.25 -10000 0 -0.52 142 142
IL2 -0.34 0.3 -10000 0 -0.75 98 98
CDK5 0.029 0.009 -10000 0 -10000 0 0
PRKACB 0.021 0.044 -10000 0 -0.26 9 9
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
IL8 -0.37 0.51 -10000 0 -1.2 88 88
CDK5R1/CDK5 0.037 0.037 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.022 0.16 -10000 0 -0.36 35 35
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.31 0.23 0.55 148 -10000 0 148
SMARCA4 0.027 0.015 -10000 0 -10000 0 0
chromatin remodeling 0.2 0.18 0.42 102 -0.43 1 103
NF kappa B1 p50/RelA/Cbp 0.003 0.18 0.4 16 -0.39 26 42
JUN (dimer) -0.25 0.22 -10000 0 -0.5 122 122
YWHAH 0.022 0.013 -10000 0 -10000 0 0
VIPR1 -0.22 0.28 -10000 0 -0.69 77 77
NR3C1 0.23 0.21 0.48 116 -10000 0 116
NR4A1 -0.072 0.2 -10000 0 -0.51 47 47
TIF2/SUV420H1 -0.002 0.14 -10000 0 -0.42 35 35
MAPKKK cascade 0.042 0.2 0.53 28 -0.51 6 34
cortisol/GR alpha (dimer)/Src-1 0.32 0.25 0.58 148 -10000 0 148
PBX1 0.026 0.032 -10000 0 -0.58 1 1
POU1F1 0.018 0.033 -10000 0 -0.26 5 5
SELE -0.32 0.43 -10000 0 -0.92 101 101
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.2 0.18 0.42 102 -0.43 1 103
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.31 0.23 0.55 148 -10000 0 148
mol:cortisol 0.22 0.22 0.43 159 -10000 0 159
MMP1 -0.27 0.45 -10000 0 -1.3 55 55
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 -0.089 0.19 -10000 0 -0.39 85 85
NFATC2 -0.14 0.29 -10000 0 -0.64 74 74
NFATC3 -0.028 0.095 -10000 0 -0.3 9 9
CD40LG -0.4 0.49 -10000 0 -1.1 103 103
ITCH 0.04 0.024 -10000 0 -10000 0 0
CBLB 0.039 0.031 -10000 0 -10000 0 0
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.44 0.58 -10000 0 -1.2 112 112
JUNB 0.022 0.051 -10000 0 -0.39 5 5
CaM/Ca2+/Calcineurin A alpha-beta B1 0.043 0.028 -10000 0 -0.29 2 2
T cell anergy 0.019 0.062 0.4 1 -0.39 2 3
TLE4 -0.1 0.23 -10000 0 -0.57 51 51
Jun/NFAT1-c-4/p21SNFT -0.28 0.47 -10000 0 -1.1 71 71
AP-1/NFAT1-c-4 -0.44 0.63 -10000 0 -1.3 99 99
IKZF1 -0.12 0.26 -10000 0 -0.64 54 54
T-helper 2 cell differentiation -0.2 0.31 -10000 0 -0.71 83 83
AP-1/NFAT1 -0.15 0.24 -10000 0 -0.51 82 82
CALM1 0.039 0.019 -10000 0 -10000 0 0
EGR2 -0.24 0.49 -10000 0 -1.3 48 48
EGR3 -0.24 0.51 -10000 0 -1.4 48 48
NFAT1/FOXP3 -0.18 0.29 -10000 0 -0.56 104 104
EGR1 -0.012 0.13 -10000 0 -0.41 29 29
JUN -0.023 0.1 -10000 0 -0.34 25 25
EGR4 -0.01 0.094 -10000 0 -0.29 35 35
mol:Ca2+ 0.011 0.019 -10000 0 -0.22 1 1
GBP3 -0.15 0.3 -10000 0 -0.72 68 68
FOSL1 -0.032 0.16 -10000 0 -0.38 56 56
NFAT1-c-4/MAF/IRF4 -0.26 0.44 -10000 0 -1 72 72
DGKA -0.096 0.21 -10000 0 -0.54 46 46
CREM 0.029 0.005 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.22 0.42 -10000 0 -1 62 62
CTLA4 -0.23 0.34 0.32 1 -0.67 114 115
NFAT1-c-4 (dimer)/EGR1 -0.24 0.45 -10000 0 -1.1 66 66
NFAT1-c-4 (dimer)/EGR4 -0.24 0.43 -10000 0 -1 67 67
FOS -0.075 0.18 -10000 0 -0.44 61 61
IFNG -0.24 0.4 -10000 0 -0.99 66 66
T cell activation -0.16 0.25 -10000 0 -0.78 30 30
MAF 0.027 0.016 -10000 0 -0.26 1 1
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.15 0.29 0.8 45 -10000 0 45
TNF -0.28 0.43 -10000 0 -0.97 85 85
FASLG -0.35 0.64 -10000 0 -1.6 74 74
TBX21 -0.048 0.16 -10000 0 -0.4 57 57
BATF3 -0.021 0.15 -10000 0 -0.44 38 38
PRKCQ 0.013 0.053 -10000 0 -0.57 2 2
PTPN1 -0.095 0.21 -10000 0 -0.56 40 40
NFAT1-c-4/ICER1 -0.22 0.42 -10000 0 -1 61 61
GATA3 -0.018 0.16 -10000 0 -0.54 31 31
T-helper 1 cell differentiation -0.24 0.39 -10000 0 -0.95 67 67
IL2RA -0.36 0.51 -10000 0 -1.1 98 98
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.094 0.21 -10000 0 -0.54 44 44
E2F1 0.02 0.089 -10000 0 -0.54 9 9
PPARG 0.018 0.065 -10000 0 -0.32 12 12
SLC3A2 -0.093 0.21 -10000 0 -0.53 48 48
IRF4 -0.12 0.22 -10000 0 -0.4 126 126
PTGS2 -0.41 0.5 -10000 0 -1.1 102 102
CSF2 -0.41 0.5 -10000 0 -1.1 115 115
JunB/Fra1/NFAT1-c-4 -0.23 0.43 -10000 0 -1 68 68
IL4 -0.21 0.33 -10000 0 -0.75 82 82
IL5 -0.38 0.45 -10000 0 -0.99 109 109
IL2 -0.17 0.26 -10000 0 -0.8 29 29
IL3 -0.068 0.12 -10000 0 -0.89 5 5
RNF128 0.035 0.053 -10000 0 -0.66 2 2
NFATC1 -0.15 0.29 -10000 0 -0.81 45 45
CDK4 0.12 0.2 0.59 29 -10000 0 29
PTPRK -0.095 0.21 -10000 0 -0.53 48 48
IL8 -0.42 0.51 -10000 0 -1.1 110 110
POU2F1 0.022 0.049 -10000 0 -0.42 4 4
Signaling events regulated by Ret tyrosine kinase

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.021 0.065 -10000 0 -0.47 2 2
Crk/p130 Cas/Paxillin -0.094 0.13 -10000 0 -0.33 61 61
JUN -0.085 0.14 -10000 0 -0.38 35 35
HRAS 0.027 0.022 -10000 0 -0.26 2 2
RET51/GFRalpha1/GDNF/GRB10 -0.13 0.18 -10000 0 -0.36 120 120
RAP1A 0.028 0.006 -10000 0 -10000 0 0
FRS2 0.028 0.006 -10000 0 -10000 0 0
RAP1A/GDP 0.021 0.004 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 -0.13 0.18 -10000 0 -0.36 122 122
EntrezGene:5979 0 0 -10000 0 -10000 0 0
PTPN11 0.028 0.006 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.027 0.008 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma -0.05 0.14 -10000 0 -0.33 61 61
RHOA 0.029 0.004 -10000 0 -10000 0 0
RAP1A/GTP -0.11 0.17 -10000 0 -0.32 120 120
GRB7 -0.008 0.14 -10000 0 -0.58 22 22
RET51/GFRalpha1/GDNF -0.13 0.18 -10000 0 -0.36 120 120
MAPKKK cascade -0.1 0.16 -10000 0 -0.34 82 82
BCAR1 0.028 0.007 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 -0.054 0.14 -10000 0 -0.34 62 62
lamellipodium assembly -0.074 0.13 -10000 0 -0.31 63 63
RET51/GFRalpha1/GDNF/SHC -0.12 0.18 -10000 0 -0.36 117 117
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
RET9/GFRalpha1/GDNF/SHC -0.047 0.13 -10000 0 -0.32 60 60
RET9/GFRalpha1/GDNF/Shank3 -0.054 0.13 -10000 0 -0.33 60 60
MAPK3 -0.11 0.15 -10000 0 -0.32 100 100
DOK1 0.028 0.005 -10000 0 -10000 0 0
DOK6 -0.024 0.15 -10000 0 -0.42 44 44
PXN 0.028 0.006 -10000 0 -10000 0 0
neurite development -0.13 0.16 -10000 0 -0.4 62 62
DOK5 -0.011 0.13 -10000 0 -0.36 38 38
GFRA1 -0.11 0.23 -10000 0 -0.42 120 120
MAPK8 -0.081 0.13 -10000 0 -0.39 26 26
HRAS/GTP -0.11 0.18 -10000 0 -0.37 99 99
tube development -0.047 0.13 0.19 5 -0.31 59 64
MAPK1 -0.11 0.15 0.29 2 -0.32 100 102
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.031 0.1 -10000 0 -0.26 59 59
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
SRC 0.026 0.035 -10000 0 -0.42 2 2
PDLIM7 0.026 0.032 -10000 0 -0.58 1 1
RET51/GFRalpha1/GDNF/Dok6 -0.14 0.2 -10000 0 -0.37 131 131
SHC1 0.027 0.008 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 -0.12 0.18 -10000 0 -0.36 121 121
RET51/GFRalpha1/GDNF/Dok5 -0.15 0.19 -10000 0 -0.37 133 133
PRKCA 0.015 0.067 -10000 0 -0.3 14 14
HRAS/GDP 0.02 0.015 -10000 0 -0.17 2 2
CREB1 -0.053 0.13 -10000 0 -0.34 55 55
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.03 0.1 -10000 0 -0.26 54 54
RET51/GFRalpha1/GDNF/Grb7 -0.14 0.19 -10000 0 -0.36 133 133
mol:GDP 0 0 -10000 0 -10000 0 0
RET -0.13 0.22 -10000 0 -0.38 140 140
DOK4 0.028 0.007 -10000 0 -10000 0 0
JNK cascade -0.084 0.14 -10000 0 -0.38 36 36
RET9/GFRalpha1/GDNF/FRS2 -0.049 0.14 -10000 0 -0.33 60 60
SHANK3 0.021 0.013 -10000 0 -10000 0 0
RASA1 0.028 0.006 -10000 0 -10000 0 0
NCK1 0.029 0.004 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.031 0.1 -10000 0 -0.26 54 54
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.081 0.14 -10000 0 -0.3 94 94
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK -0.083 0.14 -10000 0 -0.3 101 101
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.085 0.16 -10000 0 -0.32 91 91
PI3K -0.11 0.19 -10000 0 -0.46 63 63
SOS1 0.028 0.006 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 -0.043 0.13 -10000 0 -0.31 59 59
GRB10 0.026 0.032 -10000 0 -0.58 1 1
activation of MAPKK activity -0.066 0.12 -10000 0 -0.29 62 62
RET51/GFRalpha1/GDNF/FRS2 -0.13 0.18 -10000 0 -0.36 120 120
GAB1 0.029 0.004 -10000 0 -10000 0 0
IRS1 0.019 0.069 -10000 0 -0.42 8 8
IRS2 0.012 0.098 -10000 0 -0.58 10 10
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.085 0.16 -10000 0 -0.32 90 90
RET51/GFRalpha1/GDNF/PKC alpha -0.13 0.19 -10000 0 -0.36 118 118
GRB2 0.028 0.007 -10000 0 -10000 0 0
PRKACA 0.027 0.008 -10000 0 -10000 0 0
GDNF 0 0 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 -0.13 0.19 -10000 0 -0.36 124 124
Rac1/GTP -0.082 0.16 -10000 0 -0.37 60 60
RET9/GFRalpha1/GDNF -0.068 0.14 -10000 0 -0.25 120 120
GFRalpha1/GDNF -0.081 0.16 -10000 0 -0.3 120 120
IL12-mediated signaling events

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.067 0.16 -10000 0 -0.38 54 54
TBX21 -0.25 0.51 0.66 1 -1.2 69 70
B2M 0.014 0.073 -10000 0 -0.53 6 6
TYK2 0.012 0.036 -10000 0 -10000 0 0
IL12RB1 -0.042 0.16 -10000 0 -0.37 57 57
GADD45B -0.21 0.45 -10000 0 -1.1 62 62
IL12RB2 -0.045 0.16 -10000 0 -0.4 55 55
GADD45G -0.22 0.44 -10000 0 -0.97 72 72
natural killer cell activation -0.003 0.023 -10000 0 -10000 0 0
RELB 0.026 0.032 -10000 0 -0.58 1 1
RELA 0.028 0.005 -10000 0 -10000 0 0
IL18 -0.06 0.2 -10000 0 -0.5 61 61
IL2RA -0.061 0.2 -10000 0 -0.44 72 72
IFNG -0.065 0.17 -10000 0 -0.34 92 92
STAT3 (dimer) -0.2 0.38 -10000 0 -0.84 76 76
HLA-DRB5 -0.084 0.21 -10000 0 -0.42 92 92
FASLG -0.27 0.55 0.58 1 -1.2 76 77
NF kappa B2 p52/RelB -0.22 0.48 -10000 0 -1.1 67 67
CD4 0.012 0.072 -10000 0 -0.33 13 13
SOCS1 0.008 0.091 -10000 0 -0.36 19 19
EntrezGene:6955 -0.005 0.012 -10000 0 -10000 0 0
CD3D -0.1 0.21 -10000 0 -0.41 108 108
CD3E -0.069 0.18 -10000 0 -0.38 82 82
CD3G -0.09 0.2 -10000 0 -0.41 95 95
IL12Rbeta2/JAK2 -0.022 0.13 -10000 0 -0.35 37 37
CCL3 -0.26 0.53 0.66 1 -1.2 69 70
CCL4 -0.25 0.52 0.6 2 -1.2 67 69
HLA-A 0.021 0.031 -10000 0 -0.26 3 3
IL18/IL18R -0.088 0.25 -10000 0 -0.47 93 93
NOS2 -0.27 0.54 -10000 0 -1.2 76 76
IL12/IL12R/TYK2/JAK2/SPHK2 -0.062 0.16 -10000 0 -0.37 50 50
IL1R1 -0.22 0.47 -10000 0 -1.2 56 56
IL4 0.003 0.023 -10000 0 -10000 0 0
JAK2 0.011 0.036 -10000 0 -10000 0 0
EntrezGene:6957 -0.005 0.012 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.24 0.5 -10000 0 -1.1 74 74
RAB7A -0.16 0.35 -10000 0 -0.85 49 49
lysosomal transport -0.15 0.34 -10000 0 -0.79 50 50
FOS -0.28 0.51 -10000 0 -1.1 84 84
STAT4 (dimer) -0.23 0.45 -10000 0 -0.98 78 78
STAT5A (dimer) -0.26 0.48 -10000 0 -1 84 84
GZMA -0.26 0.53 0.63 1 -1.3 62 63
GZMB -0.27 0.54 -10000 0 -1.3 63 63
HLX 0.019 0.054 -10000 0 -0.29 10 10
LCK -0.27 0.55 -10000 0 -1.2 79 79
TCR/CD3/MHC II/CD4 -0.19 0.39 -10000 0 -0.74 87 87
IL2/IL2R -0.089 0.23 -10000 0 -0.43 92 92
MAPK14 -0.21 0.45 -10000 0 -0.96 75 75
CCR5 -0.24 0.49 -10000 0 -1.2 57 57
IL1B -0.072 0.2 -10000 0 -0.46 68 68
STAT6 -0.039 0.14 -10000 0 -0.64 5 5
STAT4 -0.056 0.19 -10000 0 -0.45 66 66
STAT3 0.028 0.007 -10000 0 -10000 0 0
STAT1 0.017 0.077 -10000 0 -0.42 10 10
NFKB1 0.029 0.004 -10000 0 -10000 0 0
NFKB2 0.029 0.005 -10000 0 -10000 0 0
IL12B -0.034 0.13 -10000 0 -0.35 45 45
CD8A -0.02 0.13 -10000 0 -0.33 47 47
CD8B -0.084 0.2 -10000 0 -0.42 91 91
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.067 0.16 0.37 54 -10000 0 54
IL2RB -0.029 0.14 -10000 0 -0.38 46 46
proteasomal ubiquitin-dependent protein catabolic process -0.2 0.4 -10000 0 -0.86 78 78
IL2RG -0.065 0.18 -10000 0 -0.38 85 85
IL12 -0.042 0.16 -10000 0 -0.36 53 53
STAT5A 0.028 0.007 -10000 0 -10000 0 0
CD247 -0.052 0.17 -10000 0 -0.39 65 65
IL2 0.013 0.045 -10000 0 -0.26 10 10
SPHK2 0.028 0.007 -10000 0 -10000 0 0
FRAP1 0 0 -10000 0 -10000 0 0
IL12A -0.033 0.15 -10000 0 -0.42 39 39
IL12/IL12R/TYK2/JAK2 -0.3 0.66 -10000 0 -1.4 71 71
MAP2K3 -0.22 0.46 -10000 0 -0.99 74 74
RIPK2 0.029 0.005 -10000 0 -10000 0 0
MAP2K6 -0.22 0.46 -10000 0 -0.94 82 82
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA -0.045 0.18 -10000 0 -0.44 55 55
IL18RAP -0.026 0.16 -10000 0 -0.45 40 40
IL12Rbeta1/TYK2 -0.021 0.13 -10000 0 -0.45 17 17
EOMES -0.15 0.42 -10000 0 -1.4 38 38
STAT1 (dimer) -0.22 0.4 0.43 1 -0.85 82 83
T cell proliferation -0.16 0.33 0.45 1 -0.69 77 78
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 -0.067 0.2 -10000 0 -0.44 75 75
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.2 0.36 -10000 0 -0.75 85 85
ATF2 -0.2 0.4 -10000 0 -0.87 75 75
Calcium signaling in the CD4+ TCR pathway

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 -0.022 0.057 -10000 0 -0.33 6 6
NFATC2 -0.055 0.12 -10000 0 -0.39 36 36
NFATC3 -0.017 0.039 -10000 0 -10000 0 0
CD40LG -0.28 0.32 0.38 1 -0.64 140 141
PTGS2 -0.29 0.34 0.48 2 -0.68 125 127
JUNB 0.022 0.051 -10000 0 -0.39 5 5
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.006 0.03 -10000 0 -10000 0 0
CaM/Ca2+ -0.006 0.03 -10000 0 -10000 0 0
CALM1 0.012 0.025 -10000 0 -10000 0 0
JUN -0.012 0.099 -10000 0 -0.36 23 23
mol:Ca2+ -0.015 0.027 -10000 0 -0.17 7 7
Calcineurin A alpha-beta B1/FKBP12/FK506 0.011 0.014 -10000 0 -10000 0 0
FOSL1 -0.032 0.16 -10000 0 -0.38 56 56
CREM 0.029 0.005 -10000 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT -0.14 0.22 -10000 0 -0.5 68 68
FOS -0.064 0.18 -10000 0 -0.44 61 61
IFNG -0.28 0.32 0.38 1 -0.63 142 143
AP-1/NFAT1-c-4 -0.3 0.38 -10000 0 -0.75 118 118
FASLG -0.28 0.33 0.48 2 -0.65 136 138
NFAT1-c-4/ICER1 -0.079 0.14 -10000 0 -0.4 31 31
IL2RA -0.28 0.34 0.48 2 -0.68 123 125
FKBP12/FK506 0.021 0.004 -10000 0 -10000 0 0
CSF2 -0.29 0.34 0.38 1 -0.68 131 132
JunB/Fra1/NFAT1-c-4 -0.091 0.17 -10000 0 -0.43 51 51
IL4 -0.26 0.28 -10000 0 -0.61 118 118
IL2 0 0.075 -10000 0 -0.91 2 2
IL3 -0.027 0.098 -10000 0 -1.1 3 3
FKBP1A 0.028 0.005 -10000 0 -10000 0 0
BATF3 -0.021 0.15 -10000 0 -0.44 38 38
mol:FK506 0 0 -10000 0 -10000 0 0
POU2F1 0.022 0.049 -10000 0 -0.42 4 4
amb2 Integrin signaling

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.056 0.23 -10000 0 -0.6 48 48
alphaM/beta2 Integrin/GPIbA -0.06 0.22 -10000 0 -0.55 52 52
alphaM/beta2 Integrin/proMMP-9 -0.11 0.29 -10000 0 -0.61 75 75
PLAUR -0.067 0.21 -10000 0 -0.48 70 70
HMGB1 0.014 0.03 -10000 0 -10000 0 0
alphaM/beta2 Integrin/Talin -0.042 0.21 -10000 0 -0.59 42 42
AGER -0.055 0.17 -10000 0 -0.41 61 61
RAP1A 0.028 0.006 -10000 0 -10000 0 0
SELPLG 0.003 0.11 -10000 0 -0.45 20 20
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.12 0.27 -10000 0 -0.58 73 73
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 -0.087 0.22 -10000 0 -0.45 91 91
CYR61 -0.003 0.11 -10000 0 -0.33 33 33
TLN1 0.027 0.008 -10000 0 -10000 0 0
Rap1/GTP -0.13 0.27 -10000 0 -0.63 63 63
RHOA 0.029 0.004 -10000 0 -10000 0 0
P-selectin oligomer -0.006 0.13 -10000 0 -0.48 24 24
MYH2 -0.16 0.25 -10000 0 -0.52 93 93
MST1R -0.047 0.2 -10000 0 -0.58 47 47
leukocyte activation during inflammatory response -0.052 0.2 -10000 0 -0.52 46 46
APOB 0.002 0.085 -10000 0 -0.28 29 29
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.003 0.11 -10000 0 -0.44 20 20
JAM3 0.026 0.035 -10000 0 -0.42 2 2
GP1BA -0.002 0.1 -10000 0 -0.33 30 30
alphaM/beta2 Integrin/CTGF -0.07 0.23 -10000 0 -0.56 55 55
alphaM/beta2 Integrin -0.17 0.32 -10000 0 -0.66 78 78
JAM3 homodimer 0.026 0.035 -10000 0 -0.42 2 2
ICAM2 0.024 0.038 -10000 0 -0.36 3 3
ICAM1 -0.033 0.18 -10000 0 -0.58 37 37
phagocytosis triggered by activation of immune response cell surface activating receptor -0.17 0.31 -10000 0 -0.65 78 78
cell adhesion -0.06 0.22 -10000 0 -0.55 52 52
NFKB1 -0.18 0.33 0.39 1 -0.66 91 92
THY1 0.019 0.066 -10000 0 -0.38 9 9
RhoA/GDP 0.021 0.003 -10000 0 -10000 0 0
Lipoprotein(a) 0.007 0.067 -10000 0 -0.38 3 3
alphaM/beta2 Integrin/LRP/tPA -0.038 0.22 -10000 0 -0.53 51 51
IL6 -0.23 0.38 -10000 0 -0.89 80 80
ITGB2 -0.046 0.17 -10000 0 -0.5 43 43
elevation of cytosolic calcium ion concentration -0.14 0.33 -10000 0 -0.62 92 92
alphaM/beta2 Integrin/JAM2/JAM3 -0.028 0.21 -10000 0 -0.55 45 45
JAM2 0.018 0.073 -10000 0 -0.49 7 7
alphaM/beta2 Integrin/ICAM1 -0.084 0.31 -10000 0 -0.64 71 71
alphaM/beta2 Integrin/uPA/Plg -0.1 0.26 -10000 0 -0.56 72 72
RhoA/GTP -0.17 0.28 -10000 0 -0.55 95 95
positive regulation of phagocytosis -0.14 0.29 -10000 0 -0.73 58 58
Ron/MSP -0.027 0.17 -10000 0 -0.45 52 52
alphaM/beta2 Integrin/uPAR/uPA -0.14 0.34 -10000 0 -0.63 92 92
alphaM/beta2 Integrin/uPAR -0.094 0.28 -10000 0 -0.62 68 68
PLAU -0.094 0.22 -10000 0 -0.43 99 99
PLAT 0.003 0.11 -10000 0 -0.42 21 21
actin filament polymerization -0.15 0.24 -10000 0 -0.5 89 89
MST1 0.014 0.094 -10000 0 -0.55 10 10
alphaM/beta2 Integrin/lipoprotein(a) -0.049 0.2 -10000 0 -0.53 46 46
TNF -0.21 0.37 0.38 1 -0.91 69 70
RAP1B 0.028 0.006 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPA -0.11 0.28 -10000 0 -0.6 72 72
fibrinolysis -0.1 0.26 -10000 0 -0.56 72 72
HCK -0.027 0.16 -10000 0 -0.48 41 41
dendritic cell antigen processing and presentation -0.17 0.31 -10000 0 -0.65 78 78
VTN -0.028 0.15 -10000 0 -0.4 49 49
alphaM/beta2 Integrin/CYR61 -0.058 0.22 -10000 0 -0.57 48 48
LPA 0.005 0.063 -10000 0 -0.26 20 20
LRP1 0.025 0.044 -10000 0 -0.58 2 2
cell migration -0.12 0.28 -10000 0 -0.57 81 81
FN1 -0.15 0.26 -10000 0 -0.52 123 123
alphaM/beta2 Integrin/Thy1 -0.047 0.22 -10000 0 -0.58 45 45
MPO -0.016 0.14 -10000 0 -0.45 33 33
KNG1 0.011 0.057 -10000 0 -0.26 16 16
RAP1/GDP 0.037 0.01 -10000 0 -10000 0 0
ROCK1 -0.16 0.25 -10000 0 -0.59 72 72
ELA2 0 0 -10000 0 -10000 0 0
PLG 0 0 -10000 0 -10000 0 0
CTGF -0.019 0.14 -10000 0 -0.36 46 46
alphaM/beta2 Integrin/Hck -0.069 0.28 -10000 0 -0.72 49 49
ITGAM -0.046 0.18 -10000 0 -0.53 40 40
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.05 0.26 -10000 0 -0.64 49 49
HP -0.085 0.21 -10000 0 -0.41 96 96
leukocyte adhesion -0.1 0.26 -10000 0 -0.66 51 51
SELP -0.006 0.13 -10000 0 -0.48 24 24
PDGFR-alpha signaling pathway

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.11 0.23 -10000 0 -0.46 103 103
PDGF/PDGFRA/CRKL -0.067 0.17 -10000 0 -0.4 69 69
positive regulation of JUN kinase activity -0.017 0.14 -10000 0 -0.32 56 56
CRKL 0.022 0.013 -10000 0 -10000 0 0
PDGF/PDGFRA/Caveolin-3 -0.078 0.17 -10000 0 -0.4 70 70
AP1 -0.15 0.32 0.46 1 -0.92 44 45
mol:IP3 -0.08 0.17 -10000 0 -0.42 65 65
PLCG1 -0.08 0.17 -10000 0 -0.42 65 65
PDGF/PDGFRA/alphaV Integrin -0.067 0.18 -10000 0 -0.43 67 67
RAPGEF1 0.027 0.008 -10000 0 -10000 0 0
CRK 0.027 0.008 -10000 0 -10000 0 0
mol:Ca2+ -0.079 0.17 -10000 0 -0.42 65 65
CAV3 0 0 -10000 0 -10000 0 0
CAV1 0.006 0.1 -10000 0 -0.42 18 18
SHC/Grb2/SOS1 -0.016 0.14 -10000 0 -0.32 56 56
PDGF/PDGFRA/Shf -0.075 0.2 -10000 0 -0.48 66 66
FOS -0.16 0.31 -10000 0 -0.91 44 44
JUN -0.041 0.071 -10000 0 -0.3 19 19
oligodendrocyte development -0.067 0.18 -10000 0 -0.42 67 67
GRB2 0.028 0.007 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:DAG -0.08 0.17 -10000 0 -0.42 65 65
PDGF/PDGFRA -0.11 0.23 -10000 0 -0.46 103 103
actin cytoskeleton reorganization -0.064 0.17 -10000 0 -0.41 64 64
SRF 0.02 0.02 -10000 0 -10000 0 0
SHC1 0.027 0.008 -10000 0 -10000 0 0
PI3K -0.034 0.16 -10000 0 -0.35 63 63
PDGF/PDGFRA/Crk/C3G -0.034 0.15 -10000 0 -0.35 57 57
JAK1 -0.079 0.16 -10000 0 -0.42 65 65
ELK1/SRF -0.053 0.13 -10000 0 -0.34 57 57
SHB 0.027 0.008 -10000 0 -10000 0 0
SHF 0.01 0.1 -10000 0 -0.55 12 12
CSNK2A1 0.035 0.02 -10000 0 -10000 0 0
GO:0007205 -0.085 0.17 -10000 0 -0.45 62 62
SOS1 0.028 0.006 -10000 0 -10000 0 0
Ras protein signal transduction -0.017 0.14 -10000 0 -0.32 56 56
PDGF/PDGFRA/SHB -0.064 0.17 -10000 0 -0.42 64 64
PDGF/PDGFRA/Caveolin-1 -0.075 0.18 -10000 0 -0.43 69 69
ITGAV 0.022 0.062 -10000 0 -0.58 4 4
ELK1 -0.078 0.15 0.33 1 -0.4 61 62
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
PDGF/PDGFRA/Crk -0.06 0.17 -10000 0 -0.41 60 60
JAK-STAT cascade -0.079 0.16 -10000 0 -0.42 65 65
cell proliferation -0.075 0.2 -10000 0 -0.47 66 66
Glypican 2 network

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK -0.034 0.18 -9999 0 -0.54 41 41
GPC2 -0.013 0.14 -9999 0 -0.43 33 33
GPC2/Midkine -0.031 0.18 -9999 0 -0.45 47 47
neuron projection morphogenesis -0.031 0.17 -9999 0 -0.45 47 47
Endothelins

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.068 0.2 0.29 20 -0.51 32 52
PTK2B 0.024 0.054 -10000 0 -0.58 3 3
mol:Ca2+ -0.054 0.22 0.68 1 -0.67 23 24
EDN1 -0.049 0.18 0.25 22 -0.39 42 64
EDN3 -0.22 0.25 -10000 0 -0.41 206 206
EDN2 -0.031 0.16 -10000 0 -0.39 53 53
HRAS/GDP -0.073 0.2 0.44 1 -0.49 43 44
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.054 0.18 0.46 1 -0.44 47 48
ADCY4 -0.075 0.19 -10000 0 -0.5 35 35
ADCY5 -0.12 0.22 0.39 2 -0.47 69 71
ADCY6 -0.073 0.18 -10000 0 -0.51 33 33
ADCY7 -0.075 0.19 -10000 0 -0.52 33 33
ADCY1 -0.078 0.19 -10000 0 -0.46 47 47
ADCY2 -0.11 0.21 -10000 0 -0.48 62 62
ADCY3 -0.076 0.19 -10000 0 -0.49 37 37
ADCY8 -0.17 0.22 -10000 0 -0.49 79 79
ADCY9 -0.073 0.19 -10000 0 -0.52 32 32
arachidonic acid secretion -0.086 0.23 0.43 6 -0.52 55 61
ETB receptor/Endothelin-1/Gq/GTP -0.055 0.16 0.22 1 -0.36 61 62
GNAO1 -0.028 0.17 -10000 0 -0.54 37 37
HRAS 0.026 0.022 -10000 0 -0.26 2 2
ETA receptor/Endothelin-1/G12/GTP -0.023 0.22 0.38 27 -0.49 28 55
ETA receptor/Endothelin-1/Gs/GTP -0.046 0.23 0.36 27 -0.47 46 73
mol:GTP 0 0.004 -10000 0 -10000 0 0
COL3A1 -0.096 0.25 0.55 1 -0.66 36 37
EDNRB -0.028 0.15 -10000 0 -0.49 33 33
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.16 0.32 0.55 1 -0.67 84 85
CYSLTR1 -0.073 0.22 0.73 1 -0.7 23 24
SLC9A1 -0.024 0.12 0.21 22 -0.31 21 43
mol:GDP -0.082 0.22 0.56 3 -0.52 46 49
SLC9A3 -0.066 0.24 0.56 1 -0.62 43 44
RAF1 -0.094 0.22 0.51 3 -0.54 46 49
JUN -0.06 0.24 0.51 1 -0.8 20 21
JAK2 -0.069 0.2 0.28 21 -0.51 32 53
mol:IP3 -0.075 0.2 0.4 1 -0.46 55 56
ETA receptor/Endothelin-1 -0.055 0.26 0.46 28 -0.54 41 69
PLCB1 0.012 0.092 -10000 0 -0.47 12 12
PLCB2 -0.003 0.12 -10000 0 -0.44 25 25
ETA receptor/Endothelin-3 -0.17 0.21 -10000 0 -0.42 132 132
FOS -0.13 0.31 0.53 3 -0.9 43 46
Gai/GDP -0.056 0.24 -10000 0 -0.76 38 38
CRK 0.027 0.008 -10000 0 -10000 0 0
mol:Ca ++ -0.11 0.25 0.55 1 -0.58 52 53
BCAR1 0.028 0.007 -10000 0 -10000 0 0
PRKCB1 -0.073 0.19 0.38 1 -0.45 53 54
GNAQ 0.027 0.011 -10000 0 -10000 0 0
GNAZ 0.012 0.074 -10000 0 -0.5 7 7
GNAL -0.01 0.14 -10000 0 -0.43 32 32
Gs family/GDP -0.085 0.22 0.46 2 -0.51 51 53
ETA receptor/Endothelin-1/Gq/GTP -0.05 0.18 0.42 1 -0.45 42 43
MAPK14 -0.058 0.17 0.27 1 -0.43 43 44
TRPC6 -0.058 0.22 0.68 1 -0.72 22 23
GNAI2 0.029 0.004 -10000 0 -10000 0 0
GNAI3 0.028 0.006 -10000 0 -10000 0 0
GNAI1 0.018 0.053 -10000 0 -0.26 13 13
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.061 0.18 0.29 1 -0.43 52 53
ETB receptor/Endothelin-2 -0.045 0.16 -10000 0 -0.42 50 50
ETB receptor/Endothelin-3 -0.18 0.22 -10000 0 -0.45 123 123
ETB receptor/Endothelin-1 -0.051 0.18 0.35 1 -0.4 57 58
MAPK3 -0.12 0.28 0.59 2 -0.74 49 51
MAPK1 -0.15 0.31 0.55 3 -0.8 53 56
Rac1/GDP -0.07 0.2 -10000 0 -0.5 40 40
cAMP biosynthetic process -0.11 0.21 0.52 5 -0.49 51 56
MAPK8 -0.066 0.24 0.54 1 -0.67 32 33
SRC 0.026 0.035 -10000 0 -0.42 2 2
ETB receptor/Endothelin-1/Gi/GTP -0.047 0.13 -10000 0 -0.37 34 34
p130Cas/CRK/Src/PYK2 -0.07 0.21 0.62 4 -0.54 38 42
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.07 0.2 -10000 0 -0.5 40 40
COL1A2 -0.093 0.26 0.61 1 -0.72 33 34
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.043 0.16 0.34 1 -0.4 38 39
mol:DAG -0.075 0.2 0.4 1 -0.46 55 56
MAP2K2 -0.098 0.24 0.47 5 -0.58 51 56
MAP2K1 -0.11 0.25 0.48 3 -0.62 54 57
EDNRA -0.027 0.15 0.5 1 -0.42 17 18
positive regulation of muscle contraction -0.053 0.18 0.79 1 -0.5 23 24
Gq family/GDP -0.078 0.21 -10000 0 -0.52 48 48
HRAS/GTP -0.088 0.2 0.48 2 -0.51 46 48
PRKCH -0.07 0.19 0.56 1 -0.47 47 48
RAC1 0.028 0.007 -10000 0 -10000 0 0
PRKCA -0.073 0.2 0.53 1 -0.51 41 42
PRKCB -0.092 0.2 0.53 1 -0.49 53 54
PRKCE -0.072 0.19 0.57 1 -0.47 47 48
PRKCD -0.074 0.19 0.37 1 -0.5 40 41
PRKCG -0.074 0.19 0.35 2 -0.47 49 51
regulation of vascular smooth muscle contraction -0.16 0.36 0.57 3 -1.1 43 46
PRKCQ -0.075 0.19 0.34 1 -0.47 49 50
PLA2G4A -0.095 0.25 0.44 6 -0.56 55 61
GNA14 -0.013 0.11 -10000 0 -0.28 48 48
GNA15 -0.028 0.16 -10000 0 -0.48 41 41
GNA12 0.028 0.007 -10000 0 -10000 0 0
GNA11 0.01 0.1 -10000 0 -0.58 11 11
Rac1/GTP -0.022 0.22 0.38 27 -0.49 28 55
MMP1 -0.1 0.34 0.51 3 -0.96 46 49
Class IB PI3K non-lipid kinase events

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process 0.01 0.12 0.36 38 -10000 0 38
PI3K Class IB/PDE3B -0.01 0.12 -10000 0 -0.36 38 38
PDE3B -0.011 0.12 -10000 0 -0.36 38 38
Fc-epsilon receptor I signaling in mast cells

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.025 0.038 -10000 0 -0.36 3 3
LAT2 -0.071 0.18 -10000 0 -0.43 51 51
AP1 -0.093 0.26 0.42 1 -0.66 51 52
mol:PIP3 -0.071 0.27 0.59 13 -0.55 54 67
IKBKB -0.019 0.2 0.62 17 -0.3 41 58
AKT1 -0.065 0.18 0.32 22 -0.5 26 48
IKBKG -0.014 0.21 0.66 18 -0.3 42 60
MS4A2 -0.056 0.18 -10000 0 -0.43 63 63
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.025 0.044 -10000 0 -0.58 2 2
MAP3K1 -0.058 0.21 0.47 7 -0.53 41 48
mol:Ca2+ -0.039 0.22 0.53 18 -0.39 53 71
LYN 0.028 0.011 -10000 0 -10000 0 0
CBLB -0.063 0.15 -10000 0 -0.39 50 50
SHC1 0.027 0.008 -10000 0 -10000 0 0
RasGAP/p62DOK 0.031 0.083 -10000 0 -0.33 15 15
positive regulation of cell migration 0 0 -10000 0 -10000 0 0
INPP5D 0.017 0.064 -10000 0 -0.31 12 12
PLD2 -0.076 0.2 0.33 21 -0.37 88 109
PTPN13 -0.051 0.21 0.46 4 -0.59 32 36
PTPN11 0.019 0.022 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation -0.019 0.2 0.62 16 -0.38 30 46
SYK 0.026 0.013 -10000 0 -10000 0 0
GRB2 0.027 0.007 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.1 0.23 -10000 0 -0.52 69 69
LAT -0.069 0.16 -10000 0 -0.4 55 55
PAK2 -0.074 0.22 0.36 1 -0.59 44 45
NFATC2 -0.078 0.19 -10000 0 -0.65 31 31
HRAS -0.087 0.25 -10000 0 -0.64 47 47
GAB2 0.024 0.054 -10000 0 -0.58 3 3
PLA2G1B 0.011 0.11 -10000 0 -0.78 5 5
Fc epsilon R1 -0.1 0.23 -10000 0 -0.44 103 103
Antigen/IgE/Fc epsilon R1 -0.092 0.21 -10000 0 -0.4 103 103
mol:GDP -0.1 0.26 -10000 0 -0.69 49 49
JUN 0.006 0.094 -10000 0 -0.35 22 22
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
FOS -0.047 0.18 -10000 0 -0.44 60 60
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.067 0.16 -10000 0 -0.4 54 54
CHUK -0.02 0.19 0.6 17 -0.3 41 58
KLRG1 -0.065 0.15 -10000 0 -0.38 43 43
VAV1 -0.088 0.2 -10000 0 -0.47 59 59
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.064 0.15 -10000 0 -0.38 52 52
negative regulation of mast cell degranulation -0.056 0.15 -10000 0 -0.4 38 38
BTK -0.11 0.29 -10000 0 -0.8 46 46
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.1 0.25 0.27 1 -0.52 76 77
GAB2/PI3K/SHP2 -0.091 0.17 -10000 0 -0.4 65 65
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.067 0.16 -10000 0 -0.42 45 45
RAF1 0.021 0.1 -10000 0 -1 3 3
Fc epsilon R1/FcgammaRIIB/SHIP -0.1 0.26 -10000 0 -0.48 98 98
FCER1G -0.005 0.13 -10000 0 -0.47 25 25
FCER1A -0.11 0.24 -10000 0 -0.49 98 98
Antigen/IgE/Fc epsilon R1/Fyn -0.076 0.21 -10000 0 -0.38 102 102
MAPK3 0.024 0.1 -10000 0 -0.84 4 4
MAPK1 -0.008 0.12 -10000 0 -0.8 5 5
NFKB1 0.029 0.004 -10000 0 -10000 0 0
MAPK8 -0.029 0.21 -10000 0 -0.72 26 26
DUSP1 -0.008 0.13 -10000 0 -0.42 30 30
NF-kappa-B/RelA -0.02 0.081 0.15 2 -0.2 23 25
actin cytoskeleton reorganization -0.054 0.21 0.38 3 -0.62 31 34
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.069 0.22 -10000 0 -0.58 42 42
FER -0.065 0.16 -10000 0 -0.39 53 53
RELA 0.028 0.005 -10000 0 -10000 0 0
ITK -0.056 0.15 -10000 0 -0.53 32 32
SOS1 0.028 0.006 -10000 0 -10000 0 0
PLCG1 -0.097 0.27 0.39 2 -0.67 51 53
cytokine secretion -0.02 0.053 -10000 0 -10000 0 0
SPHK1 -0.068 0.16 0.27 1 -0.4 55 56
PTK2 -0.058 0.22 0.38 3 -0.66 31 34
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.096 0.24 -10000 0 -0.55 65 65
EDG1 0 0 -10000 0 -10000 0 0
mol:DAG -0.061 0.26 0.65 13 -0.55 50 63
MAP2K2 0.023 0.1 -10000 0 -0.94 3 3
MAP2K1 0.017 0.093 -10000 0 -0.94 3 3
MAP2K7 0.027 0.008 -10000 0 -10000 0 0
KLRG1/SHP2 -0.057 0.14 -10000 0 -0.38 37 37
MAP2K4 -0.019 0.23 -10000 0 -0.9 22 22
Fc epsilon R1/FcgammaRIIB -0.12 0.27 -10000 0 -0.47 108 108
mol:Choline -0.075 0.2 0.33 21 -0.37 88 109
SHC/Grb2/SOS1 -0.03 0.16 -10000 0 -0.46 26 26
FYN 0.026 0.044 -10000 0 -0.58 2 2
DOK1 0.028 0.005 -10000 0 -10000 0 0
PXN -0.047 0.21 0.47 5 -0.6 29 34
HCLS1 -0.068 0.16 -10000 0 -0.4 50 50
PRKCB -0.041 0.23 0.63 17 -0.41 51 68
FCGR2B -0.039 0.17 -10000 0 -0.43 54 54
IGHE -0.001 0.012 -10000 0 -10000 0 0
KLRG1/SHIP -0.057 0.15 -10000 0 -0.41 38 38
LCP2 0.018 0.058 -10000 0 -0.29 12 12
PLA2G4A -0.083 0.19 -10000 0 -0.46 60 60
RASA1 0.028 0.006 -10000 0 -10000 0 0
mol:Phosphatidic acid -0.075 0.2 0.33 21 -0.37 88 109
IKK complex 0.002 0.19 0.68 18 -0.24 29 47
WIPF1 0.028 0.016 -10000 0 -0.26 1 1
p75(NTR)-mediated signaling

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.04 0.026 -10000 0 -0.42 1 1
Necdin/E2F1 0.023 0.09 -10000 0 -0.42 14 14
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E -0.008 0.15 -10000 0 -0.32 60 60
NGF (dimer)/p75(NTR)/BEX1 -0.12 0.21 -10000 0 -0.41 114 114
NT-4/5 (dimer)/p75(NTR) -0.1 0.22 -10000 0 -0.46 89 89
IKBKB 0.029 0.004 -10000 0 -10000 0 0
AKT1 -0.042 0.14 -10000 0 -0.32 61 61
IKBKG 0.026 0.009 -10000 0 -10000 0 0
BDNF -0.027 0.16 -10000 0 -0.4 48 48
MGDIs/NGR/p75(NTR)/LINGO1 -0.043 0.16 -10000 0 -0.37 61 61
FURIN 0.029 0.004 -10000 0 -10000 0 0
proBDNF (dimer)/p75(NTR)/Sortilin -0.062 0.18 -10000 0 -0.38 78 78
LINGO1 0.016 0.067 -10000 0 -0.3 14 14
Sortilin/TRAF6/NRIF 0.035 0.022 -10000 0 -10000 0 0
proBDNF (dimer) -0.027 0.16 -10000 0 -0.4 48 48
NTRK1 -0.002 0.086 -10000 0 -0.28 32 32
RTN4R 0.022 0.013 -10000 0 -10000 0 0
neuron apoptosis -0.041 0.19 0.46 8 -0.61 13 21
IRAK1 0.026 0.009 -10000 0 -10000 0 0
SHC1 -0.057 0.15 -10000 0 -0.37 59 59
ARHGDIA 0.028 0.007 -10000 0 -10000 0 0
RhoA/GTP 0.021 0.003 -10000 0 -10000 0 0
Gamma Secretase 0.075 0.031 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 -0.02 0.15 -10000 0 -0.34 61 61
MAGEH1 0.027 0.008 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/Necdin -0.024 0.16 -10000 0 -0.34 66 66
Mammalian IAPs/DIABLO 0.007 0.13 -10000 0 -0.33 38 38
proNGF (dimer) 0.013 0.082 -10000 0 -0.37 14 14
MAGED1 0.027 0.008 -10000 0 -10000 0 0
APP 0.028 0.006 -10000 0 -10000 0 0
NT-4/5 (dimer) -0.049 0.18 -10000 0 -0.45 60 60
ZNF274 0.028 0.007 -10000 0 -10000 0 0
RhoA/GDP/RHOGDI -0.034 0.14 -10000 0 -0.32 62 62
NGF 0.013 0.082 -10000 0 -0.37 14 14
cell cycle arrest -0.029 0.16 0.38 14 -0.3 60 74
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK -0.024 0.12 -10000 0 -0.27 62 62
NT-4/5 (dimer)/p75(NTR)/TRAF6 -0.076 0.2 -10000 0 -0.4 89 89
NCSTN 0.027 0.008 -10000 0 -10000 0 0
mol:GTP -0.04 0.17 -10000 0 -0.38 62 62
PSENEN 0.028 0.007 -10000 0 -10000 0 0
mol:ceramide -0.047 0.14 -10000 0 -0.34 62 62
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs -0.014 0.099 -10000 0 -0.34 10 10
p75(NTR)/beta APP -0.052 0.17 -10000 0 -0.42 59 59
BEX1 -0.1 0.22 -10000 0 -0.43 107 107
mol:GDP -0.069 0.14 -10000 0 -0.37 63 63
NGF (dimer) -0.073 0.16 -10000 0 -0.34 87 87
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI -0.027 0.15 -10000 0 -0.34 61 61
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
RAC1/GTP -0.029 0.14 -10000 0 -0.32 61 61
MYD88 0.029 0.004 -10000 0 -10000 0 0
CHUK 0.029 0.005 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/PKA -0.04 0.17 -10000 0 -0.38 62 62
RHOB 0.025 0.033 -10000 0 -0.26 5 5
RHOA 0.029 0.004 -10000 0 -10000 0 0
MAGE-G1/E2F1 0.032 0.068 -10000 0 -0.42 8 8
NT3 (dimer) -0.044 0.17 -10000 0 -0.39 64 64
TP53 -0.057 0.14 0.32 1 -0.32 66 67
PRDM4 -0.049 0.14 -10000 0 -0.34 59 59
BDNF (dimer) -0.13 0.2 -10000 0 -0.36 129 129
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
SORT1 0.028 0.006 -10000 0 -10000 0 0
activation of caspase activity -0.012 0.15 -10000 0 -0.32 60 60
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 -0.02 0.16 -10000 0 -0.34 63 63
RHOC 0.028 0.006 -10000 0 -10000 0 0
XIAP 0.027 0.008 -10000 0 -10000 0 0
MAPK10 -0.045 0.15 0.34 9 -0.35 55 64
DIABLO 0.028 0.006 -10000 0 -10000 0 0
SMPD2 -0.048 0.14 -10000 0 -0.34 62 62
APH1B 0.029 0.004 -10000 0 -10000 0 0
APH1A 0.027 0.008 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin -0.036 0.16 -10000 0 -0.37 62 62
PSEN1 0.028 0.005 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.041 0.011 -10000 0 -10000 0 0
NT3 (dimer)/p75(NTR) -0.1 0.21 -10000 0 -0.46 78 78
MAPK8 -0.048 0.16 0.34 9 -0.35 55 64
MAPK9 -0.047 0.15 0.3 7 -0.35 54 61
APAF1 0.028 0.006 -10000 0 -10000 0 0
NTF3 -0.044 0.17 -10000 0 -0.39 64 64
NTF4 -0.049 0.19 -10000 0 -0.45 60 60
NDN 0.017 0.083 -10000 0 -0.54 8 8
RAC1/GDP 0.021 0.005 -10000 0 -10000 0 0
RhoA-B-C/GDP -0.014 0.15 -10000 0 -0.31 61 61
p75 CTF/Sortilin/TRAF6/NRIF 0.064 0.052 -10000 0 -0.43 3 3
RhoA-B-C/GTP -0.04 0.16 -10000 0 -0.38 62 62
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF -0.03 0.17 -10000 0 -0.34 68 68
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 -0.045 0.18 -10000 0 -0.35 79 79
PRKACB 0.021 0.044 -10000 0 -0.26 9 9
proBDNF (dimer)/p75 ECD -0.004 0.12 -10000 0 -0.42 25 25
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 -0.067 0.2 -10000 0 -0.43 78 78
BIRC2 0.028 0.005 -10000 0 -10000 0 0
neuron projection morphogenesis -0.029 0.15 0.42 4 -0.33 53 57
BAD -0.025 0.19 0.49 19 -0.35 54 73
RIPK2 0.029 0.005 -10000 0 -10000 0 0
NGFR -0.092 0.22 -10000 0 -0.47 90 90
CYCS -0.038 0.14 0.36 8 -0.32 60 68
ADAM17 0.024 0.054 -10000 0 -0.58 3 3
NGF (dimer)/p75(NTR)/TRAF6/RIP2 -0.021 0.16 -10000 0 -0.34 63 63
BCL2L11 -0.026 0.19 0.48 19 -0.35 55 74
BDNF (dimer)/p75(NTR) -0.089 0.2 -10000 0 -0.44 82 82
PI3K -0.02 0.16 -10000 0 -0.34 62 62
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 -0.019 0.16 -10000 0 -0.34 62 62
NDNL2 0.029 0.004 -10000 0 -10000 0 0
YWHAE 0.027 0.008 -10000 0 -10000 0 0
PRKCI 0.029 0.004 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR) -0.06 0.18 -10000 0 -0.43 63 63
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE -0.02 0.15 -10000 0 -0.34 61 61
TRAF6 0.027 0.032 -10000 0 -0.58 1 1
RAC1 0.028 0.007 -10000 0 -10000 0 0
PRKCZ 0.027 0.016 -10000 0 -0.26 1 1
PLG 0 0 -10000 0 -10000 0 0
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 -0.071 0.16 -10000 0 -0.37 73 73
SQSTM1 0.028 0.006 -10000 0 -10000 0 0
NGFRAP1 0.027 0.008 -10000 0 -10000 0 0
CASP3 -0.02 0.18 0.47 19 -0.33 54 73
E2F1 0.015 0.089 -10000 0 -0.54 9 9
CASP9 0.028 0.006 -10000 0 -10000 0 0
IKK complex 0.018 0.11 -10000 0 -0.42 5 5
NGF (dimer)/TRKA 0.009 0.086 -10000 0 -0.38 8 8
MMP7 -0.16 0.25 -10000 0 -0.43 155 155
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF -0.007 0.15 -10000 0 -0.32 59 59
MMP3 -0.032 0.14 -10000 0 -0.36 52 52
APAF-1/Caspase 9 -0.07 0.14 -10000 0 -0.46 25 25
Noncanonical Wnt signaling pathway

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 -0.032 0.18 -10000 0 -0.55 39 39
GNB1/GNG2 -0.06 0.18 -10000 0 -0.49 25 25
mol:DAG -0.074 0.15 -10000 0 -0.45 24 24
PLCG1 -0.076 0.15 -10000 0 -0.47 24 24
YES1 -0.09 0.16 -10000 0 -0.4 50 50
FZD3 0.029 0.004 -10000 0 -10000 0 0
FZD6 0.028 0.005 -10000 0 -10000 0 0
G protein -0.072 0.16 -10000 0 -0.45 29 29
MAP3K7 -0.074 0.14 0.25 3 -0.42 22 25
mol:Ca2+ -0.072 0.14 -10000 0 -0.44 24 24
mol:IP3 -0.074 0.15 -10000 0 -0.45 24 24
NLK 0.007 0.063 -10000 0 -0.82 2 2
GNB1 0.028 0.006 -10000 0 -10000 0 0
CAMK2A -0.079 0.15 0.25 3 -0.41 32 35
MAP3K7IP1 0 0 -10000 0 -10000 0 0
Noncanonical Wnts/FZD -0.094 0.17 -10000 0 -0.33 109 109
CSNK1A1 0.028 0.006 -10000 0 -10000 0 0
GNAS -0.092 0.16 -10000 0 -0.41 50 50
GO:0007205 -0.075 0.14 -10000 0 -0.44 24 24
WNT6 -0.026 0.16 -10000 0 -0.46 41 41
WNT4 -0.1 0.2 -10000 0 -0.37 120 120
NFAT1/CK1 alpha -0.074 0.18 -10000 0 -0.46 34 34
GNG2 0.026 0.026 -10000 0 -0.26 3 3
WNT5A -0.009 0.15 -10000 0 -0.56 24 24
WNT11 -0.088 0.2 -10000 0 -0.39 104 104
CDC42 -0.086 0.15 -10000 0 -0.38 50 50
Thromboxane A2 receptor signaling

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.003 0.098 -10000 0 -0.33 26 26
GNB1/GNG2 -0.053 0.078 -10000 0 -0.19 81 81
AKT1 -0.016 0.12 0.34 6 -0.24 4 10
EGF -0.033 0.15 -10000 0 -0.34 64 64
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR 0.007 0.1 0.4 7 -0.43 7 14
mol:Ca2+ -0.051 0.16 0.4 4 -0.32 81 85
LYN 0.016 0.082 0.4 7 -0.33 3 10
RhoA/GTP -0.018 0.065 -10000 0 -0.14 12 12
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.06 0.18 0.41 5 -0.35 82 87
GNG2 0.026 0.026 -10000 0 -0.26 3 3
ARRB2 0.027 0.017 -10000 0 -0.26 1 1
TP alpha/Gq family/GDP/G beta5/gamma2 -0.043 0.18 0.27 1 -0.47 44 45
G beta5/gamma2 -0.07 0.1 -10000 0 -0.26 80 80
PRKCH -0.062 0.18 0.38 5 -0.37 83 88
DNM1 -0.002 0.11 -10000 0 -0.35 29 29
TXA2/TP beta/beta Arrestin3 -0.013 0.11 -10000 0 -0.51 15 15
mol:GTP 0 0.002 -10000 0 -10000 0 0
PTGDR 0 0.11 -10000 0 -0.4 25 25
G12 family/GTP -0.057 0.14 -10000 0 -0.31 76 76
ADRBK1 0.028 0.005 -10000 0 -10000 0 0
ADRBK2 0.022 0.013 -10000 0 -10000 0 0
RhoA/GTP/ROCK1 0.038 0.008 -10000 0 -10000 0 0
mol:GDP 0.076 0.16 0.44 44 -0.3 2 46
mol:NADP 0.026 0.032 -10000 0 -0.58 1 1
RAB11A 0.029 0.004 -10000 0 -10000 0 0
PRKG1 -0.037 0.18 -10000 0 -0.46 50 50
mol:IP3 -0.07 0.2 0.42 4 -0.4 82 86
cell morphogenesis 0.037 0.008 -10000 0 -10000 0 0
PLCB2 -0.1 0.27 0.56 2 -0.56 82 84
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK -0.043 0.13 0.46 6 -0.4 11 17
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK -0.012 0.11 0.38 3 -0.42 9 12
RHOA 0.029 0.004 -10000 0 -10000 0 0
PTGIR 0.016 0.079 -10000 0 -0.5 8 8
PRKCB1 -0.072 0.2 0.4 4 -0.4 86 90
GNAQ 0.027 0.008 -10000 0 -10000 0 0
mol:L-citrulline 0.026 0.032 -10000 0 -0.58 1 1
TXA2/TXA2-R family -0.1 0.26 0.51 3 -0.55 83 86
LCK -0.011 0.11 0.34 6 -0.4 10 16
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.025 0.077 -10000 0 -0.35 5 5
TXA2-R family/G12 family/GDP/G beta/gamma 0.034 0.024 -10000 0 -10000 0 0
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.03 0.079 -10000 0 -0.34 5 5
MAPK14 -0.033 0.12 0.35 5 -0.24 43 48
TGM2/GTP -0.082 0.21 0.34 1 -0.44 82 83
MAPK11 -0.038 0.12 0.35 5 -0.24 35 40
ARHGEF1 -0.027 0.088 -10000 0 -0.19 33 33
GNAI2 0.029 0.004 -10000 0 -10000 0 0
JNK cascade -0.07 0.2 0.44 4 -0.4 83 87
RAB11/GDP 0.029 0.004 -10000 0 -10000 0 0
ICAM1 -0.062 0.18 0.38 4 -0.36 88 92
cAMP biosynthetic process -0.063 0.18 0.43 4 -0.36 83 87
Gq family/GTP/EBP50 -0.023 0.1 0.24 1 -0.27 43 44
actin cytoskeleton reorganization 0.037 0.008 -10000 0 -10000 0 0
SRC 0.011 0.072 0.35 4 -0.33 3 7
GNB5 0.027 0.031 -10000 0 -0.58 1 1
GNB1 0.028 0.006 -10000 0 -10000 0 0
EGF/EGFR -0.021 0.13 0.44 9 -0.34 18 27
VCAM1 -0.053 0.16 0.37 4 -0.31 83 87
TP beta/Gq family/GDP/G beta5/gamma2 -0.043 0.18 0.27 1 -0.47 44 45
platelet activation -0.043 0.16 0.46 5 -0.31 79 84
PGI2/IP 0.012 0.058 -10000 0 -0.36 8 8
PRKACA 0.006 0.066 -10000 0 -0.3 15 15
Gq family/GDP/G beta5/gamma2 -0.034 0.16 0.28 1 -0.42 41 42
TXA2/TP beta/beta Arrestin2 0.003 0.087 -10000 0 -0.46 11 11
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R -0.001 0.069 -10000 0 -0.3 16 16
mol:DAG -0.082 0.22 0.47 3 -0.45 84 87
EGFR 0.002 0.12 -10000 0 -0.54 17 17
TXA2/TP alpha -0.092 0.24 0.52 3 -0.5 83 86
Gq family/GTP -0.029 0.091 -10000 0 -0.24 55 55
YES1 0.018 0.083 0.4 8 -0.33 3 11
GNAI2/GTP 0.005 0.066 -10000 0 -0.38 3 3
PGD2/DP 0 0.083 -10000 0 -0.28 25 25
SLC9A3R1 0.023 0.039 -10000 0 -0.28 6 6
FYN 0.019 0.092 0.39 11 -0.33 4 15
mol:NO 0.026 0.032 -10000 0 -0.58 1 1
GNA15 -0.028 0.16 -10000 0 -0.48 41 41
PGK/cGMP -0.006 0.12 -10000 0 -0.37 31 31
RhoA/GDP 0.029 0.004 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma 0.026 0.1 -10000 0 -0.43 9 9
NOS3 0.026 0.032 -10000 0 -0.58 1 1
RAC1 0.028 0.007 -10000 0 -10000 0 0
PRKCA -0.064 0.19 0.42 5 -0.38 81 86
PRKCB -0.074 0.19 0.37 7 -0.39 81 88
PRKCE -0.065 0.19 0.38 4 -0.38 84 88
PRKCD -0.07 0.19 0.43 3 -0.39 82 85
PRKCG -0.071 0.2 0.43 4 -0.4 80 84
muscle contraction -0.095 0.24 0.46 4 -0.5 84 88
PRKCZ -0.058 0.18 0.4 5 -0.35 80 85
ARR3 0.019 0.016 -10000 0 -0.26 1 1
TXA2/TP beta 0.013 0.075 -10000 0 -0.38 4 4
PRKCQ -0.063 0.18 0.38 4 -0.37 80 84
MAPKKK cascade -0.089 0.23 0.44 4 -0.48 81 85
SELE -0.065 0.18 0.38 4 -0.35 86 90
TP beta/GNAI2/GDP/G beta/gamma 0.038 0.081 -10000 0 -0.4 3 3
ROCK1 0.029 0.005 -10000 0 -10000 0 0
GNA14 -0.013 0.11 -10000 0 -0.28 48 48
chemotaxis -0.12 0.29 0.59 2 -0.62 88 90
GNA12 0.028 0.007 -10000 0 -10000 0 0
GNA13 0.028 0.007 -10000 0 -10000 0 0
GNA11 0.009 0.1 -10000 0 -0.58 11 11
Rac1/GTP 0.02 0.005 -10000 0 -10000 0 0
HIF-1-alpha transcription factor network

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.099 0.41 -10000 0 -0.98 38 38
HDAC7 0.03 0.008 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.074 0.39 -10000 0 -0.83 39 39
SMAD4 0.03 0.006 -10000 0 -10000 0 0
ID2 -0.098 0.41 -10000 0 -0.96 41 41
AP1 -0.028 0.16 -10000 0 -0.42 44 44
ABCG2 -0.12 0.42 -10000 0 -0.98 45 45
HIF1A 0.004 0.085 -10000 0 -10000 0 0
TFF3 -0.18 0.45 -10000 0 -0.99 53 53
GATA2 0.023 0.052 -10000 0 -0.38 5 5
AKT1 -0.01 0.1 -10000 0 -0.25 7 7
response to hypoxia -0.033 0.1 -10000 0 -0.26 24 24
MCL1 -0.1 0.4 -10000 0 -0.97 38 38
NDRG1 -0.098 0.41 -10000 0 -0.94 42 42
SERPINE1 -0.11 0.42 -10000 0 -0.97 41 41
FECH -0.097 0.41 -10000 0 -0.94 42 42
FURIN -0.099 0.41 -10000 0 -0.98 38 38
NCOA2 -0.027 0.18 -10000 0 -0.58 35 35
EP300 -0.031 0.15 -10000 0 -0.32 49 49
HMOX1 -0.13 0.4 -10000 0 -0.98 43 43
BHLHE40 -0.11 0.44 -10000 0 -1 46 46
BHLHE41 -0.1 0.42 -10000 0 -0.98 43 43
HIF1A/ARNT/SMAD3/SMAD4/SP1 0.07 0.12 -10000 0 -10000 0 0
ENG 0.033 0.099 0.42 2 -10000 0 2
JUN 0.006 0.095 -10000 0 -0.34 22 22
RORA -0.1 0.41 -10000 0 -0.95 43 43
ABCB1 -0.047 0.21 -10000 0 -1.3 9 9
TFRC -0.1 0.41 -10000 0 -0.95 41 41
CXCR4 -0.11 0.42 -10000 0 -0.99 40 40
TF -0.12 0.42 -10000 0 -0.97 44 44
CITED2 -0.1 0.41 -10000 0 -0.94 44 44
HIF1A/ARNT -0.088 0.49 -10000 0 -1.1 41 41
LDHA -0.019 0.14 -10000 0 -0.78 10 10
ETS1 -0.099 0.41 -10000 0 -0.94 43 43
PGK1 -0.097 0.4 -10000 0 -0.94 41 41
NOS2 -0.12 0.43 -10000 0 -0.97 48 48
ITGB2 -0.12 0.44 -10000 0 -1 46 46
ALDOA -0.096 0.4 -10000 0 -0.95 40 40
Cbp/p300/CITED2 -0.12 0.44 -10000 0 -1 39 39
FOS -0.047 0.18 -10000 0 -0.44 60 60
HK2 -0.1 0.42 -10000 0 -0.97 43 43
SP1 0.032 0.021 -10000 0 -10000 0 0
GCK -0.14 0.43 -10000 0 -1.4 34 34
HK1 -0.1 0.41 -10000 0 -0.95 42 42
NPM1 -0.096 0.4 -10000 0 -0.97 37 37
EGLN1 -0.1 0.4 -10000 0 -0.95 41 41
CREB1 0.035 0.006 -10000 0 -10000 0 0
PGM1 -0.1 0.41 -10000 0 -0.95 41 41
SMAD3 0.03 0.006 -10000 0 -10000 0 0
EDN1 -0.073 0.28 -10000 0 -0.86 26 26
IGFBP1 -0.1 0.41 -10000 0 -0.97 40 40
VEGFA -0.064 0.33 -10000 0 -0.75 28 28
HIF1A/JAB1 0.025 0.066 -10000 0 -10000 0 0
CP -0.18 0.47 -10000 0 -0.98 66 66
CXCL12 -0.12 0.43 -10000 0 -0.99 47 47
COPS5 0.029 0.005 -10000 0 -10000 0 0
SMAD3/SMAD4 0.044 0.011 -10000 0 -10000 0 0
BNIP3 -0.099 0.41 -10000 0 -0.95 42 42
EGLN3 -0.14 0.45 -10000 0 -0.99 55 55
CA9 -0.12 0.41 -10000 0 -0.99 42 42
TERT -0.12 0.39 -10000 0 -0.92 47 47
ENO1 -0.1 0.41 -10000 0 -0.97 39 39
PFKL -0.099 0.41 -10000 0 -0.94 42 42
NCOA1 0.029 0.005 -10000 0 -10000 0 0
ADM -0.11 0.43 -10000 0 -0.97 49 49
ARNT 0.003 0.088 -10000 0 -0.34 5 5
HNF4A -0.009 0.03 -10000 0 -10000 0 0
ADFP -0.12 0.39 -10000 0 -0.92 47 47
SLC2A1 -0.064 0.32 -10000 0 -0.77 24 24
LEP -0.11 0.41 -10000 0 -0.96 41 41
HIF1A/ARNT/Cbp/p300 -0.085 0.4 -10000 0 -0.85 41 41
EPO -0.047 0.29 -10000 0 -0.93 14 14
CREBBP -0.011 0.14 -10000 0 -0.32 34 34
HIF1A/ARNT/Cbp/p300/HDAC7 -0.066 0.39 -10000 0 -0.88 29 29
PFKFB3 -0.1 0.42 -10000 0 -0.97 42 42
NT5E -0.12 0.44 -10000 0 -0.99 51 51
FOXA2 and FOXA3 transcription factor networks

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.19 0.31 -10000 0 -0.86 39 39
PCK1 -0.13 0.21 -10000 0 -0.76 11 11
HNF4A -0.22 0.36 -10000 0 -0.95 53 53
KCNJ11 -0.2 0.35 -10000 0 -0.96 40 40
AKT1 -0.033 0.16 -10000 0 -0.68 8 8
response to starvation -0.009 0.027 -10000 0 -0.34 1 1
DLK1 -0.2 0.32 -10000 0 -0.74 63 63
NKX2-1 -0.047 0.19 -10000 0 -1.3 2 2
ACADM -0.19 0.31 -10000 0 -0.85 41 41
TAT -0.12 0.2 -10000 0 -0.66 20 20
CEBPB 0.028 0.005 -10000 0 -10000 0 0
CEBPA 0.01 0.082 -10000 0 -0.33 18 18
TTR -0.14 0.24 0.46 3 -0.6 49 52
PKLR -0.19 0.31 -10000 0 -0.86 39 39
APOA1 -0.27 0.48 -10000 0 -1.3 50 50
CPT1C -0.22 0.35 -10000 0 -0.98 43 43
ALAS1 -0.066 0.15 -10000 0 -0.54 1 1
TFRC -0.15 0.28 -10000 0 -0.88 24 24
FOXF1 0.005 0.094 0.2 1 -0.45 14 15
NF1 0.033 0.009 -10000 0 -10000 0 0
HNF1A (dimer) 0.026 0.032 -10000 0 -0.58 1 1
CPT1A -0.19 0.31 -10000 0 -0.86 39 39
HMGCS1 -0.19 0.31 -10000 0 -0.83 42 42
NR3C1 0.029 0.024 -10000 0 -10000 0 0
CPT1B -0.2 0.33 -10000 0 -0.92 42 42
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.028 0.006 -10000 0 -10000 0 0
GCK -0.24 0.39 0.63 1 -1 57 58
CREB1 0.024 0.023 -10000 0 -10000 0 0
IGFBP1 -0.075 0.16 -10000 0 -1.6 1 1
PDX1 -0.075 0.15 -10000 0 -0.37 28 28
UCP2 -0.22 0.36 -10000 0 -0.97 51 51
ALDOB -0.2 0.32 -10000 0 -0.9 38 38
AFP -0.084 0.16 -10000 0 -0.34 93 93
BDH1 -0.19 0.31 -10000 0 -0.87 40 40
HADH -0.19 0.32 -10000 0 -0.9 35 35
F2 -0.22 0.37 -10000 0 -0.92 56 56
HNF1A 0.026 0.032 -10000 0 -0.58 1 1
G6PC -0.025 0.095 -10000 0 -0.3 6 6
SLC2A2 -0.1 0.19 -10000 0 -0.47 32 32
INS -0.007 0.013 -10000 0 -10000 0 0
FOXA1 -0.08 0.2 -10000 0 -0.4 88 88
FOXA3 -0.08 0.21 -10000 0 -0.52 58 58
FOXA2 -0.22 0.37 -10000 0 -0.88 56 56
ABCC8 -0.38 0.5 -10000 0 -1.1 117 117
ALB -0.13 0.29 -10000 0 -0.9 35 35
Arf6 downstream pathway

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.14 0.39 -10000 0 -1.1 54 54
regulation of axonogenesis 0.004 0.057 0.24 2 -10000 0 2
myoblast fusion 0.041 0.15 0.38 58 -10000 0 58
mol:GTP -0.018 0.084 -10000 0 -0.22 52 52
regulation of calcium-dependent cell-cell adhesion 0.023 0.16 0.34 66 -10000 0 66
ARF1/GTP 0.003 0.07 -10000 0 -0.21 2 2
mol:GM1 -0.016 0.061 -10000 0 -0.18 27 27
mol:Choline -0.004 0.052 -10000 0 -10000 0 0
lamellipodium assembly -0.045 0.16 -10000 0 -0.4 55 55
MAPK3 -0.028 0.13 -10000 0 -0.33 53 53
ARF6/GTP/NME1/Tiam1 -0.023 0.16 -10000 0 -0.34 66 66
ARF1 0.027 0.008 -10000 0 -10000 0 0
ARF6/GDP -0.041 0.15 -10000 0 -0.38 58 58
ARF1/GDP -0.031 0.14 -10000 0 -0.35 57 57
ARF6 0.007 0.058 -10000 0 -10000 0 0
RAB11A 0.029 0.004 -10000 0 -10000 0 0
TIAM1 -0.042 0.18 -10000 0 -0.55 42 42
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 -0.031 0.12 -10000 0 -0.33 52 52
actin filament bundle formation 0.026 0.14 0.35 57 -10000 0 57
KALRN -0.03 0.11 -10000 0 -0.28 57 57
RAB11FIP3/RAB11A 0.04 0.012 -10000 0 -10000 0 0
RhoA/GDP -0.026 0.14 -10000 0 -0.35 57 57
NME1 0.022 0.018 -10000 0 -10000 0 0
Rac1/GDP -0.021 0.14 -10000 0 -0.35 50 50
substrate adhesion-dependent cell spreading -0.018 0.084 -10000 0 -0.22 52 52
cortical actin cytoskeleton organization -0.045 0.16 -10000 0 -0.41 55 55
RAC1 0.028 0.007 -10000 0 -10000 0 0
liver development -0.018 0.084 -10000 0 -0.22 52 52
ARF6/GTP -0.018 0.084 -10000 0 -0.22 52 52
RhoA/GTP 0.004 0.071 -10000 0 -0.21 2 2
mol:GDP -0.039 0.14 -10000 0 -0.38 50 50
ARF6/GTP/RAB11FIP3/RAB11A 0.022 0.067 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
PLD1 -0.005 0.065 -10000 0 -0.23 1 1
RAB11FIP3 0.027 0.008 -10000 0 -10000 0 0
tube morphogenesis -0.045 0.16 -10000 0 -0.4 55 55
ruffle organization -0.004 0.057 -10000 0 -0.24 2 2
regulation of epithelial cell migration -0.018 0.084 -10000 0 -0.22 52 52
PLD2 -0.003 0.062 -10000 0 -0.23 1 1
PIP5K1A -0.004 0.057 -10000 0 -0.24 2 2
mol:Phosphatidic acid -0.004 0.052 -10000 0 -10000 0 0
Rac1/GTP -0.045 0.16 -10000 0 -0.41 55 55
Glypican 1 network

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.035 0.094 -10000 0 -0.38 18 18
fibroblast growth factor receptor signaling pathway 0.035 0.094 -10000 0 -0.38 18 18
LAMA1 -0.059 0.21 -10000 0 -0.56 55 55
PRNP 0.028 0.005 -10000 0 -10000 0 0
GPC1/SLIT2 -0.038 0.17 -10000 0 -0.42 56 56
SMAD2 0.016 0.051 -10000 0 -0.35 6 6
GPC1/PrPc/Cu2+ 0.034 0.034 -10000 0 -0.36 2 2
GPC1/Laminin alpha1 -0.03 0.17 -10000 0 -0.43 55 55
TDGF1 -0.088 0.21 -10000 0 -0.4 101 101
CRIPTO/GPC1 -0.05 0.16 -10000 0 -0.42 49 49
APP/GPC1 0.037 0.04 -10000 0 -0.42 2 2
mol:NO 0 0 -10000 0 -10000 0 0
YES1 -0.05 0.13 -10000 0 -0.37 47 47
FLT1 0.012 0.094 -10000 0 -0.55 10 10
GPC1/TGFB/TGFBR1/TGFBR2 0.044 0.061 -10000 0 -0.38 6 6
SERPINC1 0.022 0.041 -10000 0 -0.34 4 4
FYN -0.051 0.14 -10000 0 -0.37 49 49
FGR -0.063 0.14 -10000 0 -0.37 58 58
positive regulation of MAPKKK cascade -0.11 0.19 -10000 0 -0.48 62 62
SLIT2 -0.07 0.22 -10000 0 -0.51 69 69
GPC1/NRG -0.017 0.15 -10000 0 -0.43 42 42
NRG1 -0.043 0.19 -10000 0 -0.52 49 49
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.037 0.084 -10000 0 -0.39 12 12
LYN -0.049 0.13 -10000 0 -0.37 47 47
mol:Spermine 0.006 0.035 -10000 0 -0.42 2 2
cell growth 0.035 0.094 -10000 0 -0.38 18 18
BMP signaling pathway -0.023 0.051 0.38 5 -10000 0 5
SRC -0.051 0.13 -10000 0 -0.37 47 47
TGFBR1 0.023 0.047 -10000 0 -0.47 3 3
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.17 0.24 -10000 0 -0.41 169 169
GPC1 0.023 0.051 -10000 0 -0.39 5 5
TGFBR1 (dimer) 0.023 0.047 -10000 0 -0.47 3 3
VEGFA 0.025 0.047 -10000 0 -0.47 3 3
BLK -0.13 0.18 -10000 0 -0.38 110 110
HCK -0.082 0.17 -10000 0 -0.39 72 72
FGF2 0.013 0.098 -10000 0 -0.58 10 10
FGFR1 0.019 0.076 -10000 0 -0.58 6 6
VEGFR1 homodimer 0.012 0.094 -10000 0 -0.54 10 10
TGFBR2 0.026 0.044 -10000 0 -0.58 2 2
cell death 0.037 0.04 -10000 0 -0.42 2 2
ATIII/GPC1 0.031 0.051 -10000 0 -0.42 3 3
PLA2G2A/GPC1 -0.11 0.19 -10000 0 -0.43 84 84
LCK -0.085 0.16 -10000 0 -0.39 70 70
neuron differentiation -0.017 0.15 -10000 0 -0.43 42 42
PrPc/Cu2+ 0.021 0.004 -10000 0 -10000 0 0
APP 0.028 0.006 -10000 0 -10000 0 0
TGFBR2 (dimer) 0.026 0.044 -10000 0 -0.58 2 2
Osteopontin-mediated events

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.044 0.17 -10000 0 -0.44 42 42
NF kappa B1 p50/RelA/I kappa B alpha -0.047 0.19 0.32 1 -0.56 31 32
alphaV/beta3 Integrin/Osteopontin/Src -0.044 0.18 -10000 0 -0.45 52 52
AP1 -0.072 0.23 -10000 0 -0.57 41 41
ILK -0.047 0.16 -10000 0 -0.48 29 29
bone resorption -0.039 0.17 -10000 0 -0.47 30 30
PTK2B 0.024 0.054 -10000 0 -0.58 3 3
PYK2/p130Cas -0.004 0.18 -10000 0 -0.45 31 31
ITGAV 0.019 0.064 -10000 0 -0.57 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.017 0.1 -10000 0 -0.42 20 20
alphaV/beta3 Integrin/Osteopontin -0.036 0.19 -10000 0 -0.43 60 60
MAP3K1 -0.05 0.17 -10000 0 -0.41 56 56
JUN 0.005 0.096 -10000 0 -0.35 22 22
MAPK3 -0.066 0.18 -10000 0 -0.56 31 31
MAPK1 -0.068 0.18 -10000 0 -0.52 37 37
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
NFKB1 0.029 0.004 -10000 0 -10000 0 0
MAPK8 -0.056 0.17 -10000 0 -0.41 56 56
ITGB3 -0.004 0.13 -10000 0 -0.59 18 18
NFKBIA -0.073 0.19 -10000 0 -0.6 32 32
FOS -0.048 0.18 -10000 0 -0.44 61 61
CD44 0.017 0.082 -10000 0 -0.58 7 7
CHUK 0.029 0.005 -10000 0 -10000 0 0
PLAU -0.2 0.43 0.65 1 -1.2 60 61
NF kappa B1 p50/RelA -0.042 0.2 -10000 0 -0.6 30 30
BCAR1 0.028 0.007 -10000 0 -10000 0 0
RELA 0.028 0.005 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.011 0.12 -10000 0 -0.47 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
SYK -0.049 0.16 -10000 0 -0.4 57 57
VAV3 -0.069 0.18 0.22 1 -0.4 66 67
MAP3K14 -0.058 0.18 -10000 0 -0.43 56 56
ROCK2 0.007 0.11 -10000 0 -0.58 13 13
SPP1 -0.076 0.22 -10000 0 -0.47 77 77
RAC1 0.028 0.007 -10000 0 -10000 0 0
Rac1/GTP -0.052 0.17 -10000 0 -0.43 41 41
MMP2 -0.085 0.19 -10000 0 -0.52 41 41
IL6-mediated signaling events

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.066 0.24 0.55 3 -0.68 19 22
CRP -0.062 0.26 0.55 7 -0.66 27 34
cell cycle arrest -0.086 0.27 0.44 3 -0.68 41 44
TIMP1 -0.18 0.39 -10000 0 -0.92 70 70
IL6ST -0.045 0.19 -10000 0 -0.57 43 43
Rac1/GDP -0.065 0.21 -10000 0 -0.5 45 45
AP1 -0.01 0.18 -10000 0 -0.65 13 13
GAB2 0.024 0.054 -10000 0 -0.58 3 3
TNFSF11 -0.2 0.45 0.6 1 -1 81 82
HSP90B1 0.03 0.071 -10000 0 -0.89 1 1
GAB1 0.029 0.004 -10000 0 -10000 0 0
MAPK14 -0.056 0.2 0.34 2 -0.66 26 28
AKT1 0.042 0.056 -10000 0 -0.42 1 1
FOXO1 0.039 0.054 -10000 0 -0.4 1 1
MAP2K6 -0.055 0.2 0.27 5 -0.47 46 51
mol:GTP -0.001 0.006 -10000 0 -10000 0 0
MAP2K4 -0.065 0.21 0.35 2 -0.53 41 43
MITF -0.053 0.18 0.24 4 -0.43 49 53
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.027 0.008 -10000 0 -10000 0 0
A2M 0.022 0.11 -10000 0 -1.2 3 3
CEBPB 0.034 0.008 -10000 0 -10000 0 0
GRB2/SOS1/GAB family/SHP2 -0.005 0.14 -10000 0 -0.8 8 8
STAT3 -0.096 0.28 -10000 0 -0.73 40 40
STAT1 -0.005 0.16 -10000 0 -1.1 8 8
CEBPD -0.083 0.27 -10000 0 -0.76 27 27
PIK3CA 0.027 0.044 -10000 0 -0.58 2 2
PI3K 0.041 0.035 -10000 0 -0.42 2 2
JUN 0.006 0.095 -10000 0 -0.35 22 22
PIAS3/MITF -0.039 0.18 0.32 1 -0.44 41 42
MAPK11 -0.06 0.2 0.29 1 -0.65 26 27
STAT3 (dimer)/FOXO1 -0.034 0.21 -10000 0 -0.56 21 21
GRB2/SOS1/GAB family -0.044 0.22 -10000 0 -0.57 34 34
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.091 0.23 -10000 0 -0.45 79 79
GRB2 0.028 0.007 -10000 0 -10000 0 0
JAK2 0.027 0.008 -10000 0 -10000 0 0
LBP -0.049 0.22 0.51 3 -0.63 14 17
PIK3R1 0.029 0.006 -10000 0 -10000 0 0
JAK1 0.023 0.021 -10000 0 -10000 0 0
MYC -0.085 0.29 0.54 1 -0.9 24 25
FGG -0.071 0.24 0.41 3 -0.59 41 44
macrophage differentiation -0.086 0.27 0.44 3 -0.68 41 44
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.061 0.22 -10000 0 -0.41 83 83
JUNB -0.066 0.25 0.49 1 -0.66 27 28
FOS -0.047 0.18 -10000 0 -0.44 60 60
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.052 0.2 0.27 4 -0.44 53 57
STAT1/PIAS1 -0.04 0.19 0.29 4 -0.44 42 46
GRB2/SOS1/GAB family/SHP2/PI3K 0.04 0.05 -10000 0 -0.32 1 1
STAT3 (dimer) -0.095 0.28 -10000 0 -0.72 41 41
PRKCD -0.074 0.23 0.4 3 -0.56 41 44
IL6R -0.012 0.13 -10000 0 -0.48 26 26
SOCS3 -0.061 0.27 0.44 1 -1.1 18 19
gp130 (dimer)/JAK1/JAK1/LMO4 0.001 0.13 -10000 0 -0.36 40 40
Rac1/GTP -0.07 0.21 -10000 0 -0.51 46 46
HCK -0.027 0.16 -10000 0 -0.48 41 41
MAPKKK cascade 0.01 0.14 -10000 0 -0.86 7 7
bone resorption -0.18 0.41 0.6 1 -0.92 81 82
IRF1 -0.066 0.24 0.54 4 -0.62 31 35
mol:GDP -0.079 0.21 0.25 1 -0.49 52 53
SOS1 0.028 0.006 -10000 0 -10000 0 0
VAV1 -0.079 0.21 0.25 1 -0.49 52 53
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.048 0.22 -10000 0 -0.65 30 30
PTPN11 0.016 0.057 -10000 0 -0.97 1 1
IL6/IL6RA -0.084 0.19 -10000 0 -0.46 64 64
gp130 (dimer)/TYK2/TYK2/LMO4 0.005 0.13 -10000 0 -0.36 36 36
gp130 (dimer)/JAK2/JAK2/LMO4 0.002 0.13 -10000 0 -0.36 39 39
IL6 -0.11 0.22 -10000 0 -0.4 119 119
PIAS3 0.027 0.008 -10000 0 -10000 0 0
PTPRE -0.077 0.22 -10000 0 -0.56 65 65
PIAS1 0.029 0.004 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.045 0.17 0.23 12 -0.36 64 76
LMO4 0.021 0.029 -10000 0 -0.25 1 1
STAT3 (dimer)/PIAS3 -0.084 0.27 0.43 1 -0.7 39 40
MCL1 0.053 0.068 -10000 0 -10000 0 0
Ras signaling in the CD4+ TCR pathway

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.08 0.22 -9999 0 -0.55 45 45
MAP3K8 0.025 0.035 -9999 0 -0.42 2 2
FOS -0.077 0.21 -9999 0 -0.53 47 47
PRKCA 0.011 0.068 -9999 0 -0.31 14 14
PTPN7 -0.073 0.19 -9999 0 -0.39 84 84
HRAS 0.026 0.022 -9999 0 -0.26 2 2
PRKCB -0.035 0.14 -9999 0 -0.33 61 61
NRAS 0.028 0.006 -9999 0 -10000 0 0
RAS family/GTP 0.048 0.022 -9999 0 -10000 0 0
MAPK3 -0.031 0.18 -9999 0 -0.51 38 38
MAP2K1 -0.003 0.11 -9999 0 -0.48 15 15
ELK1 0.022 0.018 -9999 0 -10000 0 0
BRAF -0.005 0.1 -9999 0 -0.47 15 15
mol:GTP -0.001 0.003 -9999 0 -0.005 56 56
MAPK1 -0.11 0.23 -9999 0 -0.44 103 103
RAF1 -0.006 0.11 -9999 0 -0.48 15 15
KRAS 0.028 0.006 -9999 0 -10000 0 0
Effects of Botulinum toxin

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.009 0.002 -10000 0 -10000 0 0
UniProt:P19321 0 0 -10000 0 -10000 0 0
RIMS1/UNC13B 0.034 0.041 -10000 0 -0.42 2 2
STXBP1 0.027 0.008 -10000 0 -10000 0 0
ACh/CHRNA1 -0.049 0.13 -10000 0 -0.27 73 73
RAB3GAP2/RIMS1/UNC13B 0.047 0.041 -10000 0 -0.36 2 2
mol:Ca2+ 0 0 -10000 0 -10000 0 0
UniProt:P30996 0 0 -10000 0 -10000 0 0
UniProt:Q60393 0 0 -10000 0 -10000 0 0
CST086 0 0 -10000 0 -10000 0 0
RIMS1 0.021 0.053 -10000 0 -0.36 6 6
mol:ACh -0.014 0.06 0.13 14 -0.13 65 79
RAB3GAP2 0.027 0.008 -10000 0 -10000 0 0
STX1A/SNAP25/VAMP2 0.008 0.088 -10000 0 -0.26 6 6
UniProt:P10844 0 0 -10000 0 -10000 0 0
muscle contraction -0.049 0.13 -10000 0 -0.27 73 73
UNC13B 0.027 0.008 -10000 0 -10000 0 0
CHRNA1 -0.057 0.19 -10000 0 -0.41 72 72
UniProt:P10845 0 0 -10000 0 -10000 0 0
ACh/Synaptotagmin 1 -0.13 0.17 -10000 0 -0.28 179 179
SNAP25 -0.051 0.12 -10000 0 -0.31 68 68
VAMP2 0.006 0.002 -10000 0 -10000 0 0
SYT1 -0.18 0.25 -10000 0 -0.41 178 178
UniProt:Q00496 0 0 -10000 0 -10000 0 0
STXIA/STXBP1 0.026 0.01 -10000 0 -10000 0 0
STX1A/SNAP25 fragment 1/VAMP2 0.008 0.088 -10000 0 -0.26 6 6
TCGA08_retinoblastoma

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.014 0.075 -10000 0 -0.32 16 16
CDKN2C 0.028 0.052 -10000 0 -0.42 4 4
CDKN2A -0.041 0.16 -10000 0 -0.36 67 67
CCND2 0.01 0.053 0.19 24 -0.13 1 25
RB1 -0.015 0.064 -10000 0 -0.22 28 28
CDK4 0.016 0.067 0.23 29 -10000 0 29
CDK6 0.016 0.068 0.22 29 -0.16 2 31
G1/S progression 0.014 0.066 0.22 28 -0.27 1 29
ErbB2/ErbB3 signaling events

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 0.003 0.009 -10000 0 -10000 0 0
RAS family/GTP -0.022 0.14 -10000 0 -0.36 24 24
NFATC4 -0.052 0.11 0.32 2 -0.39 7 9
ERBB2IP 0.029 0.007 -10000 0 -10000 0 0
HSP90 (dimer) 0.028 0.006 -10000 0 -10000 0 0
mammary gland morphogenesis -0.05 0.14 -10000 0 -0.3 82 82
JUN -0.008 0.11 0.34 8 -0.39 11 19
HRAS 0.026 0.022 -10000 0 -0.26 2 2
DOCK7 -0.058 0.13 0.29 1 -0.29 79 80
ErbB2/ErbB3/neuregulin 1 beta/SHC -0.043 0.16 -10000 0 -0.34 83 83
AKT1 0.006 0.008 -10000 0 -10000 0 0
BAD 0.004 0.006 -10000 0 -10000 0 0
MAPK10 -0.027 0.076 0.31 1 -0.22 4 5
mol:GTP -0.001 0.002 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta -0.053 0.15 -10000 0 -0.33 82 82
RAF1 -0.036 0.14 0.37 5 -0.39 20 25
ErbB2/ErbB3/neuregulin 2 -0.057 0.16 -10000 0 -0.35 76 76
STAT3 0.027 0.086 -10000 0 -0.91 3 3
cell migration -0.009 0.12 0.39 16 -0.23 3 19
mol:PI-3-4-5-P3 -0.001 0.003 -10000 0 -10000 0 0
cell proliferation -0.1 0.25 0.58 2 -0.67 42 44
FOS -0.075 0.21 0.5 4 -0.44 66 70
NRAS 0.028 0.005 -10000 0 -10000 0 0
mol:Ca2+ -0.05 0.14 -10000 0 -0.3 82 82
MAPK3 -0.055 0.2 0.53 2 -0.54 32 34
MAPK1 -0.13 0.27 0.68 1 -0.6 65 66
JAK2 -0.057 0.13 0.29 1 -0.29 78 79
NF2 -0.017 0.13 -10000 0 -0.68 14 14
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 -0.053 0.14 -10000 0 -0.31 83 83
NRG1 -0.043 0.19 -10000 0 -0.52 49 49
GRB2/SOS1 0.04 0.011 -10000 0 -10000 0 0
MAPK8 -0.051 0.14 -10000 0 -0.3 84 84
MAPK9 -0.027 0.075 0.31 1 -0.22 3 4
ERBB2 -0.018 0.007 -10000 0 -10000 0 0
ERBB3 -0.058 0.21 -10000 0 -0.58 53 53
SHC1 0.027 0.008 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
apoptosis 0.004 0.018 -10000 0 -0.16 1 1
STAT3 (dimer) 0.027 0.084 -10000 0 -0.89 3 3
RNF41 -0.001 0.009 -10000 0 -10000 0 0
FRAP1 0.002 0.005 -10000 0 -10000 0 0
RAC1-CDC42/GTP -0.039 0.098 -10000 0 -0.23 35 35
ErbB2/ErbB2/HSP90 (dimer) 0.011 0.017 -10000 0 -10000 0 0
CHRNA1 -0.083 0.23 0.65 1 -0.64 41 42
myelination -0.038 0.16 0.56 13 -0.37 7 20
PPP3CB -0.054 0.12 0.28 1 -0.29 31 32
KRAS 0.028 0.006 -10000 0 -10000 0 0
RAC1-CDC42/GDP -0.019 0.14 -10000 0 -0.34 21 21
NRG2 -0.039 0.17 -10000 0 -0.42 56 56
mol:GDP -0.053 0.14 -10000 0 -0.31 83 83
SOS1 0.028 0.006 -10000 0 -10000 0 0
MAP2K2 -0.038 0.14 0.39 4 -0.4 17 21
SRC 0.026 0.035 -10000 0 -0.42 2 2
mol:cAMP -0.001 0.003 -10000 0 -10000 0 0
PTPN11 -0.057 0.13 0.29 1 -0.29 79 80
MAP2K1 -0.062 0.21 0.69 1 -0.62 21 22
heart morphogenesis -0.05 0.14 -10000 0 -0.3 82 82
RAS family/GDP -0.013 0.15 -10000 0 -0.36 21 21
GRB2 0.027 0.007 -10000 0 -10000 0 0
PRKACA -0.018 0.14 -10000 0 -0.71 15 15
CHRNE 0.005 0.049 0.2 8 -0.16 14 22
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
activation of caspase activity -0.006 0.008 -10000 0 -10000 0 0
nervous system development -0.05 0.14 -10000 0 -0.3 82 82
CDC42 0.028 0.006 -10000 0 -10000 0 0
IL27-mediated signaling events

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.023 0.054 -10000 0 -0.58 3 3
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.069 0.16 0.52 20 -10000 0 20
IL27/IL27R/JAK1 -0.057 0.19 -10000 0 -0.68 7 7
TBX21 -0.11 0.2 0.37 2 -0.54 38 40
IL12B -0.022 0.13 -10000 0 -0.34 45 45
IL12A -0.024 0.098 -10000 0 -0.28 40 40
IL6ST -0.046 0.19 -10000 0 -0.58 43 43
IL27RA/JAK1 0.013 0.089 0.62 1 -1.3 1 2
IL27 0.005 0.052 -10000 0 -0.26 11 11
TYK2 0.021 0.018 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.046 0.12 0.19 4 -0.31 53 57
T-helper 2 cell differentiation 0.069 0.16 0.52 20 -10000 0 20
T cell proliferation during immune response 0.069 0.16 0.52 20 -10000 0 20
MAPKKK cascade -0.069 0.16 -10000 0 -0.52 20 20
STAT3 0.028 0.007 -10000 0 -10000 0 0
STAT2 0.028 0.006 -10000 0 -10000 0 0
STAT1 0.016 0.077 -10000 0 -0.42 10 10
IL12RB1 -0.031 0.15 -10000 0 -0.35 57 57
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 -0.1 0.23 0.6 7 -0.51 48 55
IL27/IL27R/JAK2/TYK2 -0.07 0.16 -10000 0 -0.53 20 20
positive regulation of T cell mediated cytotoxicity -0.069 0.16 -10000 0 -0.52 20 20
STAT1 (dimer) -0.089 0.24 0.52 4 -0.69 23 27
JAK2 0.026 0.017 -10000 0 -10000 0 0
JAK1 0.029 0.01 -10000 0 -10000 0 0
STAT2 (dimer) -0.058 0.16 -10000 0 -0.5 20 20
T cell proliferation -0.13 0.19 -10000 0 -0.53 44 44
IL12/IL12R/TYK2/JAK2 -0.078 0.25 -10000 0 -0.87 29 29
IL17A -0.047 0.12 0.19 3 -0.31 53 56
mast cell activation 0.069 0.16 0.52 20 -10000 0 20
IFNG -0.017 0.043 0.14 1 -0.12 30 31
T cell differentiation -0.005 0.008 -10000 0 -0.022 27 27
STAT3 (dimer) -0.057 0.16 -10000 0 -0.5 20 20
STAT5A (dimer) -0.057 0.16 -10000 0 -0.5 20 20
STAT4 (dimer) -0.096 0.21 0.42 1 -0.54 47 48
STAT4 -0.056 0.19 -10000 0 -0.45 66 66
T cell activation -0.008 0.009 0.12 1 -10000 0 1
IL27R/JAK2/TYK2 -0.015 0.14 -10000 0 -0.84 2 2
GATA3 -0.11 0.4 -10000 0 -1.4 33 33
IL18 -0.051 0.14 -10000 0 -0.36 61 61
positive regulation of mast cell cytokine production -0.056 0.16 -10000 0 -0.49 20 20
IL27/EBI3 -0.046 0.15 -10000 0 -0.42 46 46
IL27RA -0.005 0.077 -10000 0 -1.4 1 1
IL6 -0.11 0.22 -10000 0 -0.4 119 119
STAT5A 0.028 0.007 -10000 0 -10000 0 0
monocyte differentiation -0.001 0.002 -10000 0 -10000 0 0
IL2 -0.009 0.039 0.49 1 -10000 0 1
IL1B -0.052 0.14 -10000 0 -0.32 70 70
EBI3 -0.065 0.2 -10000 0 -0.48 65 65
TNF -0.06 0.14 -10000 0 -0.3 83 83
BCR signaling pathway

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.061 0.15 0.39 7 -0.42 23 30
IKBKB -0.022 0.12 0.44 12 -0.34 5 17
AKT1 -0.05 0.16 0.48 18 -0.24 30 48
IKBKG -0.037 0.13 0.4 10 -0.31 24 34
CALM1 -0.051 0.11 0.32 2 -0.36 22 24
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
MAP3K1 -0.09 0.2 0.41 8 -0.47 50 58
MAP3K7 0.029 0.004 -10000 0 -10000 0 0
mol:Ca2+ -0.055 0.11 -10000 0 -0.36 27 27
DOK1 0.028 0.005 -10000 0 -10000 0 0
AP-1 -0.035 0.13 0.46 11 -0.25 13 24
LYN 0.029 0.004 -10000 0 -10000 0 0
BLNK 0.02 0.07 -10000 0 -0.58 5 5
SHC1 0.027 0.008 -10000 0 -10000 0 0
BCR complex -0.13 0.19 -10000 0 -0.39 107 107
CD22 -0.12 0.19 -10000 0 -0.54 42 42
CAMK2G -0.047 0.1 0.31 2 -0.34 22 24
CSNK2A1 0.028 0.005 -10000 0 -10000 0 0
INPP5D 0.017 0.064 -10000 0 -0.31 12 12
SHC/GRB2/SOS1 -0.077 0.13 -10000 0 -0.49 3 3
GO:0007205 -0.056 0.11 -10000 0 -0.37 27 27
SYK 0.027 0.008 -10000 0 -10000 0 0
ELK1 -0.047 0.11 0.32 2 -0.37 21 23
NFATC1 -0.092 0.15 0.36 5 -0.42 35 40
B-cell antigen/BCR complex -0.13 0.19 -10000 0 -0.39 107 107
PAG1/CSK 0.034 0.061 -10000 0 -0.42 6 6
NFKBIB 0.006 0.041 0.16 8 -0.13 5 13
HRAS -0.049 0.11 0.29 3 -0.34 22 25
NFKBIA 0.006 0.041 0.16 8 -0.13 5 13
NF-kappa-B/RelA/I kappa B beta 0.012 0.037 0.16 8 -10000 0 8
RasGAP/Csk -0.094 0.19 -10000 0 -0.36 89 89
mol:GDP -0.053 0.11 -10000 0 -0.36 26 26
PTEN 0.028 0.006 -10000 0 -10000 0 0
CD79B -0.006 0.098 -10000 0 -0.27 42 42
NF-kappa-B/RelA/I kappa B alpha 0.012 0.037 0.17 7 -10000 0 7
GRB2 0.028 0.007 -10000 0 -10000 0 0
PI3K/BCAP/CD19 -0.11 0.18 0.37 2 -0.51 31 33
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:IP3 -0.055 0.11 -10000 0 -0.37 27 27
CSK 0.028 0.015 -10000 0 -0.26 1 1
FOS -0.074 0.14 0.43 5 -0.36 29 34
CHUK -0.028 0.11 0.36 9 -0.35 5 14
IBTK 0.029 0.004 -10000 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 -0.066 0.16 0.3 1 -0.43 43 44
PTPN6 -0.12 0.18 -10000 0 -0.51 40 40
RELA 0.028 0.005 -10000 0 -10000 0 0
BCL2A1 -0.003 0.044 0.15 1 -0.11 15 16
VAV2 -0.13 0.19 -10000 0 -0.59 34 34
ubiquitin-dependent protein catabolic process 0.01 0.041 0.16 8 -0.12 5 13
BTK -0.11 0.37 -10000 0 -1.1 45 45
CD19 -0.14 0.19 -10000 0 -0.56 38 38
MAP4K1 -0.038 0.17 -10000 0 -0.42 55 55
CD72 0.01 0.077 -10000 0 -0.3 20 20
PAG1 0.018 0.077 -10000 0 -0.53 7 7
MAPK14 -0.074 0.17 0.38 10 -0.45 31 41
SH3BP5 0.027 0.021 -10000 0 -0.26 2 2
PIK3AP1 -0.047 0.11 -10000 0 -0.55 7 7
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.097 0.22 -10000 0 -0.46 79 79
RAF1 -0.045 0.11 0.31 4 -0.35 11 15
RasGAP/p62DOK/SHIP -0.093 0.19 -10000 0 -0.36 87 87
CD79A -0.17 0.23 -10000 0 -0.38 180 180
re-entry into mitotic cell cycle -0.035 0.12 0.45 11 -0.25 12 23
RASA1 0.028 0.006 -10000 0 -10000 0 0
MAPK3 -0.029 0.11 0.42 8 -0.35 5 13
MAPK1 -0.034 0.099 0.36 6 -0.35 5 11
CD72/SHP1 -0.11 0.18 -10000 0 -0.5 38 38
NFKB1 0.029 0.004 -10000 0 -10000 0 0
MAPK8 -0.077 0.18 0.43 9 -0.45 34 43
actin cytoskeleton organization -0.12 0.17 0.32 3 -0.51 32 35
NF-kappa-B/RelA 0.028 0.069 0.29 8 -0.21 1 9
Calcineurin -0.021 0.11 -10000 0 -0.4 6 6
PI3K -0.14 0.16 -10000 0 -0.45 44 44
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.049 0.12 -10000 0 -0.36 27 27
SOS1 0.028 0.006 -10000 0 -10000 0 0
Bam32/HPK1 -0.13 0.33 -10000 0 -0.88 51 51
DAPP1 -0.14 0.36 -10000 0 -1.1 43 43
cytokine secretion -0.086 0.14 0.36 5 -0.39 35 40
mol:DAG -0.055 0.11 -10000 0 -0.37 27 27
PLCG2 0.025 0.026 -10000 0 -0.26 3 3
MAP2K1 -0.041 0.1 0.34 4 -0.38 6 10
B-cell antigen/BCR complex/FcgammaRIIB -0.13 0.2 -10000 0 -0.38 120 120
mol:PI-3-4-5-P3 -0.11 0.11 -10000 0 -0.33 40 40
ETS1 -0.042 0.1 0.37 3 -0.4 7 10
B-cell antigen/BCR complex/LYN/SYK/BLNK -0.073 0.16 -10000 0 -0.32 71 71
B-cell antigen/BCR complex/LYN -0.09 0.18 -10000 0 -0.4 69 69
MALT1 0.029 0.005 -10000 0 -10000 0 0
TRAF6 0.027 0.032 -10000 0 -0.58 1 1
RAC1 -0.12 0.18 0.33 1 -0.55 32 33
B-cell antigen/BCR complex/LYN/SYK -0.12 0.19 -10000 0 -0.52 37 37
CARD11 -0.1 0.18 0.32 2 -0.49 47 49
FCGR2B -0.039 0.17 -10000 0 -0.43 54 54
PPP3CA 0.029 0.005 -10000 0 -10000 0 0
BCL10 0.028 0.006 -10000 0 -10000 0 0
IKK complex 0.003 0.095 0.39 15 -0.13 5 20
PTPRC -0.035 0.16 -10000 0 -0.38 57 57
PDPK1 -0.074 0.088 0.22 3 -0.24 34 37
PPP3CB 0.028 0.006 -10000 0 -10000 0 0
PPP3CC 0.029 0.005 -10000 0 -10000 0 0
POU2F2 0.007 0.033 0.16 5 -10000 0 5
Reelin signaling pathway

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.035 0.035 -10000 0 -10000 0 0
VLDLR 0.011 0.082 -10000 0 -0.35 16 16
CRKL 0.022 0.013 -10000 0 -10000 0 0
LRPAP1 0.027 0.032 -10000 0 -0.58 1 1
FYN 0.026 0.044 -10000 0 -0.58 2 2
ITGA3 0.02 0.07 -10000 0 -0.58 5 5
RELN/VLDLR/Fyn -0.067 0.16 -10000 0 -0.38 60 60
MAPK8IP1/MKK7/MAP3K11/JNK1 0.069 0.052 -10000 0 -0.31 4 4
AKT1 -0.04 0.1 -10000 0 -0.26 60 60
MAP2K7 0.027 0.008 -10000 0 -10000 0 0
RAPGEF1 0.027 0.008 -10000 0 -10000 0 0
DAB1 0.017 0.041 -10000 0 -0.26 8 8
RELN/LRP8/DAB1 -0.061 0.15 -10000 0 -0.35 63 63
LRPAP1/LRP8 0.028 0.072 -10000 0 -0.42 8 8
RELN/LRP8/DAB1/Fyn -0.05 0.15 -10000 0 -0.34 60 60
DAB1/alpha3/beta1 Integrin -0.055 0.14 -10000 0 -0.48 8 8
long-term memory -0.081 0.17 -10000 0 -0.35 80 80
DAB1/LIS1 -0.046 0.15 -10000 0 -0.32 61 61
DAB1/CRLK/C3G -0.058 0.14 -10000 0 -0.32 47 47
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
DAB1/NCK2 -0.046 0.15 -10000 0 -0.32 58 58
ARHGEF2 0.026 0.032 -10000 0 -0.58 1 1
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A -0.041 0.17 -10000 0 -0.41 59 59
CDK5R1 0.021 0.044 -10000 0 -0.26 9 9
RELN -0.13 0.22 -10000 0 -0.39 143 143
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
RELN/LRP8/Fyn -0.065 0.16 -10000 0 -0.38 60 60
GRIN2A/RELN/LRP8/DAB1/Fyn -0.081 0.18 -10000 0 -0.37 80 80
MAPK8 0.022 0.062 -10000 0 -0.58 4 4
RELN/VLDLR/DAB1 -0.062 0.14 -10000 0 -0.33 63 63
ITGB1 0.029 0.005 -10000 0 -10000 0 0
MAP1B -0.072 0.14 -10000 0 -0.34 62 62
RELN/LRP8 -0.065 0.16 -10000 0 -0.38 61 61
GRIN2B/RELN/LRP8/DAB1/Fyn -0.05 0.15 -10000 0 -0.34 60 60
PI3K 0.039 0.035 -10000 0 -0.42 2 2
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.034 0.055 -10000 0 -0.42 5 5
RAP1A -0.055 0.14 0.43 3 -0.47 6 9
PAFAH1B1 0.027 0.007 -10000 0 -10000 0 0
MAPK8IP1 0.028 0.016 -10000 0 -0.26 1 1
CRLK/C3G 0.03 0.02 -10000 0 -10000 0 0
GRIN2B 0 0 -10000 0 -10000 0 0
NCK2 0.028 0.005 -10000 0 -10000 0 0
neuron differentiation -0.015 0.098 -10000 0 -0.38 10 10
neuron adhesion -0.048 0.15 0.49 7 -0.44 8 15
LRP8 0.01 0.093 -10000 0 -0.4 16 16
GSK3B -0.04 0.097 -10000 0 -0.36 6 6
RELN/VLDLR/DAB1/Fyn -0.052 0.14 -10000 0 -0.32 63 63
MAP3K11 0.028 0.005 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.041 0.11 -10000 0 -0.28 60 60
CDK5 0.028 0.007 -10000 0 -10000 0 0
MAPT 0.005 0.15 0.72 12 -0.45 3 15
neuron migration -0.052 0.14 0.26 6 -0.35 56 62
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 -0.015 0.098 -10000 0 -0.39 10 10
RELN/VLDLR -0.058 0.16 -10000 0 -0.35 64 64
JNK signaling in the CD4+ TCR pathway

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 -0.03 0.18 -9999 0 -0.4 55 55
MAP4K1 -0.038 0.17 -9999 0 -0.42 55 55
MAP3K8 0.026 0.035 -9999 0 -0.42 2 2
PRKCB -0.031 0.14 -9999 0 -0.33 61 61
DBNL 0.028 0.007 -9999 0 -10000 0 0
CRKL 0.022 0.013 -9999 0 -10000 0 0
MAP3K1 -0.023 0.13 -9999 0 -0.45 21 21
JUN -0.029 0.18 -9999 0 -0.63 27 27
MAP3K7 -0.023 0.12 -9999 0 -0.44 20 20
GRAP2 -0.031 0.14 -9999 0 -0.35 52 52
CRK 0.027 0.008 -9999 0 -10000 0 0
MAP2K4 -0.029 0.13 -9999 0 -0.44 22 22
LAT 0.013 0.084 -9999 0 -0.42 12 12
LCP2 0.018 0.058 -9999 0 -0.28 12 12
MAPK8 -0.026 0.18 -9999 0 -0.65 26 26
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family -0.022 0.13 -9999 0 -0.47 20 20
LAT/GRAP2/SLP76/HPK1/HIP-55 -0.02 0.17 -9999 0 -0.4 46 46
Nongenotropic Androgen signaling

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.009 0.002 -10000 0 -10000 0 0
GNB1/GNG2 -0.004 0.12 -10000 0 -0.33 32 32
regulation of S phase of mitotic cell cycle -0.008 0.098 -10000 0 -0.28 36 36
GNAO1 -0.028 0.17 -10000 0 -0.54 37 37
HRAS 0.026 0.022 -10000 0 -0.26 2 2
SHBG/T-DHT 0.009 0.055 -10000 0 -0.27 12 12
PELP1 0.027 0.007 -10000 0 -10000 0 0
AKT1 0.01 0.002 -10000 0 -10000 0 0
MAP2K1 -0.022 0.13 0.52 6 -0.3 34 40
T-DHT/AR -0.042 0.14 -10000 0 -0.3 73 73
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.001 0.003 -10000 0 -0.007 38 38
GNAI2 0.029 0.004 -10000 0 -10000 0 0
GNAI3 0.028 0.006 -10000 0 -10000 0 0
GNAI1 0.018 0.053 -10000 0 -0.26 13 13
mol:GDP -0.049 0.14 -10000 0 -0.46 38 38
cell proliferation -0.051 0.18 0.52 11 -0.43 40 51
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
FOS -0.091 0.27 0.54 9 -0.82 37 46
mol:Ca2+ -0.013 0.025 -10000 0 -0.076 25 25
MAPK3 -0.023 0.17 0.51 14 -0.43 14 28
MAPK1 -0.093 0.19 0.34 7 -0.38 92 99
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:IP3 0 0.001 -10000 0 -0.004 36 36
cAMP biosynthetic process 0.005 0.061 0.25 6 -0.34 7 13
GNG2 0.026 0.026 -10000 0 -0.26 3 3
potassium channel inhibitor activity 0 0.001 -10000 0 -0.004 36 36
HRAS/GTP -0.006 0.12 -10000 0 -0.32 35 35
actin cytoskeleton reorganization 0.04 0.028 -10000 0 -0.29 2 2
SRC 0.026 0.035 -10000 0 -0.42 2 2
voltage-gated calcium channel activity 0 0.001 -10000 0 -0.004 36 36
PI3K 0.036 0.03 -10000 0 -0.36 2 2
apoptosis 0.061 0.18 0.44 43 -0.44 9 52
T-DHT/AR/PELP1 -0.02 0.12 -10000 0 -0.34 39 39
HRAS/GDP -0.034 0.14 -10000 0 -0.45 38 38
CREB1 -0.067 0.19 0.44 9 -0.48 43 52
RAC1-CDC42/GTP 0.051 0.03 -10000 0 -0.3 2 2
AR -0.059 0.19 -10000 0 -0.41 73 73
GNB1 0.028 0.006 -10000 0 -10000 0 0
RAF1 -0.016 0.13 0.53 6 -0.31 35 41
RAC1-CDC42/GDP -0.015 0.14 -10000 0 -0.42 37 37
T-DHT/AR/PELP1/Src -0.005 0.12 -10000 0 -0.34 35 35
MAP2K2 -0.025 0.12 0.49 4 -0.3 34 38
T-DHT/AR/PELP1/Src/PI3K -0.008 0.099 -10000 0 -0.29 36 36
GNAZ 0.012 0.074 -10000 0 -0.5 7 7
SHBG 0.012 0.088 -10000 0 -0.44 12 12
Gi family/GNB1/GNG2/GDP -0.022 0.12 -10000 0 -0.41 20 20
mol:T-DHT 0 0.002 -10000 0 -0.005 32 32
RAC1 0.028 0.007 -10000 0 -10000 0 0
GNRH1 0.001 0.057 -10000 0 -0.34 9 9
Gi family/GTP -0.044 0.097 -10000 0 -0.33 19 19
CDC42 0.028 0.006 -10000 0 -10000 0 0
IL1-mediated signaling events

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.035 0.014 -10000 0 -10000 0 0
PRKCZ 0.027 0.016 -10000 0 -0.26 1 1
MAP3K7IP2 0 0 -10000 0 -10000 0 0
ERC1 0.028 0.006 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.041 0.15 -10000 0 -0.52 22 22
IRAK/TOLLIP 0.031 0.015 -10000 0 -10000 0 0
IKBKB 0.029 0.004 -10000 0 -10000 0 0
IKBKG 0.026 0.009 -10000 0 -10000 0 0
IL1 alpha/IL1R2 -0.12 0.22 -10000 0 -0.44 102 102
IL1A -0.038 0.17 -10000 0 -0.44 53 53
IL1B -0.047 0.15 -10000 0 -0.42 44 44
IRAK/TRAF6/p62/Atypical PKCs 0.066 0.036 -10000 0 -10000 0 0
IL1R2 -0.11 0.24 -10000 0 -0.47 107 107
IL1R1 0.028 0.005 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.036 0.13 -10000 0 -0.44 23 23
TOLLIP 0.028 0.006 -10000 0 -10000 0 0
TICAM2 0.023 0.054 -10000 0 -0.58 3 3
MAP3K3 0.028 0.007 -10000 0 -10000 0 0
TAK1/TAB1/TAB2 0.02 0.002 -10000 0 -10000 0 0
IKK complex/ELKS 0.037 0.058 0.28 1 -10000 0 1
JUN -0.013 0.064 0.38 1 -0.31 7 8
MAP3K7 0.029 0.004 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.031 0.19 -10000 0 -0.36 76 76
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.031 0.18 -10000 0 -0.36 77 77
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 -0.013 0.17 -10000 0 -0.35 69 69
IL1 beta fragment/IL1R1/IL1RAP -0.062 0.19 -10000 0 -0.4 81 81
NFKB1 0.029 0.004 -10000 0 -10000 0 0
MAPK8 0.002 0.054 -10000 0 -0.32 8 8
IRAK1 0.016 0.011 -10000 0 -10000 0 0
IL1RN/IL1R1 -0.023 0.15 -10000 0 -0.42 41 41
IRAK4 0.028 0.006 -10000 0 -10000 0 0
PRKCI 0.029 0.004 -10000 0 -10000 0 0
TRAF6 0.027 0.032 -10000 0 -0.58 1 1
PI3K 0.039 0.035 -10000 0 -0.42 2 2
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.043 0.16 -10000 0 -0.53 24 24
CHUK 0.029 0.005 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.062 0.19 -10000 0 -0.4 81 81
IL1 beta/IL1R2 -0.11 0.2 -10000 0 -0.41 103 103
IRAK/TRAF6/TAK1/TAB1/TAB2 0.038 0.024 -10000 0 -0.3 1 1
NF kappa B1 p50/RelA -0.034 0.17 -10000 0 -0.53 16 16
IRAK3 0.026 0.035 -10000 0 -0.42 2 2
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.03 0.18 -10000 0 -0.36 74 74
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.037 0.15 -10000 0 -0.55 16 16
IL1 alpha/IL1R1/IL1RAP -0.05 0.19 -10000 0 -0.4 78 78
RELA 0.028 0.005 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
SQSTM1 0.028 0.006 -10000 0 -10000 0 0
MYD88 0.029 0.004 -10000 0 -10000 0 0
IRAK/TRAF6/MEKK3 0.045 0.029 -10000 0 -0.32 1 1
IL1RAP -0.064 0.22 -10000 0 -0.57 58 58
UBE2N 0.028 0.006 -10000 0 -10000 0 0
IRAK/TRAF6 -0.042 0.15 -10000 0 -0.51 14 14
CASP1 0.02 0.063 -10000 0 -0.38 8 8
IL1RN/IL1R2 -0.12 0.24 -10000 0 -0.47 103 103
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.045 0.19 -10000 0 -0.38 79 79
TMEM189-UBE2V1 0.02 0.016 -10000 0 -0.26 1 1
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.021 0.13 -10000 0 -0.48 15 15
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
IL1RN -0.055 0.2 -10000 0 -0.47 63 63
TRAF6/TAK1/TAB1/TAB2 0.049 0.025 -10000 0 -0.3 1 1
MAP2K6 0.012 0.044 -10000 0 -0.29 5 5
Plasma membrane estrogen receptor signaling

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.009 0.12 -10000 0 -0.32 33 33
ER alpha/Gai/GDP/Gbeta gamma -0.047 0.2 -10000 0 -0.55 39 39
AKT1 -0.057 0.27 -10000 0 -0.81 41 41
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.055 0.28 -10000 0 -0.83 40 40
mol:Ca2+ -0.053 0.14 -10000 0 -0.44 28 28
IGF1R 0.027 0.031 -10000 0 -0.58 1 1
E2/ER alpha (dimer)/Striatin -0.04 0.15 -10000 0 -0.38 54 54
SHC1 0.027 0.008 -10000 0 -10000 0 0
apoptosis 0.053 0.26 0.77 41 -10000 0 41
RhoA/GTP -0.012 0.089 -10000 0 -0.28 29 29
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.031 0.18 -10000 0 -0.54 34 34
regulation of stress fiber formation 0.019 0.088 0.36 5 -0.23 1 6
E2/ERA-ERB (dimer) -0.019 0.13 -10000 0 -0.38 33 33
KRAS 0.028 0.006 -10000 0 -10000 0 0
G13/GTP -0.013 0.11 -10000 0 -0.33 29 29
pseudopodium formation -0.019 0.088 0.23 1 -0.36 5 6
E2/ER alpha (dimer)/PELP1 -0.016 0.12 -10000 0 -0.34 33 33
GRB2 0.028 0.007 -10000 0 -10000 0 0
GNG2 0.026 0.026 -10000 0 -0.26 3 3
GNAO1 -0.028 0.17 -10000 0 -0.54 37 37
HRAS 0.027 0.022 -10000 0 -0.26 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.029 0.21 0.44 5 -0.6 36 41
E2/ER beta (dimer) 0.018 0.036 -10000 0 -0.3 4 4
mol:GDP -0.021 0.13 -10000 0 -0.42 34 34
mol:NADP -0.029 0.21 0.44 5 -0.6 36 41
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:IP3 -0.054 0.15 -10000 0 -0.46 28 28
IGF-1R heterotetramer 0.027 0.031 -10000 0 -0.58 1 1
PLCB1 -0.041 0.13 -10000 0 -0.41 24 24
PLCB2 -0.048 0.14 -10000 0 -0.44 30 30
IGF1 -0.057 0.17 -10000 0 -0.36 83 83
mol:L-citrulline -0.029 0.21 0.44 5 -0.6 36 41
RHOA 0.029 0.004 -10000 0 -10000 0 0
Gai/GDP -0.047 0.24 -10000 0 -0.76 36 36
JNK cascade 0.018 0.035 -10000 0 -0.3 4 4
BCAR1 0.028 0.007 -10000 0 -10000 0 0
ESR2 0.024 0.049 -10000 0 -0.42 4 4
GNAQ 0.027 0.008 -10000 0 -10000 0 0
ESR1 -0.056 0.18 -10000 0 -0.4 74 74
Gq family/GDP/Gbeta gamma -0.05 0.22 -10000 0 -0.54 52 52
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 0 0.12 -10000 0 -0.61 6 6
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.033 0.18 -10000 0 -0.55 33 33
GNAZ 0.012 0.074 -10000 0 -0.5 7 7
E2/ER alpha (dimer) -0.04 0.13 -10000 0 -0.28 76 76
STRN -0.007 0.14 -10000 0 -0.58 22 22
GNAL -0.01 0.14 -10000 0 -0.43 32 32
PELP1 0.027 0.007 -10000 0 -10000 0 0
MAPK11 0.011 0.031 0.19 1 -0.35 2 3
GNAI2 0.029 0.004 -10000 0 -10000 0 0
GNAI3 0.028 0.006 -10000 0 -10000 0 0
GNAI1 0.018 0.053 -10000 0 -0.26 13 13
HBEGF -0.07 0.2 0.36 4 -0.58 35 39
cAMP biosynthetic process -0.033 0.12 -10000 0 -0.32 50 50
SRC -0.046 0.19 -10000 0 -0.58 31 31
PI3K 0.039 0.035 -10000 0 -0.42 2 2
GNB1 0.028 0.006 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma 0.018 0.13 -10000 0 -0.39 31 31
SOS1 0.028 0.006 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.066 0.16 -10000 0 -0.48 34 34
Gs family/GTP -0.028 0.13 -10000 0 -0.32 50 50
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.051 0.021 -10000 0 -10000 0 0
vasodilation -0.024 0.2 0.45 6 -0.57 36 42
mol:DAG -0.054 0.15 -10000 0 -0.46 28 28
Gs family/GDP/Gbeta gamma -0.026 0.13 -10000 0 -0.39 34 34
MSN -0.021 0.094 0.23 1 -0.39 5 6
Gq family/GTP -0.033 0.13 -10000 0 -0.35 36 36
mol:PI-3-4-5-P3 -0.051 0.26 -10000 0 -0.78 41 41
NRAS 0.028 0.005 -10000 0 -10000 0 0
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.024 0.2 0.57 36 -0.45 6 42
GRB2/SOS1 0.041 0.011 -10000 0 -10000 0 0
RhoA/GDP -0.006 0.13 -10000 0 -0.41 33 33
NOS3 -0.036 0.21 0.38 2 -0.64 36 38
GNA11 0.009 0.1 -10000 0 -0.58 11 11
MAPKKK cascade -0.049 0.22 0.36 1 -0.62 42 43
E2/ER alpha (dimer)/PELP1/Src -0.036 0.19 -10000 0 -0.57 34 34
ruffle organization -0.019 0.088 0.23 1 -0.36 5 6
ROCK2 -0.014 0.11 0.35 5 -0.35 11 16
GNA14 -0.013 0.11 -10000 0 -0.28 48 48
GNA15 -0.028 0.16 -10000 0 -0.48 41 41
GNA13 0.028 0.007 -10000 0 -10000 0 0
MMP9 -0.091 0.22 0.47 1 -0.61 41 42
MMP2 -0.051 0.19 0.47 1 -0.59 29 30
Caspase cascade in apoptosis

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 0 0.14 0.31 4 -0.39 30 34
ACTA1 -0.02 0.17 0.33 5 -0.48 31 36
NUMA1 -0.004 0.14 0.29 4 -0.4 31 35
SPTAN1 -0.018 0.16 0.35 5 -0.47 31 36
LIMK1 -0.011 0.17 0.46 8 -0.47 30 38
BIRC3 -0.067 0.2 -10000 0 -0.43 78 78
BIRC2 0.028 0.005 -10000 0 -10000 0 0
BAX 0.028 0.007 -10000 0 -10000 0 0
CASP10 -0.052 0.14 -10000 0 -0.39 48 48
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0.027 0.008 -10000 0 -10000 0 0
PTK2 -0.007 0.15 0.28 5 -0.42 34 39
DIABLO 0.028 0.006 -10000 0 -10000 0 0
apoptotic nuclear changes -0.018 0.16 0.35 5 -0.46 31 36
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.028 0.006 -10000 0 -10000 0 0
GSN -0.022 0.17 0.35 5 -0.48 33 38
MADD 0.028 0.005 -10000 0 -10000 0 0
TFAP2A -0.047 0.23 -10000 0 -0.65 46 46
BID -0.036 0.11 -10000 0 -0.3 45 45
MAP3K1 0.009 0.068 0.26 2 -0.37 2 4
TRADD 0.028 0.007 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.041 0.011 -10000 0 -10000 0 0
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.014 0.17 0.5 6 -0.47 30 36
CASP9 0.028 0.006 -10000 0 -10000 0 0
DNA repair -0.021 0.083 0.39 4 -0.19 35 39
neuron apoptosis 0.005 0.12 -10000 0 -0.58 12 12
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.007 0.16 0.33 4 -0.46 31 35
APAF1 0.028 0.006 -10000 0 -10000 0 0
CASP6 0.005 0.11 0.34 2 -0.62 4 6
TRAF2 0.027 0.009 -10000 0 -10000 0 0
ICAD/CAD -0.011 0.17 0.39 12 -0.46 30 42
CASP7 0.036 0.12 0.3 41 -0.45 5 46
KRT18 0.015 0.06 -10000 0 -0.53 3 3
apoptosis 0 0.15 0.42 4 -0.4 29 33
DFFA -0.016 0.17 0.32 8 -0.47 31 39
DFFB -0.016 0.17 0.33 7 -0.47 31 38
PARP1 0.021 0.084 0.19 35 -0.4 4 39
actin filament polymerization 0.003 0.17 0.43 30 -0.5 12 42
TNF -0.07 0.2 -10000 0 -0.42 83 83
CYCS -0.02 0.069 0.27 2 -0.22 19 21
SATB1 0.007 0.11 0.46 2 -0.58 4 6
SLK -0.02 0.16 0.39 4 -0.47 31 35
p15 BID/BAX -0.033 0.11 -10000 0 -0.34 24 24
CASP2 -0.028 0.1 -10000 0 -0.36 18 18
JNK cascade -0.009 0.067 0.37 2 -0.26 2 4
CASP3 -0.021 0.17 0.32 6 -0.49 32 38
LMNB2 -0.007 0.12 0.32 9 -0.41 16 25
RIPK1 0.029 0.003 -10000 0 -10000 0 0
CASP4 0.019 0.056 -10000 0 -0.29 11 11
Mammalian IAPs/DIABLO 0.007 0.13 -10000 0 -0.33 38 38
negative regulation of DNA binding -0.046 0.23 -10000 0 -0.64 46 46
stress fiber formation -0.02 0.16 0.39 4 -0.46 31 35
GZMB -0.056 0.17 -10000 0 -0.46 48 48
CASP1 0.011 0.055 -10000 0 -0.52 3 3
LMNB1 0.006 0.1 0.31 9 -0.4 8 17
APP 0.005 0.12 -10000 0 -0.59 12 12
TNFRSF1A 0.028 0.006 -10000 0 -10000 0 0
response to stress 0 0.001 -10000 0 -10000 0 0
CASP8 0.01 0.002 -10000 0 -10000 0 0
VIM 0.002 0.14 0.34 6 -0.38 31 37
LMNA 0.002 0.11 0.32 10 -0.38 10 20
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD -0.026 0.11 -10000 0 -0.38 17 17
LRDD 0 0 -10000 0 -10000 0 0
SREBF1 -0.012 0.17 0.44 8 -0.47 31 39
APAF-1/Caspase 9 0.021 0.073 -10000 0 -0.54 3 3
nuclear fragmentation during apoptosis -0.004 0.14 0.29 4 -0.4 31 35
CFL2 -0.004 0.18 0.51 12 -0.44 30 42
GAS2 -0.021 0.16 0.31 6 -0.45 34 40
positive regulation of apoptosis 0.003 0.11 0.32 9 -0.4 10 19
PRF1 -0.002 0.11 -10000 0 -0.37 28 28
Syndecan-2-mediated signaling events

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.082 0.17 -10000 0 -0.36 100 100
EPHB2 0.018 0.076 -10000 0 -0.58 6 6
Syndecan-2/TACI -0.05 0.13 -10000 0 -0.36 44 44
LAMA1 -0.059 0.21 -10000 0 -0.56 55 55
Syndecan-2/alpha2 ITGB1 -0.013 0.15 -10000 0 -0.36 46 46
HRAS 0.027 0.022 -10000 0 -0.26 2 2
Syndecan-2/CASK 0.01 0.029 -10000 0 -0.36 2 2
ITGA5 0.026 0.032 -10000 0 -0.58 1 1
BAX 0.01 0.041 -10000 0 -10000 0 0
EPB41 0.028 0.006 -10000 0 -10000 0 0
positive regulation of cell-cell adhesion 0.028 0.028 -10000 0 -0.32 2 2
LAMA3 -0.032 0.16 -10000 0 -0.39 54 54
EZR 0.027 0.032 -10000 0 -0.58 1 1
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 0.015 0.088 -10000 0 -0.58 8 8
Syndecan-2/MMP2 0.015 0.08 -10000 0 -0.36 14 14
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 -0.007 0.13 -10000 0 -0.42 30 30
dendrite morphogenesis 0.024 0.055 -10000 0 -0.36 7 7
Syndecan-2/GM-CSF -0.039 0.15 -10000 0 -0.36 59 59
determination of left/right symmetry 0.014 0.032 -10000 0 -0.42 2 2
Syndecan-2/PKC delta 0.03 0.032 -10000 0 -0.36 2 2
GNB2L1 0.028 0.006 -10000 0 -10000 0 0
MAPK3 -0.039 0.13 -10000 0 -0.33 58 58
MAPK1 -0.043 0.13 -10000 0 -0.32 59 59
Syndecan-2/RACK1 0.042 0.033 -10000 0 -0.3 2 2
NF1 0.028 0.007 -10000 0 -10000 0 0
FGFR/FGF/Syndecan-2 0.014 0.032 -10000 0 -0.42 2 2
ITGA2 -0.035 0.17 -10000 0 -0.45 49 49
MAPK8 0.013 0.047 -10000 0 -0.35 6 6
Syndecan-2/alpha2/beta1 Integrin -0.026 0.16 -10000 0 -0.34 71 71
Syndecan-2/Kininogen 0.019 0.046 -10000 0 -0.36 2 2
ITGB1 0.029 0.005 -10000 0 -10000 0 0
SRC 0.023 0.038 -10000 0 -0.29 3 3
Syndecan-2/CASK/Protein 4.1 0.027 0.029 -10000 0 -0.32 2 2
extracellular matrix organization 0.027 0.045 -10000 0 -0.36 5 5
actin cytoskeleton reorganization -0.082 0.17 -10000 0 -0.36 100 100
Syndecan-2/Caveolin-2/Ras 0.037 0.062 -10000 0 -0.32 10 10
Syndecan-2/Laminin alpha3 -0.007 0.11 -10000 0 -0.37 24 24
Syndecan-2/RasGAP 0.054 0.035 -10000 0 -0.29 2 2
alpha5/beta1 Integrin 0.04 0.026 -10000 0 -0.42 1 1
PRKCD 0.029 0.004 -10000 0 -10000 0 0
Syndecan-2 dimer 0.024 0.055 -10000 0 -0.36 7 7
GO:0007205 0.003 0 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.043 0.038 -10000 0 -0.28 3 3
RHOA 0.029 0.004 -10000 0 -10000 0 0
SDCBP 0.029 0.004 -10000 0 -10000 0 0
TNFRSF13B -0.1 0.2 -10000 0 -0.37 118 118
RASA1 0.028 0.006 -10000 0 -10000 0 0
alpha2/beta1 Integrin -0.007 0.13 -10000 0 -0.42 30 30
Syndecan-2/Synbindin 0.03 0.031 -10000 0 -0.36 2 2
TGFB1 0.023 0.054 -10000 0 -0.58 3 3
CASP3 0.021 0.031 0.19 2 -0.32 2 4
FN1 -0.15 0.26 -10000 0 -0.52 123 123
Syndecan-2/IL8 -0.055 0.15 -10000 0 -0.36 69 69
SDC2 0.015 0.032 -10000 0 -0.42 2 2
KNG1 0.011 0.057 -10000 0 -0.26 16 16
Syndecan-2/Neurofibromin 0.03 0.03 -10000 0 -0.36 2 2
TRAPPC4 0.028 0.006 -10000 0 -10000 0 0
CSF2 -0.081 0.22 -10000 0 -0.5 76 76
Syndecan-2/TGFB1 0.027 0.045 -10000 0 -0.36 5 5
Syndecan-2/Syntenin/PI-4-5-P2 0.028 0.028 -10000 0 -0.32 2 2
Syndecan-2/Ezrin 0.046 0.037 -10000 0 -0.32 3 3
PRKACA 0.02 0.028 0.19 1 -0.32 2 3
angiogenesis -0.055 0.15 -10000 0 -0.36 69 69
MMP2 0.003 0.11 -10000 0 -0.44 20 20
IL8 -0.11 0.24 -10000 0 -0.47 103 103
calcineurin-NFAT signaling pathway -0.05 0.13 -10000 0 -0.36 44 44
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.055 0.14 -10000 0 -0.4 43 43
CRKL -0.03 0.13 -10000 0 -0.43 29 29
HRAS -0.048 0.14 -10000 0 -0.46 20 20
mol:PIP3 -0.019 0.13 -10000 0 -0.4 27 27
SPRED1 0.029 0.004 -10000 0 -10000 0 0
SPRED2 0.028 0.005 -10000 0 -10000 0 0
GAB1 -0.03 0.14 -10000 0 -0.45 31 31
FOXO3 -0.01 0.13 0.39 2 -0.4 22 24
AKT1 -0.013 0.14 0.34 1 -0.42 25 26
BAD -0.009 0.12 0.33 1 -0.4 22 23
megakaryocyte differentiation -0.055 0.16 -10000 0 -0.42 49 49
GSK3B -0.01 0.13 0.33 1 -0.4 22 23
RAF1 -0.036 0.12 0.24 1 -0.37 18 19
SHC1 0.027 0.008 -10000 0 -10000 0 0
STAT3 -0.028 0.14 -10000 0 -0.45 29 29
STAT1 -0.071 0.31 -10000 0 -1 32 32
HRAS/SPRED1 -0.034 0.12 -10000 0 -0.38 18 18
cell proliferation -0.032 0.14 -10000 0 -0.45 32 32
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
TEC 0.029 0.004 -10000 0 -10000 0 0
RPS6KB1 -0.02 0.14 -10000 0 -0.44 31 31
HRAS/SPRED2 -0.034 0.12 -10000 0 -0.37 19 19
LYN/TEC/p62DOK 0.005 0.15 -10000 0 -0.43 30 30
MAPK3 -0.019 0.096 0.41 1 -0.28 10 11
STAP1 -0.085 0.18 -10000 0 -0.46 47 47
GRAP2 -0.031 0.14 -10000 0 -0.35 52 52
JAK2 -0.059 0.28 -10000 0 -0.9 32 32
STAT1 (dimer) -0.071 0.3 -10000 0 -1 32 32
mol:Gleevec 0 0.006 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.023 0.17 -10000 0 -0.41 43 43
actin filament polymerization -0.028 0.13 -10000 0 -0.43 30 30
LYN 0.029 0.004 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.087 0.21 -10000 0 -0.64 35 35
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
CBL/CRKL/GRB2 0.001 0.13 -10000 0 -0.39 27 27
PI3K 0.006 0.15 -10000 0 -0.43 29 29
PTEN 0.028 0.006 -10000 0 -10000 0 0
SCF/KIT/EPO/EPOR -0.069 0.36 -10000 0 -1.3 28 28
MAPK8 -0.033 0.15 -10000 0 -0.46 32 32
STAT3 (dimer) -0.027 0.13 -10000 0 -0.44 29 29
positive regulation of transcription -0.011 0.089 0.34 4 -0.23 9 13
mol:GDP -0.054 0.16 -10000 0 -0.43 35 35
PIK3C2B -0.028 0.14 -10000 0 -0.45 28 28
CBL/CRKL -0.012 0.13 -10000 0 -0.4 29 29
FER -0.029 0.14 -10000 0 -0.45 31 31
SH2B3 -0.028 0.14 -10000 0 -0.45 30 30
PDPK1 -0.014 0.12 0.32 2 -0.38 24 26
SNAI2 -0.034 0.14 -10000 0 -0.45 32 32
positive regulation of cell proliferation -0.046 0.22 -10000 0 -0.74 31 31
KITLG 0.008 0.1 -10000 0 -0.56 11 11
cell motility -0.046 0.22 -10000 0 -0.74 31 31
PTPN6 0.028 0.018 -10000 0 -0.26 1 1
EPOR -0.009 0.15 -10000 0 -1 2 2
STAT5A (dimer) -0.035 0.19 -10000 0 -0.62 30 30
SOCS1 0.008 0.091 -10000 0 -0.36 19 19
cell migration 0.043 0.15 0.46 33 -10000 0 33
SOS1 0.028 0.006 -10000 0 -10000 0 0
EPO 0.015 0.024 -10000 0 -0.25 1 1
VAV1 -0.034 0.16 -10000 0 -0.42 51 51
GRB10 -0.03 0.14 -10000 0 -0.44 30 30
PTPN11 0.028 0.008 -10000 0 -10000 0 0
SCF/KIT -0.031 0.15 -10000 0 -0.47 32 32
GO:0007205 0.001 0.007 -10000 0 -10000 0 0
MAP2K1 -0.026 0.1 0.3 3 -0.3 14 17
CBL 0.028 0.006 -10000 0 -10000 0 0
KIT -0.084 0.37 -10000 0 -1.3 30 30
MAP2K2 -0.025 0.1 0.33 2 -0.3 14 16
SHC/Grb2/SOS1 0.005 0.14 -10000 0 -0.43 25 25
STAT5A -0.036 0.19 -10000 0 -0.64 30 30
GRB2 0.028 0.007 -10000 0 -10000 0 0
response to radiation -0.033 0.14 -10000 0 -0.44 32 32
SHC/GRAP2 -0.01 0.1 -10000 0 -0.38 13 13
PTPRO -0.057 0.16 -10000 0 -0.42 49 49
SH2B2 -0.029 0.14 -10000 0 -0.44 30 30
DOK1 0.028 0.005 -10000 0 -10000 0 0
MATK -0.044 0.15 -10000 0 -0.47 33 33
CREBBP 0.025 0.046 -10000 0 -10000 0 0
BCL2 -0.007 0.2 -10000 0 -0.93 11 11
a4b1 and a4b7 Integrin signaling

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ITGB1 0.029 0.005 -9999 0 -10000 0 0
ITGB7 -0.024 0.16 -9999 0 -0.43 42 42
ITGA4 0 0.1 -9999 0 -0.31 32 32
alpha4/beta7 Integrin -0.02 0.14 -9999 0 -0.46 27 27
alpha4/beta1 Integrin 0.02 0.076 -9999 0 -0.42 5 5
Arf6 signaling events

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.038 0.009 -10000 0 -10000 0 0
ARNO/beta Arrestin1-2 0.01 0.13 -10000 0 -0.67 10 10
EGFR 0.002 0.12 -10000 0 -0.54 17 17
EPHA2 0.025 0.044 -10000 0 -0.58 2 2
USP6 0.017 0.055 -10000 0 -0.26 14 14
IQSEC1 0.029 0.004 -10000 0 -10000 0 0
EGFR/EGFR/EGF/EGF -0.018 0.14 -10000 0 -0.44 30 30
ARRB2 0.005 0.041 -10000 0 -0.32 4 4
mol:GTP 0.019 0.04 0.18 12 -0.16 2 14
ARRB1 0.024 0.054 -10000 0 -0.58 3 3
FBXO8 0.029 0.005 -10000 0 -10000 0 0
TSHR 0.025 0.044 -10000 0 -0.58 2 2
EGF -0.033 0.15 -10000 0 -0.34 64 64
somatostatin receptor activity 0 0 0.002 12 -0.001 30 42
ARAP2 0.027 0.031 -10000 0 -0.58 1 1
mol:GDP -0.047 0.12 0.21 5 -0.29 45 50
mol:PI-3-4-5-P3 0 0 0.002 11 -0.001 16 27
ITGA2B 0 0.12 -10000 0 -0.47 21 21
ARF6 0.028 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.064 0.035 -10000 0 -0.33 1 1
ADAP1 0.028 0.007 -10000 0 -10000 0 0
KIF13B 0.029 0.004 -10000 0 -10000 0 0
HGF/MET -0.047 0.18 -10000 0 -0.44 61 61
PXN 0.028 0.006 -10000 0 -10000 0 0
ARF6/GTP -0.033 0.13 0.46 8 -0.28 32 40
EGFR/EGFR/EGF/EGF/ARFGEP100 0.002 0.13 -10000 0 -0.38 29 29
ADRB2 0.007 0.096 -10000 0 -0.37 20 20
receptor agonist activity 0 0 0.001 14 0 26 40
actin filament binding 0 0 0.002 13 -0.001 33 46
SRC 0.026 0.035 -10000 0 -0.42 2 2
ITGB3 -0.002 0.13 -10000 0 -0.58 18 18
GNAQ 0.027 0.008 -10000 0 -10000 0 0
EFA6/PI-4-5-P2 0 0.001 0.004 16 -0.001 20 36
ARF6/GDP 0.01 0.11 0.28 4 -0.38 17 21
ARF6/GDP/GULP/ACAP1 -0.061 0.17 -10000 0 -0.39 53 53
alphaIIb/beta3 Integrin/paxillin/GIT1 0.032 0.12 -10000 0 -0.36 31 31
ACAP1 -0.014 0.13 -10000 0 -0.35 41 41
ACAP2 0.029 0.004 -10000 0 -10000 0 0
LHCGR/beta Arrestin2 0.008 0.06 -10000 0 -0.45 4 4
EFNA1 0.027 0.008 -10000 0 -10000 0 0
HGF -0.031 0.16 -10000 0 -0.44 47 47
CYTH3 0.009 0.002 -10000 0 -10000 0 0
CYTH2 -0.006 0.15 -10000 0 -0.97 9 9
NCK1 0.029 0.004 -10000 0 -10000 0 0
fibronectin binding 0 0 0.001 16 0 27 43
endosomal lumen acidification 0 0 0.002 2 0 30 32
microtubule-based process 0 0 -10000 0 -0.001 5 5
GULP1 -0.04 0.18 -10000 0 -0.46 53 53
GNAQ/ARNO 0.011 0.14 -10000 0 -0.89 9 9
mol:Phosphatidic acid 0 0 0.001 12 -10000 0 12
PIP3-E 0 0 0 8 0 6 14
MET -0.03 0.18 -10000 0 -0.58 36 36
GNA14 -0.013 0.11 -10000 0 -0.28 48 48
GNA15 -0.028 0.16 -10000 0 -0.48 41 41
GIT1 0.028 0.007 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0.001 0.002 15 -0.001 23 38
GNA11 0.009 0.1 -10000 0 -0.58 11 11
LHCGR -0.007 0.09 -10000 0 -0.29 30 30
AGTR1 -0.12 0.23 -10000 0 -0.43 124 124
desensitization of G-protein coupled receptor protein signaling pathway 0.008 0.06 -10000 0 -0.45 4 4
IPCEF1/ARNO -0.012 0.16 -10000 0 -0.78 9 9
alphaIIb/beta3 Integrin -0.002 0.14 -10000 0 -0.45 32 32
Signaling events mediated by PTP1B

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.008 0.11 -10000 0 -0.55 13 13
Jak2/Leptin Receptor -0.009 0.12 0.25 2 -0.36 25 27
PTP1B/AKT1 0.012 0.083 0.26 2 -0.29 13 15
FYN 0.026 0.044 -10000 0 -0.58 2 2
p210 bcr-abl/PTP1B 0.005 0.096 0.3 9 -0.3 15 24
EGFR 0.001 0.12 -10000 0 -0.55 17 17
EGF/EGFR -0.003 0.13 -10000 0 -0.36 34 34
CSF1 0.009 0.11 -10000 0 -0.58 12 12
AKT1 0.029 0.006 -10000 0 -10000 0 0
INSR 0.028 0.008 -10000 0 -10000 0 0
PTP1B/N-cadherin -0.048 0.16 0.34 3 -0.31 80 83
Insulin Receptor/Insulin 0.019 0.071 0.21 1 -0.3 6 7
HCK -0.027 0.16 -10000 0 -0.48 41 41
CRK 0.027 0.008 -10000 0 -10000 0 0
TYK2 0.012 0.098 0.33 12 -0.31 11 23
EGF -0.034 0.15 -10000 0 -0.33 64 64
YES1 0.029 0.005 -10000 0 -10000 0 0
CAV1 0.008 0.12 0.37 12 -0.36 13 25
TXN 0.026 0.018 -10000 0 -0.26 1 1
PTP1B/IRS1/GRB2 0.018 0.094 0.32 1 -0.33 9 10
cell migration -0.005 0.096 0.3 15 -0.3 9 24
STAT3 0.028 0.007 -10000 0 -10000 0 0
PRLR -0.043 0.17 -10000 0 -0.4 63 63
ITGA2B -0.001 0.12 -10000 0 -0.47 21 21
CSF1R 0.006 0.11 -10000 0 -0.51 15 15
Prolactin Receptor/Prolactin -0.03 0.12 -10000 0 -0.28 63 63
FGR 0.006 0.11 -10000 0 -0.5 16 16
PTP1B/p130 Cas 0.013 0.086 0.25 3 -0.29 13 16
Crk/p130 Cas 0.021 0.085 -10000 0 -0.31 9 9
DOK1 0.011 0.1 0.35 11 -0.31 12 23
JAK2 -0.015 0.13 0.31 7 -0.38 27 34
Jak2/Leptin Receptor/Leptin -0.008 0.13 -10000 0 -0.43 18 18
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
PTPN1 0.005 0.096 0.3 9 -0.3 15 24
LYN 0.029 0.004 -10000 0 -10000 0 0
CDH2 -0.098 0.24 -10000 0 -0.54 84 84
SRC 0.028 0.062 0.28 1 -0.57 2 3
ITGB3 -0.002 0.13 -10000 0 -0.58 18 18
CAT1/PTP1B -0.054 0.18 0.38 10 -0.46 30 40
CAPN1 0.029 0.006 -10000 0 -10000 0 0
CSK 0.028 0.015 -10000 0 -0.26 1 1
PI3K 0.033 0.073 -10000 0 -0.32 5 5
mol:H2O2 0 0.006 0.015 29 -0.007 25 54
STAT3 (dimer) -0.007 0.13 -10000 0 -0.44 18 18
negative regulation of transcription -0.014 0.13 0.31 7 -0.37 27 34
FCGR2A 0.001 0.12 -10000 0 -0.52 18 18
FER 0.025 0.045 -10000 0 -0.59 2 2
alphaIIb/beta3 Integrin -0.003 0.14 -10000 0 -0.45 32 32
BLK -0.12 0.22 -10000 0 -0.39 132 132
Insulin Receptor/Insulin/Shc 0.035 0.015 -10000 0 -10000 0 0
RHOA 0.029 0.005 -10000 0 -10000 0 0
LEPR 0.018 0.063 -10000 0 -0.31 12 12
BCAR1 0.028 0.007 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.028 0.007 -10000 0 -10000 0 0
mol:NADPH 0 0.005 0.016 21 -0.007 26 47
TRPV6 -0.078 0.2 0.39 3 -0.57 32 35
PRL 0 0.004 0.016 16 -10000 0 16
SOCS3 -0.029 0.27 -10000 0 -1.3 16 16
SPRY2 0.025 0.03 -10000 0 -0.26 4 4
Insulin Receptor/Insulin/IRS1 0.031 0.046 -10000 0 -0.37 4 4
CSF1/CSF1R 0.004 0.13 0.24 1 -0.4 25 26
Ras protein signal transduction 0.021 0.096 0.41 19 -10000 0 19
IRS1 0.019 0.069 -10000 0 -0.42 8 8
INS 0.001 0.002 0.012 9 -0.009 3 12
LEP -0.009 0.081 -10000 0 -0.26 34 34
STAT5B 0.003 0.1 0.31 8 -0.28 17 25
STAT5A 0.003 0.1 0.31 8 -0.28 17 25
GRB2 0.028 0.007 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.002 0.1 0.24 1 -0.32 23 24
CSN2 -0.014 0.052 0.12 8 -0.16 30 38
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
LAT -0.004 0.16 0.3 2 -0.56 22 24
YBX1 0.035 0.008 -10000 0 -10000 0 0
LCK -0.034 0.16 -10000 0 -0.37 58 58
SHC1 0.027 0.008 -10000 0 -10000 0 0
NOX4 -0.006 0.14 -10000 0 -0.49 25 25
BMP receptor signaling

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.042 0.19 -10000 0 -0.38 64 64
SMAD6-7/SMURF1 0.054 0.027 -10000 0 -0.36 1 1
NOG -0.084 0.22 -10000 0 -0.51 78 78
SMAD9 -0.025 0.15 -10000 0 -0.44 38 38
SMAD4 0.029 0.005 -10000 0 -10000 0 0
SMAD5 -0.007 0.09 -10000 0 -0.38 5 5
BMP7/USAG1 -0.071 0.17 -10000 0 -0.42 54 54
SMAD5/SKI 0.009 0.1 0.34 4 -0.38 4 8
SMAD1 -0.013 0.079 -10000 0 -0.3 1 1
BMP2 0.014 0.075 -10000 0 -0.32 16 16
SMAD1/SMAD1/SMAD4 0.006 0.076 -10000 0 -10000 0 0
BMPR1A 0.028 0.006 -10000 0 -10000 0 0
BMPR1B -0.062 0.18 -10000 0 -0.38 82 82
BMPR1A-1B/BAMBI -0.033 0.16 -10000 0 -0.4 45 45
AHSG 0.006 0.067 -10000 0 -0.26 22 22
CER1 0 0 -10000 0 -10000 0 0
BMP2-4/CER1 0.003 0.098 -10000 0 -0.37 18 18
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA 0.002 0.091 -10000 0 -0.4 5 5
BMP2-4 (homodimer) 0.001 0.11 -10000 0 -0.43 18 18
RGMB 0.028 0.006 -10000 0 -10000 0 0
BMP6/BMPR2/BMPR1A-1B 0.008 0.12 -10000 0 -0.33 33 33
RGMA 0.007 0.11 -10000 0 -0.48 16 16
SMURF1 0.028 0.007 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.012 0.096 -10000 0 -0.35 11 11
BMP2-4/USAG1 -0.08 0.17 -10000 0 -0.39 72 72
SMAD6/SMURF1/SMAD5 0.008 0.094 0.3 1 -0.38 3 4
SOSTDC1 -0.12 0.22 -10000 0 -0.39 131 131
BMP7/BMPR2/BMPR1A-1B 0.011 0.12 -10000 0 -0.33 30 30
SKI 0.028 0.006 -10000 0 -10000 0 0
BMP6 (homodimer) 0.026 0.038 -10000 0 -0.36 3 3
HFE2 0.017 0.026 -10000 0 -0.26 3 3
ZFYVE16 0.028 0.006 -10000 0 -10000 0 0
MAP3K7 0.029 0.004 -10000 0 -10000 0 0
BMP2-4/CHRD 0.004 0.13 -10000 0 -0.39 29 29
SMAD5/SMAD5/SMAD4 0.011 0.1 0.34 4 -0.38 4 8
MAPK1 0.022 0.013 -10000 0 -10000 0 0
TAK1/TAB family 0.009 0.096 -10000 0 -0.36 7 7
BMP7 (homodimer) 0.028 0.005 -10000 0 -10000 0 0
NUP214 0.027 0.008 -10000 0 -10000 0 0
BMP6/FETUA 0.024 0.057 -10000 0 -0.42 1 1
SMAD1/SKI 0 0.089 0.31 1 -0.32 3 4
SMAD6 0.027 0.031 -10000 0 -0.58 1 1
CTDSP2 0.028 0.006 -10000 0 -10000 0 0
BMP2-4/FETUA 0.006 0.11 -10000 0 -0.39 19 19
MAP3K7IP1 0 0 -10000 0 -10000 0 0
GREM1 -0.14 0.23 -10000 0 -0.41 142 142
BMPR2 (homodimer) 0.028 0.005 -10000 0 -10000 0 0
GADD34/PP1CA 0.05 0.033 -10000 0 -10000 0 0
BMPR1A-1B (homodimer) -0.027 0.14 -10000 0 -0.42 32 32
CHRDL1 -0.16 0.24 -10000 0 -0.41 161 161
ENDOFIN/SMAD1 -0.003 0.086 -10000 0 -0.31 2 2
SMAD6-7/SMURF1/SMAD1 0.021 0.092 -10000 0 -10000 0 0
SMAD6/SMURF1 0.028 0.007 -10000 0 -10000 0 0
BAMBI -0.014 0.14 -10000 0 -0.39 38 38
SMURF2 0.028 0.007 -10000 0 -10000 0 0
BMP2-4/CHRDL1 -0.11 0.19 -10000 0 -0.39 94 94
BMP2-4/GREM1 -0.088 0.18 -10000 0 -0.39 77 77
SMAD7 0.029 0.005 -10000 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 -0.01 0.15 0.34 1 -0.44 32 33
SMAD1/SMAD6 0 0.084 -10000 0 -10000 0 0
TAK1/SMAD6 0.041 0.011 -10000 0 -10000 0 0
BMP7 0.028 0.005 -10000 0 -10000 0 0
BMP6 0.026 0.038 -10000 0 -0.36 3 3
MAP3K7IP2 0 0 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.001 0.083 -10000 0 -0.32 8 8
PPM1A 0.028 0.005 -10000 0 -10000 0 0
SMAD1/SMURF2 -0.001 0.087 0.32 1 -0.34 1 2
SMAD7/SMURF1 0.041 0.011 -10000 0 -10000 0 0
CTDSPL 0.029 0.004 -10000 0 -10000 0 0
PPP1CA 0.028 0.005 -10000 0 -10000 0 0
XIAP 0.027 0.008 -10000 0 -10000 0 0
CTDSP1 0.028 0.005 -10000 0 -10000 0 0
PPP1R15A 0.021 0.042 -10000 0 -0.26 8 8
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.055 0.17 -10000 0 -0.56 27 27
CHRD 0.005 0.11 -10000 0 -0.52 16 16
BMPR2 0.028 0.005 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.013 0.096 -10000 0 -0.37 9 9
BMP4 -0.01 0.13 -10000 0 -0.4 34 34
FST -0.086 0.21 -10000 0 -0.42 95 95
BMP2-4/NOG -0.057 0.18 -10000 0 -0.38 78 78
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 0.023 0.12 -10000 0 -0.31 30 30
Angiopoietin receptor Tie2-mediated signaling

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.031 0.25 -10000 0 -0.95 22 22
NCK1/PAK1/Dok-R -0.05 0.11 -10000 0 -0.43 23 23
NCK1/Dok-R -0.054 0.31 -10000 0 -1.2 22 22
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
mol:beta2-estradiol 0.004 0.051 0.23 17 -10000 0 17
RELA 0.028 0.005 -10000 0 -10000 0 0
SHC1 0.027 0.008 -10000 0 -10000 0 0
Rac/GDP 0.021 0.005 -10000 0 -10000 0 0
F2 0.003 0.052 0.23 17 -10000 0 17
TNIP2 0.029 0.005 -10000 0 -10000 0 0
NF kappa B/RelA -0.013 0.28 -10000 0 -1.1 22 22
FN1 -0.15 0.26 -10000 0 -0.52 123 123
PLD2 -0.053 0.3 -10000 0 -1.2 22 22
PTPN11 0.028 0.006 -10000 0 -10000 0 0
GRB14 0.017 0.075 -10000 0 -0.44 9 9
ELK1 -0.043 0.27 -10000 0 -1.1 22 22
GRB7 -0.008 0.14 -10000 0 -0.58 22 22
PAK1 0.028 0.005 -10000 0 -10000 0 0
Tie2/Ang1/alpha5/beta1 Integrin -0.098 0.32 -10000 0 -1.2 22 22
CDKN1A -0.029 0.23 0.56 2 -0.71 30 32
ITGA5 0.026 0.032 -10000 0 -0.58 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R -0.051 0.31 -10000 0 -1.2 22 22
CRK 0.027 0.008 -10000 0 -10000 0 0
mol:NO -0.002 0.21 0.56 8 -0.68 22 30
PLG -0.054 0.31 -10000 0 -1.2 22 22
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis -0.027 0.23 -10000 0 -0.9 22 22
GRB2 0.028 0.007 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
ANGPT2 -0.061 0.21 0.4 1 -0.77 20 21
BMX -0.065 0.31 -10000 0 -1.2 22 22
ANGPT1 -0.066 0.3 -10000 0 -1.4 17 17
tube development -0.039 0.21 0.5 1 -0.7 27 28
ANGPT4 -0.008 0.13 -10000 0 -0.41 31 31
response to hypoxia -0.006 0.018 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 -0.048 0.33 -10000 0 -1.3 22 22
alpha5/beta1 Integrin 0.04 0.026 -10000 0 -0.42 1 1
FGF2 0.012 0.098 -10000 0 -0.58 10 10
STAT5A (dimer) -0.042 0.25 -10000 0 -0.8 32 32
mol:L-citrulline -0.002 0.21 0.56 8 -0.68 22 30
AGTR1 -0.12 0.23 -10000 0 -0.43 124 124
MAPK14 -0.045 0.31 -10000 0 -1.2 22 22
Tie2/SHP2 -0.023 0.24 -10000 0 -1.2 12 12
TEK -0.021 0.26 -10000 0 -1.4 12 12
RPS6KB1 -0.022 0.24 0.51 1 -0.9 22 23
Angiotensin II/AT1 -0.086 0.17 -10000 0 -0.31 124 124
Tie2/Ang1/GRB2 -0.046 0.32 -10000 0 -1.3 22 22
MAPK3 -0.045 0.28 -10000 0 -1.1 22 22
MAPK1 -0.052 0.27 -10000 0 -1.1 22 22
Tie2/Ang1/GRB7 -0.065 0.33 -10000 0 -1.3 22 22
NFKB1 0.029 0.004 -10000 0 -10000 0 0
MAPK8 -0.056 0.31 -10000 0 -1.2 22 22
PI3K -0.038 0.29 -10000 0 -1.1 22 22
FES -0.048 0.31 -10000 0 -1.2 22 22
Crk/Dok-R -0.052 0.31 -10000 0 -1.2 22 22
Tie2/Ang1/ABIN2 -0.045 0.32 -10000 0 -1.3 22 22
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity -0.019 0.23 0.53 3 -0.84 22 25
STAT5A 0.028 0.007 -10000 0 -10000 0 0
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 -0.023 0.24 0.52 2 -0.91 22 24
Tie2/Ang2 -0.061 0.29 -10000 0 -0.99 27 27
Tie2/Ang1 -0.059 0.35 -10000 0 -1.4 22 22
FOXO1 -0.02 0.24 0.65 2 -0.81 25 27
ELF1 0.029 0.051 -10000 0 -0.57 2 2
ELF2 -0.052 0.31 -10000 0 -1.2 22 22
mol:Choline -0.047 0.29 -10000 0 -1.1 22 22
cell migration -0.047 0.073 -10000 0 -0.22 33 33
FYN -0.047 0.24 0.51 1 -0.81 27 28
DOK2 -0.027 0.16 -10000 0 -0.46 43 43
negative regulation of cell cycle -0.023 0.21 0.56 2 -0.64 30 32
ETS1 0.019 0.069 -10000 0 -0.26 17 17
PXN -0.006 0.21 0.54 7 -0.73 22 29
ITGB1 0.029 0.005 -10000 0 -10000 0 0
NOS3 -0.01 0.23 0.6 6 -0.78 22 28
RAC1 0.028 0.007 -10000 0 -10000 0 0
TNF -0.077 0.21 -10000 0 -0.41 95 95
MAPKKK cascade -0.047 0.29 -10000 0 -1.1 22 22
RASA1 0.028 0.006 -10000 0 -10000 0 0
Tie2/Ang1/Shc -0.047 0.32 -10000 0 -1.3 22 22
NCK1 0.029 0.004 -10000 0 -10000 0 0
vasculogenesis 0.004 0.19 0.55 9 -0.6 22 31
mol:Phosphatidic acid -0.047 0.29 -10000 0 -1.1 22 22
mol:Angiotensin II 0.001 0.004 -10000 0 -10000 0 0
mol:NADP -0.002 0.21 0.56 8 -0.68 22 30
Rac1/GTP -0.018 0.22 -10000 0 -0.83 22 22
MMP2 -0.064 0.31 -10000 0 -1.2 22 22
FOXM1 transcription factor network

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 0 0.4 0.77 1 -1.2 23 24
PLK1 0.028 0.13 -10000 0 -1.1 4 4
BIRC5 -0.039 0.34 -10000 0 -1.5 20 20
HSPA1B -0.007 0.4 -10000 0 -1.2 23 23
MAP2K1 0.035 0.049 -10000 0 -0.24 1 1
BRCA2 -0.018 0.43 -10000 0 -1.2 28 28
FOXM1 -0.062 0.55 -10000 0 -1.6 27 27
XRCC1 -0.002 0.4 0.77 1 -1.2 23 24
FOXM1B/p19 -0.038 0.43 -10000 0 -1.2 29 29
Cyclin D1/CDK4 0.021 0.38 -10000 0 -1 25 25
CDC2 -0.01 0.42 -10000 0 -1.2 28 28
TGFA -0.017 0.41 -10000 0 -1.1 33 33
SKP2 -0.001 0.41 0.77 1 -1.1 25 26
CCNE1 0.03 0.011 -10000 0 -10000 0 0
CKS1B 0.006 0.4 -10000 0 -1.1 24 24
RB1 0.041 0.25 -10000 0 -0.86 14 14
FOXM1C/SP1 -0.021 0.47 -10000 0 -1.4 25 25
AURKB -0.07 0.4 -10000 0 -1.5 27 27
CENPF -0.006 0.44 -10000 0 -1.3 26 26
CDK4 0.031 0.022 -10000 0 -10000 0 0
MYC -0.003 0.38 -10000 0 -1 27 27
CHEK2 0.029 0.043 -10000 0 -10000 0 0
ONECUT1 -0.003 0.4 -10000 0 -1.1 26 26
CDKN2A -0.043 0.16 -10000 0 -0.36 67 67
LAMA4 -0.011 0.41 -10000 0 -1.2 25 25
FOXM1B/HNF6 -0.029 0.49 -10000 0 -1.4 26 26
FOS -0.083 0.52 0.77 1 -1.2 57 58
SP1 0.028 0.008 -10000 0 -10000 0 0
CDC25B -0.006 0.4 -10000 0 -1.1 25 25
response to radiation 0.012 0.028 -10000 0 -10000 0 0
CENPB -0.003 0.4 -10000 0 -1.2 22 22
CENPA -0.027 0.45 -10000 0 -1.2 31 31
NEK2 -0.015 0.46 -10000 0 -1.3 29 29
HIST1H2BA -0.008 0.4 -10000 0 -1.1 28 28
CCNA2 0.018 0.078 -10000 0 -0.36 13 13
EP300 0.02 0.033 -10000 0 -0.58 1 1
CCNB1/CDK1 -0.03 0.46 -10000 0 -1.4 25 25
CCNB2 -0.01 0.41 -10000 0 -1.2 24 24
CCNB1 -0.009 0.42 -10000 0 -1.2 25 25
ETV5 -0.024 0.45 0.77 1 -1.2 30 31
ESR1 -0.081 0.52 -10000 0 -1.2 51 51
CCND1 0.007 0.39 -10000 0 -1.1 26 26
GSK3A 0.034 0.038 -10000 0 -10000 0 0
Cyclin A-E1/CDK1-2 0.055 0.069 -10000 0 -0.39 3 3
CDK2 0.031 0.01 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle 0.015 0.035 -10000 0 -10000 0 0
FOXM1B/Cbp/p300 -0.026 0.43 -10000 0 -1.3 24 24
GAS1 -0.021 0.43 -10000 0 -1.2 29 29
MMP2 -0.022 0.45 0.77 1 -1.2 33 34
RB1/FOXM1C 0.007 0.4 -10000 0 -1.1 26 26
CREBBP 0.028 0.007 -10000 0 -10000 0 0
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 -0.003 0.14 -10000 0 -0.42 36 36
CRKL -0.018 0.11 0.32 2 -0.43 5 7
mol:PIP3 -0.002 0.015 -10000 0 -10000 0 0
AKT1 0.005 0.059 0.39 3 -0.42 2 5
PTK2B 0.024 0.054 -10000 0 -0.58 3 3
RAPGEF1 -0.006 0.11 0.43 3 -0.41 5 8
RANBP10 0.028 0.007 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
HGF/MET/SHIP2 -0.024 0.16 -10000 0 -0.38 60 60
MAP3K5 -0.019 0.17 0.5 7 -0.49 21 28
HGF/MET/CIN85/CBL/ENDOPHILINS -0.007 0.16 -10000 0 -0.34 59 59
AP1 -0.021 0.15 0.22 1 -0.36 48 49
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0.027 0.008 -10000 0 -10000 0 0
apoptosis -0.046 0.25 -10000 0 -0.76 39 39
STAT3 (dimer) -0.02 0.12 -10000 0 -0.45 11 11
GAB1/CRKL/SHP2/PI3K 0.026 0.12 -10000 0 -0.42 4 4
INPP5D 0.017 0.064 -10000 0 -0.31 12 12
CBL/CRK 0.012 0.13 0.41 7 -0.4 5 12
PTPN11 0.028 0.006 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0.028 0.005 -10000 0 -10000 0 0
PTEN 0.028 0.006 -10000 0 -10000 0 0
ELK1 0.033 0.15 0.44 21 -0.38 3 24
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 -0.005 0.074 -10000 0 -0.31 5 5
PAK1 0.007 0.056 0.36 4 -0.31 2 6
HGF/MET/RANBP10 -0.024 0.16 -10000 0 -0.38 60 60
HRAS -0.054 0.22 -10000 0 -0.65 38 38
DOCK1 -0.007 0.12 0.41 3 -0.42 6 9
GAB1 -0.015 0.11 -10000 0 -0.45 5 5
CRK -0.01 0.12 0.32 3 -0.43 5 8
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP -0.058 0.22 -10000 0 -0.56 60 60
JUN 0.006 0.094 -10000 0 -0.35 22 22
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.031 0.1 -10000 0 -0.26 60 60
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
cell morphogenesis -0.011 0.14 0.65 2 -0.55 6 8
GRB2/SHC -0.002 0.1 -10000 0 -0.27 35 35
FOS -0.047 0.18 -10000 0 -0.44 60 60
GLMN 0.004 0.001 -10000 0 -10000 0 0
cell motility 0.033 0.15 0.44 21 -0.38 3 24
HGF/MET/MUC20 -0.038 0.16 -10000 0 -0.38 61 61
cell migration -0.002 0.1 -10000 0 -0.26 35 35
GRB2 0.028 0.007 -10000 0 -10000 0 0
CBL 0.028 0.006 -10000 0 -10000 0 0
MET/RANBP10 -0.004 0.14 -10000 0 -0.42 36 36
HGF/MET/Paxillin/FAK1/FAK12/RasGAP -0.017 0.12 -10000 0 -0.44 11 11
MET/MUC20 -0.022 0.13 -10000 0 -0.42 36 36
RAP1B 0.01 0.14 0.54 11 -0.4 4 15
RAP1A 0.008 0.12 0.4 8 -0.38 5 13
HGF/MET/RANBP9 -0.023 0.16 -10000 0 -0.38 59 59
RAF1 -0.05 0.2 -10000 0 -0.6 38 38
STAT3 -0.02 0.12 -10000 0 -0.46 11 11
cell proliferation -0.029 0.17 -10000 0 -0.4 55 55
RPS6KB1 0 0.04 -10000 0 -10000 0 0
MAPK3 -0.02 0.12 0.54 10 -10000 0 10
MAPK1 0.13 0.3 0.62 94 -10000 0 94
RANBP9 0.029 0.003 -10000 0 -10000 0 0
MAPK8 0.007 0.18 0.6 13 -0.55 8 21
SRC -0.022 0.12 -10000 0 -0.44 11 11
PI3K -0.002 0.11 -10000 0 -0.27 39 39
MET/Glomulin -0.013 0.12 -10000 0 -0.38 36 36
SOS1 0.028 0.006 -10000 0 -10000 0 0
MAP2K1 -0.042 0.19 -10000 0 -0.56 37 37
MET -0.03 0.18 -10000 0 -0.58 36 36
MAP4K1 -0.02 0.14 0.32 3 -0.48 17 20
PTK2 0.028 0.006 -10000 0 -10000 0 0
MAP2K2 -0.039 0.18 -10000 0 -0.55 37 37
BAD 0.007 0.056 0.36 4 -0.32 1 5
MAP2K4 -0.005 0.18 0.54 13 -0.45 20 33
SHP2/GRB2/SOS1/GAB1 -0.001 0.14 -10000 0 -0.4 34 34
INPPL1 0.028 0.005 -10000 0 -10000 0 0
PXN 0.028 0.006 -10000 0 -10000 0 0
SH3KBP1 0.027 0.008 -10000 0 -10000 0 0
HGS -0.029 0.096 -10000 0 -0.28 36 36
PLCgamma1/PKC 0.021 0.004 -10000 0 -10000 0 0
HGF -0.031 0.16 -10000 0 -0.44 47 47
RASA1 0.028 0.006 -10000 0 -10000 0 0
NCK1 0.029 0.004 -10000 0 -10000 0 0
PTPRJ 0.028 0.005 -10000 0 -10000 0 0
NCK/PLCgamma1 -0.001 0.11 -10000 0 -0.27 37 37
PDPK1 -0.001 0.049 -10000 0 -0.41 3 3
HGF/MET/SHIP -0.031 0.17 -10000 0 -0.38 63 63
S1P1 pathway

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.019 0.099 -10000 0 -0.43 16 16
PDGFRB 0.007 0.11 -10000 0 -0.56 13 13
SPHK1 -0.011 0.12 -10000 0 -0.87 7 7
mol:S1P -0.014 0.12 -10000 0 -0.78 7 7
S1P1/S1P/Gi -0.068 0.2 -10000 0 -0.46 62 62
GNAO1 -0.033 0.17 -10000 0 -0.54 37 37
PDGFB-D/PDGFRB/PLCgamma1 -0.066 0.19 -10000 0 -0.51 37 37
PLCG1 -0.065 0.18 -10000 0 -0.44 60 60
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.007 0.11 -10000 0 -0.56 13 13
GNAI2 0.024 0.016 -10000 0 -10000 0 0
GNAI3 0.023 0.016 -10000 0 -10000 0 0
GNAI1 0.014 0.055 -10000 0 -0.27 13 13
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 -0.012 0.079 -10000 0 -0.38 15 15
S1P1/S1P -0.026 0.11 -10000 0 -0.46 15 15
negative regulation of cAMP metabolic process -0.065 0.19 0.54 1 -0.45 62 63
MAPK3 -0.093 0.24 -10000 0 -0.62 59 59
calcium-dependent phospholipase C activity -0.002 0.003 -10000 0 -10000 0 0
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
RhoA/GDP 0.021 0.003 -10000 0 -10000 0 0
KDR 0.003 0.12 -10000 0 -0.54 16 16
PLCB2 -0.028 0.12 0.44 2 -0.4 23 25
RAC1 0.028 0.007 -10000 0 -10000 0 0
RhoA/GTP -0.018 0.097 -10000 0 -0.38 15 15
receptor internalization -0.025 0.1 -10000 0 -0.42 15 15
PTGS2 -0.16 0.39 0.56 2 -1 63 65
Rac1/GTP -0.017 0.096 -10000 0 -0.39 14 14
RHOA 0.029 0.004 -10000 0 -10000 0 0
VEGFA 0.023 0.047 -10000 0 -0.47 3 3
negative regulation of T cell proliferation -0.065 0.19 0.54 1 -0.45 62 63
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ 0.009 0.075 -10000 0 -0.51 7 7
MAPK1 -0.093 0.25 0.53 1 -0.62 61 62
S1P1/S1P/PDGFB-D/PDGFRB -0.028 0.14 0.24 1 -0.47 21 22
ABCC1 0.027 0.007 -10000 0 -10000 0 0
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.021 0.07 -10000 0 -0.58 5 5
Caspase 8 (4 units) -0.009 0.13 -10000 0 -0.56 11 11
NEF -0.024 0.064 -10000 0 -0.21 29 29
NFKBIA 0.007 0.048 -10000 0 -10000 0 0
BIRC3 -0.064 0.21 -10000 0 -0.59 43 43
CYCS -0.036 0.14 -10000 0 -0.51 17 17
RIPK1 0.029 0.003 -10000 0 -10000 0 0
CD247 -0.071 0.2 -10000 0 -0.38 88 88
MAP2K7 -0.031 0.2 0.34 1 -0.68 23 24
protein ubiquitination -0.01 0.1 0.29 5 -0.44 3 8
CRADD 0.028 0.006 -10000 0 -10000 0 0
DAXX 0.029 0.003 -10000 0 -10000 0 0
FAS 0.02 0.07 -10000 0 -0.58 5 5
BID -0.038 0.15 -10000 0 -0.49 22 22
NF-kappa-B/RelA/I kappa B alpha 0.007 0.12 -10000 0 -0.3 39 39
TRADD 0.028 0.007 -10000 0 -10000 0 0
MAP3K5 0.008 0.11 -10000 0 -0.58 13 13
CFLAR 0.029 0.005 -10000 0 -10000 0 0
FADD 0.028 0.005 -10000 0 -10000 0 0
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.006 0.12 -10000 0 -0.3 39 39
MAPK8 -0.028 0.18 0.32 2 -0.62 23 25
APAF1 0.028 0.006 -10000 0 -10000 0 0
TRAF1 0.023 0.036 -10000 0 -0.28 5 5
TRAF2 0.027 0.009 -10000 0 -10000 0 0
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG -0.034 0.14 -10000 0 -0.37 39 39
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD -0.019 0.12 -10000 0 -0.43 9 9
CHUK -0.014 0.11 0.27 3 -0.48 3 6
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.065 0.091 -10000 0 -0.38 13 13
TCRz/NEF -0.071 0.18 -10000 0 -0.36 88 88
TNF -0.07 0.2 -10000 0 -0.42 83 83
FASLG -0.11 0.25 -10000 0 -0.55 77 77
NFKB1 0.006 0.053 -10000 0 -0.36 1 1
TNFR1A/BAG4/TNF-alpha -0.017 0.14 -10000 0 -0.36 46 46
CASP6 0.014 0.13 -10000 0 -0.65 8 8
CASP7 -0.051 0.21 0.36 4 -0.57 45 49
RELA 0.006 0.05 -10000 0 -0.16 3 3
CASP2 0.028 0.007 -10000 0 -10000 0 0
CASP3 -0.053 0.21 0.36 1 -0.56 45 46
TNFRSF1A 0.028 0.006 -10000 0 -10000 0 0
TNFR1A/BAG4 0.035 0.054 -10000 0 -0.42 5 5
CASP8 0.028 0.005 -10000 0 -10000 0 0
CASP9 0.028 0.006 -10000 0 -10000 0 0
MAP3K14 -0.019 0.11 -10000 0 -0.46 5 5
APAF-1/Caspase 9 -0.06 0.17 -10000 0 -0.44 46 46
BCL2 -0.029 0.17 0.4 2 -0.57 21 23
IL2 signaling events mediated by STAT5

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.024 0.054 -10000 0 -0.58 3 3
ELF1 -0.023 0.13 -10000 0 -0.37 42 42
CCNA2 0.015 0.076 -10000 0 -0.36 13 13
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
JAK3 -0.051 0.2 -10000 0 -0.56 50 50
PIK3R1 0.029 0.006 -10000 0 -10000 0 0
JAK1 0.029 0.006 -10000 0 -10000 0 0
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.072 0.25 -10000 0 -0.69 40 40
SHC1 0.028 0.008 -10000 0 -10000 0 0
SP1 0.031 0.041 -10000 0 -0.36 4 4
IL2RA -0.088 0.26 -10000 0 -0.78 44 44
IL2RB -0.028 0.14 -10000 0 -0.38 46 46
SOS1 0.029 0.006 -10000 0 -10000 0 0
IL2RG -0.064 0.18 -10000 0 -0.37 85 85
G1/S transition of mitotic cell cycle 0.009 0.12 0.34 3 -0.64 10 13
PTPN11 0.029 0.006 -10000 0 -10000 0 0
CCND2 0.016 0.089 -10000 0 -0.84 4 4
LCK -0.034 0.16 -10000 0 -0.37 58 58
GRB2 0.028 0.007 -10000 0 -10000 0 0
IL2 0.013 0.045 -10000 0 -0.26 10 10
CDK6 0.02 0.062 -10000 0 -0.4 7 7
CCND3 -0.056 0.21 -10000 0 -0.67 28 28
Visual signal transduction: Rods

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.029 0.004 -10000 0 -10000 0 0
GNAT1/GTP 0.013 0.024 -10000 0 -0.17 6 6
Metarhodopsin II/Arrestin 0.015 0.015 -10000 0 -10000 0 0
PDE6G/GNAT1/GTP -0.01 0.11 -10000 0 -0.36 26 26
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.016 0.036 -10000 0 -0.26 6 6
GRK1 -0.029 0.17 -10000 0 -0.48 42 42
CNG Channel -0.035 0.15 -10000 0 -0.37 51 51
mol:Na + -0.017 0.12 -10000 0 -0.32 42 42
mol:ADP -0.029 0.17 -10000 0 -0.48 42 42
RGS9-1/Gbeta5/R9AP 0.001 0.13 -10000 0 -0.38 34 34
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel -0.01 0.13 -10000 0 -0.33 42 42
CNGB1 -0.015 0.14 -10000 0 -0.42 35 35
RDH5 -0.073 0.22 -10000 0 -0.54 66 66
SAG 0 0 -10000 0 -10000 0 0
mol:Ca2+ -0.023 0.13 0.42 8 -0.31 42 50
Na + (4 Units) -0.018 0.12 -10000 0 -0.3 42 42
RGS9 -0.018 0.14 -10000 0 -0.39 40 40
GNB1/GNGT1 0.021 0.004 -10000 0 -10000 0 0
GNAT1/GDP 0.008 0.12 -10000 0 -0.33 34 34
GUCY2D -0.007 0.13 -10000 0 -0.45 27 27
GNGT1 0 0 -10000 0 -10000 0 0
GUCY2F 0 0 -10000 0 -10000 0 0
GNB5 0.027 0.031 -10000 0 -0.58 1 1
mol:GMP (4 units) -0.02 0.11 -10000 0 -0.33 35 35
mol:11-cis-retinal -0.073 0.22 -10000 0 -0.54 66 66
mol:cGMP 0.008 0.091 -10000 0 -0.32 22 22
GNB1 0.028 0.006 -10000 0 -10000 0 0
Rhodopsin -0.041 0.17 -10000 0 -0.42 62 62
SLC24A1 0.029 0.004 -10000 0 -10000 0 0
CNGA1 0.002 0.11 -10000 0 -0.37 25 25
Metarhodopsin II -0.004 0.1 -10000 0 -0.33 30 30
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.017 0.1 -10000 0 -0.34 22 22
RGS9BP -0.004 0.13 -10000 0 -0.5 22 22
Metarhodopsin II/Transducin 0.012 0.012 -10000 0 -10000 0 0
GCAP Family/Ca ++ 0.025 0.05 -10000 0 -0.32 6 6
PDE6A/B 0.019 0.085 -10000 0 -0.42 10 10
mol:Pi 0 0.13 -10000 0 -0.38 34 34
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin 0.029 0.019 -10000 0 -10000 0 0
PDE6B 0.029 0.005 -10000 0 -10000 0 0
PDE6A -0.002 0.11 -10000 0 -0.38 26 26
PDE6G -0.035 0.16 -10000 0 -0.4 55 55
RHO 0.021 0.026 -10000 0 -0.26 3 3
PDE6 -0.022 0.17 -10000 0 -0.35 59 59
GUCA1A 0.017 0.044 -10000 0 -0.26 9 9
GC2/GCAP Family 0.025 0.05 -10000 0 -0.32 6 6
GUCA1C 0 0 -10000 0 -10000 0 0
GUCA1B 0.02 0.071 -10000 0 -0.52 6 6
IL2 signaling events mediated by PI3K

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.068 0.21 -10000 0 -0.73 26 26
UGCG -0.078 0.25 -10000 0 -0.69 47 47
AKT1/mTOR/p70S6K/Hsp90/TERT -0.021 0.16 0.41 1 -0.45 30 31
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucosylceramide -0.077 0.25 -10000 0 -0.68 47 47
mol:DAG -0.015 0.14 -10000 0 -0.83 10 10
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.034 0.2 -10000 0 -0.59 30 30
FRAP1 -0.054 0.24 -10000 0 -0.7 33 33
FOXO3 -0.051 0.23 0.41 1 -0.68 33 34
AKT1 -0.063 0.26 -10000 0 -0.75 34 34
GAB2 0.024 0.054 -10000 0 -0.58 3 3
SMPD1 0 0.1 -10000 0 -0.87 4 4
SGMS1 -0.009 0.12 -10000 0 -0.7 10 10
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP 0.01 0.027 -10000 0 -0.36 2 2
CALM1 0.028 0.005 -10000 0 -10000 0 0
cell proliferation -0.058 0.22 0.36 2 -0.55 39 41
EIF3A 0.029 0.005 -10000 0 -10000 0 0
PI3K 0.043 0.036 -10000 0 -0.42 2 2
RPS6KB1 0.003 0.084 -10000 0 -0.72 2 2
mol:sphingomyelin -0.015 0.14 -10000 0 -0.83 10 10
natural killer cell activation 0 0.003 -10000 0 -0.026 3 3
JAK3 -0.049 0.2 -10000 0 -0.56 50 50
PIK3R1 0.03 0.007 -10000 0 -10000 0 0
JAK1 0.03 0.007 -10000 0 -10000 0 0
NFKB1 0.029 0.004 -10000 0 -10000 0 0
MYC -0.052 0.24 0.48 2 -0.79 27 29
MYB -0.07 0.34 -10000 0 -1.3 26 26
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.072 0.26 -10000 0 -0.72 38 38
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.029 0.087 -10000 0 -0.65 2 2
mol:PI-3-4-5-P3 -0.068 0.25 -10000 0 -0.69 38 38
Rac1/GDP 0.028 0.028 -10000 0 -0.32 2 2
T cell proliferation -0.064 0.22 -10000 0 -0.65 35 35
SHC1 0.027 0.009 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity 0 0.017 -10000 0 -0.059 25 25
PRKCZ -0.069 0.24 -10000 0 -0.7 35 35
NF kappa B1 p50/RelA -0.024 0.21 -10000 0 -0.58 31 31
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K -0.077 0.23 -10000 0 -0.68 38 38
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
RELA 0.028 0.005 -10000 0 -10000 0 0
IL2RA -0.061 0.2 -10000 0 -0.44 72 72
IL2RB -0.027 0.14 -10000 0 -0.38 46 46
TERT 0 0 -10000 0 -10000 0 0
E2F1 -0.013 0.16 -10000 0 -0.52 29 29
SOS1 0.029 0.006 -10000 0 -10000 0 0
RPS6 0.027 0.008 -10000 0 -10000 0 0
mol:cAMP 0 0.008 0.03 25 -10000 0 25
PTPN11 0.029 0.006 -10000 0 -10000 0 0
IL2RG -0.063 0.18 -10000 0 -0.37 85 85
actin cytoskeleton organization -0.064 0.22 -10000 0 -0.65 35 35
GRB2 0.028 0.007 -10000 0 -10000 0 0
IL2 0.012 0.047 -10000 0 -0.26 10 10
PIK3CA 0.027 0.044 -10000 0 -0.57 2 2
Rac1/GTP 0.054 0.033 -10000 0 -0.31 2 2
LCK -0.032 0.16 -10000 0 -0.37 58 58
BCL2 -0.038 0.2 0.46 2 -0.59 30 32
LPA4-mediated signaling events

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 0.005 0.027 -10000 0 -0.36 2 2
ADCY5 -0.046 0.12 -10000 0 -0.36 39 39
ADCY6 0.006 0.019 -10000 0 -0.36 1 1
ADCY7 0.002 0.039 -10000 0 -0.36 4 4
ADCY1 0 0.053 0.2 5 -0.36 4 9
ADCY2 -0.04 0.11 0.2 1 -0.37 34 35
ADCY3 0.006 0.019 -10000 0 -0.36 1 1
ADCY8 -0.11 0.15 -10000 0 -0.36 85 85
PRKCE 0.008 0.022 -10000 0 -0.42 1 1
ADCY9 0.005 0.027 -10000 0 -0.36 2 2
mol:DAG 0 0 -10000 0 -10000 0 0
cAMP biosynthetic process -0.06 0.11 0.35 7 -0.26 31 38
Coregulation of Androgen receptor activity

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.009 0.067 -10000 0 -0.42 6 6
SVIL 0.015 0.044 -10000 0 -0.58 1 1
ZNF318 0.049 0.05 0.22 5 -10000 0 5
JMJD2C -0.027 0.056 -10000 0 -0.089 134 134
T-DHT/AR/Ubc9 -0.049 0.14 -10000 0 -0.33 54 54
CARM1 0.026 0.008 -10000 0 -10000 0 0
PRDX1 0.029 0.016 -10000 0 -0.26 1 1
PELP1 0.03 0.011 -10000 0 -10000 0 0
CTNNB1 0.019 0.027 -10000 0 -10000 0 0
AKT1 0.034 0.015 -10000 0 -10000 0 0
PTK2B 0.015 0.059 -10000 0 -0.59 3 3
MED1 0.033 0.017 -10000 0 -10000 0 0
MAK 0.036 0.09 0.22 5 -0.34 13 18
response to oxidative stress 0.001 0.003 -10000 0 -10000 0 0
HIP1 0.008 0.075 -10000 0 -0.58 5 5
GSN 0.009 0.069 -10000 0 -0.58 4 4
NCOA2 -0.029 0.18 -10000 0 -0.58 35 35
NCOA6 0.015 0.043 -10000 0 -0.58 1 1
DNA-PK 0.055 0.056 -10000 0 -0.36 1 1
NCOA4 0.028 0.006 -10000 0 -10000 0 0
PIAS3 0.018 0.026 -10000 0 -10000 0 0
cell proliferation 0.005 0.1 -10000 0 -0.71 5 5
XRCC5 0.032 0.012 -10000 0 -10000 0 0
UBE3A 0.011 0.043 -10000 0 -10000 0 0
T-DHT/AR/SNURF -0.064 0.15 -10000 0 -0.3 85 85
FHL2 -0.036 0.22 -10000 0 -0.93 17 17
RANBP9 0.017 0.031 -10000 0 -10000 0 0
JMJD1A -0.008 0.046 -10000 0 -0.13 39 39
CDK6 0.021 0.062 -10000 0 -0.39 7 7
TGFB1I1 0.016 0.031 -10000 0 -10000 0 0
T-DHT/AR/CyclinD1 -0.062 0.14 -10000 0 -0.33 61 61
XRCC6 0.025 0.017 -10000 0 -10000 0 0
T-DHT/AR -0.078 0.17 -10000 0 -0.35 76 76
CTDSP1 0.022 0.017 -10000 0 -10000 0 0
CTDSP2 0.042 0.036 0.2 1 -10000 0 1
BRCA1 0.016 0.034 -10000 0 -0.26 1 1
TCF4 0.033 0.06 -10000 0 -0.57 3 3
CDKN2A -0.035 0.16 -10000 0 -0.37 61 61
SRF 0.031 0.048 -10000 0 -0.27 3 3
NKX3-1 -0.049 0.14 -10000 0 -0.74 6 6
KLK3 -0.16 0.45 -10000 0 -1.5 38 38
TMF1 0.025 0.013 -10000 0 -10000 0 0
HNRNPA1 0.035 0.02 -10000 0 -10000 0 0
AOF2 -0.009 0.022 -10000 0 -0.072 38 38
APPL1 0.03 0.03 -10000 0 -10000 0 0
T-DHT/AR/Caspase 8 -0.043 0.14 -10000 0 -0.32 55 55
AR -0.083 0.19 -10000 0 -0.44 73 73
UBA3 0.023 0.017 -10000 0 -10000 0 0
PATZ1 0.027 0.021 -10000 0 -10000 0 0
PAWR 0.022 0.034 -10000 0 -0.58 1 1
PRKDC 0.031 0.033 -10000 0 -0.58 1 1
PA2G4 0.037 0.025 -10000 0 -10000 0 0
UBE2I 0.027 0.007 -10000 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.04 0.13 -10000 0 -0.3 56 56
RPS6KA3 0.016 0.032 -10000 0 -10000 0 0
T-DHT/AR/ARA70 -0.053 0.14 -10000 0 -0.33 56 56
LATS2 0.035 0.019 -10000 0 -10000 0 0
T-DHT/AR/PRX1 -0.034 0.13 -10000 0 -0.29 53 53
Cyclin D3/CDK11 p58 0.022 0.023 -10000 0 -0.42 1 1
VAV3 -0.024 0.14 -10000 0 -0.4 38 38
KLK2 -0.21 0.38 -10000 0 -0.9 79 79
CASP8 0.031 0.009 -10000 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.069 0.18 -10000 0 -0.39 68 68
TMPRSS2 -0.13 0.32 -10000 0 -0.99 42 42
CCND1 0.017 0.059 -10000 0 -0.5 4 4
PIAS1 0.011 0.043 -10000 0 -10000 0 0
mol:T-DHT -0.023 0.038 -10000 0 -0.077 104 104
CDC2L1 0.001 0.002 -10000 0 -10000 0 0
PIAS4 0 0.058 -10000 0 -0.19 1 1
T-DHT/AR/CDK6 -0.051 0.14 -10000 0 -0.33 59 59
CMTM2 -0.002 0.13 -10000 0 -0.52 21 21
SNURF 0.006 0.12 -10000 0 -0.58 14 14
ZMIZ1 -0.001 0.049 -10000 0 -10000 0 0
CCND3 0.028 0.031 -10000 0 -0.58 1 1
TGIF1 0.036 0.02 -10000 0 -10000 0 0
FKBP4 0.016 0.034 -10000 0 -0.27 1 1
Nephrin/Neph1 signaling in the kidney podocyte

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity 0.02 0.14 0.45 28 -10000 0 28
KIRREL -0.019 0.16 -10000 0 -0.58 28 28
Nephrin/NEPH1Par3/Par6/Atypical PKCs -0.02 0.14 -10000 0 -0.45 28 28
PLCG1 0.028 0.005 -10000 0 -10000 0 0
ARRB2 0.027 0.017 -10000 0 -0.26 1 1
WASL 0.028 0.007 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/CD2AP 0.001 0.11 -10000 0 -0.34 28 28
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP -0.004 0.083 -10000 0 -0.29 26 26
FYN -0.009 0.1 -10000 0 -0.32 29 29
mol:Ca2+ 0 0.11 -10000 0 -0.34 28 28
mol:DAG 0 0.11 -10000 0 -0.34 28 28
NPHS2 -0.006 0.016 -10000 0 -10000 0 0
mol:IP3 0 0.11 -10000 0 -0.34 28 28
regulation of endocytosis 0.007 0.1 -10000 0 -0.3 29 29
Nephrin/NEPH1/podocin/Cholesterol -0.013 0.1 -10000 0 -0.34 28 28
establishment of cell polarity -0.02 0.14 -10000 0 -0.45 28 28
Nephrin/NEPH1/podocin/NCK1-2 0.015 0.11 -10000 0 -0.31 28 28
Nephrin/NEPH1/beta Arrestin2 0.009 0.1 -10000 0 -0.3 29 29
NPHS1 -0.011 0.09 -10000 0 -0.28 33 33
Nephrin/NEPH1/podocin -0.008 0.099 -10000 0 -0.32 29 29
TJP1 0.029 0.004 -10000 0 -10000 0 0
NCK1 0.029 0.004 -10000 0 -10000 0 0
NCK2 0.028 0.005 -10000 0 -10000 0 0
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 0.001 0.11 -10000 0 -0.34 28 28
CD2AP 0.029 0.003 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/GRB2 0.001 0.11 -10000 0 -0.34 27 27
GRB2 0.028 0.007 -10000 0 -10000 0 0
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 -0.013 0.1 -10000 0 -0.32 29 29
cytoskeleton organization -0.012 0.098 -10000 0 -0.34 26 26
Nephrin/NEPH1 -0.01 0.099 -10000 0 -0.32 28 28
Nephrin/NEPH1/ZO-1 0.001 0.12 -10000 0 -0.37 28 28
Visual signal transduction: Cones

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.011 0.1 -9999 0 -0.32 29 29
RGS9BP -0.004 0.13 -9999 0 -0.5 22 22
mol:GTP 0 0 -9999 0 -10000 0 0
GRK1 -0.029 0.17 -9999 0 -0.48 42 42
mol:Na + -0.014 0.096 -9999 0 -0.24 48 48
mol:ADP -0.036 0.12 -9999 0 -0.42 30 30
GNAT2 0.021 0.036 -9999 0 -0.26 6 6
RGS9-1/Gbeta5/R9AP 0.001 0.13 -9999 0 -0.38 34 34
mol:GDP 0 0 -9999 0 -10000 0 0
PDE6H/GNAT2/GTP 0.015 0.02 -9999 0 -0.14 6 6
GRK7 0.022 0.016 -9999 0 -0.26 1 1
CNGB3 0 0 -9999 0 -10000 0 0
Cone Metarhodopsin II/X-Arrestin 0.014 0.011 -9999 0 -0.17 1 1
mol:Ca2+ -0.024 0.093 -9999 0 -0.32 26 26
Cone PDE6 0.001 0.12 -9999 0 -0.33 34 34
Cone Metarhodopsin II -0.003 0.1 -9999 0 -0.33 30 30
Na + (4 Units) -0.011 0.099 -9999 0 -0.32 26 26
GNAT2/GDP 0.011 0.12 -9999 0 -0.33 34 34
GNB5 0.027 0.031 -9999 0 -0.58 1 1
mol:GMP (4 units) -0.002 0.016 -9999 0 -0.13 6 6
Cone Transducin 0.013 0.11 -9999 0 -0.34 29 29
SLC24A2 0.002 0.071 -9999 0 -0.27 23 23
GNB3/GNGT2 -0.002 0.13 -9999 0 -0.42 31 31
GNB3 -0.021 0.16 -9999 0 -0.55 32 32
GNAT2/GTP 0.016 0.025 -9999 0 -0.17 6 6
CNGA3 -0.025 0.15 -9999 0 -0.41 45 45
ARR3 0.019 0.016 -9999 0 -0.26 1 1
absorption of light 0 0 -9999 0 -10000 0 0
cGMP/Cone CNG Channel -0.014 0.096 -9999 0 -0.24 48 48
mol:Pi 0 0.13 -9999 0 -0.38 34 34
Cone CNG Channel -0.004 0.083 -9999 0 -0.3 22 22
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
mol:K + 0.002 0.071 -9999 0 -0.27 23 23
RGS9 -0.018 0.14 -9999 0 -0.39 40 40
PDE6C 0 0 -9999 0 -10000 0 0
GNGT2 0.019 0.063 -9999 0 -0.38 8 8
mol:cGMP (4 units) 0 0 -9999 0 -10000 0 0
PDE6H 0 0 -9999 0 -10000 0 0
FAS signaling pathway (CD95)

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.005 0.034 0.2 10 -10000 0 10
RFC1 0.006 0.036 0.2 11 -10000 0 11
PRKDC 0.005 0.04 0.2 11 -0.34 1 12
RIPK1 0.031 0.005 -10000 0 -10000 0 0
CASP7 -0.002 0.1 -10000 0 -0.74 5 5
FASLG/FAS/FADD/FAF1 -0.026 0.11 0.22 2 -0.31 36 38
MAP2K4 -0.044 0.17 0.27 1 -0.47 29 30
mol:ceramide -0.041 0.14 -10000 0 -0.41 39 39
GSN 0.001 0.045 0.19 9 -0.34 3 12
FASLG/FAS/FADD/FAF1/Caspase 8 -0.038 0.13 -10000 0 -0.38 38 38
FAS 0.014 0.071 -10000 0 -0.58 5 5
BID -0.012 0.072 0.28 7 -0.37 10 17
MAP3K1 -0.018 0.12 0.24 2 -0.5 9 11
MAP3K7 0.028 0.005 -10000 0 -10000 0 0
RB1 0.005 0.034 0.2 10 -10000 0 10
CFLAR 0.03 0.006 -10000 0 -10000 0 0
HGF/MET -0.025 0.17 -10000 0 -0.38 60 60
ARHGDIB 0.007 0.04 0.2 14 -10000 0 14
FADD 0.022 0.017 -10000 0 -10000 0 0
actin filament polymerization -0.001 0.045 0.34 3 -0.19 9 12
NFKB1 -0.022 0.098 -10000 0 -0.56 3 3
MAPK8 -0.073 0.21 -10000 0 -0.5 60 60
DFFA 0.006 0.036 0.2 11 -10000 0 11
DNA fragmentation during apoptosis 0.006 0.036 0.23 5 -10000 0 5
FAS/FADD/MET 0.006 0.14 -10000 0 -0.39 37 37
CFLAR/RIP1 0.045 0.01 -10000 0 -10000 0 0
FAIM3 -0.008 0.11 -10000 0 -0.32 38 38
FAF1 0.021 0.018 -10000 0 -10000 0 0
PARP1 0.005 0.034 0.2 10 -10000 0 10
DFFB 0.006 0.036 0.21 9 -10000 0 9
CHUK -0.02 0.088 -10000 0 -0.6 2 2
FASLG -0.074 0.19 -10000 0 -0.41 82 82
FAS/FADD 0.026 0.058 -10000 0 -0.43 5 5
HGF -0.031 0.16 -10000 0 -0.44 47 47
LMNA 0.003 0.03 0.2 3 -10000 0 3
CASP6 0.006 0.036 0.2 11 -10000 0 11
CASP10 0.02 0.035 -10000 0 -0.57 1 1
CASP3 0.007 0.044 0.24 11 -10000 0 11
PTPN13 0.025 0.044 -10000 0 -0.58 2 2
CASP8 -0.001 0.063 0.38 8 -10000 0 8
IL6 -0.2 0.48 -10000 0 -1.3 59 59
MET -0.03 0.18 -10000 0 -0.58 36 36
ICAD/CAD 0.004 0.029 0.21 3 -10000 0 3
FASLG/FAS/FADD/FAF1/Caspase 10 -0.041 0.15 -10000 0 -0.41 39 39
activation of caspase activity by cytochrome c -0.012 0.072 0.28 7 -0.37 10 17
PAK2 0.006 0.039 0.2 13 -10000 0 13
BCL2 0.016 0.074 -10000 0 -0.36 12 12
Integrins in angiogenesis

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.021 0.099 -10000 0 -0.45 15 15
alphaV beta3 Integrin 0.021 0.13 -10000 0 -0.45 25 25
PTK2 -0.013 0.19 0.42 8 -0.55 25 33
IGF1R 0.027 0.031 -10000 0 -0.58 1 1
PI4KB 0.027 0.008 -10000 0 -10000 0 0
MFGE8 -0.01 0.15 -10000 0 -0.58 24 24
SRC 0.026 0.035 -10000 0 -0.42 2 2
CDKN1B -0.018 0.14 -10000 0 -0.51 23 23
VEGFA 0.025 0.047 -10000 0 -0.47 3 3
ILK -0.019 0.14 -10000 0 -0.52 22 22
ROCK1 0.029 0.005 -10000 0 -10000 0 0
AKT1 -0.019 0.13 -10000 0 -0.5 21 21
PTK2B -0.006 0.12 0.35 2 -0.37 34 36
alphaV/beta3 Integrin/JAM-A 0.002 0.15 -10000 0 -0.39 42 42
CBL 0.028 0.006 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.025 0.11 -10000 0 -0.41 19 19
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.007 0.12 -10000 0 -0.33 29 29
VEGF/Rho/ROCK/alphaV/beta3 Integrin -0.006 0.1 -10000 0 -0.37 13 13
alphaV/beta3 Integrin/Syndecan-1 0.029 0.11 -10000 0 -0.41 20 20
PI4KA 0.022 0.013 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.11 0.23 -10000 0 -0.6 44 44
PI4 Kinase 0.03 0.02 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
alphaV/beta3 Integrin/Osteopontin -0.032 0.18 -10000 0 -0.42 54 54
RPS6KB1 -0.12 0.2 0.5 1 -0.56 43 44
TLN1 0.027 0.008 -10000 0 -10000 0 0
MAPK3 -0.068 0.21 -10000 0 -0.78 25 25
GPR124 0.022 0.064 -10000 0 -0.51 5 5
MAPK1 -0.077 0.22 -10000 0 -0.74 29 29
PXN 0.028 0.006 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Tumstatin 0.014 0.14 -10000 0 -0.43 31 31
cell adhesion 0.007 0.14 -10000 0 -0.44 29 29
ANGPTL3 0.02 0.03 -10000 0 -0.26 4 4
VEGFR2 homodimer/VEGFA homodimer/Src 0.036 0.094 -10000 0 -0.39 16 16
IGF-1R heterotetramer 0.027 0.031 -10000 0 -0.58 1 1
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
TGFBR2 0.026 0.044 -10000 0 -0.58 2 2
ITGB3 -0.002 0.13 -10000 0 -0.58 18 18
IGF1 -0.057 0.17 -10000 0 -0.36 83 83
RAC1 0.028 0.007 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.025 0.11 -10000 0 -0.39 24 24
apoptosis 0.022 0.062 -10000 0 -0.57 4 4
CD47 0.027 0.031 -10000 0 -0.58 1 1
alphaV/beta3 Integrin/CD47 0.03 0.11 -10000 0 -0.41 20 20
VCL 0.028 0.006 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Del1 0.002 0.16 -10000 0 -0.45 37 37
CSF1 0.009 0.11 -10000 0 -0.58 12 12
PIK3C2A -0.021 0.15 -10000 0 -0.51 26 26
PI4 Kinase/Pyk2 -0.029 0.15 -10000 0 -0.51 19 19
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.029 0.13 -10000 0 -0.37 33 33
FAK1/Vinculin 0.006 0.16 0.42 8 -0.44 23 31
alphaV beta3/Integrin/ppsTEM5 0.026 0.11 -10000 0 -0.39 24 24
RHOA 0.029 0.004 -10000 0 -10000 0 0
VTN -0.028 0.15 -10000 0 -0.4 49 49
BCAR1 0.028 0.007 -10000 0 -10000 0 0
FGF2 0.013 0.098 -10000 0 -0.58 10 10
F11R 0.006 0.071 -10000 0 -0.42 10 10
alphaV/beta3 Integrin/Lactadherin 0.01 0.15 -10000 0 -0.45 31 31
alphaV/beta3 Integrin/TGFBR2 0.03 0.11 -10000 0 -0.41 20 20
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.051 0.089 -10000 0 -0.37 14 14
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.028 0.096 -10000 0 -0.36 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.15 0.26 -10000 0 -0.52 123 123
alphaV/beta3 Integrin/Pyk2 0.014 0.13 -10000 0 -0.37 34 34
SDC1 0.024 0.047 -10000 0 -0.47 3 3
VAV3 -0.01 0.11 0.36 1 -0.36 27 28
PTPN11 0.028 0.006 -10000 0 -10000 0 0
IRS1 0.019 0.069 -10000 0 -0.42 8 8
FAK1/Paxillin 0.002 0.15 0.31 4 -0.44 23 27
cell migration 0 0.13 0.3 3 -0.39 23 26
ITGAV 0.022 0.062 -10000 0 -0.58 4 4
PI3K 0.013 0.15 -10000 0 -0.55 12 12
SPP1 -0.072 0.21 -10000 0 -0.46 77 77
KDR 0.005 0.12 -10000 0 -0.54 16 16
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.022 0.062 -10000 0 -0.58 4 4
COL4A3 0.003 0.12 -10000 0 -0.58 16 16
angiogenesis -0.066 0.22 -10000 0 -0.72 30 30
Rac1/GTP 0.002 0.1 -10000 0 -0.34 26 26
EDIL3 -0.016 0.15 -10000 0 -0.52 30 30
cell proliferation 0.029 0.11 -10000 0 -0.41 20 20
LPA receptor mediated events

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.035 0.079 -10000 0 -0.3 12 12
NF kappa B1 p50/RelA/I kappa B alpha 0.003 0.11 0.3 3 -0.38 10 13
AP1 -0.052 0.15 -10000 0 -0.35 53 53
mol:PIP3 -0.031 0.099 -10000 0 -0.32 18 18
AKT1 0.04 0.075 0.3 10 -0.32 1 11
PTK2B -0.009 0.1 0.22 2 -0.41 13 15
RHOA 0.019 0.043 0.24 1 -0.25 1 2
PIK3CB 0.029 0.005 -10000 0 -10000 0 0
mol:Ca2+ -0.021 0.097 0.3 4 -0.33 15 19
MAGI3 0.027 0.032 -10000 0 -0.58 1 1
RELA 0.028 0.005 -10000 0 -10000 0 0
apoptosis -0.018 0.095 -10000 0 -0.29 31 31
HRAS/GDP 0.02 0.015 -10000 0 -0.17 2 2
positive regulation of microtubule depolymerization -0.008 0.12 0.41 7 -0.44 11 18
NF kappa B1 p50/RelA -0.023 0.11 -10000 0 -0.38 16 16
endothelial cell migration -0.009 0.13 -10000 0 -0.54 18 18
ADCY4 -0.024 0.11 -10000 0 -0.4 15 15
ADCY5 -0.046 0.12 -10000 0 -0.42 21 21
ADCY6 -0.022 0.1 -10000 0 -0.38 15 15
ADCY7 -0.024 0.11 -10000 0 -0.41 15 15
ADCY1 -0.025 0.1 -10000 0 -0.4 14 14
ADCY2 -0.047 0.13 -10000 0 -0.44 25 25
ADCY3 -0.024 0.1 -10000 0 -0.38 16 16
ADCY8 -0.077 0.15 -10000 0 -0.46 30 30
ADCY9 -0.023 0.1 -10000 0 -0.4 14 14
GSK3B -0.007 0.1 0.33 2 -0.53 7 9
arachidonic acid secretion -0.026 0.1 -10000 0 -0.36 17 17
GNG2 0.026 0.026 -10000 0 -0.26 3 3
TRIP6 0.022 0.029 -10000 0 -0.3 2 2
GNAO1 -0.029 0.13 -10000 0 -0.35 47 47
HRAS 0.027 0.022 -10000 0 -0.26 2 2
NFKBIA -0.015 0.12 0.42 5 -0.37 18 23
GAB1 0.029 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly -0.071 0.32 -10000 0 -0.9 46 46
JUN 0.006 0.095 -10000 0 -0.35 22 22
LPA/LPA2/NHERF2 0.031 0.035 -10000 0 -0.36 1 1
TIAM1 -0.099 0.37 -10000 0 -1.1 46 46
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:IP3 -0.022 0.093 0.36 1 -0.34 15 16
PLCB3 0.021 0.037 -10000 0 -0.33 1 1
FOS -0.047 0.18 -10000 0 -0.44 60 60
positive regulation of mitosis -0.026 0.1 -10000 0 -0.36 17 17
LPA/LPA1-2-3 -0.001 0.12 -10000 0 -0.3 35 35
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0.001 -10000 0 -10000 0 0
BCAR1 0.028 0.007 -10000 0 -10000 0 0
stress fiber formation -0.003 0.1 0.24 1 -0.46 9 10
GNAZ -0.006 0.085 -10000 0 -0.32 22 22
EGFR/PI3K-beta/Gab1 -0.023 0.11 -10000 0 -0.35 13 13
positive regulation of dendritic cell cytokine production -0.002 0.11 -10000 0 -0.3 35 35
LPA/LPA2/MAGI-3 0.031 0.04 -10000 0 -0.38 2 2
ARHGEF1 0.016 0.067 0.36 1 -0.35 5 6
GNAI2 0.003 0.076 -10000 0 -0.31 15 15
GNAI3 0.003 0.076 -10000 0 -0.31 15 15
GNAI1 0.001 0.077 -10000 0 -0.32 14 14
LPA/LPA3 -0.025 0.1 -10000 0 -0.24 61 61
LPA/LPA2 0.016 0.034 -10000 0 -0.42 1 1
LPA/LPA1 0.002 0.089 -10000 0 -0.33 20 20
HB-EGF/EGFR -0.071 0.17 -10000 0 -0.39 67 67
HBEGF -0.078 0.17 0.31 3 -0.43 57 60
mol:DAG -0.022 0.093 0.36 1 -0.34 15 16
cAMP biosynthetic process -0.039 0.14 0.42 8 -0.37 32 40
NFKB1 0.029 0.004 -10000 0 -10000 0 0
SRC 0.026 0.035 -10000 0 -0.42 2 2
GNB1 0.028 0.006 -10000 0 -10000 0 0
LYN -0.017 0.12 0.37 5 -0.4 12 17
GNAQ -0.008 0.075 -10000 0 -0.3 17 17
LPAR2 0.026 0.032 -10000 0 -0.58 1 1
LPAR3 -0.035 0.14 -10000 0 -0.33 60 60
LPAR1 0.011 0.086 -10000 0 -0.43 10 10
IL8 -0.13 0.23 0.33 3 -0.53 75 78
PTK2 -0.015 0.1 -10000 0 -0.31 22 22
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
CASP3 -0.018 0.095 -10000 0 -0.29 31 31
EGFR 0.002 0.12 -10000 0 -0.54 17 17
PLCG1 -0.023 0.099 -10000 0 -0.32 26 26
PLD2 -0.017 0.1 -10000 0 -0.31 22 22
G12/G13 0.038 0.073 -10000 0 -0.31 10 10
PI3K-beta 0.014 0.05 -10000 0 -0.36 1 1
cell migration -0.008 0.1 -10000 0 -0.26 40 40
SLC9A3R2 0.026 0.022 -10000 0 -0.26 2 2
PXN -0.003 0.1 0.24 1 -0.5 8 9
HRAS/GTP -0.024 0.11 -10000 0 -0.37 17 17
RAC1 0.028 0.007 -10000 0 -10000 0 0
MMP9 -0.088 0.22 -10000 0 -0.45 91 91
PRKCE 0.027 0.032 -10000 0 -0.58 1 1
PRKCD -0.02 0.1 0.33 6 -0.42 8 14
Gi(beta/gamma) -0.018 0.098 -10000 0 -0.4 10 10
mol:LPA -0.005 0.037 -10000 0 -0.18 14 14
TRIP6/p130 Cas/FAK1/Paxillin 0.007 0.12 -10000 0 -0.45 9 9
MAPKKK cascade -0.026 0.1 -10000 0 -0.36 17 17
contractile ring contraction involved in cytokinesis 0.02 0.047 0.27 2 -0.24 1 3
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.025 0.089 -10000 0 -0.32 21 21
GNA15 -0.035 0.12 -10000 0 -0.35 42 42
GNA12 0.028 0.007 -10000 0 -10000 0 0
GNA13 0.028 0.007 -10000 0 -10000 0 0
MAPT -0.011 0.11 0.38 6 -0.45 11 17
GNA11 -0.017 0.088 -10000 0 -0.31 25 25
Rac1/GTP -0.076 0.34 -10000 0 -0.97 45 45
MMP2 -0.009 0.13 -10000 0 -0.54 18 18
EGFR-dependent Endothelin signaling events

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.027 0.022 -9999 0 -0.26 2 2
EGFR 0.002 0.12 -9999 0 -0.54 17 17
EGF/EGFR -0.012 0.13 -9999 0 -0.32 44 44
EGF/EGFR dimer/SHC/GRB2/SOS1 0.026 0.12 -9999 0 -0.32 29 29
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA 0.018 0.07 -9999 0 -0.4 9 9
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.033 0.15 -9999 0 -0.34 64 64
EGF/EGFR dimer/SHC 0.001 0.12 -9999 0 -0.37 29 29
mol:GDP 0.021 0.11 -9999 0 -0.32 29 29
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 0 0.11 -9999 0 -0.36 28 28
GRB2/SOS1 0.041 0.011 -9999 0 -10000 0 0
HRAS/GTP 0.007 0.1 -9999 0 -0.3 28 28
SHC1 0.027 0.008 -9999 0 -10000 0 0
HRAS/GDP 0.021 0.11 -9999 0 -0.31 28 28
FRAP1 -0.031 0.086 -9999 0 -0.31 29 29
EGF/EGFR dimer -0.018 0.14 -9999 0 -0.43 30 30
SOS1 0.028 0.006 -9999 0 -10000 0 0
GRB2 0.028 0.007 -9999 0 -10000 0 0
ETA receptor/Endothelin-1 0.013 0.1 -9999 0 -0.43 14 14
TCGA08_p53

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.038 0.11 -10000 0 -0.25 67 67
TP53 -0.011 0.045 -10000 0 -0.22 8 8
Senescence -0.011 0.045 -10000 0 -0.22 8 8
Apoptosis -0.011 0.045 -10000 0 -0.22 8 8
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.022 0.073 0.24 28 -10000 0 28
MDM4 0.027 0.008 -10000 0 -10000 0 0
Neurotrophic factor-mediated Trk receptor signaling

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.022 0.013 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.041 0.13 -10000 0 -0.35 38 38
NT3 (dimer)/TRKC -0.078 0.19 -10000 0 -0.43 65 65
NT3 (dimer)/TRKB -0.083 0.19 -10000 0 -0.41 79 79
SHC/Grb2/SOS1/GAB1/PI3K 0.034 0.026 -10000 0 -10000 0 0
RAPGEF1 0.027 0.008 -10000 0 -10000 0 0
BDNF -0.027 0.16 -10000 0 -0.4 48 48
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
DYNLT1 0.026 0.026 -10000 0 -0.26 3 3
NTRK1 -0.002 0.086 -10000 0 -0.28 32 32
NTRK2 0.019 0.07 -10000 0 -0.58 5 5
NTRK3 -0.063 0.2 -10000 0 -0.44 74 74
NT-4/5 (dimer)/TRKB -0.083 0.2 -10000 0 -0.41 90 90
neuron apoptosis 0.068 0.19 0.44 55 -10000 0 55
SHC 2-3/Grb2 -0.074 0.21 -10000 0 -0.49 54 54
SHC1 0.027 0.008 -10000 0 -10000 0 0
SHC2 -0.046 0.16 -10000 0 -0.55 22 22
SHC3 -0.11 0.24 -10000 0 -0.57 65 65
STAT3 (dimer) 0.033 0.023 -10000 0 -0.36 1 1
NT3 (dimer)/TRKA -0.092 0.18 -10000 0 -0.4 80 80
RIN/GDP -0.027 0.094 0.26 5 -0.25 14 19
GIPC1 0.027 0.008 -10000 0 -10000 0 0
KRAS 0.028 0.006 -10000 0 -10000 0 0
DNAJA3 -0.05 0.13 -10000 0 -0.34 57 57
RIN/GTP 0 0 -10000 0 -10000 0 0
CCND1 0.02 0.055 -10000 0 -0.7 2 2
MAGED1 0.027 0.008 -10000 0 -10000 0 0
PTPN11 0.028 0.006 -10000 0 -10000 0 0
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) -0.049 0.18 -10000 0 -0.45 60 60
SHC/GRB2/SOS1 0.052 0.021 -10000 0 -10000 0 0
GRB2 0.028 0.007 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK 0.003 0.11 -10000 0 -0.33 26 26
TRKA/NEDD4-2 0.018 0.065 -10000 0 -0.3 3 3
ELMO1 -0.005 0.094 -10000 0 -0.27 42 42
RhoG/GTP/ELMO1/DOCK1 0.015 0.066 -10000 0 -0.36 3 3
NGF 0.013 0.082 -10000 0 -0.37 14 14
HRAS 0.027 0.022 -10000 0 -0.26 2 2
DOCK1 0.026 0.044 -10000 0 -0.58 2 2
GAB2 0.024 0.054 -10000 0 -0.58 3 3
RIT2 0 0 -10000 0 -10000 0 0
RIT1 0.027 0.008 -10000 0 -10000 0 0
FRS2 0.028 0.006 -10000 0 -10000 0 0
DNM1 -0.002 0.11 -10000 0 -0.35 29 29
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.027 0.008 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP -0.051 0.15 -10000 0 -0.36 58 58
mol:GDP -0.041 0.13 0.36 4 -0.38 15 19
NGF (dimer) 0.013 0.082 -10000 0 -0.37 14 14
RhoG/GDP -0.002 0.064 -10000 0 -0.42 1 1
RIT1/GDP -0.024 0.094 0.4 2 -0.27 9 11
TIAM1 -0.035 0.18 -10000 0 -0.53 42 42
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
BDNF (dimer)/TRKB 0.01 0.12 -10000 0 -0.39 25 25
KIDINS220/CRKL/C3G 0.03 0.02 -10000 0 -10000 0 0
SHC/RasGAP 0.039 0.014 -10000 0 -10000 0 0
FRS2 family/SHP2 0.057 0.013 -10000 0 -10000 0 0
SHC/GRB2/SOS1/GAB1 0.065 0.026 -10000 0 -10000 0 0
RIT1/GTP 0.02 0.006 -10000 0 -10000 0 0
NT3 (dimer) -0.044 0.17 -10000 0 -0.39 64 64
RAP1/GDP -0.02 0.077 -10000 0 -0.23 8 8
KIDINS220/CRKL 0.022 0.013 -10000 0 -10000 0 0
BDNF (dimer) -0.027 0.16 -10000 0 -0.4 48 48
ubiquitin-dependent protein catabolic process 0.025 0.079 -10000 0 -0.36 6 6
Schwann cell development -0.03 0.034 -10000 0 -10000 0 0
EHD4 0.029 0.004 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 0.069 0.021 -10000 0 -10000 0 0
FRS2 family/SHP2/CRK family/C3G/GAB2 0.019 0.045 -10000 0 -10000 0 0
RAP1B 0.028 0.006 -10000 0 -10000 0 0
RAP1A 0.028 0.006 -10000 0 -10000 0 0
CDC42/GTP -0.064 0.17 -10000 0 -0.36 68 68
ABL1 0.027 0.008 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0.041 0.011 -10000 0 -10000 0 0
Rap1/GTP -0.017 0.12 -10000 0 -0.46 11 11
STAT3 0.033 0.023 -10000 0 -0.36 1 1
axon guidance -0.069 0.16 -10000 0 -0.35 69 69
MAPK3 -0.01 0.1 -10000 0 -0.32 23 23
MAPK1 -0.014 0.095 -10000 0 -0.31 23 23
CDC42/GDP -0.021 0.098 0.4 2 -0.26 10 12
NTF3 -0.044 0.17 -10000 0 -0.39 64 64
NTF4 -0.049 0.19 -10000 0 -0.45 60 60
NGF (dimer)/TRKA/FAIM 0.026 0.08 -10000 0 -0.33 8 8
PI3K 0.039 0.035 -10000 0 -0.42 2 2
FRS3 0.029 0.003 -10000 0 -10000 0 0
FAIM 0.029 0.004 -10000 0 -10000 0 0
GAB1 0.029 0.004 -10000 0 -10000 0 0
RASGRF1 -0.12 0.21 -10000 0 -0.45 96 96
SOS1 0.028 0.006 -10000 0 -10000 0 0
MCF2L -0.076 0.15 -10000 0 -0.38 62 62
RGS19 0.028 0.006 -10000 0 -10000 0 0
CDC42 0.028 0.006 -10000 0 -10000 0 0
RAS family/GTP 0.006 0.088 -10000 0 -0.44 3 3
Rac1/GDP -0.02 0.092 0.21 2 -0.26 9 11
NGF (dimer)/TRKA/GRIT 0.01 0.073 -10000 0 -0.33 8 8
neuron projection morphogenesis -0.027 0.15 -10000 0 -0.72 4 4
NGF (dimer)/TRKA/NEDD4-2 0.026 0.079 -10000 0 -0.37 6 6
MAP2K1 0.04 0.057 0.36 3 -10000 0 3
NGFR -0.092 0.22 -10000 0 -0.47 90 90
NGF (dimer)/TRKA/GIPC/GAIP 0.01 0.07 -10000 0 -0.29 13 13
RAS family/GTP/PI3K 0.029 0.026 -10000 0 -0.29 2 2
FRS2 family/SHP2/GRB2/SOS1 0.08 0.025 -10000 0 -10000 0 0
NRAS 0.028 0.005 -10000 0 -10000 0 0
GRB2/SOS1 0.041 0.011 -10000 0 -10000 0 0
PRKCI 0.029 0.004 -10000 0 -10000 0 0
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
PRKCZ 0.027 0.016 -10000 0 -0.26 1 1
MAPKKK cascade -0.003 0.12 -10000 0 -0.59 11 11
RASA1 0.028 0.006 -10000 0 -10000 0 0
TRKA/c-Abl 0.017 0.064 -10000 0 -0.19 29 29
SQSTM1 0.028 0.006 -10000 0 -10000 0 0
BDNF (dimer)/TRKB/GIPC 0.023 0.12 -10000 0 -0.36 24 24
NGF (dimer)/TRKA/p62/Atypical PKCs 0.05 0.079 -10000 0 -0.32 6 6
MATK -0.006 0.12 -10000 0 -0.39 29 29
NEDD4L 0.029 0.005 -10000 0 -10000 0 0
RAS family/GDP -0.037 0.055 -10000 0 -0.23 3 3
NGF (dimer)/TRKA -0.051 0.14 -10000 0 -0.34 61 61
Rac1/GTP -0.094 0.15 -10000 0 -0.36 76 76
FRS2 family/SHP2/CRK family 0.063 0.04 -10000 0 -10000 0 0
Aurora B signaling

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.017 0.16 -9999 0 -0.58 21 21
STMN1 -0.012 0.1 -9999 0 -0.43 18 18
Aurora B/RasGAP/Survivin 0.004 0.16 -9999 0 -0.43 36 36
Chromosomal passenger complex/Cul3 protein complex -0.024 0.13 -9999 0 -0.39 26 26
BIRC5 -0.014 0.14 -9999 0 -0.45 32 32
DES -0.12 0.34 -9999 0 -0.74 77 77
Aurora C/Aurora B/INCENP 0.005 0.11 -9999 0 -0.34 26 26
Aurora B/TACC1 0.009 0.095 -9999 0 -0.36 19 19
Aurora B/PP2A 0.007 0.11 -9999 0 -0.42 19 19
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 0.003 0.038 -9999 0 -0.17 17 17
mitotic metaphase/anaphase transition 0.001 0.006 -9999 0 -10000 0 0
NDC80 -0.023 0.12 -9999 0 -0.42 29 29
Cul3 protein complex 0.01 0.11 -9999 0 -0.36 24 24
KIF2C -0.002 0.073 -9999 0 -0.27 20 20
PEBP1 0.026 0.011 -9999 0 -10000 0 0
KIF20A -0.019 0.15 -9999 0 -0.45 37 37
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP 0.008 0.11 -9999 0 -0.43 17 17
SEPT1 0.001 0.084 -9999 0 -0.26 35 35
SMC2 0.027 0.008 -9999 0 -10000 0 0
SMC4 0.029 0.004 -9999 0 -10000 0 0
NSUN2/NPM1/Nucleolin -0.029 0.21 -9999 0 -0.75 27 27
PSMA3 0.028 0.005 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle 0 0.004 -9999 0 -10000 0 0
H3F3B -0.006 0.084 -9999 0 -0.35 20 20
AURKB -0.016 0.15 -9999 0 -0.42 38 38
AURKC 0.001 0.092 -9999 0 -0.29 31 31
CDCA8 0.024 0.033 -9999 0 -0.27 4 4
cytokinesis -0.043 0.22 -9999 0 -0.76 26 26
Aurora B/Septin1 -0.016 0.22 -9999 0 -0.73 25 25
AURKA 0.026 0.027 -9999 0 -0.26 3 3
INCENP 0.023 0.05 -9999 0 -0.49 3 3
KLHL13 -0.034 0.16 -9999 0 -0.4 54 54
BUB1 -0.011 0.14 -9999 0 -0.46 31 31
hSgo1/Aurora B/Survivin -0.011 0.17 -9999 0 -0.42 48 48
EVI5 0.029 0.007 -9999 0 -10000 0 0
RhoA/GTP -0.002 0.19 -9999 0 -0.66 23 23
SGOL1 0.003 0.11 -9999 0 -0.4 23 23
CENPA -0.024 0.17 -9999 0 -0.52 29 29
NCAPG -0.008 0.13 -9999 0 -0.43 30 30
Aurora B/HC8 Proteasome 0.007 0.11 -9999 0 -0.43 18 18
NCAPD2 0.028 0.006 -9999 0 -10000 0 0
Aurora B/PP1-gamma 0.008 0.11 -9999 0 -0.43 17 17
RHOA 0.029 0.004 -9999 0 -10000 0 0
NCAPH -0.004 0.13 -9999 0 -0.46 25 25
NPM1 -0.019 0.14 -9999 0 -0.58 21 21
RASA1 0.028 0.006 -9999 0 -10000 0 0
KLHL9 0.027 0.008 -9999 0 -10000 0 0
mitotic prometaphase -0.001 0.007 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.007 0.11 -9999 0 -0.42 18 18
PPP1CC 0.028 0.006 -9999 0 -10000 0 0
Centraspindlin -0.014 0.21 -9999 0 -0.66 27 27
RhoA/GDP 0.021 0.003 -9999 0 -10000 0 0
NSUN2 -0.018 0.14 -9999 0 -0.58 21 21
MYLK -0.01 0.094 -9999 0 -0.36 24 24
KIF23 0.005 0.11 -9999 0 -0.43 20 20
VIM -0.013 0.1 -9999 0 -0.42 19 19
RACGAP1 0.028 0.008 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
NCL -0.028 0.18 -9999 0 -0.71 22 22
Chromosomal passenger complex -0.03 0.18 -9999 0 -0.6 27 27
Chromosomal passenger complex/EVI5 0.029 0.16 -9999 0 -0.44 31 31
TACC1 0.029 0.004 -9999 0 -10000 0 0
PPP2R5D 0.029 0.003 -9999 0 -10000 0 0
CUL3 0.028 0.006 -9999 0 -10000 0 0
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
Signaling events mediated by the Hedgehog family

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.036 0.21 -10000 0 -0.66 33 33
IHH 0.003 0.082 -10000 0 -0.25 20 20
SHH Np/Cholesterol/GAS1 -0.001 0.069 -10000 0 -0.34 6 6
LRPAP1 0.027 0.032 -10000 0 -0.58 1 1
dorsoventral neural tube patterning 0.001 0.068 0.34 6 -10000 0 6
SMO/beta Arrestin2 0.016 0.11 -10000 0 -0.46 4 4
SMO -0.002 0.11 -10000 0 -0.43 8 8
AKT1 0.028 0.076 -10000 0 -0.63 2 2
ARRB2 0.027 0.017 -10000 0 -0.26 1 1
BOC 0.007 0.11 -10000 0 -0.51 15 15
ADRBK1 0.028 0.005 -10000 0 -10000 0 0
heart looping 0 0.11 -10000 0 -0.42 8 8
STIL -0.006 0.1 -10000 0 -0.42 8 8
DHH N/PTCH2 0.002 0.13 -10000 0 -0.44 28 28
DHH N/PTCH1 -0.012 0.14 -10000 0 -0.37 37 37
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
DHH -0.001 0.13 -10000 0 -0.54 19 19
PTHLH -0.056 0.29 -10000 0 -0.91 34 34
determination of left/right symmetry 0 0.11 -10000 0 -0.42 8 8
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
skeletal system development -0.055 0.28 -10000 0 -0.9 34 34
IHH N/Hhip 0.002 0.083 -10000 0 -0.27 7 7
DHH N/Hhip -0.001 0.11 -10000 0 -0.43 17 17
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development 0 0.11 -10000 0 -0.42 8 8
pancreas development 0 0.082 -10000 0 -0.26 34 34
HHAT 0.026 0.032 -10000 0 -0.58 1 1
PI3K 0.039 0.035 -10000 0 -0.42 2 2
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.01 0.11 -10000 0 -0.31 42 42
somite specification 0 0.11 -10000 0 -0.42 8 8
SHH Np/Cholesterol/PTCH1 -0.008 0.099 -10000 0 -0.4 9 9
SHH Np/Cholesterol/PTCH2 0.005 0.07 -10000 0 -0.32 12 12
SHH Np/Cholesterol/Megalin -0.023 0.11 -10000 0 -0.34 31 31
SHH -0.01 0.045 -10000 0 -0.42 1 1
catabolic process -0.009 0.12 -10000 0 -0.36 34 34
SMO/Vitamin D3 0.002 0.11 -10000 0 -0.44 7 7
SHH Np/Cholesterol/Hhip 0.002 0.059 -10000 0 -0.26 6 6
LRP2 -0.05 0.19 -10000 0 -0.47 59 59
receptor-mediated endocytosis -0.025 0.13 -10000 0 -0.52 10 10
SHH Np/Cholesterol/BOC 0.008 0.066 -10000 0 -0.33 9 9
SHH Np/Cholesterol/CDO -0.001 0.064 -10000 0 -0.3 4 4
mesenchymal cell differentiation -0.002 0.059 0.26 6 -10000 0 6
mol:Vitamin D3 0.004 0.11 0.29 1 -0.4 9 10
IHH N/PTCH2 0.007 0.11 -10000 0 -0.39 19 19
CDON -0.009 0.1 -10000 0 -0.27 47 47
IHH N/PTCH1 0 0.13 -10000 0 -0.36 34 34
Megalin/LRPAP1 -0.021 0.15 -10000 0 -0.34 59 59
PTCH2 0.005 0.11 -10000 0 -0.48 17 17
SHH Np/Cholesterol 0.006 0.035 -10000 0 -0.33 1 1
PTCH1 -0.009 0.12 -10000 0 -0.36 34 34
HHIP 0 0.082 -10000 0 -0.26 34 34
Regulation of p38-alpha and p38-beta

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.037 0.01 -10000 0 -10000 0 0
response to insulin stimulus 0 0 -10000 0 -10000 0 0
RIPK1 0.029 0.003 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0.017 0.07 -10000 0 -0.4 9 9
mol:GTP 0 0 -10000 0 -10000 0 0
MAP2K4 0.027 0.007 -10000 0 -10000 0 0
RAC1-CDC42/GTP/PAK family -0.02 0.086 -10000 0 -0.22 50 50
response to UV 0 0 -10000 0 -10000 0 0
YES1 0.029 0.005 -10000 0 -10000 0 0
interleukin-1 receptor activity 0 0 -10000 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
MAP3K3 0.028 0.007 -10000 0 -10000 0 0
FYN 0.026 0.044 -10000 0 -0.58 2 2
MAP3K12 0.027 0.016 -10000 0 -0.26 1 1
FGR 0.006 0.11 -10000 0 -0.5 16 16
p38 alpha/TAB1 -0.043 0.097 -10000 0 -0.35 25 25
PRKG1 -0.037 0.18 -10000 0 -0.46 50 50
DUSP8 0.003 0.12 -10000 0 -0.48 19 19
PGK/cGMP/p38 alpha -0.031 0.14 0.42 1 -0.35 36 37
apoptosis -0.041 0.093 -10000 0 -0.34 24 24
RAL/GTP 0.037 0.009 -10000 0 -10000 0 0
LYN 0.029 0.004 -10000 0 -10000 0 0
DUSP1 -0.008 0.13 -10000 0 -0.42 30 30
PAK1 0.028 0.005 -10000 0 -10000 0 0
SRC 0.026 0.035 -10000 0 -0.42 2 2
RAC1/OSM/MEKK3/MKK3 0.069 0.022 -10000 0 -10000 0 0
TRAF6 0.027 0.032 -10000 0 -0.58 1 1
RAC1 0.028 0.007 -10000 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
mol:cGMP 0 0 -10000 0 -10000 0 0
CCM2 0.028 0.007 -10000 0 -10000 0 0
RAC1-CDC42/GTP 0.036 0.011 -10000 0 -10000 0 0
MAPK11 -0.031 0.18 0.42 13 -0.48 26 39
BLK -0.12 0.22 -10000 0 -0.39 132 132
HCK -0.027 0.16 -10000 0 -0.48 41 41
MAP2K3 0.027 0.007 -10000 0 -10000 0 0
DUSP16 0.028 0.006 -10000 0 -10000 0 0
DUSP10 0.018 0.063 -10000 0 -0.38 8 8
TRAF6/MEKK3 0.034 0.021 -10000 0 -0.33 1 1
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 -0.002 0.14 0.36 12 -0.39 24 36
positive regulation of innate immune response -0.02 0.19 0.44 14 -0.5 26 40
LCK -0.034 0.16 -10000 0 -0.37 58 58
p38alpha-beta/MKP7 -0.02 0.16 0.29 4 -0.47 26 30
p38alpha-beta/MKP5 -0.017 0.18 0.45 10 -0.48 27 37
PGK/cGMP -0.027 0.13 -10000 0 -0.33 51 51
PAK2 0.029 0.005 -10000 0 -10000 0 0
p38alpha-beta/MKP1 -0.033 0.17 0.28 2 -0.49 27 29
CDC42 0.028 0.006 -10000 0 -10000 0 0
RALB 0.029 0.005 -10000 0 -10000 0 0
RALA 0.028 0.007 -10000 0 -10000 0 0
PAK3 -0.094 0.22 -10000 0 -0.43 99 99
Circadian rhythm pathway

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
chromatin modification 0.013 0.11 -10000 0 -0.46 2 2
CLOCK -0.007 0.14 -10000 0 -0.58 20 20
TIMELESS/CRY2 0 0.11 -10000 0 -0.48 2 2
DEC1/BMAL1 -0.031 0.14 -10000 0 -0.4 45 45
ATR 0.029 0.004 -10000 0 -10000 0 0
NR1D1 -0.093 0.38 -10000 0 -1.4 30 30
ARNTL -0.041 0.19 -10000 0 -0.56 42 42
TIMELESS -0.014 0.12 -10000 0 -0.51 3 3
NPAS2 0.016 0.07 -10000 0 -0.44 7 7
CRY2 0.028 0.005 -10000 0 -10000 0 0
mol:CO 0.001 0.041 0.14 30 -10000 0 30
CHEK1 0.028 0.006 -10000 0 -10000 0 0
mol:HEME -0.001 0.041 -10000 0 -0.14 30 30
PER1 0.026 0.022 -10000 0 -0.26 2 2
BMAL/CLOCK/NPAS2 -0.017 0.18 -10000 0 -0.41 56 56
BMAL1/CLOCK -0.09 0.3 -10000 0 -0.88 37 37
S phase of mitotic cell cycle 0.013 0.11 -10000 0 -0.46 2 2
TIMELESS/CHEK1/ATR 0.013 0.11 -10000 0 -0.46 2 2
mol:NADPH -0.001 0.041 -10000 0 -0.14 30 30
PER1/TIMELESS 0 0.11 -10000 0 -10000 0 0
PER1-2 / CRY1-2 0 0 -10000 0 -10000 0 0
DEC1 0 0 -10000 0 -10000 0 0
ceramide signaling pathway

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 -0.034 0.14 -10000 0 -0.45 19 19
BAG4 0.021 0.07 -10000 0 -0.58 5 5
BAD 0.002 0.072 0.34 8 -10000 0 8
NFKBIA 0.028 0.005 -10000 0 -10000 0 0
BIRC3 -0.067 0.2 -10000 0 -0.43 78 78
BAX 0.005 0.07 0.27 13 -10000 0 13
EnzymeConsortium:3.1.4.12 -0.003 0.042 0.16 8 -0.1 19 27
IKBKB -0.031 0.13 0.31 1 -0.43 19 20
MAP2K2 0.012 0.092 0.36 16 -10000 0 16
MAP2K1 0.007 0.082 0.33 13 -10000 0 13
SMPD1 0.001 0.049 0.22 7 -0.15 3 10
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 -0.027 0.13 -10000 0 -0.44 19 19
MAP2K4 0.011 0.1 0.38 17 -0.27 1 18
protein ubiquitination -0.03 0.13 0.33 3 -0.43 19 22
EnzymeConsortium:2.7.1.37 0.014 0.11 0.4 18 -10000 0 18
response to UV 0 0.002 0.006 21 -0.002 1 22
RAF1 0.008 0.085 0.32 15 -10000 0 15
CRADD 0.028 0.006 -10000 0 -10000 0 0
mol:ceramide -0.002 0.063 0.25 8 -0.15 17 25
I-kappa-B-alpha/RELA/p50/ubiquitin 0.038 0.009 -10000 0 -10000 0 0
MADD 0.029 0.005 -10000 0 -10000 0 0
MAP3K1 0.004 0.082 0.32 14 -0.28 1 15
TRADD 0.028 0.007 -10000 0 -10000 0 0
RELA/p50 0.028 0.005 -10000 0 -10000 0 0
MAPK3 0.013 0.086 0.35 14 -10000 0 14
MAPK1 -0.007 0.093 0.34 13 -0.23 2 15
p50/RELA/I-kappa-B-alpha 0.041 0.01 -10000 0 -10000 0 0
FADD -0.033 0.13 -10000 0 -0.45 19 19
KSR1 0.006 0.08 0.28 17 -10000 0 17
MAPK8 0.01 0.11 0.41 16 -0.27 5 21
TRAF2 0.027 0.009 -10000 0 -10000 0 0
response to radiation 0 0.001 0.005 11 -10000 0 11
CHUK -0.031 0.13 0.31 1 -0.42 19 20
TNF R/SODD 0.036 0.054 -10000 0 -0.42 5 5
TNF -0.07 0.2 -10000 0 -0.42 83 83
CYCS 0.007 0.079 0.27 17 -0.18 2 19
IKBKG -0.029 0.13 0.38 1 -0.42 19 20
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD -0.035 0.14 -10000 0 -0.47 19 19
RELA 0.028 0.005 -10000 0 -10000 0 0
RIPK1 0.029 0.003 -10000 0 -10000 0 0
AIFM1 0.004 0.078 0.29 14 -10000 0 14
TNF/TNF R/SODD -0.017 0.14 -10000 0 -0.36 46 46
TNFRSF1A 0.028 0.006 -10000 0 -10000 0 0
response to heat 0 0.001 0.005 11 -10000 0 11
CASP8 0.007 0.12 -10000 0 -0.69 10 10
NSMAF -0.033 0.13 -10000 0 -0.44 19 19
response to hydrogen peroxide 0 0.002 0.006 21 -0.002 1 22
BCL2 0.016 0.074 -10000 0 -0.36 12 12
RXR and RAR heterodimerization with other nuclear receptor

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.02 0.17 0.92 3 -1.3 4 7
VDR 0.023 0.056 -10000 0 -0.5 4 4
FAM120B 0.029 0.004 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA -0.028 0.14 -10000 0 -0.42 24 24
RXRs/LXRs/DNA/Oxysterols -0.042 0.18 -10000 0 -0.57 19 19
MED1 0.028 0.007 -10000 0 -10000 0 0
mol:9cRA -0.002 0.018 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 0.03 0.048 -10000 0 -0.25 10 10
RXRs/NUR77 -0.031 0.16 -10000 0 -0.37 54 54
RXRs/PPAR -0.027 0.12 -10000 0 -0.34 30 30
NCOR2 0.028 0.006 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.017 0.041 -10000 0 -0.36 4 4
RARs/VDR/DNA/Vit D3 0.06 0.044 -10000 0 -0.31 4 4
RARA 0.028 0.007 -10000 0 -10000 0 0
NCOA1 0.028 0.005 -10000 0 -10000 0 0
VDR/VDR/DNA 0.023 0.056 -10000 0 -0.5 4 4
RARs/RARs/DNA/9cRA 0.046 0.026 -10000 0 -0.31 1 1
RARG 0.028 0.006 -10000 0 -10000 0 0
RPS6KB1 0.046 0.14 0.6 18 -0.42 4 22
RARs/THRs/DNA/SMRT 0.03 0.048 -10000 0 -0.25 10 10
THRA 0.028 0.007 -10000 0 -10000 0 0
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.017 0.041 -10000 0 -0.36 4 4
RXRs/PPAR/9cRA/PGJ2/DNA -0.019 0.15 -10000 0 -0.35 52 52
NR1H4 0.015 0.038 -10000 0 -0.26 7 7
RXRs/LXRs/DNA 0.01 0.16 -10000 0 -0.35 45 45
NR1H2 0.024 0.024 -10000 0 -10000 0 0
NR1H3 0.024 0.025 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 0 0.14 -10000 0 -0.34 46 46
NR4A1 -0.029 0.14 -10000 0 -0.31 63 63
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.019 0.096 -10000 0 -0.25 45 45
RXRG -0.068 0.22 -10000 0 -0.56 58 58
RXR alpha/CCPG 0.034 0.025 -10000 0 -10000 0 0
RXRA 0.022 0.025 -10000 0 -10000 0 0
RXRB 0.025 0.026 -10000 0 -10000 0 0
THRB 0.013 0.098 -10000 0 -0.58 10 10
PPARG 0.018 0.065 -10000 0 -0.32 12 12
PPARD 0.029 0.003 -10000 0 -10000 0 0
TNF -0.12 0.37 -10000 0 -1.1 42 42
mol:Oxysterols -0.002 0.016 -10000 0 -10000 0 0
cholesterol transport -0.04 0.18 -10000 0 -0.56 19 19
PPARA 0.022 0.013 -10000 0 -10000 0 0
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB 0.027 0.031 -10000 0 -0.58 1 1
RXRs/NUR77/BCL2 -0.033 0.12 -10000 0 -0.29 57 57
SREBF1 -0.031 0.17 -10000 0 -0.61 14 14
RXRs/RXRs/DNA/9cRA -0.019 0.15 -10000 0 -0.35 52 52
ABCA1 -0.03 0.16 -10000 0 -0.56 14 14
RARs/THRs 0.07 0.067 -10000 0 -0.31 10 10
RXRs/FXR -0.003 0.14 -10000 0 -0.36 45 45
BCL2 0.016 0.074 -10000 0 -0.36 12 12
EPHB forward signaling

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 -0.009 0.12 -10000 0 -0.37 35 35
cell-cell adhesion 0.018 0.078 0.28 22 -10000 0 22
Ephrin B/EPHB2/RasGAP 0.049 0.094 -10000 0 -0.31 19 19
ITSN1 0.028 0.006 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
SHC1 0.027 0.008 -10000 0 -10000 0 0
Ephrin B1/EPHB3 -0.034 0.15 -10000 0 -0.36 61 61
Ephrin B1/EPHB1 0.011 0.081 -10000 0 -0.32 14 14
HRAS/GDP 0.014 0.087 -10000 0 -0.3 12 12
Ephrin B/EPHB1/GRB7 0.011 0.15 -10000 0 -0.35 44 44
Endophilin/SYNJ1 0.01 0.092 0.47 3 -0.29 20 23
KRAS 0.028 0.006 -10000 0 -10000 0 0
Ephrin B/EPHB1/Src 0.03 0.12 -10000 0 -0.32 26 26
endothelial cell migration 0.055 0.033 -10000 0 -0.31 2 2
GRB2 0.028 0.007 -10000 0 -10000 0 0
GRB7 -0.008 0.14 -10000 0 -0.58 22 22
PAK1 0.013 0.098 0.49 4 -0.3 19 23
HRAS 0.027 0.022 -10000 0 -0.26 2 2
RRAS 0.009 0.089 0.47 3 -0.29 19 22
DNM1 -0.002 0.11 -10000 0 -0.35 29 29
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.013 0.089 -10000 0 -0.3 25 25
lamellipodium assembly -0.018 0.078 -10000 0 -0.28 22 22
Ephrin B/EPHB1/Src/p52 SHC/GRB2 0.008 0.078 -10000 0 -0.3 11 11
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
EPHB2 0.018 0.076 -10000 0 -0.58 6 6
EPHB3 -0.083 0.23 -10000 0 -0.56 71 71
EPHB1 -0.013 0.13 -10000 0 -0.36 41 41
EPHB4 0.028 0.007 -10000 0 -10000 0 0
mol:GDP 0.008 0.089 0.4 2 -0.31 11 13
Ephrin B/EPHB2 0.035 0.089 -10000 0 -0.31 19 19
Ephrin B/EPHB3 -0.018 0.16 -10000 0 -0.34 69 69
JNK cascade 0.005 0.085 0.36 1 -0.35 13 14
Ephrin B/EPHB1 0.018 0.11 -10000 0 -0.31 26 26
RAP1/GDP 0.033 0.09 0.3 3 -0.3 1 4
EFNB2 0.028 0.006 -10000 0 -10000 0 0
EFNB3 -0.008 0.13 -10000 0 -0.42 30 30
EFNB1 0.027 0.008 -10000 0 -10000 0 0
Ephrin B2/EPHB1-2 0.021 0.097 -10000 0 -0.36 16 16
RAP1B 0.028 0.006 -10000 0 -10000 0 0
RAP1A 0.028 0.006 -10000 0 -10000 0 0
CDC42/GTP 0.018 0.11 -10000 0 -0.33 20 20
Rap1/GTP -0.003 0.09 -10000 0 -0.46 3 3
axon guidance -0.009 0.12 -10000 0 -0.37 35 35
MAPK3 0.001 0.069 -10000 0 -0.38 3 3
MAPK1 -0.002 0.066 -10000 0 -0.38 3 3
Rac1/GDP 0.023 0.087 0.31 1 -0.29 10 11
actin cytoskeleton reorganization -0.008 0.065 -10000 0 -0.36 2 2
CDC42/GDP 0.029 0.1 0.46 6 -0.29 10 16
PI3K 0.061 0.034 -10000 0 -0.31 2 2
EFNA5 -0.033 0.17 -10000 0 -0.46 47 47
Ephrin B2/EPHB4 0.036 0.012 -10000 0 -10000 0 0
Ephrin B/EPHB2/Intersectin/N-WASP 0.017 0.065 -10000 0 -0.26 17 17
CDC42 0.028 0.006 -10000 0 -10000 0 0
RAS family/GTP -0.007 0.086 -10000 0 -0.44 3 3
PTK2 0.012 0.054 0.59 3 -10000 0 3
MAP4K4 0.005 0.086 0.36 1 -0.35 13 14
SRC 0.026 0.035 -10000 0 -0.42 2 2
KALRN 0.027 0.026 -10000 0 -0.26 3 3
Intersectin/N-WASP 0.04 0.011 -10000 0 -10000 0 0
neuron projection morphogenesis 0.005 0.087 0.28 7 -0.42 1 8
MAP2K1 0.005 0.072 -10000 0 -0.37 4 4
WASL 0.028 0.007 -10000 0 -10000 0 0
Ephrin B1/EPHB1-2/NCK1 0.037 0.099 -10000 0 -0.38 13 13
cell migration 0.02 0.11 0.45 8 -0.39 5 13
NRAS 0.028 0.005 -10000 0 -10000 0 0
SYNJ1 0.01 0.093 0.47 3 -0.3 20 23
PXN 0.028 0.006 -10000 0 -10000 0 0
TF -0.019 0.11 0.44 2 -0.29 35 37
HRAS/GTP 0.014 0.1 -10000 0 -0.3 23 23
Ephrin B1/EPHB1-2 0.022 0.094 -10000 0 -0.38 13 13
cell adhesion mediated by integrin 0.028 0.094 0.31 20 -0.29 6 26
RAC1 0.028 0.007 -10000 0 -10000 0 0
mol:GTP 0.017 0.11 -10000 0 -0.31 27 27
RAC1-CDC42/GTP -0.055 0.14 -10000 0 -0.4 31 31
RASA1 0.028 0.006 -10000 0 -10000 0 0
RAC1-CDC42/GDP 0.033 0.087 0.31 1 -0.3 1 2
ruffle organization -0.003 0.1 0.48 5 -0.44 2 7
NCK1 0.029 0.004 -10000 0 -10000 0 0
receptor internalization -0.01 0.095 0.44 2 -0.29 25 27
Ephrin B/EPHB2/KALRN 0.048 0.096 -10000 0 -0.32 19 19
ROCK1 -0.038 0.13 -10000 0 -0.33 61 61
RAS family/GDP -0.012 0.062 -10000 0 -0.35 2 2
Rac1/GTP -0.012 0.085 -10000 0 -0.29 22 22
Ephrin B/EPHB1/Src/Paxillin 0.006 0.085 -10000 0 -0.28 27 27
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.028 0.006 -10000 0 -10000 0 0
VLDLR 0.011 0.082 -10000 0 -0.35 16 16
LRPAP1 0.027 0.032 -10000 0 -0.58 1 1
NUDC 0.028 0.006 -10000 0 -10000 0 0
RELN/LRP8 -0.065 0.16 -10000 0 -0.38 61 61
CaM/Ca2+ 0.021 0.004 -10000 0 -10000 0 0
KATNA1 0.029 0.004 -10000 0 -10000 0 0
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 -0.069 0.14 -10000 0 -0.34 59 59
IQGAP1/CaM 0.042 0.009 -10000 0 -10000 0 0
DAB1 0.017 0.041 -10000 0 -0.26 8 8
IQGAP1 0.029 0.004 -10000 0 -10000 0 0
PLA2G7 -0.013 0.14 -10000 0 -0.44 34 34
CALM1 0.028 0.005 -10000 0 -10000 0 0
DYNLT1 0.026 0.026 -10000 0 -0.26 3 3
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.028 0.072 -10000 0 -0.42 8 8
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0.028 0.006 -10000 0 -10000 0 0
CDK5R1 0.021 0.044 -10000 0 -0.26 9 9
LIS1/Poliovirus Protein 3A 0.013 0.004 -10000 0 -10000 0 0
CDK5R2 0.014 0.046 -10000 0 -0.26 10 10
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.07 0.16 -10000 0 -0.36 63 63
YWHAE 0.027 0.008 -10000 0 -10000 0 0
NDEL1/14-3-3 E -0.042 0.12 0.4 4 -0.46 4 8
MAP1B 0.007 0.005 -10000 0 -10000 0 0
RAC1 0.018 0.006 -10000 0 -10000 0 0
p35/CDK5 -0.06 0.13 -10000 0 -0.31 58 58
RELN -0.13 0.22 -10000 0 -0.39 143 143
PAFAH/LIS1 0.01 0.088 -10000 0 -0.36 17 17
LIS1/CLIP170 0.033 0.011 -10000 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain -0.034 0.1 -10000 0 -0.41 3 3
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.042 0.12 -10000 0 -0.43 11 11
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 -0.056 0.12 0.66 1 -0.4 7 8
LIS1/IQGAP1 0.033 0.01 -10000 0 -10000 0 0
RHOA 0.018 0.006 -10000 0 -10000 0 0
PAFAH1B1 0.018 0.005 -10000 0 -10000 0 0
PAFAH1B3 0.027 0.016 -10000 0 -0.26 1 1
PAFAH1B2 0.015 0.088 -10000 0 -0.58 8 8
MAP1B/LIS1/Dynein heavy chain 0.032 0.013 -10000 0 -10000 0 0
NDEL1/Katanin 60/Dynein heavy chain -0.035 0.12 0.32 3 -0.45 4 7
LRP8 0.01 0.093 -10000 0 -0.4 16 16
NDEL1/Katanin 60 -0.044 0.12 0.32 3 -0.46 4 7
P39/CDK5 -0.063 0.13 0.33 1 -0.31 58 59
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.033 0.011 -10000 0 -10000 0 0
CDK5 -0.069 0.13 0.34 1 -0.32 59 60
PPP2R5D 0.029 0.003 -10000 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.028 0.009 -10000 0 -10000 0 0
CSNK2A1 0.028 0.005 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 -0.05 0.14 -10000 0 -0.32 57 57
RELN/VLDLR -0.058 0.16 -10000 0 -0.35 64 64
CDC42 0.018 0.006 -10000 0 -10000 0 0
Aurora C signaling

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0.024 0.047 -9999 0 -0.47 3 3
Aurora C/Aurora B/INCENP 0.003 0.11 -9999 0 -0.33 26 26
metaphase 0 0 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
H3F3B 0.003 0.03 -9999 0 -10000 0 0
AURKB -0.018 0.14 -9999 0 -0.42 38 38
AURKC 0.001 0.092 -9999 0 -0.29 31 31
Ceramide signaling pathway

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.017 0.006 -10000 0 -10000 0 0
MAP4K4 -0.032 0.12 -10000 0 -0.49 16 16
BAG4 0.021 0.07 -10000 0 -0.58 5 5
PKC zeta/ceramide -0.011 0.097 -10000 0 -0.32 23 23
NFKBIA 0.028 0.005 -10000 0 -10000 0 0
BIRC3 -0.067 0.2 -10000 0 -0.43 78 78
BAX -0.009 0.078 -10000 0 -0.36 15 15
RIPK1 0.029 0.003 -10000 0 -10000 0 0
AKT1 0.028 0.15 0.78 13 -10000 0 13
BAD -0.025 0.088 0.18 1 -0.32 22 23
SMPD1 -0.017 0.083 0.24 5 -0.25 20 25
RB1 -0.026 0.09 -10000 0 -0.32 22 22
FADD/Caspase 8 -0.019 0.12 -10000 0 -0.48 16 16
MAP2K4 -0.013 0.066 0.19 5 -0.29 13 18
NSMAF 0.029 0.004 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.016 0.075 -10000 0 -0.32 14 14
EGF -0.033 0.15 -10000 0 -0.34 64 64
mol:ceramide -0.029 0.099 -10000 0 -0.33 25 25
MADD 0.028 0.005 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid 0.017 0.023 -10000 0 -0.42 1 1
ASAH1 0.027 0.032 -10000 0 -0.58 1 1
negative regulation of cell cycle -0.025 0.088 -10000 0 -0.32 22 22
cell proliferation -0.015 0.09 -10000 0 -0.27 23 23
BID -0.17 0.31 -10000 0 -0.66 100 100
MAP3K1 -0.021 0.077 -10000 0 -0.33 17 17
EIF2A -0.021 0.078 -10000 0 -0.46 8 8
TRADD 0.028 0.007 -10000 0 -10000 0 0
CRADD 0.028 0.006 -10000 0 -10000 0 0
MAPK3 -0.007 0.063 -10000 0 -0.35 6 6
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 -0.034 0.08 -10000 0 -0.36 9 9
Cathepsin D/ceramide -0.009 0.092 -10000 0 -0.32 22 22
FADD -0.032 0.12 -10000 0 -0.51 15 15
KSR1 -0.017 0.08 0.18 7 -0.33 16 23
MAPK8 -0.009 0.084 -10000 0 -0.36 14 14
PRKRA -0.026 0.092 0.19 1 -0.32 23 24
PDGFA 0.028 0.007 -10000 0 -10000 0 0
TRAF2 0.027 0.009 -10000 0 -10000 0 0
IGF1 -0.057 0.17 -10000 0 -0.36 83 83
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.029 0.098 -10000 0 -0.33 25 25
CTSD 0.028 0.006 -10000 0 -10000 0 0
regulation of nitric oxide biosynthetic process 0.042 0.009 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta -0.015 0.096 -10000 0 -0.29 23 23
PRKCD 0.029 0.004 -10000 0 -10000 0 0
PRKCZ 0.027 0.016 -10000 0 -0.26 1 1
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine 0.017 0.023 -10000 0 -0.42 1 1
RelA/NF kappa B1 0.042 0.009 -10000 0 -10000 0 0
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.027 0.032 -10000 0 -0.58 1 1
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD -0.032 0.13 -10000 0 -0.51 17 17
TNFR1A/BAG4/TNF-alpha -0.017 0.14 -10000 0 -0.36 46 46
mol:Sphingosine-1-phosphate 0.017 0.006 -10000 0 -10000 0 0
MAP2K1 -0.014 0.071 -10000 0 -0.37 9 9
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.028 0.005 -10000 0 -10000 0 0
CYCS -0.01 0.059 0.15 3 -0.25 15 18
TNFRSF1A 0.028 0.006 -10000 0 -10000 0 0
NFKB1 0.029 0.004 -10000 0 -10000 0 0
TNFR1A/BAG4 0.035 0.054 -10000 0 -0.42 5 5
EIF2AK2 -0.023 0.085 0.19 1 -0.35 17 18
TNF-alpha/TNFR1A/FAN -0.011 0.14 -10000 0 -0.36 41 41
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.008 0.076 -10000 0 -0.53 1 1
MAP2K2 -0.007 0.057 -10000 0 -0.31 5 5
SMPD3 -0.023 0.098 -10000 0 -0.31 24 24
TNF -0.07 0.2 -10000 0 -0.42 83 83
PKC zeta/PAR4 0.039 0.029 -10000 0 -0.42 1 1
mol:PHOSPHOCHOLINE -0.005 0.073 0.24 13 -0.25 12 25
NF kappa B1/RelA/I kappa B alpha 0.079 0.033 -10000 0 -0.31 1 1
AIFM1 -0.015 0.08 0.16 1 -0.28 22 23
BCL2 0.016 0.074 -10000 0 -0.36 12 12
Regulation of nuclear SMAD2/3 signaling

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.023 0.039 0.34 1 -0.58 1 2
HSPA8 0.026 0.032 -10000 0 -0.58 1 1
SMAD3/SMAD4/ER alpha -0.006 0.16 -10000 0 -0.4 36 36
AKT1 0.028 0.015 -10000 0 -10000 0 0
GSC -0.12 0.42 -10000 0 -1.5 33 33
NKX2-5 0.002 0.001 -10000 0 -10000 0 0
muscle cell differentiation -0.022 0.075 0.38 2 -10000 0 2
SMAD2-3/SMAD4/SP1 0.054 0.11 -10000 0 -0.43 3 3
SMAD4 0.005 0.066 -10000 0 -0.31 3 3
CBFB 0.028 0.007 -10000 0 -10000 0 0
SAP18 0.028 0.006 -10000 0 -10000 0 0
Cbp/p300/MSG1 -0.029 0.15 -10000 0 -0.36 56 56
SMAD3/SMAD4/VDR 0.058 0.081 -10000 0 -0.31 2 2
MYC 0.006 0.1 -10000 0 -0.45 17 17
CDKN2B -0.003 0.17 -10000 0 -1.4 3 3
AP1 -0.007 0.15 -10000 0 -0.47 17 17
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.036 0.063 -10000 0 -0.57 2 2
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 0.014 0.057 -10000 0 -0.34 3 3
SP3 0.03 0.009 -10000 0 -10000 0 0
CREB1 0.028 0.005 -10000 0 -10000 0 0
FOXH1 -0.015 0.13 -10000 0 -0.47 25 25
SMAD3/SMAD4/GR 0.04 0.076 -10000 0 -0.34 1 1
GATA3 -0.037 0.17 -10000 0 -0.53 33 33
SKI/SIN3/HDAC complex/NCoR1 0.03 0.065 -10000 0 -0.75 2 2
MEF2C/TIF2 -0.019 0.14 0.33 2 -0.36 19 21
endothelial cell migration 0.014 0.2 1.2 9 -10000 0 9
MAX 0.029 0.009 -10000 0 -10000 0 0
RBBP7 0.027 0.008 -10000 0 -10000 0 0
RBBP4 0.025 0.044 -10000 0 -0.58 2 2
RUNX2 -0.1 0.25 -10000 0 -0.57 81 81
RUNX3 -0.035 0.16 -10000 0 -0.38 58 58
RUNX1 -0.045 0.2 -10000 0 -0.58 45 45
CTBP1 0.029 0.005 -10000 0 -10000 0 0
NR3C1 0.028 0.009 -10000 0 -10000 0 0
VDR 0.023 0.056 -10000 0 -0.5 4 4
CDKN1A -0.001 0.21 -10000 0 -1.3 9 9
KAT2B 0.029 0.007 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.013 0.13 -10000 0 -0.36 26 26
DCP1A 0.029 0.004 -10000 0 -10000 0 0
SKI 0.028 0.006 -10000 0 -10000 0 0
SERPINE1 -0.014 0.21 -10000 0 -1.2 9 9
SMAD3/SMAD4/ATF2 0.03 0.1 -10000 0 -0.37 12 12
SMAD3/SMAD4/ATF3 -0.034 0.17 -10000 0 -0.43 44 44
SAP30 0.027 0.032 -10000 0 -0.58 1 1
Cbp/p300/PIAS3 0.043 0.046 -10000 0 -0.36 1 1
JUN -0.021 0.15 0.3 2 -0.54 12 14
SMAD3/SMAD4/IRF7 0.041 0.08 -10000 0 -0.35 2 2
TFE3 0.03 0.013 -10000 0 -10000 0 0
COL1A2 -0.011 0.19 -10000 0 -0.98 11 11
mesenchymal cell differentiation 0.049 0.19 0.4 77 -10000 0 77
DLX1 -0.024 0.16 -10000 0 -0.51 37 37
TCF3 0.027 0.008 -10000 0 -10000 0 0
FOS -0.046 0.19 -10000 0 -0.45 60 60
SMAD3/SMAD4/Max 0.039 0.081 -10000 0 -0.39 2 2
Cbp/p300/SNIP1 0.043 0.036 -10000 0 -0.36 1 1
ZBTB17 0.027 0.008 -10000 0 -10000 0 0
LAMC1 0.017 0.061 -10000 0 -10000 0 0
TGIF2/HDAC complex/SMAD3/SMAD4 0.041 0.076 -10000 0 -0.32 2 2
IRF7 0.027 0.017 -10000 0 -10000 0 0
ESR1 -0.055 0.19 -10000 0 -0.4 73 73
HNF4A 0 0 -10000 0 -10000 0 0
MEF2C -0.006 0.1 0.34 2 -0.36 10 12
SMAD2-3/SMAD4 0.04 0.089 -10000 0 -0.35 5 5
Cbp/p300/Src-1 0.044 0.039 -10000 0 -0.36 1 1
IGHV3OR16-13 -0.007 0.06 -10000 0 -0.52 3 3
TGIF2/HDAC complex 0.028 0.005 -10000 0 -10000 0 0
CREBBP 0.029 0.012 -10000 0 -10000 0 0
SKIL 0.025 0.047 -10000 0 -0.47 3 3
HDAC1 0.028 0.006 -10000 0 -10000 0 0
HDAC2 0.029 0.004 -10000 0 -10000 0 0
SNIP1 0.028 0.006 -10000 0 -10000 0 0
GCN5L2 0.002 0.013 0.19 1 -10000 0 1
SMAD3/SMAD4/TFE3 0.051 0.077 -10000 0 -0.34 2 2
MSG1/HSC70 -0.05 0.17 -10000 0 -0.4 64 64
SMAD2 0.021 0.04 -10000 0 -10000 0 0
SMAD3 0.012 0.062 -10000 0 -0.28 3 3
SMAD3/E2F4-5/DP1/p107/SMAD4 0.02 0.067 -10000 0 -0.32 4 4
SMAD2/SMAD2/SMAD4 0.009 0.036 0.24 2 -0.21 2 4
NCOR1 0.027 0.007 -10000 0 -10000 0 0
NCOA2 -0.028 0.18 -10000 0 -0.58 35 35
NCOA1 0.028 0.005 -10000 0 -10000 0 0
MYOD/E2A 0.02 0.006 -10000 0 -10000 0 0
SMAD2-3/SMAD4/SP1/MIZ-1 0.067 0.1 -10000 0 -0.47 2 2
IFNB1 0.001 0.069 -10000 0 -0.4 2 2
SMAD3/SMAD4/MEF2C 0.02 0.12 -10000 0 -0.41 7 7
CITED1 -0.083 0.22 -10000 0 -0.49 80 80
SMAD2-3/SMAD4/ARC105 0.04 0.084 -10000 0 -0.35 3 3
RBL1 0.009 0.11 -10000 0 -0.58 12 12
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB 0.029 0.061 -10000 0 -0.56 3 3
RUNX1-3/PEBPB2 -0.036 0.18 -10000 0 -0.41 57 57
SMAD7 0.018 0.12 -10000 0 -0.54 7 7
MYC/MIZ-1 0.022 0.082 -10000 0 -0.43 10 10
SMAD3/SMAD4 0.01 0.11 0.28 20 -0.45 7 27
IL10 -0.067 0.21 -10000 0 -0.6 37 37
PIASy/HDAC complex 0.023 0.018 -10000 0 -10000 0 0
PIAS3 0.028 0.009 -10000 0 -10000 0 0
CDK2 0.029 0.012 -10000 0 -10000 0 0
IL5 -0.045 0.13 -10000 0 -0.36 39 39
CDK4 0.029 0.012 -10000 0 -10000 0 0
PIAS4 0.023 0.018 -10000 0 -10000 0 0
ATF3 -0.08 0.2 -10000 0 -0.41 92 92
SMAD3/SMAD4/SP1 0.039 0.1 -10000 0 -0.4 4 4
FOXG1 -0.04 0.14 -10000 0 -0.34 55 55
FOXO3 0.019 0.015 -10000 0 -10000 0 0
FOXO1 0.018 0.015 -10000 0 -10000 0 0
FOXO4 0.018 0.015 -10000 0 -10000 0 0
heart looping -0.006 0.1 0.33 2 -0.36 10 12
CEBPB 0.029 0.009 -10000 0 -10000 0 0
SMAD3/SMAD4/DLX1 0.003 0.14 -10000 0 -0.4 31 31
MYOD1 0 0 -10000 0 -10000 0 0
SMAD3/SMAD4/HNF4 0.022 0.074 -10000 0 -0.31 5 5
SMAD3/SMAD4/GATA3 -0.012 0.17 -10000 0 -0.41 38 38
SnoN/SIN3/HDAC complex/NCoR1 0.025 0.047 -10000 0 -0.47 3 3
SMAD3/SMAD4/RUNX1-3/PEBPB2 -0.007 0.19 -10000 0 -0.4 54 54
SMAD3/SMAD4/SP1-3 0.062 0.097 -10000 0 -0.42 2 2
MED15 0.022 0.013 -10000 0 -10000 0 0
SP1 0.017 0.042 -10000 0 -10000 0 0
SIN3B 0.027 0.008 -10000 0 -10000 0 0
SIN3A 0.029 0.004 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.02 0.12 -10000 0 -0.35 20 20
ITGB5 0.014 0.079 0.37 1 -0.38 2 3
TGIF/SIN3/HDAC complex/CtBP 0.033 0.046 -10000 0 -0.67 1 1
SMAD3/SMAD4/AR -0.02 0.16 -10000 0 -0.39 39 39
AR -0.059 0.19 -10000 0 -0.41 73 73
negative regulation of cell growth 0.005 0.093 -10000 0 -0.37 5 5
SMAD3/SMAD4/MYOD 0.022 0.074 -10000 0 -0.31 5 5
E2F5 0.027 0.032 -10000 0 -0.58 1 1
E2F4 0.028 0.007 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.027 0.12 -10000 0 -0.34 18 18
SMAD2-3/SMAD4/FOXO1-3a-4 0.028 0.052 -10000 0 -0.38 3 3
TFDP1 0.028 0.007 -10000 0 -10000 0 0
SMAD3/SMAD4/AP1 0.017 0.16 -10000 0 -0.53 13 13
SMAD3/SMAD4/RUNX2 -0.048 0.19 -10000 0 -0.4 77 77
TGIF2 0.028 0.005 -10000 0 -10000 0 0
TGIF1 0.029 0.005 -10000 0 -10000 0 0
ATF2 0.014 0.093 -10000 0 -0.58 9 9
IFN-gamma pathway

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.038 0.097 -10000 0 -0.29 24 24
positive regulation of NF-kappaB transcription factor activity 0 0.002 -10000 0 -10000 0 0
CRKL 0.022 0.013 -10000 0 -10000 0 0
STAT1 (dimer)/Cbp/p300 -0.002 0.1 -10000 0 -0.31 3 3
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.044 0.04 -10000 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class I 0.005 0.068 -10000 0 -0.23 4 4
CaM/Ca2+ 0.041 0.093 -10000 0 -0.27 23 23
RAP1A 0.028 0.006 -10000 0 -10000 0 0
STAT1 (dimer)/SHP2 -0.009 0.099 -10000 0 -0.28 31 31
AKT1 -0.006 0.094 0.39 5 -0.29 1 6
MAP2K1 -0.017 0.084 0.31 2 -0.26 6 8
MAP3K11 -0.011 0.093 0.33 5 -0.27 23 28
IFNGR1 0.026 0.019 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII 0.004 0.12 -10000 0 -0.47 16 16
Rap1/GTP -0.012 0.064 -10000 0 -10000 0 0
CRKL/C3G 0.03 0.02 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP 0.02 0.11 -10000 0 -0.3 24 24
CEBPB -0.045 0.18 0.57 6 -0.46 28 34
STAT3 0.028 0.007 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.025 0.2 -10000 0 -1 9 9
STAT1 -0.014 0.1 0.34 7 -0.27 31 38
CALM1 0.028 0.005 -10000 0 -10000 0 0
IFN-gamma (dimer) -0.064 0.17 -10000 0 -0.34 92 92
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
STAT1 (dimer)/PIAS1 0 0.11 0.34 7 -0.27 13 20
CEBPB/PTGES2/Cbp/p300 -0.017 0.11 -10000 0 -0.37 6 6
mol:Ca2+ 0.011 0.1 -10000 0 -0.28 24 24
MAPK3 -0.002 0.1 -10000 0 -0.67 3 3
STAT1 (dimer) 0.014 0.094 -10000 0 -0.32 4 4
MAPK1 -0.16 0.3 0.43 1 -0.68 86 87
JAK2 0.024 0.019 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
JAK1 0.025 0.019 -10000 0 -10000 0 0
CAMK2D 0.026 0.044 -10000 0 -0.58 2 2
DAPK1 -0.036 0.19 0.53 8 -0.6 24 32
SMAD7 0.019 0.079 0.42 8 -10000 0 8
CBL/CRKL/C3G 0.001 0.086 0.3 2 -10000 0 2
PI3K 0.038 0.094 -10000 0 -0.27 25 25
IFNG -0.064 0.17 -10000 0 -0.34 92 92
apoptosis -0.031 0.16 0.56 6 -0.46 27 33
CAMK2G 0.028 0.006 -10000 0 -10000 0 0
STAT3 (dimer) 0.028 0.007 -10000 0 -10000 0 0
CAMK2A -0.008 0.12 -10000 0 -0.39 30 30
CAMK2B 0.016 0.083 -10000 0 -0.54 8 8
FRAP1 -0.013 0.087 0.37 5 -0.28 1 6
PRKCD 0 0.11 0.46 10 -0.3 1 11
RAP1B 0.028 0.006 -10000 0 -10000 0 0
negative regulation of cell growth 0.005 0.068 -10000 0 -0.23 4 4
PTPN2 0.029 0.005 -10000 0 -10000 0 0
EP300 0.02 0.033 -10000 0 -0.58 1 1
IRF1 -0.022 0.09 -10000 0 -0.38 4 4
STAT1 (dimer)/PIASy -0.004 0.1 0.37 4 -0.27 13 17
SOCS1 -0.007 0.21 -10000 0 -1.3 10 10
mol:GDP 0 0.082 0.28 2 -10000 0 2
CASP1 0.015 0.081 0.42 7 -0.25 5 12
PTGES2 0.027 0.009 -10000 0 -10000 0 0
IRF9 0.001 0.057 0.34 1 -0.28 1 2
mol:PI-3-4-5-P3 0.003 0.09 -10000 0 -0.26 25 25
RAP1/GDP 0 0.073 -10000 0 -10000 0 0
CBL -0.011 0.093 0.32 6 -0.27 23 29
MAP3K1 -0.015 0.088 0.32 2 -0.27 24 26
PIAS1 0.029 0.004 -10000 0 -10000 0 0
PIAS4 0.027 0.008 -10000 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class II 0.005 0.068 -10000 0 -0.23 4 4
PTPN11 -0.016 0.088 -10000 0 -0.28 24 24
CREBBP 0.028 0.007 -10000 0 -10000 0 0
RAPGEF1 0.027 0.008 -10000 0 -10000 0 0
Ephrin B reverse signaling

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.028 0.006 -10000 0 -10000 0 0
EPHB2 0.018 0.076 -10000 0 -0.58 6 6
EFNB1 -0.004 0.073 -10000 0 -0.41 8 8
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.009 0.15 -10000 0 -0.36 48 48
Ephrin B2/EPHB1-2 0.02 0.096 -10000 0 -0.37 15 15
neuron projection morphogenesis -0.021 0.14 -10000 0 -0.34 48 48
Ephrin B1/EPHB1-2/Tiam1 -0.02 0.16 -10000 0 -0.39 49 49
DNM1 -0.003 0.11 -10000 0 -0.35 29 29
cell-cell signaling -0.001 0.004 -10000 0 -10000 0 0
MAP2K4 0.005 0.074 0.41 1 -0.6 4 5
YES1 0.01 0.088 -10000 0 -0.82 4 4
Ephrin B1/EPHB1-2/NCK2 0.013 0.11 -10000 0 -0.36 21 21
PI3K 0.034 0.076 -10000 0 -0.57 5 5
mol:GDP -0.021 0.16 -10000 0 -0.38 49 49
ITGA2B 0 0.12 -10000 0 -0.47 21 21
endothelial cell proliferation 0.035 0.011 -10000 0 -10000 0 0
FYN 0.01 0.089 -10000 0 -0.82 4 4
MAP3K7 -0.002 0.067 -10000 0 -0.64 4 4
FGR 0.004 0.092 -10000 0 -0.82 4 4
TIAM1 -0.035 0.18 -10000 0 -0.53 42 42
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
RGS3 0.027 0.008 -10000 0 -10000 0 0
cell adhesion -0.002 0.13 -10000 0 -0.4 22 22
LYN 0.011 0.089 -10000 0 -0.84 4 4
Ephrin B1/EPHB1-2/Src Family Kinases 0.003 0.082 -10000 0 -0.78 4 4
Ephrin B1/EPHB1-2 -0.002 0.073 -10000 0 -0.68 4 4
SRC 0.009 0.087 -10000 0 -0.82 4 4
ITGB3 -0.002 0.13 -10000 0 -0.58 18 18
EPHB1 -0.014 0.13 -10000 0 -0.36 41 41
EPHB4 0.028 0.007 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.036 0.012 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin -0.002 0.14 -10000 0 -0.45 32 32
BLK -0.015 0.11 -10000 0 -0.87 4 4
HCK -0.002 0.1 -10000 0 -0.86 4 4
regulation of stress fiber formation -0.011 0.11 0.36 21 -10000 0 21
MAPK8 0.006 0.09 0.33 6 -0.64 4 10
Ephrin B1/EPHB1-2/RGS3 0.012 0.11 -10000 0 -0.36 21 21
endothelial cell migration 0.003 0.063 0.39 1 -0.49 4 5
NCK2 0.028 0.005 -10000 0 -10000 0 0
PTPN13 0.029 0.054 -10000 0 -0.7 2 2
regulation of focal adhesion formation -0.011 0.11 0.36 21 -10000 0 21
chemotaxis -0.011 0.11 0.36 21 -10000 0 21
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
Rac1/GTP -0.014 0.14 -10000 0 -0.35 48 48
angiogenesis -0.002 0.072 -10000 0 -0.68 4 4
LCK 0.001 0.099 -10000 0 -0.86 4 4
Class I PI3K signaling events

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP 0.029 0.047 0.29 9 -10000 0 9
DAPP1 -0.068 0.22 0.3 4 -0.6 38 42
Src family/SYK family/BLNK-LAT/BTK-ITK -0.08 0.24 0.32 1 -0.68 37 38
mol:DAG -0.024 0.11 0.37 9 -0.27 27 36
HRAS 0.028 0.023 -10000 0 -0.26 2 2
RAP1A 0.03 0.009 -10000 0 -10000 0 0
ARF5/GDP -0.002 0.12 -10000 0 -0.4 19 19
PLCG2 0.025 0.026 -10000 0 -0.26 3 3
PLCG1 0.028 0.005 -10000 0 -10000 0 0
ARF5 0.028 0.007 -10000 0 -10000 0 0
mol:GTP 0 0.053 0.3 9 -0.27 1 10
ARF1/GTP 0.005 0.019 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
YES1 0.029 0.005 -10000 0 -10000 0 0
RAP1A/GTP 0.019 0.024 -10000 0 -0.27 1 1
ADAP1 -0.001 0.049 0.29 9 -10000 0 9
ARAP3 0 0.052 0.3 9 -0.27 1 10
INPPL1 0.028 0.005 -10000 0 -10000 0 0
PREX1 0.028 0.005 -10000 0 -10000 0 0
ARHGEF6 0.018 0.065 -10000 0 -0.36 9 9
ARHGEF7 0.028 0.006 -10000 0 -10000 0 0
ARF1 0.027 0.008 -10000 0 -10000 0 0
NRAS 0.03 0.009 -10000 0 -10000 0 0
FYN 0.026 0.044 -10000 0 -0.58 2 2
ARF6 0.028 0.005 -10000 0 -10000 0 0
FGR 0.006 0.11 -10000 0 -0.5 16 16
mol:Ca2+ -0.008 0.068 0.3 7 -10000 0 7
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 -0.035 0.18 -10000 0 -0.53 42 42
ZAP70 -0.039 0.16 -10000 0 -0.36 65 65
mol:IP3 -0.018 0.076 0.23 10 -0.2 16 26
LYN 0.029 0.004 -10000 0 -10000 0 0
ARF1/GDP -0.003 0.13 0.32 4 -0.4 21 25
RhoA/GDP 0.022 0.069 0.29 2 -0.38 2 4
PDK1/Src/Hsp90 0.052 0.038 -10000 0 -0.36 2 2
BLNK 0.02 0.07 -10000 0 -0.58 5 5
actin cytoskeleton reorganization 0.011 0.096 0.28 11 -0.48 2 13
SRC 0.026 0.035 -10000 0 -0.42 2 2
PLEKHA2 0.004 0.036 -10000 0 -0.36 2 2
RAC1 0.028 0.007 -10000 0 -10000 0 0
PTEN 0.025 0.015 -10000 0 -10000 0 0
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
ARF6/GTP 0.027 0.045 0.29 8 -10000 0 8
RhoA/GTP 0.025 0.045 0.3 7 -10000 0 7
Src family/SYK family/BLNK-LAT -0.068 0.2 -10000 0 -0.56 36 36
BLK -0.12 0.22 -10000 0 -0.39 132 132
PDPK1 0.024 0.045 -10000 0 -0.58 2 2
CYTH1 0.001 0.058 0.31 10 -10000 0 10
HCK -0.027 0.16 -10000 0 -0.48 41 41
CYTH3 -0.001 0.049 0.29 9 -10000 0 9
CYTH2 0.005 0.066 0.32 13 -10000 0 13
KRAS 0.029 0.008 -10000 0 -10000 0 0
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.023 0.074 -10000 0 -0.49 5 5
SGK1 0.024 0.08 -10000 0 -0.53 5 5
INPP5D 0.017 0.064 -10000 0 -0.31 12 12
mol:GDP -0.014 0.13 0.3 5 -0.42 22 27
SOS1 0.028 0.006 -10000 0 -10000 0 0
SYK 0.027 0.008 -10000 0 -10000 0 0
ARF6/GDP 0.015 0.074 0.29 8 -0.38 2 10
mol:PI-3-4-5-P3 -0.008 0.02 -10000 0 -0.27 1 1
ARAP3/RAP1A/GTP 0.019 0.024 -10000 0 -0.27 1 1
VAV1 -0.034 0.16 -10000 0 -0.42 51 51
mol:PI-3-4-P2 0.011 0.044 -10000 0 -0.42 2 2
RAS family/GTP/PI3K Class I 0.045 0.037 0.33 1 -0.27 1 2
PLEKHA1 0.004 0.036 -10000 0 -0.36 2 2
Rac1/GDP -0.002 0.12 -10000 0 -0.4 20 20
LAT 0.013 0.084 -10000 0 -0.42 12 12
Rac1/GTP -0.024 0.15 -10000 0 -0.43 34 34
ITK -0.041 0.1 0.28 9 -0.31 28 37
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma -0.042 0.14 0.38 7 -0.39 28 35
LCK -0.034 0.16 -10000 0 -0.37 58 58
BTK -0.026 0.096 0.3 10 -0.31 23 33
ErbB4 signaling events

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.014 0.073 -10000 0 -0.36 5 5
epithelial cell differentiation -0.011 0.096 -10000 0 -0.57 1 1
ITCH 0.032 0.012 -10000 0 -10000 0 0
WWP1 0.016 0.036 -10000 0 -10000 0 0
FYN 0.026 0.044 -10000 0 -0.58 2 2
EGFR 0.002 0.12 -10000 0 -0.54 17 17
PRL 0 0 -10000 0 -10000 0 0
neuron projection morphogenesis -0.01 0.11 0.35 2 -0.47 3 5
PTPRZ1 -0.041 0.17 -10000 0 -0.42 56 56
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.015 0.13 -10000 0 -0.49 4 4
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.018 0.12 -10000 0 -0.34 42 42
ADAM17 0.026 0.054 -10000 0 -0.57 3 3
ErbB4/ErbB4 0.02 0.046 -10000 0 -0.42 1 1
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.003 0.11 -10000 0 -0.36 23 23
NCOR1 0.027 0.007 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.005 0.12 -10000 0 -0.42 9 9
GRIN2B -0.02 0.11 -10000 0 -0.4 9 9
ErbB4/ErbB2/betacellulin 0.021 0.1 -10000 0 -0.51 9 9
STAT1 0.017 0.077 -10000 0 -0.42 10 10
HBEGF -0.002 0.098 -10000 0 -0.3 34 34
PRLR -0.044 0.17 -10000 0 -0.4 63 63
E4ICDs/ETO2 0.021 0.066 -10000 0 -0.33 6 6
axon guidance 0.019 0.066 -10000 0 -0.34 1 1
NEDD4 0.031 0.032 -10000 0 -0.55 1 1
Prolactin receptor/Prolactin receptor/Prolactin -0.03 0.12 -10000 0 -0.42 27 27
CBFA2T3 0.014 0.078 -10000 0 -0.4 11 11
ErbB4/ErbB2/HBEGF 0.021 0.074 -10000 0 -0.48 3 3
MAPK3 -0.004 0.11 -10000 0 -0.46 4 4
STAT1 (dimer) 0.025 0.072 -10000 0 -0.38 6 6
MAPK1 -0.008 0.11 -10000 0 -0.46 4 4
JAK2 0.027 0.008 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 1 beta -0.012 0.11 -10000 0 -0.44 7 7
NRG1 -0.036 0.15 -10000 0 -0.44 42 42
NRG3 -0.02 0.15 -10000 0 -0.46 37 37
NRG2 -0.039 0.17 -10000 0 -0.42 56 56
NRG4 0.019 0.059 -10000 0 -0.33 9 9
heart development 0.019 0.066 -10000 0 -0.34 1 1
neural crest cell migration -0.012 0.11 -10000 0 -0.43 7 7
ERBB2 0.016 0.039 -10000 0 -0.41 3 3
WWOX/E4ICDs 0.03 0.049 -10000 0 -0.37 1 1
SHC1 0.027 0.008 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 0.026 0.094 -10000 0 -0.4 6 6
apoptosis 0.028 0.16 0.5 26 -10000 0 26
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.009 0.11 -10000 0 -0.34 28 28
ErbB4/ErbB2/epiregulin -0.057 0.14 -10000 0 -0.39 11 11
ErbB4/ErbB4/betacellulin/betacellulin 0.015 0.1 -10000 0 -0.42 17 17
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 -0.001 0.12 -10000 0 -0.43 6 6
MDM2 0.018 0.045 -10000 0 -0.37 1 1
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.005 0.12 -10000 0 -0.32 41 41
STAT5A 0.022 0.067 0.37 1 -10000 0 1
ErbB4/EGFR/neuregulin 1 beta -0.017 0.14 -10000 0 -0.42 13 13
DLG4 0.013 0.093 -10000 0 -0.58 9 9
GRB2/SHC 0.038 0.015 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 0.027 0.045 -10000 0 -0.35 1 1
STAT5A (dimer) 0 0.11 -10000 0 -0.62 1 1
MAP3K7IP2 0 0 -10000 0 -10000 0 0
STAT5B (dimer) 0.031 0.066 -10000 0 -10000 0 0
LRIG1 0.026 0.038 -10000 0 -0.36 3 3
EREG -0.15 0.24 -10000 0 -0.42 150 150
BTC 0.001 0.13 -10000 0 -0.58 17 17
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta 0.02 0.066 -10000 0 -0.35 1 1
ERBB4 0.02 0.046 -10000 0 -0.42 1 1
STAT5B 0.028 0.007 -10000 0 -10000 0 0
YAP1 0.017 0.053 -10000 0 -0.44 4 4
GRB2 0.028 0.007 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.031 0.062 -10000 0 -0.41 3 3
glial cell differentiation -0.027 0.045 0.34 1 -10000 0 1
WWOX 0.028 0.007 -10000 0 -10000 0 0
cell proliferation -0.017 0.15 0.4 1 -0.95 4 5
Signaling events mediated by VEGFR1 and VEGFR2

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.013 0.12 -10000 0 -0.46 20 20
AKT1 0.02 0.15 0.32 2 -0.65 16 18
PTK2B -0.011 0.17 0.35 1 -0.67 19 20
VEGFR2 homodimer/Frs2 0.01 0.16 -10000 0 -0.74 15 15
CAV1 0.006 0.1 -10000 0 -0.42 18 18
CALM1 0.028 0.005 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 0.027 0.16 -10000 0 -0.69 16 16
endothelial cell proliferation 0.034 0.18 0.6 14 -0.57 16 30
mol:Ca2+ 0.006 0.14 -10000 0 -0.68 14 14
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac 0.042 0.15 -10000 0 -0.65 16 16
RP11-342D11.1 -0.006 0.14 -10000 0 -0.62 17 17
CDH5 0.026 0.032 -10000 0 -0.58 1 1
VEGFA homodimer 0.064 0.046 -10000 0 -0.33 3 3
SHC1 0.027 0.008 -10000 0 -10000 0 0
SHC2 0.02 0.064 -10000 0 -0.51 5 5
HRAS/GDP 0.025 0.12 -10000 0 -0.55 15 15
SH2D2A -0.056 0.18 -10000 0 -0.4 73 73
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS 0.041 0.14 -10000 0 -0.59 14 14
VEGFR2 homodimer/VEGFA homodimer/TsAd -0.025 0.19 -10000 0 -0.46 46 46
VEGFR1 homodimer 0.012 0.094 -10000 0 -0.54 10 10
SHC/GRB2/SOS1 0.052 0.14 -10000 0 -0.62 14 14
GRB10 0.005 0.14 -10000 0 -0.69 14 14
PTPN11 0.028 0.006 -10000 0 -10000 0 0
GRB2 0.028 0.007 -10000 0 -10000 0 0
PAK1 0.028 0.005 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin 0.052 0.15 -10000 0 -0.69 14 14
HRAS 0.027 0.022 -10000 0 -0.26 2 2
VEGF/Rho/ROCK1/Integrin Complex 0.011 0.11 -10000 0 -0.41 16 16
HIF1A 0.028 0.005 -10000 0 -10000 0 0
FRS2 0.028 0.006 -10000 0 -10000 0 0
oxygen and reactive oxygen species metabolic process 0.04 0.15 -10000 0 -0.64 16 16
mol:GTP 0 0 -10000 0 -10000 0 0
FLT4 0.014 0.089 -10000 0 -0.54 9 9
Nck/Pak 0.042 0.009 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Fyn 0.025 0.16 -10000 0 -0.65 18 18
mol:GDP 0.037 0.13 -10000 0 -0.6 14 14
mol:NADP 0.028 0.14 0.46 6 -0.48 16 22
eNOS/Hsp90 0.032 0.12 -10000 0 -0.46 15 15
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:IP3 0.005 0.14 -10000 0 -0.7 14 14
HIF1A/ARNT 0.039 0.013 -10000 0 -10000 0 0
SHB 0.027 0.008 -10000 0 -10000 0 0
VEGFA 0.027 0.047 -10000 0 -0.47 3 3
VEGFC 0.027 0.032 -10000 0 -0.58 1 1
FAK1/Vinculin 0.011 0.17 0.33 2 -0.69 17 19
mol:Ca ++ 0 0 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.02 0.18 -10000 0 -0.71 17 17
PTPN6 0.027 0.016 -10000 0 -0.26 1 1
EPAS1 0.017 0.1 -10000 0 -0.44 15 15
mol:L-citrulline 0.028 0.14 0.46 6 -0.48 16 22
ITGAV 0.022 0.062 -10000 0 -0.58 4 4
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 0.041 0.15 -10000 0 -0.67 15 15
VEGFR2 homodimer/VEGFA homodimer 0.031 0.16 -10000 0 -0.67 17 17
VEGFR2/3 heterodimer 0.002 0.18 -10000 0 -0.69 20 20
VEGFB 0.028 0.005 -10000 0 -10000 0 0
MAPK11 -0.013 0.15 0.38 1 -0.7 15 16
VEGFR2 homodimer -0.006 0.17 -10000 0 -0.83 15 15
FLT1 0.012 0.094 -10000 0 -0.55 10 10
NEDD4 0.029 0.031 -10000 0 -0.57 1 1
MAPK3 -0.019 0.13 0.33 1 -0.61 15 16
MAPK1 -0.023 0.13 0.33 1 -0.61 15 16
VEGFA145/NRP2 0.01 0.11 -10000 0 -0.42 22 22
VEGFR1/2 heterodimer 0.001 0.19 -10000 0 -0.84 17 17
KDR -0.006 0.17 -10000 0 -0.83 15 15
VEGFA165/NRP1/VEGFR2 homodimer 0.015 0.17 -10000 0 -0.7 14 14
SRC 0.026 0.035 -10000 0 -0.42 2 2
platelet activating factor biosynthetic process -0.007 0.15 0.41 10 -0.62 15 25
PI3K 0.019 0.18 -10000 0 -0.79 16 16
VEGFR2 homodimer/VEGFA homodimer/NCK1 0.028 0.16 -10000 0 -0.69 16 16
FES 0.007 0.15 -10000 0 -0.71 14 14
GAB1 0.006 0.17 -10000 0 -0.8 15 15
VEGFR2 homodimer/VEGFA homodimer/Src 0.025 0.16 -10000 0 -0.68 17 17
CTNNB1 0.029 0.004 -10000 0 -10000 0 0
SOS1 0.028 0.006 -10000 0 -10000 0 0
ARNT 0.027 0.008 -10000 0 -10000 0 0
eNOS/Caveolin-1 0.026 0.12 -10000 0 -0.47 15 15
VEGFR2 homodimer/VEGFA homodimer/Yes 0.027 0.16 -10000 0 -0.69 16 16
PI3K/GAB1 0.033 0.15 -10000 0 -0.64 16 16
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak 0.053 0.15 -10000 0 -0.69 14 14
PRKACA 0.027 0.008 -10000 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer 0.018 0.17 -10000 0 -0.68 19 19
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
CDC42 0.006 0.14 -10000 0 -0.68 14 14
actin cytoskeleton reorganization -0.025 0.18 -10000 0 -0.46 46 46
PTK2 -0.005 0.18 0.31 1 -0.69 20 21
EDG1 -0.006 0.14 -10000 0 -0.62 17 17
mol:DAG 0.005 0.14 -10000 0 -0.7 14 14
CaM/Ca2+ 0.02 0.14 -10000 0 -0.64 14 14
MAP2K3 -0.013 0.15 0.37 1 -0.7 15 16
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 0.035 0.16 -10000 0 -0.72 14 14
PLCG1 0.005 0.15 -10000 0 -0.71 14 14
VEGFR2 homodimer/VEGFA homodimer/Src/Shb 0.037 0.16 -10000 0 -0.66 16 16
IQGAP1 0.029 0.004 -10000 0 -10000 0 0
YES1 0.029 0.005 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/SHP2 0.027 0.16 -10000 0 -0.69 16 16
VEGFR2 homodimer/VEGFA homodimer/SHP1 0.026 0.16 -10000 0 -0.69 16 16
cell migration 0.023 0.15 0.34 1 -0.59 16 17
mol:PI-3-4-5-P3 0.021 0.16 -10000 0 -0.71 16 16
FYN 0.026 0.044 -10000 0 -0.58 2 2
VEGFB/NRP1 0.011 0.14 -10000 0 -0.65 14 14
mol:NO 0.028 0.14 0.46 6 -0.48 16 22
PXN 0.028 0.006 -10000 0 -10000 0 0
HRAS/GTP 0.005 0.12 -10000 0 -0.55 15 15
VEGFR2 homodimer/VEGFA homodimer/GRB10 0.024 0.16 -10000 0 -0.72 14 14
VHL 0.026 0.044 -10000 0 -0.58 2 2
ITGB3 -0.002 0.13 -10000 0 -0.58 18 18
NOS3 0.023 0.15 0.5 4 -0.54 16 20
VEGFR2 homodimer/VEGFA homodimer/Sck 0.02 0.16 -10000 0 -0.64 19 19
RAC1 0.028 0.007 -10000 0 -10000 0 0
PRKCA -0.006 0.13 0.28 1 -0.64 14 15
PRKCB -0.028 0.15 0.37 1 -0.66 15 16
VCL 0.028 0.006 -10000 0 -10000 0 0
VEGFA165/NRP1 0.012 0.14 -10000 0 -0.62 17 17
VEGFR1/2 heterodimer/VEGFA homodimer 0.017 0.19 -10000 0 -0.81 17 17
VEGFA165/NRP2 0.01 0.11 -10000 0 -0.42 22 22
MAPKKK cascade 0.036 0.13 0.36 1 -0.57 14 15
NRP2 -0.008 0.14 -10000 0 -0.51 25 25
VEGFC homodimer 0.027 0.032 -10000 0 -0.58 1 1
NCK1 0.029 0.004 -10000 0 -10000 0 0
ROCK1 0.029 0.005 -10000 0 -10000 0 0
FAK1/Paxillin 0.011 0.17 -10000 0 -0.69 17 17
MAP3K13 -0.006 0.16 -10000 0 -0.74 15 15
PDPK1 0.009 0.14 -10000 0 -0.65 15 15
IGF1 pathway

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.028 0.005 -10000 0 -10000 0 0
PTK2 0.028 0.006 -10000 0 -10000 0 0
CRKL -0.02 0.086 -10000 0 -0.29 29 29
GRB2/SOS1/SHC 0.052 0.021 -10000 0 -10000 0 0
HRAS 0.027 0.022 -10000 0 -0.26 2 2
IRS1/Crk -0.011 0.09 -10000 0 -0.29 27 27
IGF-1R heterotetramer/IGF1/PTP1B -0.001 0.11 -10000 0 -0.34 25 25
AKT1 -0.02 0.081 -10000 0 -0.39 3 3
BAD -0.022 0.075 -10000 0 -0.42 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.017 0.086 -10000 0 -0.29 27 27
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.008 0.095 -10000 0 -0.29 29 29
RAF1 -0.005 0.082 0.38 1 -0.58 2 3
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos 0.043 0.095 -10000 0 -0.29 23 23
YWHAZ 0.029 0.005 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.011 0.1 -10000 0 -0.32 29 29
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
RPS6KB1 -0.021 0.081 -10000 0 -0.27 26 26
GNB2L1 0.028 0.006 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade -0.004 0.081 0.32 5 -0.48 2 7
PXN 0.028 0.006 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.041 0.011 -10000 0 -10000 0 0
HRAS/GTP -0.005 0.079 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc 0.055 0.091 -10000 0 -0.28 22 22
IGF-1R heterotetramer 0.012 0.046 -10000 0 -0.53 1 1
IGF-1R heterotetramer/IGF1/IRS/Nck 0.03 0.097 -10000 0 -0.29 29 29
Crk/p130 Cas/Paxillin 0.044 0.093 -10000 0 -0.28 23 23
IGF1R 0.012 0.046 -10000 0 -0.54 1 1
IGF1 -0.057 0.18 -10000 0 -0.36 83 83
IRS2/Crk -0.016 0.1 -10000 0 -0.31 30 30
PI3K 0.042 0.1 -10000 0 -0.29 27 27
apoptosis 0.005 0.078 0.36 2 -0.39 1 3
HRAS/GDP 0.02 0.015 -10000 0 -0.17 2 2
PRKCD -0.007 0.1 -10000 0 -0.38 24 24
RAF1/14-3-3 E 0.011 0.082 0.37 1 -0.49 2 3
BAD/14-3-3 -0.005 0.082 0.4 1 -0.39 2 3
PRKCZ -0.021 0.083 -10000 0 -0.36 4 4
Crk/p130 Cas/Paxillin/FAK1 0.006 0.083 -10000 0 -0.47 1 1
PTPN1 0.028 0.005 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.008 0.11 -10000 0 -0.39 25 25
BCAR1 0.028 0.007 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/SHC/GRB10 0.011 0.1 -10000 0 -0.3 25 25
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.028 0.006 -10000 0 -10000 0 0
IRS1/NCK2 -0.005 0.096 -10000 0 -0.3 25 25
GRB10 0.026 0.032 -10000 0 -0.58 1 1
PTPN11 -0.018 0.089 -10000 0 -0.29 29 29
IRS1 -0.022 0.097 -10000 0 -0.32 29 29
IRS2 -0.027 0.1 -10000 0 -0.31 36 36
IGF-1R heterotetramer/IGF1 -0.026 0.14 -10000 0 -0.44 26 26
GRB2 0.028 0.007 -10000 0 -10000 0 0
PDPK1 -0.017 0.09 -10000 0 -0.29 28 28
YWHAE 0.027 0.008 -10000 0 -10000 0 0
PRKD1 -0.007 0.1 -10000 0 -0.38 24 24
SHC1 0.027 0.008 -10000 0 -10000 0 0
Cellular roles of Anthrax toxin

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 0.021 0.061 -10000 0 -0.4 7 7
ANTXR2 0.023 0.045 -10000 0 -0.31 6 6
negative regulation of myeloid dendritic cell antigen processing and presentation -0.001 0.01 -10000 0 -0.069 6 6
monocyte activation -0.046 0.17 -10000 0 -0.44 55 55
MAP2K2 -0.008 0.12 -10000 0 -0.55 17 17
MAP2K1 -0.001 0.011 -10000 0 -0.12 1 1
MAP2K7 0 0.011 0.14 1 -10000 0 1
MAP2K6 -0.004 0.038 0.17 2 -0.21 9 11
CYAA -0.004 0.039 -10000 0 -0.28 6 6
MAP2K4 0 0.009 -10000 0 -10000 0 0
IL1B -0.037 0.096 0.18 1 -0.29 41 42
Channel 0.028 0.048 -10000 0 -0.3 6 6
NLRP1 -0.003 0.029 -10000 0 -0.31 3 3
CALM1 0.028 0.005 -10000 0 -10000 0 0
negative regulation of phagocytosis 0.012 0.028 -10000 0 -0.47 1 1
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.001 0.01 0.069 6 -10000 0 6
MAPK3 0 0.008 -10000 0 -10000 0 0
MAPK1 0 0.008 -10000 0 -10000 0 0
PGR -0.038 0.099 0.17 1 -0.26 57 58
PA/Cellular Receptors 0.029 0.053 -10000 0 -0.33 6 6
apoptosis -0.001 0.01 -10000 0 -0.069 6 6
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.028 0.045 -10000 0 -0.28 6 6
macrophage activation 0 0.008 -10000 0 -10000 0 0
TNF -0.07 0.2 -10000 0 -0.42 83 83
VCAM1 -0.047 0.17 -10000 0 -0.44 55 55
platelet activation 0.012 0.028 -10000 0 -0.47 1 1
MAPKKK cascade -0.004 0.024 -10000 0 -0.14 6 6
IL18 -0.037 0.1 -10000 0 -0.28 49 49
negative regulation of macrophage activation -0.001 0.01 -10000 0 -0.069 6 6
LEF -0.001 0.01 -10000 0 -0.069 6 6
CASP1 0 0.019 -10000 0 -0.14 4 4
mol:cAMP 0.012 0.028 -10000 0 -0.48 1 1
necrosis -0.001 0.01 -10000 0 -0.069 6 6
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.028 0.046 -10000 0 -0.28 6 6
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
Hedgehog signaling events mediated by Gli proteins

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.029 0.006 -10000 0 -10000 0 0
HDAC2 0.029 0.004 -10000 0 -10000 0 0
GNB1/GNG2 0.049 0.035 -10000 0 -0.36 1 1
forebrain development -0.075 0.19 0.42 5 -0.52 37 42
GNAO1 -0.029 0.17 -10000 0 -0.54 37 37
SMO/beta Arrestin2 0.03 0.035 -10000 0 -0.42 1 1
SMO 0.022 0.038 -10000 0 -0.37 3 3
ARRB2 0.025 0.017 -10000 0 -0.26 1 1
GLI3/SPOP 0.044 0.064 -10000 0 -0.35 3 3
mol:GTP -0.002 0.005 -10000 0 -10000 0 0
GSK3B 0.029 0.004 -10000 0 -10000 0 0
GNAI2 0.027 0.007 -10000 0 -10000 0 0
SIN3/HDAC complex 0.067 0.033 -10000 0 -0.33 1 1
GNAI1 0.017 0.053 -10000 0 -0.26 13 13
XPO1 0.02 0.019 -10000 0 -10000 0 0
GLI1/Su(fu) -0.052 0.14 -10000 0 -0.48 17 17
SAP30 0.028 0.032 -10000 0 -0.58 1 1
mol:GDP 0.022 0.038 -10000 0 -0.37 3 3
MIM/GLI2A -0.019 0.091 -10000 0 -0.42 10 10
IFT88 0.028 0.006 -10000 0 -10000 0 0
GNAI3 0.027 0.007 -10000 0 -10000 0 0
GLI2 0.004 0.077 0.29 3 -0.31 8 11
GLI3 0.032 0.066 0.26 2 -0.37 3 5
CSNK1D 0.028 0.007 -10000 0 -10000 0 0
CSNK1E 0.022 0.013 -10000 0 -10000 0 0
SAP18 0.028 0.007 -10000 0 -10000 0 0
embryonic digit morphogenesis 0.028 0.006 -10000 0 -10000 0 0
GNG2 0.026 0.026 -10000 0 -0.26 3 3
Gi family/GTP -0.027 0.096 -10000 0 -0.32 21 21
SIN3B 0.028 0.008 -10000 0 -10000 0 0
SIN3A 0.029 0.004 -10000 0 -10000 0 0
GLI3/Su(fu) 0.044 0.06 -10000 0 -0.58 1 1
GLI2/Su(fu) 0.014 0.077 -10000 0 -0.55 2 2
FOXA2 -0.26 0.49 -10000 0 -1.1 91 91
neural tube patterning -0.075 0.19 0.42 5 -0.52 37 42
SPOP 0.028 0.007 -10000 0 -10000 0 0
Su(fu)/PIAS1 0.039 0.03 -10000 0 -10000 0 0
GNB1 0.028 0.006 -10000 0 -10000 0 0
CSNK1G2 0.027 0.008 -10000 0 -10000 0 0
CSNK1G3 0.028 0.006 -10000 0 -10000 0 0
MTSS1 -0.019 0.091 -10000 0 -0.42 10 10
embryonic limb morphogenesis -0.075 0.19 0.42 5 -0.52 37 42
SUFU 0.023 0.019 -10000 0 -10000 0 0
LGALS3 -0.069 0.22 -10000 0 -0.57 61 61
catabolic process 0.039 0.095 -10000 0 -0.44 6 6
GLI3A/CBP -0.025 0.12 -10000 0 -0.36 36 36
KIF3A 0.028 0.006 -10000 0 -10000 0 0
GLI1 -0.078 0.19 0.42 5 -0.53 37 42
RAB23 0.024 0.054 -10000 0 -0.58 3 3
CSNK1A1 0.028 0.006 -10000 0 -10000 0 0
IFT172 0.028 0.005 -10000 0 -10000 0 0
RBBP7 0.028 0.008 -10000 0 -10000 0 0
Su(fu)/Galectin3 -0.017 0.13 -10000 0 -0.33 55 55
GNAZ 0.011 0.074 -10000 0 -0.5 7 7
RBBP4 0.025 0.044 -10000 0 -0.58 2 2
CSNK1G1 0.029 0.004 -10000 0 -10000 0 0
PIAS1 0.029 0.004 -10000 0 -10000 0 0
PRKACA 0.027 0.008 -10000 0 -10000 0 0
GLI2/SPOP 0.012 0.081 -10000 0 -0.32 9 9
STK36 0.02 0.018 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.003 0.081 -10000 0 -0.34 7 7
PTCH1 -0.07 0.2 0.57 2 -0.63 22 24
MIM/GLI1 -0.14 0.27 0.4 3 -0.55 96 99
CREBBP -0.025 0.12 -10000 0 -0.36 36 36
Su(fu)/SIN3/HDAC complex 0.038 0.065 -10000 0 -0.68 2 2
Presenilin action in Notch and Wnt signaling

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.011 0.13 -10000 0 -0.63 7 7
HDAC1 0.026 0.01 -10000 0 -10000 0 0
AES 0.027 0.008 -10000 0 -10000 0 0
FBXW11 0.028 0.006 -10000 0 -10000 0 0
DTX1 0.023 0.054 -10000 0 -0.58 3 3
LRP6/FZD1 0.035 0.054 -10000 0 -0.42 5 5
TLE1 0.026 0.008 -10000 0 -10000 0 0
AP1 -0.038 0.14 -10000 0 -0.34 54 54
NCSTN 0.027 0.008 -10000 0 -10000 0 0
ADAM10 0.018 0.082 -10000 0 -0.58 7 7
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 0.029 0.088 -10000 0 -0.68 3 3
NICD/RBPSUH 0.013 0.13 -10000 0 -0.62 7 7
WIF1 -0.008 0.085 -10000 0 -0.26 38 38
NOTCH1 0.002 0.12 -10000 0 -0.64 7 7
PSENEN 0.028 0.007 -10000 0 -10000 0 0
KREMEN2 -0.007 0.14 -10000 0 -0.51 24 24
DKK1 -0.066 0.2 -10000 0 -0.42 79 79
beta catenin/beta TrCP1 0.05 0.052 0.27 3 -10000 0 3
APH1B 0.029 0.004 -10000 0 -10000 0 0
APH1A 0.027 0.008 -10000 0 -10000 0 0
AXIN1 -0.007 0.083 -10000 0 -0.44 6 6
CtBP/CBP/TCF1/TLE1/AES 0.025 0.028 -10000 0 -0.27 1 1
PSEN1 0.028 0.005 -10000 0 -10000 0 0
FOS -0.047 0.18 -10000 0 -0.44 60 60
JUN 0.006 0.094 -10000 0 -0.35 22 22
MAP3K7 0.028 0.005 -10000 0 -10000 0 0
CTNNB1 0.043 0.066 0.3 10 -10000 0 10
MAPK3 0.028 0.007 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.014 0.16 -10000 0 -0.38 51 51
HNF1A 0.026 0.032 -10000 0 -0.58 1 1
CTBP1 0.028 0.005 -10000 0 -10000 0 0
MYC -0.031 0.29 -10000 0 -1.3 17 17
NKD1 -0.011 0.14 -10000 0 -0.45 30 30
FZD1 0.02 0.07 -10000 0 -0.58 5 5
NOTCH1 precursor/Deltex homolog 1 0.011 0.13 -10000 0 -0.6 9 9
apoptosis -0.037 0.14 -10000 0 -0.33 54 54
Delta 1/NOTCHprecursor 0.009 0.13 -10000 0 -0.61 7 7
DLL1 0.019 0.072 -10000 0 -0.49 7 7
PPARD 0.028 0.045 -10000 0 -0.74 1 1
Gamma Secretase 0.076 0.031 -10000 0 -10000 0 0
APC 0.002 0.055 -10000 0 -10000 0 0
DVL1 0.024 0.016 -10000 0 -10000 0 0
CSNK2A1 0.029 0.006 -10000 0 -10000 0 0
MAP3K7IP1 -0.001 0.004 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.029 0.16 -10000 0 -0.37 54 54
LRP6 0.028 0.006 -10000 0 -10000 0 0
CSNK1A1 0.028 0.006 -10000 0 -10000 0 0
NLK 0.015 0.008 -10000 0 -10000 0 0
CCND1 0 0.19 -10000 0 -1.1 10 10
WNT1 0.014 0.061 -10000 0 -0.28 14 14
Axin1/APC/beta catenin 0.05 0.091 0.41 10 -10000 0 10
DKK2 -0.04 0.18 -10000 0 -0.5 49 49
NOTCH1 precursor/DVL1 0.019 0.11 -10000 0 -0.54 8 8
GSK3B 0.029 0.004 -10000 0 -10000 0 0
FRAT1 0.028 0.005 -10000 0 -10000 0 0
NOTCH/Deltex homolog 1 0.013 0.13 -10000 0 -0.62 9 9
PPP2R5D 0.038 0.069 0.3 18 -0.43 1 19
MAPK1 0.022 0.013 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 0.033 0.086 -10000 0 -0.36 7 7
RBPJ 0.028 0.015 -10000 0 -0.26 1 1
CREBBP 0.029 0.009 -10000 0 -10000 0 0
S1P5 pathway

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
telencephalon oligodendrocyte cell migration 0.016 0.1 0.34 15 -10000 0 15
GNAI2 0.029 0.004 -10000 0 -10000 0 0
S1P/S1P5/G12 0.025 0.064 -10000 0 -0.36 9 9
mol:GDP 0 0 -10000 0 -10000 0 0
GNAO1 -0.028 0.17 -10000 0 -0.54 37 37
RhoA/GTP -0.016 0.11 -10000 0 -0.35 15 15
negative regulation of cAMP metabolic process -0.024 0.11 -10000 0 -0.3 42 42
GNAZ 0.012 0.074 -10000 0 -0.5 7 7
GNAI3 0.028 0.006 -10000 0 -10000 0 0
GNA12 0.028 0.007 -10000 0 -10000 0 0
S1PR5 0.009 0.098 -10000 0 -0.49 13 13
mol:GTP 0 0 -10000 0 -10000 0 0
S1P/S1P5/Gi -0.024 0.11 -10000 0 -0.3 42 42
RhoA/GDP 0.021 0.003 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
GNAI1 0.018 0.053 -10000 0 -0.26 13 13
TCGA08_rtk_signaling

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.1 0.23 -10000 0 -0.46 103 103
HRAS 0.027 0.022 -10000 0 -0.26 2 2
EGFR 0.002 0.12 -10000 0 -0.54 17 17
AKT 0.014 0.096 0.29 6 -0.28 10 16
FOXO3 0.029 0.004 -10000 0 -10000 0 0
AKT1 0.028 0.006 -10000 0 -10000 0 0
FOXO1 0.028 0.007 -10000 0 -10000 0 0
AKT3 0.027 0.008 -10000 0 -10000 0 0
FOXO4 0.027 0.008 -10000 0 -10000 0 0
MET -0.03 0.18 -10000 0 -0.58 36 36
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
PIK3CB 0.029 0.004 -10000 0 -10000 0 0
NRAS 0.028 0.005 -10000 0 -10000 0 0
PIK3CG -0.014 0.14 -10000 0 -0.44 33 33
PIK3R3 0.027 0.032 -10000 0 -0.58 1 1
PIK3R2 0.027 0.008 -10000 0 -10000 0 0
NF1 0.028 0.007 -10000 0 -10000 0 0
RAS -0.032 0.11 -10000 0 -0.34 29 29
ERBB2 0.028 0.007 -10000 0 -10000 0 0
proliferation/survival/translation -0.03 0.077 0.38 7 -10000 0 7
PI3K -0.02 0.11 0.23 3 -0.3 33 36
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
KRAS 0.028 0.006 -10000 0 -10000 0 0
FOXO 0.053 0.053 0.25 6 -10000 0 6
AKT2 0.026 0.022 -10000 0 -0.26 2 2
PTEN 0.028 0.006 -10000 0 -10000 0 0
PDGFR-beta signaling pathway

Figure S87.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S87.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.006 0.11 -10000 0 -0.5 13 13
PDGFB-D/PDGFRB/SLAP 0.015 0.096 -10000 0 -0.41 14 14
PDGFB-D/PDGFRB/APS/CBL 0.041 0.076 -10000 0 -0.36 12 12
AKT1 0.021 0.098 0.47 9 -10000 0 9
mol:PI-4-5-P2 0 0.001 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.009 0.12 0.29 1 -0.54 13 14
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
FGR -0.012 0.14 0.38 1 -0.5 23 24
mol:Ca2+ 0.012 0.13 0.36 9 -0.58 12 21
MYC 0.005 0.2 0.59 11 -0.69 17 28
SHC1 0.027 0.008 -10000 0 -10000 0 0
HRAS/GDP 0.026 0.062 -10000 0 -0.3 12 12
LRP1/PDGFRB/PDGFB 0.027 0.081 -10000 0 -0.36 14 14
GRB10 0.026 0.032 -10000 0 -0.58 1 1
PTPN11 0.028 0.006 -10000 0 -10000 0 0
GO:0007205 0.011 0.13 0.36 9 -0.59 12 21
PTEN 0.028 0.006 -10000 0 -10000 0 0
GRB2 0.028 0.007 -10000 0 -10000 0 0
GRB7 -0.008 0.14 -10000 0 -0.58 22 22
PDGFB-D/PDGFRB/SHP2 0.026 0.083 -10000 0 -0.42 12 12
PDGFB-D/PDGFRB/GRB10 0.025 0.086 -10000 0 -0.42 13 13
cell cycle arrest 0.015 0.095 -10000 0 -0.41 14 14
HRAS 0.027 0.022 -10000 0 -0.26 2 2
HIF1A 0.015 0.093 0.45 9 -10000 0 9
GAB1 0.002 0.14 0.37 8 -0.51 17 25
mol:GTP 0 0 -10000 0 -10000 0 0
DNM2 0.009 0.14 0.47 11 -0.46 17 28
PDGFB-D/PDGFRB 0.043 0.078 -10000 0 -0.37 12 12
mol:GDP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.026 0.083 -10000 0 -0.42 12 12
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB 0.004 0.12 0.27 1 -0.43 19 20
positive regulation of MAPKKK cascade 0.026 0.083 -10000 0 -0.42 12 12
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
mol:IP3 0.011 0.13 0.36 9 -0.6 12 21
E5 -0.001 0.001 -10000 0 -10000 0 0
CSK 0.027 0.016 -10000 0 -0.26 1 1
PDGFB-D/PDGFRB/GRB7 -0.002 0.13 -10000 0 -0.42 34 34
SHB 0.027 0.008 -10000 0 -10000 0 0
BLK -0.076 0.22 0.31 1 -0.55 62 63
PTPN2 0.03 0.006 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.026 0.083 -10000 0 -0.42 12 12
BCAR1 0.028 0.007 -10000 0 -10000 0 0
VAV2 0.003 0.16 0.46 9 -0.53 19 28
CBL 0.028 0.006 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.026 0.083 -10000 0 -0.42 12 12
LCK -0.026 0.16 -10000 0 -0.54 29 29
PDGFRB 0.008 0.11 -10000 0 -0.56 13 13
ACP1 0.028 0.005 -10000 0 -10000 0 0
HCK -0.034 0.17 -10000 0 -0.57 29 29
ABL1 0.004 0.14 0.37 10 -0.48 17 27
PDGFB-D/PDGFRB/CBL -0.003 0.14 0.32 3 -0.57 17 20
PTPN1 0.029 0.006 -10000 0 -10000 0 0
SNX15 0.028 0.005 -10000 0 -10000 0 0
STAT3 0.028 0.007 -10000 0 -10000 0 0
STAT1 0.017 0.077 -10000 0 -0.42 10 10
cell proliferation 0.009 0.19 0.56 12 -0.61 17 29
SLA 0.014 0.066 -10000 0 -0.28 17 17
actin cytoskeleton reorganization 0.027 0.061 -10000 0 -0.31 1 1
SRC 0.007 0.076 -10000 0 -0.38 13 13
PI3K 0.003 0.059 -10000 0 -0.29 5 5
PDGFB-D/PDGFRB/GRB7/SHC 0.015 0.12 -10000 0 -0.36 32 32
SH2B2 0.027 0.016 -10000 0 -0.26 1 1
PLCgamma1/SPHK1 0.009 0.12 0.3 1 -0.56 13 14
LYN 0.008 0.083 0.35 2 -0.38 14 16
LRP1 0.025 0.044 -10000 0 -0.58 2 2
SOS1 0.028 0.006 -10000 0 -10000 0 0
STAT5B 0.028 0.007 -10000 0 -10000 0 0
STAT5A 0.028 0.007 -10000 0 -10000 0 0
NCK1-2/p130 Cas 0.071 0.073 -10000 0 -0.3 12 12
SPHK1 0.02 0.07 -10000 0 -0.58 5 5
EDG1 0 0.005 -10000 0 -10000 0 0
mol:DAG 0.011 0.13 0.36 9 -0.6 12 21
PLCG1 0.011 0.14 0.38 8 -0.61 12 20
NHERF/PDGFRB 0.037 0.079 -10000 0 -0.36 12 12
YES1 0.004 0.092 0.37 2 -0.4 16 18
cell migration 0.036 0.079 -10000 0 -0.36 12 12
SHC/Grb2/SOS1 0.066 0.073 -10000 0 -0.3 11 11
SLC9A3R2 0.026 0.022 -10000 0 -0.26 2 2
SLC9A3R1 0.023 0.039 -10000 0 -0.28 6 6
NHERF1-2/PDGFRB/PTEN 0.05 0.078 -10000 0 -0.33 12 12
FYN 0.003 0.099 0.35 2 -0.42 16 18
DOK1 0.013 0.066 -10000 0 -0.33 12 12
HRAS/GTP 0.02 0.015 -10000 0 -0.17 2 2
PDGFB 0.022 0.013 -10000 0 -10000 0 0
RAC1 0.011 0.18 0.55 12 -0.5 24 36
PRKCD 0.014 0.067 -10000 0 -0.34 12 12
FER 0.011 0.071 -10000 0 -0.34 14 14
MAPKKK cascade 0.008 0.075 0.37 1 -0.3 5 6
RASA1 0.013 0.066 -10000 0 -0.34 12 12
NCK1 0.029 0.004 -10000 0 -10000 0 0
NCK2 0.028 0.005 -10000 0 -10000 0 0
p62DOK/Csk 0.03 0.066 -10000 0 -0.31 12 12
PDGFB-D/PDGFRB/SHB 0.024 0.083 -10000 0 -0.42 12 12
chemotaxis 0.005 0.13 0.37 10 -0.46 17 27
STAT1-3-5/STAT1-3-5 0.049 0.081 -10000 0 -0.29 17 17
Bovine Papilomavirus E5/PDGFRB 0.006 0.08 -10000 0 -0.41 13 13
PTPRJ 0.028 0.005 -10000 0 -10000 0 0
Regulation of Androgen receptor activity

Figure S88.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S88.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.015 0.009 -10000 0 -10000 0 0
SMARCC1 0.017 0.04 -10000 0 -0.71 1 1
REL -0.002 0.14 -10000 0 -0.53 22 22
HDAC7 -0.019 0.091 -10000 0 -0.42 4 4
JUN 0.005 0.094 -10000 0 -0.35 22 22
EP300 0.02 0.033 -10000 0 -0.58 1 1
KAT2B 0.028 0.004 -10000 0 -10000 0 0
KAT5 0.029 0.005 -10000 0 -10000 0 0
MAPK14 0.003 0.057 0.22 3 -0.43 4 7
FOXO1 0.027 0.007 -10000 0 -10000 0 0
T-DHT/AR -0.005 0.11 -10000 0 -0.4 7 7
MAP2K6 0.011 0.072 -10000 0 -0.41 9 9
BRM/BAF57 0.03 0.025 -10000 0 -10000 0 0
MAP2K4 0.021 0.017 -10000 0 -10000 0 0
SMARCA2 0.022 0.016 -10000 0 -10000 0 0
PDE9A -0.002 0.15 -10000 0 -0.87 8 8
NCOA2 -0.031 0.18 -10000 0 -0.58 35 35
CEBPA 0.011 0.082 -10000 0 -0.33 18 18
EHMT2 0.027 0.005 -10000 0 -10000 0 0
cell proliferation -0.018 0.18 0.52 15 -0.42 15 30
NR0B1 0 0 -10000 0 -10000 0 0
EGR1 -0.011 0.13 -10000 0 -0.42 29 29
RXRs/9cRA -0.015 0.14 -10000 0 -0.33 55 55
AR/RACK1/Src -0.037 0.1 0.35 2 -0.38 10 12
AR/GR -0.014 0.11 0.25 3 -0.36 13 16
GNB2L1 0.026 0.007 -10000 0 -10000 0 0
PKN1 0.027 0.008 -10000 0 -10000 0 0
RCHY1 0.029 0.004 -10000 0 -10000 0 0
epidermal growth factor receptor activity -0.004 0.008 -10000 0 -0.026 25 25
MAPK8 0.003 0.05 -10000 0 -0.43 4 4
T-DHT/AR/TIF2/CARM1 -0.042 0.14 0.35 2 -0.42 25 27
SRC -0.021 0.059 -10000 0 -0.33 9 9
NR3C1 0.028 0.006 -10000 0 -10000 0 0
KLK3 -0.15 0.37 -10000 0 -1.2 39 39
APPBP2 0.024 0.015 -10000 0 -10000 0 0
TRIM24 0.022 0.016 -10000 0 -10000 0 0
T-DHT/AR/TIP60 -0.009 0.091 0.34 5 -0.38 8 13
TMPRSS2 -0.094 0.35 -10000 0 -1.1 41 41
RXRG -0.067 0.22 -10000 0 -0.57 58 58
mol:9cRA -0.001 0.002 -10000 0 -0.011 4 4
RXRA 0.026 0.008 -10000 0 -10000 0 0
RXRB 0.029 0.003 -10000 0 -10000 0 0
CARM1 0.025 0.01 -10000 0 -10000 0 0
NR2C2 0.022 0.062 -10000 0 -0.58 4 4
KLK2 -0.15 0.29 0.48 4 -0.66 77 81
AR -0.029 0.1 -10000 0 -0.3 34 34
SENP1 0.028 0.006 -10000 0 -10000 0 0
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
MDM2 0.033 0.013 -10000 0 -10000 0 0
SRY 0.005 0.01 0.028 51 -10000 0 51
GATA2 0.023 0.051 -10000 0 -0.39 5 5
MYST2 0.001 0.001 -10000 0 -10000 0 0
HOXB13 -0.005 0.011 -10000 0 -0.03 46 46
T-DHT/AR/RACK1/Src -0.024 0.093 0.32 3 -0.39 8 11
positive regulation of transcription 0.023 0.051 -10000 0 -0.38 5 5
DNAJA1 0.023 0.017 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.026 0.008 -10000 0 -10000 0 0
NCOA1 0.027 0.016 -10000 0 -10000 0 0
SPDEF -0.019 0.14 -10000 0 -0.42 34 34
T-DHT/AR/TIF2 -0.042 0.13 0.3 3 -0.41 24 27
T-DHT/AR/Hsp90 -0.011 0.086 0.33 4 -0.39 7 11
GSK3B 0.027 0.008 -10000 0 -10000 0 0
NR2C1 0.029 0.007 -10000 0 -10000 0 0
mol:T-DHT -0.017 0.059 -10000 0 -0.35 8 8
SIRT1 0.026 0.032 -10000 0 -0.58 1 1
ZMIZ2 0.032 0.013 -10000 0 -10000 0 0
POU2F1 0.018 0.066 -10000 0 -0.41 4 4
T-DHT/AR/DAX-1 -0.028 0.072 -10000 0 -0.38 8 8
CREBBP 0.027 0.007 -10000 0 -10000 0 0
SMARCE1 0.022 0.016 -10000 0 -10000 0 0
Paxillin-independent events mediated by a4b1 and a4b7

Figure S89.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S89.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.011 0.11 -9999 0 -0.36 25 25
CRKL 0.022 0.013 -9999 0 -10000 0 0
Rac1/GDP 0.021 0.005 -9999 0 -10000 0 0
DOCK1 0.026 0.044 -9999 0 -0.58 2 2
ITGA4 0 0.1 -9999 0 -0.31 32 32
alpha4/beta7 Integrin/MAdCAM1 -0.013 0.14 -9999 0 -0.32 40 40
EPO 0.021 0.017 -9999 0 -0.26 1 1
alpha4/beta7 Integrin -0.02 0.14 -9999 0 -0.46 27 27
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.027 0.008 -9999 0 -10000 0 0
alpha4/beta1 Integrin 0.02 0.076 -9999 0 -0.42 5 5
EPO/EPOR (dimer) 0.031 0.036 -9999 0 -0.42 1 1
lamellipodium assembly 0.023 0.031 -9999 0 -0.32 2 2
PIK3CA 0.026 0.044 -9999 0 -0.58 2 2
PI3K 0.039 0.035 -9999 0 -0.42 2 2
ARF6 0.028 0.005 -9999 0 -10000 0 0
JAK2 0.016 0.05 -9999 0 -0.29 6 6
PXN 0.028 0.006 -9999 0 -10000 0 0
PIK3R1 0.028 0.006 -9999 0 -10000 0 0
MADCAM1 -0.018 0.1 -9999 0 -0.26 55 55
cell adhesion -0.014 0.13 -9999 0 -0.32 40 40
CRKL/CBL 0.032 0.019 -9999 0 -10000 0 0
ITGB1 0.029 0.005 -9999 0 -10000 0 0
SRC -0.009 0.1 -9999 0 -0.35 18 18
ITGB7 -0.024 0.16 -9999 0 -0.43 42 42
RAC1 0.028 0.007 -9999 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 0.012 0.12 -9999 0 -0.33 32 32
p130Cas/Crk/Dock1 0.011 0.099 -9999 0 -0.47 2 2
VCAM1 -0.011 0.13 -9999 0 -0.37 37 37
RHOA 0.029 0.004 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.049 0.07 -9999 0 -0.33 5 5
BCAR1 -0.016 0.095 -9999 0 -0.33 18 18
EPOR 0.022 0.043 -9999 0 -0.32 5 5
mol:GDP 0 0 -9999 0 -10000 0 0
CBL 0.028 0.006 -9999 0 -10000 0 0
GIT1 0.028 0.007 -9999 0 -10000 0 0
Rac1/GTP 0.023 0.032 -9999 0 -0.33 2 2
Syndecan-3-mediated signaling events

Figure S90.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S90.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.028 0.005 -9999 0 -10000 0 0
Syndecan-3/Src/Cortactin 0.037 0.094 -9999 0 -0.48 1 1
Syndecan-3/Neurocan 0.003 0.089 -9999 0 -0.49 1 1
POMC -0.052 0.19 -9999 0 -0.44 65 65
EGFR 0.002 0.12 -9999 0 -0.54 17 17
Syndecan-3/EGFR 0.017 0.072 -9999 0 -0.31 15 15
AGRP 0.012 0.054 -9999 0 -0.26 14 14
NCSTN 0.027 0.008 -9999 0 -10000 0 0
PSENEN 0.028 0.007 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.029 0.004 -9999 0 -10000 0 0
APH1A 0.027 0.008 -9999 0 -10000 0 0
NCAN -0.03 0.16 -9999 0 -0.46 43 43
long-term memory 0.05 0.046 -9999 0 -0.48 1 1
Syndecan-3/IL8 -0.036 0.13 -9999 0 -0.55 2 2
PSEN1 0.028 0.005 -9999 0 -10000 0 0
Src/Cortactin 0.04 0.028 -9999 0 -0.42 1 1
FYN 0.026 0.044 -9999 0 -0.58 2 2
limb bud formation 0.015 0.029 -9999 0 -0.52 1 1
MC4R 0.015 0.046 -9999 0 -0.26 10 10
SRC 0.026 0.035 -9999 0 -0.42 2 2
PTN -0.019 0.15 -9999 0 -0.48 35 35
FGFR/FGF/Syndecan-3 0.015 0.029 -9999 0 -0.53 1 1
neuron projection morphogenesis -0.014 0.11 -9999 0 -0.41 6 6
Syndecan-3/AgRP 0.027 0.043 -9999 0 -0.41 2 2
Syndecan-3/AgRP/MC4R 0.038 0.052 -9999 0 -0.5 1 1
Fyn/Cortactin 0.04 0.034 -9999 0 -0.41 2 2
SDC3 0.015 0.029 -9999 0 -0.53 1 1
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.036 0.13 -9999 0 -0.54 2 2
IL8 -0.11 0.24 -9999 0 -0.47 103 103
Syndecan-3/Fyn/Cortactin 0.052 0.047 -9999 0 -0.49 1 1
Syndecan-3/CASK 0.011 0.037 -9999 0 -0.41 2 2
alpha-MSH/MC4R -0.03 0.15 -9999 0 -0.42 39 39
Gamma Secretase 0.075 0.031 -9999 0 -10000 0 0
Canonical Wnt signaling pathway

Figure S91.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S91.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.028 0.024 0.26 2 -10000 0 2
AES 0.027 0.019 0.21 1 -10000 0 1
FBXW11 0.028 0.006 -10000 0 -10000 0 0
mol:GTP 0 0.003 -10000 0 -10000 0 0
LRP6/FZD1 0.035 0.055 -10000 0 -0.42 5 5
SMAD4 0.029 0.005 -10000 0 -10000 0 0
DKK2 -0.04 0.18 -10000 0 -0.5 49 49
TLE1 0.027 0.021 0.24 1 -10000 0 1
MACF1 0.029 0.006 -10000 0 -10000 0 0
CTNNB1 0.034 0.11 0.5 14 -10000 0 14
WIF1 -0.021 0.083 -10000 0 -0.26 38 38
beta catenin/RanBP3 0.01 0.084 0.38 12 -10000 0 12
KREMEN2 -0.008 0.14 -10000 0 -0.51 24 24
DKK1 -0.066 0.2 -10000 0 -0.42 79 79
beta catenin/beta TrCP1 0.03 0.066 0.34 1 -10000 0 1
FZD1 0.02 0.07 -10000 0 -0.58 5 5
AXIN2 -0.001 0.19 0.63 7 -1.2 5 12
AXIN1 0.027 0.008 -10000 0 -10000 0 0
RAN 0.028 0.006 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.027 0.077 -10000 0 -0.52 3 3
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.028 0.11 -10000 0 -0.66 4 4
Axin1/APC/GSK3 0.034 0.049 0.36 3 -10000 0 3
Axin1/APC/GSK3/beta catenin/Macf1 0.029 0.065 0.51 2 -0.36 1 3
HNF1A 0.026 0.036 0.24 1 -0.58 1 2
CTBP1 0.028 0.021 0.23 2 -10000 0 2
MYC -0.048 0.27 0.6 2 -1.4 14 16
RANBP3 0.027 0.008 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.014 0.16 -10000 0 -0.38 51 51
NKD1 -0.011 0.14 -10000 0 -0.45 30 30
TCF4 0.023 0.055 0.23 1 -0.56 3 4
TCF3 0.027 0.022 0.25 2 -10000 0 2
WNT1/LRP6/FZD1/Axin1 0.055 0.065 -10000 0 -0.34 6 6
Ran/GTP 0.021 0.005 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.01 0.11 0.52 11 -0.45 2 13
LEF1 0.003 0.12 0.3 1 -0.45 20 21
DVL1 0.029 0.019 -10000 0 -10000 0 0
CSNK2A1 0.029 0.006 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES 0.033 0.12 -10000 0 -0.68 4 4
DKK1/LRP6/Kremen 2 -0.029 0.16 -10000 0 -0.37 54 54
LRP6 0.028 0.006 -10000 0 -10000 0 0
CSNK1A1 0.026 0.015 -10000 0 -10000 0 0
NLK 0.028 0.008 -10000 0 -10000 0 0
CCND1 -0.019 0.17 0.59 2 -1.2 6 8
WNT1 0.013 0.061 -10000 0 -0.28 14 14
GSK3A 0.028 0.007 -10000 0 -10000 0 0
GSK3B 0.029 0.005 -10000 0 -10000 0 0
FRAT1 0.028 0.007 -10000 0 -10000 0 0
PPP2R5D 0.04 0.067 0.3 18 -0.32 1 19
APC 0.015 0.06 0.36 3 -0.31 6 9
WNT1/LRP6/FZD1 0.029 0.043 0.22 1 -0.26 3 4
CREBBP 0.027 0.019 0.24 1 -10000 0 1
VEGFR1 specific signals

Figure S92.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S92.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.017 0.12 -10000 0 -0.72 10 10
VEGFR1 homodimer/NRP1 -0.002 0.12 -10000 0 -0.72 10 10
mol:DAG -0.015 0.13 -10000 0 -0.57 15 15
VEGFR1 homodimer/NRP1/VEGFR 121 0.013 0.12 -10000 0 -0.66 11 11
CaM/Ca2+ 0.001 0.13 -10000 0 -0.67 10 10
HIF1A 0.025 0.063 -10000 0 -0.35 10 10
GAB1 0.029 0.004 -10000 0 -10000 0 0
AKT1 -0.008 0.12 -10000 0 -0.64 11 11
PLCG1 -0.016 0.13 -10000 0 -0.58 15 15
NOS3 -0.003 0.12 -10000 0 -0.64 10 10
CBL 0.028 0.006 -10000 0 -10000 0 0
mol:NO 0.001 0.12 0.46 2 -0.6 10 12
FLT1 0.002 0.14 -10000 0 -0.81 10 10
PGF -0.011 0.11 -10000 0 -0.3 45 45
VEGFR1 homodimer/NRP2/VEGFR121 0.008 0.15 -10000 0 -0.46 29 29
CALM1 0.028 0.005 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
eNOS/Hsp90 0.015 0.12 0.29 1 -0.59 10 11
endothelial cell proliferation -0.032 0.14 0.36 1 -0.63 14 15
mol:Ca2+ -0.015 0.13 -10000 0 -0.57 15 15
MAPK3 -0.024 0.12 0.38 2 -0.6 10 12
MAPK1 -0.026 0.11 0.23 1 -0.6 10 11
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
PLGF homodimer -0.011 0.11 -10000 0 -0.3 45 45
PRKACA 0.027 0.008 -10000 0 -10000 0 0
RP11-342D11.1 0 0 -10000 0 -10000 0 0
CAV1 0.006 0.1 -10000 0 -0.42 18 18
VEGFA homodimer 0.025 0.047 -10000 0 -0.47 3 3
VEGFR1 homodimer/VEGFA homodimer 0.015 0.13 -10000 0 -0.71 11 11
platelet activating factor biosynthetic process -0.026 0.11 0.39 1 -0.59 10 11
PI3K 0.024 0.14 -10000 0 -0.68 10 10
PRKCA -0.023 0.12 0.26 1 -0.64 10 11
PRKCB -0.046 0.14 -10000 0 -0.59 16 16
VEGFR1 homodimer/PLGF homodimer -0.006 0.14 -10000 0 -0.62 15 15
VEGFA 0.025 0.047 -10000 0 -0.47 3 3
VEGFB 0.028 0.005 -10000 0 -10000 0 0
mol:IP3 -0.015 0.13 -10000 0 -0.57 15 15
RASA1 0.005 0.11 -10000 0 -0.65 10 10
NRP2 -0.008 0.14 -10000 0 -0.51 25 25
VEGFR1 homodimer 0.002 0.14 -10000 0 -0.8 10 10
VEGFB homodimer 0.028 0.005 -10000 0 -10000 0 0
NCK1 0.029 0.004 -10000 0 -10000 0 0
eNOS/Caveolin-1 0.008 0.13 0.45 2 -0.61 10 12
PTPN11 0.028 0.006 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.022 0.14 -10000 0 -0.67 10 10
mol:L-citrulline 0.001 0.12 0.46 2 -0.6 10 12
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.045 0.12 -10000 0 -0.67 10 10
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.031 0.13 -10000 0 -0.66 11 11
CD2AP 0.029 0.003 -10000 0 -10000 0 0
PI3K/GAB1 0.035 0.14 -10000 0 -0.65 10 10
PDPK1 -0.009 0.12 0.34 2 -0.63 11 13
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.031 0.12 -10000 0 -0.66 11 11
mol:NADP 0.001 0.12 0.46 2 -0.6 10 12
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.043 0.12 -10000 0 -0.66 10 10
VEGFR1 homodimer/NRP2 -0.005 0.15 -10000 0 -0.49 28 28
BARD1 signaling events

Figure S93.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S93.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BARD1/CSTF1 0.011 0.11 -10000 0 -0.42 23 23
ATM 0.027 0.032 -10000 0 -0.58 1 1
UBE2D3 0.029 0.004 -10000 0 -10000 0 0
PRKDC 0.027 0.032 -10000 0 -0.58 1 1
ATR 0.029 0.004 -10000 0 -10000 0 0
UBE2L3 0.022 0.013 -10000 0 -10000 0 0
FANCD2 0.024 0.033 -10000 0 -0.34 3 3
protein ubiquitination 0.045 0.096 -10000 0 -0.31 23 23
XRCC5 0.028 0.005 -10000 0 -10000 0 0
XRCC6 0.022 0.013 -10000 0 -10000 0 0
M/R/N Complex 0.056 0.015 -10000 0 -10000 0 0
MRE11A 0.028 0.005 -10000 0 -10000 0 0
DNA-PK 0.042 0.034 -10000 0 -0.36 1 1
FA complex/FANCD2/Ubiquitin 0.001 0.13 -10000 0 -0.5 21 21
FANCF 0.028 0.005 -10000 0 -10000 0 0
BRCA1 0.027 0.016 -10000 0 -0.26 1 1
CCNE1 0.027 0.008 -10000 0 -10000 0 0
CDK2/Cyclin E1 0.04 0.013 -10000 0 -10000 0 0
FANCG 0.027 0.008 -10000 0 -10000 0 0
BRCA1/BACH1/BARD1 0.01 0.11 -10000 0 -0.42 22 22
FANCE 0.027 0.031 -10000 0 -0.58 1 1
FANCC 0.027 0.008 -10000 0 -10000 0 0
NBN 0.029 0.005 -10000 0 -10000 0 0
FANCA 0.004 0.12 -10000 0 -0.56 15 15
DNA repair 0.006 0.11 0.4 2 -0.45 10 12
BRCA1/BARD1/ubiquitin 0.01 0.11 -10000 0 -0.42 22 22
BARD1/DNA-PK 0.03 0.1 -10000 0 -0.33 24 24
FANCL 0.028 0.005 -10000 0 -10000 0 0
mRNA polyadenylation -0.011 0.11 0.42 23 -10000 0 23
BRCA1/BARD1/CTIP/M/R/N Complex 0.014 0.077 -10000 0 -0.38 2 2
BRCA1/BACH1/BARD1/TopBP1 0.028 0.1 -10000 0 -0.36 22 22
BRCA1/BARD1/P53 0.044 0.098 -10000 0 -0.33 22 22
BARD1/CSTF1/BRCA1 0.028 0.1 -10000 0 -0.36 22 22
BRCA1/BACH1 0.027 0.016 -10000 0 -0.26 1 1
BARD1 -0.01 0.15 -10000 0 -0.58 24 24
PCNA 0.028 0.005 -10000 0 -10000 0 0
BRCA1/BARD1/UbcH5C 0.028 0.1 -10000 0 -0.36 22 22
BRCA1/BARD1/UbcH7 0.018 0.099 -10000 0 -0.36 22 22
BRCA1/BARD1/RAD51/PCNA 0.038 0.11 -10000 0 -0.34 26 26
BARD1/DNA-PK/P53 0.038 0.099 -10000 0 -0.31 24 24
BRCA1/BARD1/Ubiquitin 0.01 0.11 -10000 0 -0.42 22 22
BRCA1/BARD1/CTIP 0.023 0.093 -10000 0 -0.33 23 23
FA complex 0.021 0.069 -10000 0 -0.28 15 15
BARD1/EWS 0.002 0.11 -10000 0 -0.42 23 23
RBBP8 0.017 0.023 -10000 0 -0.42 1 1
TP53 0.027 0.007 -10000 0 -10000 0 0
TOPBP1 0.029 0.004 -10000 0 -10000 0 0
G1/S transition of mitotic cell cycle -0.042 0.097 0.33 22 -10000 0 22
BRCA1/BARD1 0.051 0.099 -10000 0 -0.31 23 23
CSTF1 0.028 0.005 -10000 0 -10000 0 0
BARD1/EWS-Fli1 -0.009 0.11 -10000 0 -0.42 24 24
CDK2 0.028 0.006 -10000 0 -10000 0 0
UniProt:Q9BZD1 0 0 -10000 0 -10000 0 0
RAD51 0.019 0.072 -10000 0 -0.49 7 7
RAD50 0.028 0.006 -10000 0 -10000 0 0
BRCA1/BARD1/DNA-directed RNA polymerase II holoenzyme 0.01 0.11 -10000 0 -0.42 22 22
EWSR1 0.022 0.013 -10000 0 -10000 0 0
Sphingosine 1-phosphate (S1P) pathway

Figure S94.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S94.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.028 0.007 -10000 0 -10000 0 0
SPHK1 0.02 0.07 -10000 0 -0.58 5 5
GNAI2 0.029 0.004 -10000 0 -10000 0 0
mol:S1P 0.015 0.037 -10000 0 -0.29 5 5
GNAO1 -0.028 0.17 -10000 0 -0.54 37 37
mol:Sphinganine-1-P 0.012 0.052 0.22 1 -0.42 5 6
growth factor activity 0 0 -10000 0 -10000 0 0
S1P/S1P2/G12/G13 0.052 0.057 -10000 0 -0.3 5 5
GNAI3 0.028 0.006 -10000 0 -10000 0 0
G12/G13 0.04 0.012 -10000 0 -10000 0 0
S1PR3 0.025 0.022 -10000 0 -0.26 2 2
S1PR2 0.017 0.077 -10000 0 -0.53 7 7
EDG1 0 0 -10000 0 -10000 0 0
S1P1/S1P 0.008 0.033 -10000 0 -0.25 5 5
S1PR5 0.009 0.098 -10000 0 -0.49 13 13
S1PR4 0.016 0.055 -10000 0 -0.26 14 14
GNAI1 0.018 0.053 -10000 0 -0.26 13 13
S1P/S1P5/G12 0.034 0.069 -10000 0 -0.29 14 14
S1P/S1P3/Gq -0.019 0.13 -10000 0 -0.37 23 23
S1P/S1P4/Gi -0.017 0.1 -10000 0 -0.37 15 15
GNAQ 0.027 0.008 -10000 0 -10000 0 0
GNAZ 0.012 0.074 -10000 0 -0.5 7 7
GNA14 -0.013 0.11 -10000 0 -0.28 48 48
GNA15 -0.028 0.16 -10000 0 -0.48 41 41
GNA12 0.028 0.007 -10000 0 -10000 0 0
GNA13 0.028 0.007 -10000 0 -10000 0 0
GNA11 0.009 0.1 -10000 0 -0.58 11 11
ABCC1 0.028 0.007 -10000 0 -10000 0 0
PLK1 signaling events

Figure S95.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S95.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion 0.001 0.047 0.24 12 -0.12 2 14
BUB1B 0.009 0.059 0.22 8 -0.31 7 15
PLK1 0.01 0.036 0.17 11 -0.11 4 15
PLK1S1 0.015 0.028 0.17 9 -10000 0 9
KIF2A 0.017 0.075 0.32 16 -0.36 2 18
regulation of mitotic centrosome separation 0.01 0.036 0.17 11 -0.11 4 15
GOLGA2 0.027 0.009 -10000 0 -10000 0 0
Hec1/SPC24 0.008 0.099 -10000 0 -0.31 27 27
WEE1 0.021 0.053 0.29 5 -0.28 5 10
cytokinesis -0.013 0.14 0.31 5 -0.45 26 31
PP2A-alpha B56 0.018 0.18 -10000 0 -0.66 24 24
AURKA 0.014 0.027 0.17 7 -10000 0 7
PICH/PLK1 0.015 0.046 -10000 0 -0.31 5 5
CENPE 0.001 0.076 0.25 10 -0.32 11 21
RhoA/GTP 0.021 0.003 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization 0.017 0.074 0.32 16 -0.36 2 18
PPP2CA 0.028 0.006 -10000 0 -10000 0 0
FZR1 0.027 0.008 -10000 0 -10000 0 0
TPX2 0.009 0.05 0.18 9 -0.28 7 16
PAK1 0.028 0.005 -10000 0 -10000 0 0
SPC24 -0.008 0.13 -10000 0 -0.49 25 25
FBXW11 0.028 0.006 -10000 0 -10000 0 0
CLSPN 0.001 0.068 0.16 2 -0.3 16 18
GORASP1 0.029 0.004 -10000 0 -10000 0 0
metaphase 0.002 0.006 0.024 23 -0.016 2 25
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.005 0.022 0.1 11 -0.056 4 15
G2 phase of mitotic cell cycle 0 0.004 0.016 13 -10000 0 13
STAG2 0.027 0.008 -10000 0 -10000 0 0
GRASP65/GM130/RAB1/GTP 0.024 0.039 -10000 0 -0.48 2 2
spindle elongation 0.01 0.036 0.17 11 -0.11 4 15
ODF2 0.027 0.009 -10000 0 -10000 0 0
BUB1 -0.014 0.2 -10000 0 -0.74 25 25
TPT1 0.005 0.045 0.15 5 -0.19 16 21
CDC25C 0 0.089 0.22 3 -0.39 17 20
CDC25B 0.025 0.043 -10000 0 -0.32 5 5
SGOL1 -0.001 0.047 0.12 2 -0.24 12 14
RHOA 0.029 0.004 -10000 0 -10000 0 0
CCNB1/CDK1 0.04 0.033 -10000 0 -0.36 1 1
CDC14B 0.007 0.023 -10000 0 -0.43 1 1
CDC20 0.022 0.048 -10000 0 -0.3 7 7
PLK1/PBIP1 0.007 0.043 0.15 4 -0.33 4 8
mitosis -0.002 0.003 0.019 4 -10000 0 4
FBXO5 0.013 0.039 0.22 8 -0.13 1 9
CDC2 0.001 0.002 0.011 1 -0.018 1 2
NDC80 0.01 0.092 -10000 0 -0.4 16 16
metaphase plate congression 0.013 0.031 0.17 2 -0.24 3 5
ERCC6L 0.02 0.045 -10000 0 -0.31 5 5
NLP/gamma Tubulin 0.01 0.03 0.15 12 -0.081 1 13
microtubule cytoskeleton organization 0.005 0.045 0.15 5 -0.18 16 21
G2/M transition DNA damage checkpoint 0 0.004 0.019 12 -10000 0 12
PPP1R12A 0.027 0.032 -10000 0 -0.58 1 1
interphase 0 0.004 0.019 12 -10000 0 12
PLK1/PRC1-2 0.011 0.096 -10000 0 -0.32 24 24
GRASP65/GM130/RAB1/GTP/PLK1 0.049 0.027 -10000 0 -10000 0 0
RAB1A 0.028 0.005 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.009 0.031 0.16 10 -0.078 3 13
mitotic prometaphase 0 0.004 0.026 6 -0.013 1 7
proteasomal ubiquitin-dependent protein catabolic process 0.025 0.025 -10000 0 -10000 0 0
microtubule-based process -0.004 0.09 -10000 0 -0.31 26 26
Golgi organization 0.01 0.036 0.17 11 -0.11 4 15
Cohesin/SA2 0.019 0.023 0.18 1 -0.14 1 2
PPP1CB/MYPT1 0.04 0.026 -10000 0 -0.43 1 1
KIF20A -0.019 0.15 -10000 0 -0.45 37 37
APC/C/CDC20 0.021 0.04 0.2 3 -0.25 2 5
PPP2R1A 0.028 0.007 -10000 0 -10000 0 0
chromosome segregation 0.007 0.042 0.15 4 -0.33 4 8
PRC1 0.027 0.035 -10000 0 -0.42 2 2
ECT2 0.009 0.045 0.21 9 -0.34 2 11
C13orf34 0.009 0.031 0.15 11 -0.093 2 13
NUDC 0.013 0.031 0.17 2 -0.24 3 5
regulation of attachment of spindle microtubules to kinetochore 0.009 0.058 0.22 8 -0.31 7 15
spindle assembly 0.012 0.042 0.17 16 -0.094 3 19
spindle stabilization 0.015 0.028 0.17 9 -10000 0 9
APC/C/HCDH1 0.023 0.025 -10000 0 -0.37 1 1
MKLP2/PLK1 -0.004 0.091 -10000 0 -0.31 26 26
CCNB1 0.029 0.007 -10000 0 -10000 0 0
PPP1CB 0.029 0.006 -10000 0 -10000 0 0
BTRC 0.029 0.005 -10000 0 -10000 0 0
ROCK2 0 0.097 0.24 2 -0.38 20 22
TUBG1 0.014 0.031 0.18 8 -0.16 2 10
G2/M transition of mitotic cell cycle 0.01 0.027 -10000 0 -0.35 1 1
MLF1IP 0.005 0.046 -10000 0 -0.43 4 4
INCENP 0.024 0.047 -10000 0 -0.48 3 3
Insulin-mediated glucose transport

Figure S96.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S96.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Insulin responsive Vesicles 0.028 0.12 -10000 0 -0.59 3 3
CaM/Ca2+ 0.021 0.004 -10000 0 -10000 0 0
AKT1 0.028 0.006 -10000 0 -10000 0 0
AKT2 0.026 0.022 -10000 0 -0.26 2 2
STXBP4 0.027 0.007 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucose 0.023 0.13 0.28 27 -0.5 6 33
YWHAZ 0.029 0.005 -10000 0 -10000 0 0
CALM1 0.028 0.005 -10000 0 -10000 0 0
YWHAQ 0.028 0.005 -10000 0 -10000 0 0
TBC1D4 0.015 0.024 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
YWHAH 0.022 0.013 -10000 0 -10000 0 0
YWHAB 0.028 0.005 -10000 0 -10000 0 0
SNARE/Synip 0.054 0.018 -10000 0 -10000 0 0
YWHAG 0.028 0.007 -10000 0 -10000 0 0
ASIP -0.056 0.19 -10000 0 -0.44 66 66
PRKCI 0.029 0.004 -10000 0 -10000 0 0
AS160/CaM/Ca2+ 0.021 0.004 -10000 0 -10000 0 0
RHOQ 0.028 0.005 -10000 0 -10000 0 0
GYS1 0.018 0.008 -10000 0 -10000 0 0
PRKCZ 0.027 0.016 -10000 0 -0.26 1 1
TRIP10 0.027 0.008 -10000 0 -10000 0 0
TC10/GTP/CIP4/Exocyst 0.036 0.011 -10000 0 -10000 0 0
AS160/14-3-3 -0.039 0.11 -10000 0 -0.32 23 23
VAMP2 0.027 0.007 -10000 0 -10000 0 0
SLC2A4 0.022 0.14 0.29 22 -0.62 5 27
STX4 0.028 0.006 -10000 0 -10000 0 0
GSK3B 0.026 0.015 -10000 0 -10000 0 0
SFN -0.13 0.25 -10000 0 -0.47 123 123
LNPEP 0.002 0.12 -10000 0 -0.58 16 16
YWHAE 0.027 0.008 -10000 0 -10000 0 0
Stabilization and expansion of the E-cadherin adherens junction

Figure S97.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S97.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization 0.029 0.029 -10000 0 -0.27 3 3
epithelial cell differentiation 0.058 0.019 -10000 0 -10000 0 0
CYFIP2 0.026 0.032 -10000 0 -0.58 1 1
ENAH 0.025 0.085 0.51 8 -10000 0 8
EGFR 0.002 0.12 -10000 0 -0.54 17 17
EPHA2 0.025 0.044 -10000 0 -0.58 2 2
MYO6 0.036 0.074 0.45 10 -10000 0 10
CTNNB1 0.029 0.004 -10000 0 -10000 0 0
ABI1/Sra1/Nap1 0.055 0.026 -10000 0 -0.36 1 1
AQP5 -0.046 0.18 -10000 0 -0.5 46 46
CTNND1 0.028 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.028 0.054 0.41 6 -10000 0 6
regulation of calcium-dependent cell-cell adhesion -0.033 0.12 0.42 3 -0.3 54 57
EGF -0.033 0.15 -10000 0 -0.34 64 64
NCKAP1 0.029 0.005 -10000 0 -10000 0 0
AQP3 -0.043 0.17 -10000 0 -0.48 45 45
cortical microtubule organization 0.058 0.019 -10000 0 -10000 0 0
GO:0000145 0.015 0.054 0.4 6 -10000 0 6
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.064 0.02 -10000 0 -10000 0 0
MLLT4 0.029 0.004 -10000 0 -10000 0 0
ARF6/GDP 0.006 0.014 -10000 0 -10000 0 0
ARF6 0.028 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.064 0.035 -10000 0 -0.33 1 1
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP 0.017 0.019 -10000 0 -10000 0 0
PVRL2 0.028 0.007 -10000 0 -10000 0 0
ZYX 0.022 0.02 -10000 0 -10000 0 0
ARF6/GTP 0.071 0.035 -10000 0 -0.31 1 1
CDH1 0.028 0.007 -10000 0 -10000 0 0
EGFR/EGFR/EGF/EGF 0.01 0.1 -10000 0 -0.3 29 29
RhoA/GDP 0.06 0.019 -10000 0 -10000 0 0
actin cytoskeleton organization 0.024 0.059 0.42 7 -10000 0 7
IGF-1R heterotetramer 0.027 0.031 -10000 0 -0.58 1 1
GIT1 0.028 0.007 -10000 0 -10000 0 0
IGF1R 0.027 0.031 -10000 0 -0.58 1 1
IGF1 -0.057 0.17 -10000 0 -0.36 83 83
DIAPH1 0.052 0.062 -10000 0 -0.62 1 1
Wnt receptor signaling pathway -0.058 0.019 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
RhoA/GTP 0.006 0.014 -10000 0 -10000 0 0
CTNNA1 0.028 0.006 -10000 0 -10000 0 0
VCL 0.025 0.059 0.42 7 -10000 0 7
EFNA1 0.027 0.008 -10000 0 -10000 0 0
LPP 0.016 0.041 0.36 2 -0.29 1 3
Ephrin A1/EPHA2 0.049 0.028 -10000 0 -0.29 1 1
SEC6/SEC8 0.015 0.006 -10000 0 -10000 0 0
MGAT3 -0.034 0.12 0.42 3 -0.3 54 57
HGF/MET -0.011 0.13 -10000 0 -0.31 57 57
HGF -0.031 0.16 -10000 0 -0.44 47 47
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN 0.029 0.029 -10000 0 -0.28 3 3
actin cable formation 0.071 0.14 0.51 22 -0.33 1 23
KIAA1543 0.013 0.06 0.37 6 -0.29 4 10
KIFC3 0.023 0.024 -10000 0 -10000 0 0
NCK1 0.029 0.004 -10000 0 -10000 0 0
EXOC3 0.027 0.007 -10000 0 -10000 0 0
ACTN1 0.026 0.039 0.36 3 -10000 0 3
NCK1/GIT1 0.041 0.011 -10000 0 -10000 0 0
mol:GDP 0.058 0.019 -10000 0 -10000 0 0
EXOC4 0.028 0.007 -10000 0 -10000 0 0
STX4 0.024 0.024 -10000 0 -10000 0 0
PIP5K1C 0.028 0.054 0.41 6 -10000 0 6
LIMA1 0.025 0.044 -10000 0 -0.58 2 2
ABI1 0.029 0.005 -10000 0 -10000 0 0
ROCK1 0.048 0.11 0.46 17 -10000 0 17
adherens junction assembly 0.028 0.096 0.51 9 -10000 0 9
IGF-1R heterotetramer/IGF1 0.006 0.096 -10000 0 -0.29 22 22
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.041 0.011 -10000 0 -10000 0 0
MET -0.03 0.18 -10000 0 -0.58 36 36
PLEKHA7 0.026 0.061 0.38 6 -0.3 4 10
mol:GTP 0.062 0.034 -10000 0 -0.33 1 1
establishment of epithelial cell apical/basal polarity 0.033 0.065 0.51 5 -10000 0 5
cortical actin cytoskeleton stabilization 0.029 0.029 -10000 0 -0.27 3 3
regulation of cell-cell adhesion 0.024 0.059 0.42 7 -10000 0 7
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton 0.029 0.029 -10000 0 -0.28 3 3
S1P3 pathway

Figure S98.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S98.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.008 0.11 -10000 0 -0.55 13 13
mol:S1P 0.001 0 -10000 0 -10000 0 0
S1P1/S1P/Gi -0.005 0.087 -10000 0 -0.32 13 13
GNAO1 -0.026 0.17 -10000 0 -0.54 37 37
S1P/S1P3/G12/G13 0.05 0.024 -10000 0 -10000 0 0
AKT1 0.003 0.1 -10000 0 -0.5 13 13
AKT3 0.006 0.089 -10000 0 -0.5 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.008 0.11 -10000 0 -0.55 13 13
GNAI2 0.03 0.004 -10000 0 -10000 0 0
GNAI3 0.03 0.006 -10000 0 -10000 0 0
GNAI1 0.019 0.053 -10000 0 -0.26 13 13
mol:GDP 0 0 -10000 0 -10000 0 0
S1PR3 0.027 0.023 -10000 0 -0.26 2 2
S1PR2 0.017 0.077 -10000 0 -0.53 7 7
EDG1 0 0 -10000 0 -10000 0 0
mol:Ca2+ -0.012 0.097 -10000 0 -0.34 12 12
MAPK3 -0.013 0.09 -10000 0 -0.36 8 8
MAPK1 -0.002 0.087 -10000 0 -0.32 12 12
JAK2 -0.017 0.1 0.28 1 -0.38 12 13
CXCR4 -0.025 0.1 -10000 0 -0.4 13 13
FLT1 0.015 0.094 -10000 0 -0.54 10 10
RhoA/GDP 0.021 0.003 -10000 0 -10000 0 0
Rac1/GDP 0.021 0.005 -10000 0 -10000 0 0
SRC -0.014 0.092 -10000 0 -0.32 13 13
S1P/S1P3/Gi -0.012 0.098 -10000 0 -0.35 12 12
RAC1 0.028 0.007 -10000 0 -10000 0 0
RhoA/GTP -0.005 0.096 -10000 0 -0.34 8 8
VEGFA 0.028 0.047 -10000 0 -0.47 3 3
S1P/S1P2/Gi -0.016 0.11 -10000 0 -0.39 12 12
VEGFR1 homodimer/VEGFA homodimer 0.032 0.086 -10000 0 -0.46 10 10
RHOA 0.029 0.004 -10000 0 -10000 0 0
S1P/S1P3/Gq -0.017 0.11 -10000 0 -0.29 49 49
GNAQ 0.027 0.008 -10000 0 -10000 0 0
GNAZ 0.013 0.074 -10000 0 -0.5 7 7
G12/G13 0.04 0.012 -10000 0 -10000 0 0
GNA14 -0.013 0.11 -10000 0 -0.28 48 48
GNA15 -0.028 0.16 -10000 0 -0.48 41 41
GNA12 0.028 0.007 -10000 0 -10000 0 0
GNA13 0.028 0.007 -10000 0 -10000 0 0
GNA11 0.009 0.1 -10000 0 -0.58 11 11
Rac1/GTP -0.003 0.094 -10000 0 -0.34 8 8
Nectin adhesion pathway

Figure S99.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S99.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.008 0.11 -10000 0 -0.55 13 13
alphaV beta3 Integrin 0.013 0.12 -10000 0 -0.46 20 20
PTK2 0.017 0.13 -10000 0 -0.61 12 12
positive regulation of JNK cascade 0.024 0.084 -10000 0 -0.34 13 13
CDC42/GDP 0.044 0.12 0.4 2 -0.47 15 17
Rac1/GDP 0.04 0.12 -10000 0 -0.48 13 13
RAP1B 0.028 0.006 -10000 0 -10000 0 0
RAP1A 0.028 0.006 -10000 0 -10000 0 0
CTNNB1 0.029 0.004 -10000 0 -10000 0 0
CDC42/GTP 0.035 0.1 -10000 0 -0.42 13 13
nectin-3/I-afadin 0.023 0.088 -10000 0 -0.41 13 13
RAPGEF1 0.022 0.12 0.35 1 -0.53 12 13
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.021 0.13 -10000 0 -0.6 13 13
PDGFB-D/PDGFRB 0.008 0.11 -10000 0 -0.55 13 13
TLN1 0 0.062 -10000 0 -0.57 3 3
Rap1/GTP 0.022 0.079 -10000 0 -0.36 12 12
IQGAP1 0.029 0.004 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.052 0.016 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin 0.023 0.088 -10000 0 -0.41 13 13
PVR 0.028 0.007 -10000 0 -10000 0 0
Necl-5(dimer) 0.028 0.007 -10000 0 -10000 0 0
mol:GDP 0.028 0.15 0.43 2 -0.59 16 18
MLLT4 0.029 0.004 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
PI3K 0.053 0.11 -10000 0 -0.35 22 22
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.038 0.03 -10000 0 -10000 0 0
positive regulation of lamellipodium assembly 0.02 0.096 -10000 0 -0.39 12 12
PVRL1 0.022 0.042 -10000 0 -0.26 8 8
PVRL3 0.002 0.12 -10000 0 -0.46 20 20
PVRL2 0.028 0.007 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
CDH1 0.028 0.007 -10000 0 -10000 0 0
CLDN1 -0.039 0.19 -10000 0 -0.58 42 42
JAM-A/CLDN1 0.01 0.14 -10000 0 -0.35 46 46
SRC 0.021 0.14 -10000 0 -0.7 12 12
ITGB3 -0.002 0.13 -10000 0 -0.58 18 18
nectin-1(dimer)/I-afadin/I-afadin 0.038 0.03 -10000 0 -10000 0 0
FARP2 0.032 0.14 -10000 0 -0.57 15 15
RAC1 0.028 0.007 -10000 0 -10000 0 0
CTNNA1 0.028 0.006 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) 0.038 0.08 -10000 0 -0.36 12 12
nectin-1/I-afadin 0.038 0.03 -10000 0 -10000 0 0
nectin-2/I-afadin 0.041 0.011 -10000 0 -10000 0 0
RAC1/GTP/IQGAP1/filamentous actin 0.037 0.01 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin 0.036 0.082 -10000 0 -0.36 12 12
CDC42/GTP/IQGAP1/filamentous actin 0.038 0.009 -10000 0 -10000 0 0
F11R 0.027 0.008 -10000 0 -10000 0 0
positive regulation of filopodium formation 0.024 0.084 -10000 0 -0.34 13 13
alphaV/beta3 Integrin/Talin 0.019 0.12 -10000 0 -0.59 8 8
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.041 0.011 -10000 0 -10000 0 0
nectin-2(dimer)/I-afadin/I-afadin 0.041 0.011 -10000 0 -10000 0 0
PIP5K1C 0.002 0.067 -10000 0 -0.61 3 3
VAV2 0.013 0.17 0.35 1 -0.62 17 18
RAP1/GDP 0.045 0.11 0.28 1 -0.43 14 15
ITGAV 0.022 0.062 -10000 0 -0.58 4 4
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.038 0.08 -10000 0 -0.36 12 12
nectin-3(dimer)/I-afadin/I-afadin 0.023 0.088 -10000 0 -0.41 13 13
Rac1/GTP 0.027 0.12 -10000 0 -0.48 12 12
PTPRM 0.006 0.073 -10000 0 -0.32 13 13
E-cadherin/beta catenin/alpha catenin 0.075 0.038 -10000 0 -10000 0 0
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.028 0.006 -10000 0 -10000 0 0
Regulation of Telomerase

Figure S100.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S100.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex 0.013 0.11 0.39 8 -0.55 5 13
RAD9A 0.028 0.016 -10000 0 -0.26 1 1
AP1 -0.027 0.16 -10000 0 -0.42 44 44
IFNAR2 0.029 0.007 -10000 0 -10000 0 0
AKT1 -0.009 0.068 -10000 0 -0.21 32 32
ER alpha/Oestrogen -0.04 0.13 -10000 0 -0.28 76 76
NFX1/SIN3/HDAC complex 0.035 0.027 -10000 0 -10000 0 0
EGF -0.033 0.15 -10000 0 -0.34 64 64
SMG5 0.027 0.008 -10000 0 -10000 0 0
SMG6 0.027 0.007 -10000 0 -10000 0 0
SP3/HDAC2 0.043 0.01 -10000 0 -10000 0 0
TERT/c-Abl 0.017 0.099 0.43 2 -0.51 5 7
SAP18 0.028 0.006 -10000 0 -10000 0 0
MRN complex 0.056 0.015 -10000 0 -10000 0 0
WT1 -0.006 0.093 -10000 0 -0.27 40 40
WRN 0.027 0.032 -10000 0 -0.58 1 1
SP1 0.029 0.007 -10000 0 -10000 0 0
SP3 0.029 0.005 -10000 0 -10000 0 0
TERF2IP 0.028 0.007 -10000 0 -10000 0 0
Telomerase/Nucleolin 0.037 0.087 -10000 0 -0.47 4 4
Mad/Max 0.042 0.01 -10000 0 -10000 0 0
TERT 0.013 0.12 0.4 8 -0.57 5 13
CCND1 0.009 0.15 0.52 5 -0.98 5 10
MAX 0.029 0.005 -10000 0 -10000 0 0
RBBP7 0.027 0.008 -10000 0 -10000 0 0
RBBP4 0.025 0.044 -10000 0 -0.58 2 2
TERF2 0.025 0.009 -10000 0 -10000 0 0
PTGES3 0.028 0.006 -10000 0 -10000 0 0
SIN3A 0.029 0.004 -10000 0 -10000 0 0
Telomerase/911 0.03 0.063 -10000 0 -10000 0 0
CDKN1B -0.028 0.11 -10000 0 -0.35 24 24
RAD1 0.028 0.007 -10000 0 -10000 0 0
XRCC5 0.028 0.005 -10000 0 -10000 0 0
XRCC6 0.022 0.013 -10000 0 -10000 0 0
SAP30 0.027 0.032 -10000 0 -0.58 1 1
TRF2/PARP2 0.039 0.012 -10000 0 -10000 0 0
UBE3A 0.029 0.004 -10000 0 -10000 0 0
JUN 0.007 0.095 -10000 0 -0.35 22 22
E6 0 0.001 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.022 0.004 -10000 0 -10000 0 0
FOS -0.046 0.18 -10000 0 -0.44 60 60
IFN-gamma/IRF1 -0.024 0.14 -10000 0 -0.38 35 35
PARP2 0.028 0.006 -10000 0 -10000 0 0
BLM 0.023 0.056 -10000 0 -0.5 4 4
Telomerase 0.004 0.15 -10000 0 -0.59 16 16
IRF1 0.024 0.049 -10000 0 -0.25 11 11
ESR1 -0.056 0.18 -10000 0 -0.4 74 74
KU/TER 0.032 0.019 -10000 0 -10000 0 0
ATM/TRF2 0.04 0.025 -10000 0 -0.39 1 1
ubiquitin-dependent protein catabolic process 0.039 0.046 -10000 0 -0.41 2 2
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.04 0.047 -10000 0 -0.42 2 2
HDAC1 0.028 0.006 -10000 0 -10000 0 0
HDAC2 0.029 0.008 -10000 0 -10000 0 0
ATM 0.01 0.024 -10000 0 -0.44 1 1
SMAD3 0.014 0.04 -10000 0 -0.42 3 3
ABL1 0.027 0.008 -10000 0 -10000 0 0
MXD1 0.029 0.005 -10000 0 -10000 0 0
MRE11A 0.028 0.005 -10000 0 -10000 0 0
HUS1 0.028 0.007 -10000 0 -10000 0 0
RPS6KB1 0.028 0.007 -10000 0 -10000 0 0
TERT/NF kappa B1/14-3-3 0.028 0.098 -10000 0 -0.47 5 5
NR2F2 0.028 0.004 -10000 0 -10000 0 0
MAPK3 0.007 0.03 -10000 0 -10000 0 0
MAPK1 0.005 0.03 -10000 0 -10000 0 0
TGFB1/TGF beta receptor Type II 0.023 0.054 -10000 0 -0.58 3 3
NFKB1 0.029 0.004 -10000 0 -10000 0 0
HNRNPC 0.028 0.005 -10000 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.01 0.024 -10000 0 -0.44 1 1
NBN 0.029 0.005 -10000 0 -10000 0 0
EGFR 0.002 0.12 -10000 0 -0.54 17 17
mol:Oestrogen 0 0.001 -10000 0 -10000 0 0
EGF/EGFR -0.018 0.14 -10000 0 -0.43 30 30
MYC 0.007 0.1 -10000 0 -0.44 17 17
IL2 0.013 0.046 -10000 0 -0.26 10 10
KU 0.032 0.019 -10000 0 -10000 0 0
RAD50 0.028 0.006 -10000 0 -10000 0 0
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
TGFB1 0.023 0.054 -10000 0 -0.58 3 3
TRF2/BLM 0.037 0.029 -10000 0 -0.4 1 1
FRAP1 0 0 -10000 0 -10000 0 0
KU/TERT 0.022 0.1 0.48 2 -0.55 4 6
SP1/HDAC2 0.043 0.012 -10000 0 -10000 0 0
PINX1 0.029 0.004 -10000 0 -10000 0 0
Telomerase/EST1A 0.036 0.083 -10000 0 -0.45 4 4
Smad3/Myc 0.016 0.075 -10000 0 -0.35 13 13
911 complex 0.055 0.019 -10000 0 -10000 0 0
IFNG -0.06 0.17 -10000 0 -0.33 92 92
Telomerase/PinX1 0.037 0.087 -10000 0 -0.48 4 4
Telomerase/AKT1/mTOR/p70S6K 0.012 0.072 -10000 0 -0.39 5 5
SIN3B 0.027 0.008 -10000 0 -10000 0 0
YWHAE 0.027 0.008 -10000 0 -10000 0 0
Telomerase/EST1B 0.034 0.085 -10000 0 -0.48 4 4
response to DNA damage stimulus 0.004 0.018 -10000 0 -10000 0 0
MRN complex/TRF2/Rap1 0.078 0.023 -10000 0 -10000 0 0
TRF2/WRN 0.039 0.025 -10000 0 -0.4 1 1
Telomerase/hnRNP C1/C2 0.037 0.088 -10000 0 -0.48 4 4
E2F1 0.015 0.089 -10000 0 -0.54 9 9
ZNFX1 0.029 0.005 -10000 0 -10000 0 0
PIF1 -0.002 0.12 -10000 0 -0.38 28 28
NCL 0.028 0.006 -10000 0 -10000 0 0
DKC1 0.026 0.009 -10000 0 -10000 0 0
telomeric DNA binding 0 0 -10000 0 -10000 0 0
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S101.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S101.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A -0.01 0.12 -10000 0 -0.36 37 37
oxygen homeostasis 0 0 -10000 0 -10000 0 0
TCEB2 0.027 0.016 -10000 0 -0.26 1 1
TCEB1 0.029 0.005 -10000 0 -10000 0 0
HIF1A/p53 0.021 0.055 0.35 1 -0.48 1 2
HIF1A 0.005 0.047 -10000 0 -0.38 2 2
COPS5 0.029 0.005 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2 0.06 0.05 -10000 0 -0.36 2 2
FIH (dimer) 0.029 0.005 -10000 0 -10000 0 0
CDKN2A -0.042 0.16 -10000 0 -0.36 67 67
ARNT/IPAS 0.01 0.093 -10000 0 -0.41 12 12
HIF1AN 0.029 0.005 -10000 0 -10000 0 0
GNB2L1 0.028 0.006 -10000 0 -10000 0 0
HIF1A/ARNT 0.021 0.064 0.3 7 -0.48 1 8
CUL2 0.029 0.005 -10000 0 -10000 0 0
OS9 0.028 0.006 -10000 0 -10000 0 0
RACK1/Elongin B/Elongin C 0.055 0.019 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF1A/Hsp90 0.019 0.055 0.28 1 -0.48 1 2
PHD1-3/OS9 0.005 0.13 -10000 0 -0.33 45 45
HIF1A/RACK1/Elongin B/Elongin C 0.042 0.059 -10000 0 -0.45 1 1
VHL 0.026 0.044 -10000 0 -0.58 2 2
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
HIF1A/JAB1 0.025 0.067 0.33 6 -0.48 1 7
EGLN3 -0.067 0.21 -10000 0 -0.47 71 71
EGLN2 0.028 0.007 -10000 0 -10000 0 0
EGLN1 0.027 0.008 -10000 0 -10000 0 0
TP53 0.027 0.007 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.026 0.079 -10000 0 -0.56 5 5
ARNT 0.027 0.008 -10000 0 -10000 0 0
ARD1A 0 0 -10000 0 -10000 0 0
RBX1 0.022 0.013 -10000 0 -10000 0 0
HIF1A/p19ARF -0.004 0.1 0.32 5 -0.32 19 24
Rapid glucocorticoid signaling

Figure S102.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S102.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Gs family/GDP/Gbeta gamma 0.025 0.082 -10000 0 -0.31 17 17
MAPK9 0.009 0.002 -10000 0 -10000 0 0
adrenocorticotropin secretion -0.008 0.039 -10000 0 -0.17 19 19
GNB1/GNG2 0.036 0.019 -10000 0 -10000 0 0
GNB1 0.028 0.006 -10000 0 -10000 0 0
regulation of calcium ion transport via voltage-gated calcium channel activity 0 0 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
MAPK14 0.009 0.001 -10000 0 -10000 0 0
Gs family/GTP -0.004 0.078 -10000 0 -0.23 34 34
EntrezGene:2778 0 0 -10000 0 -10000 0 0
vasopressin secretion 0 0 -10000 0 -10000 0 0
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
glutamate secretion 0.006 0.019 0.062 34 -10000 0 34
GNAL -0.01 0.14 -10000 0 -0.43 32 32
GNG2 0.026 0.026 -10000 0 -0.26 3 3
CRH 0.009 0.062 -10000 0 -0.26 19 19
mol:cortisol 0 0 -10000 0 -10000 0 0
MAPK8 0.005 0.038 -10000 0 -0.36 4 4
MAPK11 0.007 0.006 -10000 0 -10000 0 0
S1P4 pathway

Figure S103.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S103.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
GNAO1 -0.028 0.17 -10000 0 -0.54 37 37
CDC42/GTP -0.012 0.098 -10000 0 -0.35 11 11
PLCG1 -0.02 0.093 -10000 0 -0.36 11 11
mol:GTP 0 0 -10000 0 -10000 0 0
GNAI2 0.029 0.004 -10000 0 -10000 0 0
GNAI3 0.028 0.006 -10000 0 -10000 0 0
G12/G13 0.04 0.012 -10000 0 -10000 0 0
cell migration -0.012 0.096 -10000 0 -0.34 11 11
S1PR5 0.009 0.098 -10000 0 -0.49 13 13
S1PR4 0.016 0.055 -10000 0 -0.26 14 14
MAPK3 -0.02 0.093 -10000 0 -0.36 11 11
MAPK1 -0.009 0.09 -10000 0 -0.35 11 11
S1P/S1P5/Gi -0.024 0.11 -10000 0 -0.3 42 42
GNAI1 0.018 0.053 -10000 0 -0.26 13 13
CDC42/GDP 0.021 0.004 -10000 0 -10000 0 0
S1P/S1P5/G12 0.025 0.064 -10000 0 -0.36 9 9
RHOA 0.03 0.072 0.44 7 -10000 0 7
S1P/S1P4/Gi -0.019 0.1 -10000 0 -0.37 12 12
mol:GDP 0 0 -10000 0 -10000 0 0
GNAZ 0.012 0.074 -10000 0 -0.5 7 7
S1P/S1P4/G12/G13 0.043 0.038 -10000 0 -10000 0 0
GNA12 0.028 0.007 -10000 0 -10000 0 0
GNA13 0.028 0.007 -10000 0 -10000 0 0
CDC42 0.028 0.006 -10000 0 -10000 0 0
Canonical NF-kappaB pathway

Figure S104.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S104.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FBXW11 0.031 0.007 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.04 0.079 0.36 1 -0.33 5 6
ERC1 0.028 0.006 -10000 0 -10000 0 0
RIP2/NOD2 -0.018 0.15 -10000 0 -0.42 39 39
NFKBIA 0.024 0.012 -10000 0 -10000 0 0
BIRC2 0.028 0.005 -10000 0 -10000 0 0
IKBKB 0.029 0.004 -10000 0 -10000 0 0
RIPK2 0.029 0.005 -10000 0 -10000 0 0
IKBKG 0.008 0.097 -10000 0 -0.64 4 4
IKK complex/A20 -0.001 0.16 0.3 1 -0.47 22 23
NEMO/A20/RIP2 0.029 0.005 -10000 0 -10000 0 0
XPO1 0.028 0.005 -10000 0 -10000 0 0
NEMO/ATM 0.011 0.11 -10000 0 -0.57 5 5
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
RAN 0.028 0.006 -10000 0 -10000 0 0
Exportin 1/RanGTP 0.038 0.009 -10000 0 -10000 0 0
IKK complex/ELKS 0.024 0.11 -10000 0 -0.5 5 5
BCL10/MALT1/TRAF6 0.054 0.027 -10000 0 -0.36 1 1
NOD2 -0.05 0.19 -10000 0 -0.47 58 58
NFKB1 0.032 0.005 -10000 0 -10000 0 0
RELA 0.031 0.006 -10000 0 -10000 0 0
MALT1 0.029 0.005 -10000 0 -10000 0 0
cIAP1/UbcH5C 0.042 0.009 -10000 0 -10000 0 0
ATM 0.027 0.032 -10000 0 -0.58 1 1
TNF/TNFR1A -0.033 0.15 -10000 0 -0.42 41 41
TRAF6 0.027 0.032 -10000 0 -0.58 1 1
PRKCA 0.015 0.067 -10000 0 -0.3 14 14
CHUK 0.029 0.005 -10000 0 -10000 0 0
UBE2D3 0.029 0.004 -10000 0 -10000 0 0
TNF -0.07 0.2 -10000 0 -0.42 83 83
NF kappa B1 p50/RelA 0.065 0.016 -10000 0 -10000 0 0
BCL10 0.028 0.006 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.024 0.012 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.031 0.007 -10000 0 -10000 0 0
TNFRSF1A 0.028 0.006 -10000 0 -10000 0 0
IKK complex 0.025 0.12 -10000 0 -0.56 5 5
CYLD 0.028 0.007 -10000 0 -10000 0 0
IKK complex/PKC alpha 0.031 0.12 -10000 0 -0.57 6 6
Signaling events mediated by HDAC Class III

Figure S105.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S105.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.02 0.033 -10000 0 -0.58 1 1
HDAC4 0.028 0.016 -10000 0 -0.26 1 1
induction of apoptosis 0 0 -10000 0 -10000 0 0
regulation of S phase of mitotic cell cycle -0.015 0.05 0.42 3 -0.33 2 5
CDKN1A -0.021 0.11 -10000 0 -0.77 8 8
KAT2B 0.029 0.004 -10000 0 -10000 0 0
BAX 0.028 0.007 -10000 0 -10000 0 0
FOXO3 -0.004 0.025 0.44 1 -10000 0 1
FOXO1 0.028 0.007 -10000 0 -10000 0 0
FOXO4 0.014 0.019 -10000 0 -0.29 1 1
response to UV 0 0 -10000 0 -10000 0 0
XRCC6 0.022 0.013 -10000 0 -10000 0 0
TAT 0.019 0.036 -10000 0 -0.26 6 6
mol:Lysophosphatidic acid 0 0 -10000 0 -10000 0 0
MYOD1 0.01 0.001 -10000 0 -10000 0 0
PPARGC1A -0.087 0.21 -10000 0 -0.43 95 95
FHL2 -0.005 0.12 -10000 0 -0.42 28 28
response to nutrient levels 0 0 -10000 0 -10000 0 0
KU70/SIRT1 0.03 0.037 0.33 1 -0.42 1 2
HIST2H4A 0.015 0.05 0.33 2 -0.43 3 5
SIRT1/FOXO3a 0.042 0.058 0.27 5 -0.26 2 7
SIRT1 0.028 0.047 0.25 8 -0.58 1 9
response to hypoxia 0 0 -10000 0 -10000 0 0
SIRT1/MEF2D/HDAC4 0.051 0.037 0.31 1 -0.36 1 2
SIRT1/Histone H1b -0.011 0.089 0.43 1 -0.28 20 21
apoptosis -0.041 0.036 0.36 1 -10000 0 1
SIRT1/PGC1A -0.038 0.14 -10000 0 -0.36 51 51
p53/SIRT1 0.037 0.07 0.46 8 -0.43 1 9
SIRT1/FOXO4 0.002 0.066 0.22 2 -0.24 8 10
FOXO1/FHL2/SIRT1 0.029 0.082 -10000 0 -0.31 16 16
HIST1H1E -0.005 0.075 -10000 0 -0.33 15 15
SIRT1/p300 0.029 0.044 0.33 1 -0.42 2 3
muscle cell differentiation -0.039 0.031 0.36 1 -0.3 1 2
TP53 0.028 0.035 0.25 8 -10000 0 8
KU70/SIRT1/BAX 0.041 0.036 -10000 0 -0.36 1 1
CREBBP 0.028 0.007 -10000 0 -10000 0 0
MEF2D 0.027 0.008 -10000 0 -10000 0 0
HIV-1 Tat/SIRT1 0.033 0.044 0.33 1 -0.43 1 2
ACSS2 0.018 0.033 0.33 1 -0.42 1 2
SIRT1/PCAF/MYOD 0.039 0.031 0.31 1 -0.36 1 2
HIF-2-alpha transcription factor network

Figure S106.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S106.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 0.008 0.084 -10000 0 -1.3 1 1
oxygen homeostasis 0.007 0.014 -10000 0 -10000 0 0
TCEB2 0.027 0.016 -10000 0 -0.26 1 1
TCEB1 0.029 0.005 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/HIF2A 0.051 0.13 -10000 0 -0.41 4 4
EPO 0.065 0.17 -10000 0 -0.58 6 6
FIH (dimer) 0.034 0.019 -10000 0 -10000 0 0
APEX1 0.033 0.022 -10000 0 -10000 0 0
SERPINE1 0.05 0.2 -10000 0 -0.68 12 12
FLT1 -0.049 0.26 -10000 0 -0.98 23 23
ADORA2A 0.037 0.18 -10000 0 -0.65 8 8
germ cell development 0.061 0.19 -10000 0 -0.66 7 7
SLC11A2 0.061 0.19 -10000 0 -0.68 6 6
BHLHE40 0.046 0.23 -10000 0 -0.65 23 23
HIF1AN 0.034 0.019 -10000 0 -10000 0 0
HIF2A/ARNT/SIRT1 0.056 0.15 -10000 0 -0.44 5 5
ETS1 0.031 0.05 -10000 0 -0.22 10 10
CITED2 0.004 0.15 -10000 0 -0.8 11 11
KDR -0.039 0.26 -10000 0 -1.2 18 18
PGK1 0.057 0.19 -10000 0 -0.64 7 7
SIRT1 0.027 0.032 -10000 0 -0.58 1 1
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF2A/ARNT 0.09 0.22 -10000 0 -0.75 8 8
EPAS1 0.017 0.12 -10000 0 -0.34 15 15
SP1 0.034 0.011 -10000 0 -10000 0 0
ABCG2 0.047 0.22 -10000 0 -0.68 17 17
EFNA1 0.062 0.19 -10000 0 -0.64 8 8
FXN 0.056 0.19 0.46 4 -0.62 8 12
POU5F1 0.061 0.19 -10000 0 -0.69 7 7
neuron apoptosis -0.089 0.22 0.72 8 -10000 0 8
EP300 0.02 0.033 -10000 0 -0.58 1 1
EGLN3 -0.061 0.21 -10000 0 -0.47 71 71
EGLN2 0.033 0.019 -10000 0 -10000 0 0
EGLN1 0.033 0.019 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C 0.053 0.038 -10000 0 -0.42 2 2
VHL 0.026 0.044 -10000 0 -0.58 2 2
ARNT 0.032 0.021 -10000 0 -10000 0 0
SLC2A1 0.063 0.19 0.62 1 -0.64 7 8
TWIST1 0.044 0.22 -10000 0 -0.62 19 19
ELK1 0.031 0.018 -10000 0 -10000 0 0
HIF2A/ARNT/Cbp/p300 0.039 0.14 -10000 0 -0.48 3 3
VEGFA 0.06 0.2 -10000 0 -0.68 8 8
CREBBP 0.028 0.007 -10000 0 -10000 0 0
FoxO family signaling

Figure S107.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S107.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G6PC 0.016 0.073 0.37 11 -10000 0 11
PLK1 0.046 0.16 0.54 3 -0.86 4 7
CDKN1B 0.07 0.11 0.55 4 -0.36 4 8
FOXO3 0.043 0.14 -10000 0 -0.69 5 5
KAT2B 0.031 0.023 -10000 0 -10000 0 0
FOXO1/SIRT1 0.023 0.056 0.34 3 -0.3 1 4
CAT 0.042 0.16 0.53 1 -1 4 5
CTNNB1 0.029 0.004 -10000 0 -10000 0 0
AKT1 0.031 0.024 -10000 0 -10000 0 0
FOXO1 0.017 0.084 0.44 10 -10000 0 10
MAPK10 0.032 0.035 0.2 5 -0.3 1 6
mol:GTP 0.002 0.002 -10000 0 -10000 0 0
FOXO4 0.065 0.081 0.49 5 -0.4 2 7
response to oxidative stress 0.007 0.015 -10000 0 -10000 0 0
FOXO3A/SIRT1 0.079 0.11 -10000 0 -0.55 5 5
XPO1 0.029 0.006 -10000 0 -10000 0 0
EP300 0.021 0.034 -10000 0 -0.58 1 1
BCL2L11 0.018 0.13 -10000 0 -0.95 6 6
FOXO1/SKP2 0.017 0.045 -10000 0 -0.3 1 1
mol:GDP 0.007 0.015 -10000 0 -10000 0 0
RAN 0.029 0.006 -10000 0 -10000 0 0
GADD45A 0.072 0.2 0.47 6 -0.88 13 19
YWHAQ 0.028 0.005 -10000 0 -10000 0 0
FOXO1/14-3-3 family -0.024 0.14 -10000 0 -0.4 22 22
MST1 0.015 0.096 -10000 0 -0.54 10 10
CSNK1D 0.028 0.007 -10000 0 -10000 0 0
CSNK1E 0.022 0.013 -10000 0 -10000 0 0
FOXO4/14-3-3 family -0.062 0.19 -10000 0 -0.57 28 28
YWHAB 0.028 0.005 -10000 0 -10000 0 0
MAPK8 0.03 0.049 0.21 3 -0.33 4 7
MAPK9 0.03 0.022 0.2 3 -10000 0 3
YWHAG 0.028 0.007 -10000 0 -10000 0 0
YWHAE 0.027 0.008 -10000 0 -10000 0 0
YWHAZ 0.029 0.005 -10000 0 -10000 0 0
SIRT1 0.029 0.039 -10000 0 -0.57 1 1
SOD2 0.095 0.12 0.57 9 -0.4 1 10
RBL2 0.062 0.16 0.49 1 -0.76 7 8
RAL/GDP 0.045 0.019 -10000 0 -10000 0 0
CHUK 0.03 0.023 -10000 0 -10000 0 0
Ran/GTP 0.023 0.008 -10000 0 -10000 0 0
CSNK1G2 0.027 0.008 -10000 0 -10000 0 0
RAL/GTP 0.048 0.022 -10000 0 -10000 0 0
CSNK1G1 0.029 0.004 -10000 0 -10000 0 0
FASLG -0.14 0.46 -10000 0 -1.4 42 42
SKP2 0.026 0.032 -10000 0 -0.58 1 1
USP7 0.029 0.007 -10000 0 -10000 0 0
IKBKB 0.031 0.023 -10000 0 -10000 0 0
CCNB1 0.05 0.14 0.54 3 -0.69 3 6
FOXO1-3a-4/beta catenin 0.083 0.12 0.44 4 -0.41 4 8
proteasomal ubiquitin-dependent protein catabolic process 0.017 0.045 -10000 0 -0.3 1 1
CSNK1A1 0.028 0.006 -10000 0 -10000 0 0
SGK1 0.017 0.082 -10000 0 -0.39 12 12
CSNK1G3 0.028 0.006 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.042 0.011 -10000 0 -10000 0 0
ZFAND5 0.078 0.12 0.58 13 -10000 0 13
SFN -0.13 0.25 -10000 0 -0.47 123 123
CDK2 0.028 0.006 -10000 0 -10000 0 0
FOXO3A/14-3-3 -0.042 0.18 -10000 0 -0.48 34 34
CREBBP 0.027 0.007 -10000 0 -10000 0 0
FBXO32 0.04 0.17 0.55 2 -1.3 3 5
BCL6 0.068 0.15 0.49 1 -0.87 4 5
RALB 0.03 0.005 -10000 0 -10000 0 0
RALA 0.029 0.007 -10000 0 -10000 0 0
YWHAH 0.022 0.013 -10000 0 -10000 0 0
Retinoic acid receptors-mediated signaling

Figure S108.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S108.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.028 0.006 -10000 0 -10000 0 0
HDAC3 0.028 0.006 -10000 0 -10000 0 0
VDR 0.023 0.056 -10000 0 -0.5 4 4
Cbp/p300/PCAF 0.042 0.034 -10000 0 -0.36 1 1
EP300 0.02 0.033 -10000 0 -0.58 1 1
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.015 0.051 -10000 0 -0.34 1 1
KAT2B 0.029 0.004 -10000 0 -10000 0 0
MAPK14 0.029 0.003 -10000 0 -10000 0 0
AKT1 0.034 0.06 0.24 21 -0.25 1 22
RAR alpha/9cRA/Cyclin H 0.047 0.058 -10000 0 -0.3 1 1
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0.025 0.049 0.24 1 -0.38 3 4
CDC2 0 0.001 -10000 0 -10000 0 0
response to UV 0.001 0.002 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.024 0.065 -10000 0 -0.45 5 5
NCOR2 0.028 0.006 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.017 0.041 -10000 0 -0.36 4 4
RXRs/RARs/NRIP1/9cRA 0.02 0.097 0.37 2 -0.49 8 10
NCOA2 -0.028 0.18 -10000 0 -0.58 35 35
NCOA3 0.028 0.005 -10000 0 -10000 0 0
NCOA1 0.028 0.005 -10000 0 -10000 0 0
VDR/VDR/DNA 0.023 0.056 -10000 0 -0.5 4 4
RARG 0.029 0.007 -10000 0 -10000 0 0
RAR gamma1/9cRA 0.036 0.012 -10000 0 -10000 0 0
MAPK3 0.028 0.008 -10000 0 -10000 0 0
MAPK1 0.022 0.013 -10000 0 -10000 0 0
MAPK8 0.022 0.063 -10000 0 -0.58 4 4
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 0.018 0.089 -10000 0 -0.42 8 8
RARA 0.015 0.043 -10000 0 -0.27 6 6
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0 0.098 0.24 1 -0.36 16 17
PRKCA 0.017 0.067 -10000 0 -0.3 14 14
RXRs/RARs/NRIP1/9cRA/HDAC1 0.02 0.1 0.29 1 -0.53 8 9
RXRG -0.031 0.13 -10000 0 -0.36 47 47
RXRA 0.012 0.044 -10000 0 -0.24 8 8
RXRB 0.017 0.039 0.18 2 -0.26 4 6
VDR/Vit D3/DNA 0.017 0.041 -10000 0 -0.36 4 4
RBP1 -0.02 0.15 -10000 0 -0.4 42 42
CRBP1/9-cic-RA -0.013 0.11 -10000 0 -0.29 42 42
RARB 0.029 0.032 -10000 0 -0.58 1 1
PRKCG 0.013 0.054 -10000 0 -0.26 14 14
MNAT1 0.028 0.005 -10000 0 -10000 0 0
RAR alpha/RXRs 0.024 0.081 0.4 1 -0.38 7 8
RXRs/RARs/SMRT(N-CoR2)/9cRA 0.021 0.072 0.38 1 -0.34 7 8
proteasomal ubiquitin-dependent protein catabolic process 0.025 0.059 0.29 2 -0.38 3 5
RXRs/RARs/NRIP1/9cRA/HDAC3 0.021 0.1 0.32 3 -0.52 8 11
positive regulation of DNA binding 0.035 0.052 -10000 0 -0.29 1 1
NRIP1 0.016 0.14 -10000 0 -1.2 4 4
RXRs/RARs 0.019 0.092 -10000 0 -0.45 9 9
RXRs/RXRs/DNA/9cRA 0.001 0.08 -10000 0 -0.42 7 7
PRKACA 0.027 0.008 -10000 0 -10000 0 0
CDK7 0.028 0.006 -10000 0 -10000 0 0
TFIIH 0.057 0.013 -10000 0 -10000 0 0
RAR alpha/9cRA 0.058 0.042 -10000 0 -10000 0 0
CCNH 0.028 0.006 -10000 0 -10000 0 0
CREBBP 0.028 0.007 -10000 0 -10000 0 0
RAR gamma2/9cRA 0.053 0.019 -10000 0 -10000 0 0
Paxillin-dependent events mediated by a4b1

Figure S109.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S109.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.022 0.013 -10000 0 -10000 0 0
Rac1/GDP 0.027 0.011 -10000 0 -10000 0 0
DOCK1 0.026 0.044 -10000 0 -0.58 2 2
ITGA4 0 0.1 -10000 0 -0.31 32 32
RAC1 0.028 0.007 -10000 0 -10000 0 0
alpha4/beta7 Integrin -0.02 0.14 -10000 0 -0.46 27 27
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.027 0.008 -10000 0 -10000 0 0
alpha4/beta1 Integrin 0.035 0.07 -10000 0 -0.36 5 5
alpha4/beta7 Integrin/Paxillin -0.002 0.12 -10000 0 -0.36 27 27
lamellipodium assembly 0.028 0.06 -10000 0 -0.45 4 4
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
PI3K 0.039 0.035 -10000 0 -0.42 2 2
ARF6 0.028 0.005 -10000 0 -10000 0 0
TLN1 0.027 0.008 -10000 0 -10000 0 0
PXN 0.017 0.006 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
ARF6/GTP 0.042 0.061 -10000 0 -0.28 5 5
cell adhesion 0.04 0.064 -10000 0 -0.3 5 5
CRKL/CBL 0.032 0.019 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin 0.03 0.063 -10000 0 -0.33 5 5
ITGB1 0.029 0.005 -10000 0 -10000 0 0
ITGB7 -0.024 0.16 -10000 0 -0.43 42 42
ARF6/GDP 0.027 0.011 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/VCAM1 0.023 0.1 -10000 0 -0.34 15 15
p130Cas/Crk/Dock1 0.051 0.035 -10000 0 -0.36 2 2
VCAM1 -0.011 0.13 -10000 0 -0.37 37 37
alpha4/beta1 Integrin/Paxillin/Talin 0.041 0.065 -10000 0 -0.31 5 5
alpha4/beta1 Integrin/Paxillin/GIT1 0.043 0.065 -10000 0 -0.31 5 5
BCAR1 0.028 0.007 -10000 0 -10000 0 0
mol:GDP -0.041 0.064 0.3 5 -10000 0 5
CBL 0.028 0.006 -10000 0 -10000 0 0
PRKACA 0.027 0.008 -10000 0 -10000 0 0
GIT1 0.028 0.007 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/Talin/Actin Cytoskeleton 0.041 0.065 -10000 0 -0.31 5 5
Rac1/GTP 0.029 0.067 -10000 0 -0.51 4 4
Signaling events mediated by PRL

Figure S110.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S110.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.027 0.008 -10000 0 -10000 0 0
mol:Halofuginone 0.004 0.001 -10000 0 -10000 0 0
ITGA1 0.015 0.084 -10000 0 -0.51 9 9
CDKN1A 0.011 0.076 -10000 0 -0.43 9 9
PRL-3/alpha Tubulin 0.039 0.029 -10000 0 -0.42 1 1
mol:Ca2+ -0.063 0.13 0.2 1 -0.44 36 37
AGT -0.049 0.19 -10000 0 -0.47 57 57
CCNA2 -0.012 0.075 -10000 0 -0.46 2 2
TUBA1B 0.028 0.006 -10000 0 -10000 0 0
EGR1 -0.003 0.088 -10000 0 -0.41 14 14
CDK2/Cyclin E1 0.04 0.077 -10000 0 -0.38 9 9
MAPK3 0.016 0.025 -10000 0 -0.42 1 1
PRL-2 /Rab GGTase beta 0.042 0.009 -10000 0 -10000 0 0
MAPK1 0.012 0.026 -10000 0 -0.42 1 1
PTP4A1 -0.005 0.071 -10000 0 -0.43 1 1
PTP4A3 0.026 0.035 -10000 0 -0.42 2 2
PTP4A2 0.028 0.006 -10000 0 -10000 0 0
ITGB1 0.016 0.025 -10000 0 -0.42 1 1
SRC 0.026 0.035 -10000 0 -0.42 2 2
RAC1 0.014 0.062 -10000 0 -0.34 8 8
Rab GGTase beta/Rab GGTase alpha 0.041 0.01 -10000 0 -10000 0 0
PRL-1/ATF-5 0.006 0.081 0.35 1 -0.41 4 5
RABGGTA 0.028 0.005 -10000 0 -10000 0 0
BCAR1 -0.015 0.022 0.39 1 -10000 0 1
RHOC 0.017 0.051 -10000 0 -0.31 6 6
RHOA 0.014 0.062 -10000 0 -0.34 8 8
cell motility 0.024 0.075 0.28 4 -0.35 8 12
PRL-1/alpha Tubulin 0.014 0.072 -10000 0 -0.41 1 1
PRL-3/alpha1 Integrin 0.029 0.07 -10000 0 -0.36 11 11
ROCK1 0.022 0.071 0.28 2 -0.37 7 9
RABGGTB 0.028 0.005 -10000 0 -10000 0 0
CDK2 0.028 0.006 -10000 0 -10000 0 0
mitosis -0.005 0.07 -10000 0 -0.43 1 1
ATF5 0.011 0.068 -10000 0 -0.26 22 22
TRAIL signaling pathway

Figure S111.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S111.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 0.019 0.066 -10000 0 -0.35 10 10
positive regulation of NF-kappaB transcription factor activity 0.028 0.074 -10000 0 -0.42 8 8
MAP2K4 0.024 0.055 -10000 0 -0.37 1 1
IKBKB 0.029 0.004 -10000 0 -10000 0 0
TNFRSF10B 0.029 0.005 -10000 0 -10000 0 0
TNFRSF10A 0.003 0.12 -10000 0 -0.58 16 16
SMPD1 0.015 0.023 -10000 0 -0.22 3 3
IKBKG 0.026 0.009 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
TNFRSF10D 0.021 0.07 -10000 0 -0.58 5 5
TRAIL/TRAILR2 0.035 0.051 -10000 0 -0.42 3 3
TRAIL/TRAILR3 0.014 0.11 -10000 0 -0.43 19 19
TRAIL/TRAILR1 0.015 0.11 -10000 0 -0.44 18 18
TRAIL/TRAILR4 0.028 0.074 -10000 0 -0.42 8 8
TRAIL/TRAILR1/DAP3/GTP 0.03 0.09 -10000 0 -0.34 18 18
IKK complex 0.021 0.057 -10000 0 -10000 0 0
RIPK1 0.029 0.003 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
DAP3/GTP 0.02 0.006 -10000 0 -10000 0 0
MAPK3 0.011 0.047 -10000 0 -0.42 3 3
MAP3K1 0.024 0.057 -10000 0 -0.33 4 4
TRAILR4 (trimer) 0.021 0.069 -10000 0 -0.58 5 5
TRADD 0.028 0.007 -10000 0 -10000 0 0
TRAILR1 (trimer) 0.003 0.12 -10000 0 -0.58 16 16
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 0.017 0.073 -10000 0 -0.28 17 17
CFLAR 0.029 0.005 -10000 0 -10000 0 0
MAPK1 0.007 0.046 -10000 0 -0.42 3 3
TRAIL/TRAILR1/FADD/TRADD/RIP 0.059 0.092 -10000 0 -0.33 16 16
mol:ceramide 0.015 0.023 -10000 0 -0.22 3 3
FADD 0.028 0.005 -10000 0 -10000 0 0
MAPK8 0.017 0.068 0.28 1 -0.37 3 4
TRAF2 0.027 0.009 -10000 0 -10000 0 0
TRAILR3 (trimer) 0.003 0.12 -10000 0 -0.58 16 16
CHUK 0.029 0.005 -10000 0 -10000 0 0
TRAIL/TRAILR1/FADD 0.032 0.098 -10000 0 -0.38 18 18
DAP3 0.027 0.008 -10000 0 -10000 0 0
CASP10 0.002 0.066 0.25 2 -0.41 5 7
JNK cascade 0.028 0.074 -10000 0 -0.42 8 8
TRAIL (trimer) 0.019 0.066 -10000 0 -0.35 10 10
TNFRSF10C 0.003 0.12 -10000 0 -0.58 16 16
TRAIL/TRAILR1/DAP3/GTP/FADD 0.042 0.089 -10000 0 -0.32 18 18
TRAIL/TRAILR2/FADD 0.05 0.047 -10000 0 -0.36 3 3
cell death 0.015 0.023 -10000 0 -0.22 3 3
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 0.03 0.035 -10000 0 -10000 0 0
TRAILR2 (trimer) 0.029 0.004 -10000 0 -10000 0 0
CASP8 0.012 0.042 -10000 0 -0.73 1 1
negative regulation of caspase activity 0 0 -10000 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.074 0.049 -10000 0 -0.31 3 3
Role of Calcineurin-dependent NFAT signaling in lymphocytes

Figure S112.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S112.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.028 0.005 -10000 0 -10000 0 0
NFATC1 0.043 0.088 0.46 7 -0.48 2 9
NFATC2 0.012 0.076 0.28 8 -0.31 6 14
NFATC3 0.024 0.01 -10000 0 -10000 0 0
YWHAE 0.027 0.008 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/CABIN1 -0.008 0.081 0.28 1 -0.37 8 9
Exportin 1/Ran/NUP214 0.052 0.02 -10000 0 -10000 0 0
mol:DAG 0 0.002 -10000 0 -10000 0 0
CABIN1/MEF2D/CaM/Ca2+/CAMK IV 0.002 0.1 -10000 0 -0.38 13 13
BCL2/BAX 0.032 0.056 -10000 0 -0.42 4 4
CaM/Ca2+/Calcineurin A alpha-beta B1 0.017 0.014 -10000 0 -10000 0 0
CaM/Ca2+ 0.017 0.014 -10000 0 -10000 0 0
BAX 0.028 0.007 -10000 0 -10000 0 0
MAPK14 0.029 0.004 -10000 0 -10000 0 0
BAD 0.028 0.005 -10000 0 -10000 0 0
CABIN1/MEF2D 0.01 0.086 0.32 4 -0.42 5 9
Calcineurin A alpha-beta B1/BCL2 0.016 0.074 -10000 0 -0.36 12 12
FKBP8 0.027 0.008 -10000 0 -10000 0 0
activation-induced cell death of T cells -0.01 0.085 0.42 5 -0.32 4 9
KPNB1 0.028 0.007 -10000 0 -10000 0 0
KPNA2 0.028 0.007 -10000 0 -10000 0 0
XPO1 0.028 0.005 -10000 0 -10000 0 0
SFN -0.13 0.25 -10000 0 -0.47 123 123
MAP3K8 0.026 0.035 -10000 0 -0.42 2 2
NFAT4/CK1 alpha 0.034 0.026 -10000 0 -0.31 1 1
MEF2D/NFAT1/Cbp/p300 0.009 0.1 -10000 0 -0.46 3 3
CABIN1 -0.008 0.081 0.28 1 -0.37 8 9
CALM1 0.028 0.006 -10000 0 -10000 0 0
RAN 0.028 0.006 -10000 0 -10000 0 0
MAP3K1 0.027 0.032 -10000 0 -0.58 1 1
CAMK4 -0.012 0.13 -10000 0 -0.36 39 39
mol:Ca2+ -0.001 0.005 -10000 0 -10000 0 0
MAPK3 0.028 0.007 -10000 0 -10000 0 0
YWHAH 0.022 0.013 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/AKAP79/PKA 0.037 0.031 -10000 0 -0.42 1 1
YWHAB 0.028 0.005 -10000 0 -10000 0 0
MAPK8 0.021 0.062 -10000 0 -0.58 4 4
MAPK9 0.028 0.006 -10000 0 -10000 0 0
YWHAG 0.028 0.007 -10000 0 -10000 0 0
FKBP1A 0.028 0.005 -10000 0 -10000 0 0
NFAT1-c-4/YWHAQ 0.046 0.072 0.33 1 -0.59 1 2
PRKCH 0.027 0.032 -10000 0 -0.58 1 1
CABIN1/Cbp/p300 0.029 0.032 -10000 0 -0.43 1 1
CASP3 0.028 0.005 -10000 0 -10000 0 0
PIM1 0.021 0.054 -10000 0 -0.29 10 10
Calcineurin A alpha-beta B1/FKBP12/FK506 0.019 0.005 -10000 0 -10000 0 0
apoptosis 0.021 0.018 -10000 0 -10000 0 0
14-3-3 family/BAD/CaM/Ca2+/Calcineurin A alpha-beta B1 -0.024 0.1 -10000 0 -0.32 24 24
PRKCB -0.031 0.14 -10000 0 -0.33 61 61
PRKCE 0.027 0.032 -10000 0 -0.58 1 1
JNK2/NFAT4 0.037 0.025 -10000 0 -10000 0 0
BAD/BCL-XL 0.041 0.01 -10000 0 -10000 0 0
PRKCD 0.029 0.004 -10000 0 -10000 0 0
NUP214 0.027 0.008 -10000 0 -10000 0 0
PRKCZ 0.027 0.016 -10000 0 -0.26 1 1
PRKCA 0.015 0.067 -10000 0 -0.3 14 14
PRKCG 0.011 0.054 -10000 0 -0.26 14 14
PRKCQ 0.025 0.044 -10000 0 -0.58 2 2
FKBP38/BCL2 0.031 0.057 -10000 0 -0.42 4 4
EP300 0.019 0.034 -10000 0 -0.58 1 1
PRKCB1 0 0 -10000 0 -10000 0 0
CSNK2A1 0.028 0.005 -10000 0 -10000 0 0
NFATc/JNK1 0.052 0.088 0.44 5 -0.46 2 7
CaM/Ca2+/FKBP38 0.034 0.015 -10000 0 -10000 0 0
FKBP12/FK506 0.021 0.004 -10000 0 -10000 0 0
CSNK1A1 0.014 0.013 -10000 0 -10000 0 0
CaM/Ca2+/CAMK IV 0.01 0.083 -10000 0 -0.36 12 12
NFATc/ERK1 0.05 0.071 0.4 2 -0.46 2 4
CABIN1/YWHAQ/CaM/Ca2+/CAMK IV 0.002 0.1 -10000 0 -0.37 14 14
NR4A1 -0.017 0.13 -10000 0 -0.53 12 12
GSK3B 0.028 0.005 -10000 0 -10000 0 0
positive T cell selection 0.024 0.01 -10000 0 -10000 0 0
NFAT1/CK1 alpha 0.008 0.049 -10000 0 -0.23 5 5
RCH1/ KPNB1 0.041 0.01 -10000 0 -10000 0 0
YWHAQ 0.028 0.005 -10000 0 -10000 0 0
PRKACA 0.027 0.008 -10000 0 -10000 0 0
AKAP5 0.025 0.038 -10000 0 -0.36 3 3
MEF2D 0.025 0.012 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
YWHAZ 0.029 0.005 -10000 0 -10000 0 0
NFATc/p38 alpha 0.058 0.087 0.44 7 -0.46 2 9
CREBBP 0.026 0.011 -10000 0 -10000 0 0
BCL2 0.016 0.074 -10000 0 -0.36 12 12
Atypical NF-kappaB pathway

Figure S113.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S113.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL3/RelA 0.038 0.032 -10000 0 -0.42 1 1
FBXW11 0.028 0.006 -10000 0 -10000 0 0
NF kappa B1 p50/c-Rel 0.013 0.089 -10000 0 -0.36 19 19
NF kappa B1 p50/RelA/I kappa B alpha 0.024 0.061 -10000 0 -10000 0 0
NFKBIA 0.002 0.053 -10000 0 -0.22 18 18
MAPK14 0.029 0.003 -10000 0 -10000 0 0
NF kappa B1 p105/p50 0.034 0.008 -10000 0 -10000 0 0
ARRB2 0.017 0.007 -10000 0 -10000 0 0
REL -0.005 0.14 -10000 0 -0.53 22 22
response to oxidative stress 0 0 -10000 0 -10000 0 0
BCL3/NF kappa B1 p50 0.031 0.027 -10000 0 -0.36 1 1
response to UV 0 0 -10000 0 -10000 0 0
NF kappa B1 p105/RelA 0.034 0.008 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
NF kappa B1 p50 dimer 0.028 0.026 0.25 5 -10000 0 5
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
NFKB1 0.019 0.004 -10000 0 -10000 0 0
RELA 0.028 0.005 -10000 0 -10000 0 0
positive regulation of anti-apoptosis 0.008 0.062 -10000 0 -0.33 3 3
NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2 0.028 0.06 -10000 0 -10000 0 0
SRC 0.026 0.035 -10000 0 -0.42 2 2
PI3K 0.039 0.035 -10000 0 -0.42 2 2
NF kappa B1 p50/RelA 0.008 0.063 -10000 0 -0.34 3 3
IKBKB 0.029 0.004 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.028 0.006 -10000 0 -10000 0 0
SYK 0.027 0.008 -10000 0 -10000 0 0
I kappa B alpha/PIK3R1 0.016 0.059 -10000 0 -0.24 1 1
cell death 0.027 0.058 -10000 0 -10000 0 0
NF kappa B1 p105/c-Rel 0.013 0.089 -10000 0 -0.36 19 19
LCK -0.034 0.16 -10000 0 -0.37 58 58
BCL3 0.024 0.041 -10000 0 -0.34 4 4
p38 MAPK signaling pathway

Figure S114.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S114.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TRAF6/ASK1 0.011 0.062 -10000 0 -0.3 14 14
TRAF2/ASK1 0.022 0.074 -10000 0 -0.36 13 13
ATM 0.027 0.032 -10000 0 -0.58 1 1
MAP2K3 0.033 0.11 0.41 12 -0.53 3 15
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0.019 0.1 0.34 10 -0.34 13 23
hyperosmotic response 0 0 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
GADD45G 0.009 0.081 -10000 0 -0.31 20 20
TXN 0.008 0.005 -10000 0 -10000 0 0
CALM1 0.028 0.005 -10000 0 -10000 0 0
GADD45A 0.009 0.1 -10000 0 -0.49 14 14
GADD45B 0.007 0.087 -10000 0 -0.33 21 21
MAP3K1 0.027 0.032 -10000 0 -0.58 1 1
MAP3K6 0.025 0.044 -10000 0 -0.58 2 2
MAP3K7 0.029 0.004 -10000 0 -10000 0 0
MAP3K4 0.029 0.004 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
ASK1/ASK2 0.023 0.092 -10000 0 -0.42 15 15
TAK1/TAB family 0.011 0.032 -10000 0 -0.18 2 2
RAC1/OSM/MEKK3 0.052 0.015 -10000 0 -10000 0 0
TRAF2 0.027 0.009 -10000 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.035 0.068 -10000 0 -0.46 2 2
TRAF6 0.008 0.019 -10000 0 -0.36 1 1
RAC1 0.028 0.007 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
CAMK2B 0.016 0.083 -10000 0 -0.54 8 8
CCM2 0.028 0.007 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB 0.029 0.056 -10000 0 -0.36 7 7
MAPK11 0.021 0.019 -10000 0 -0.26 1 1
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB/ASK1 0.034 0.088 -10000 0 -0.36 17 17
OSM/MEKK3 0.04 0.012 -10000 0 -10000 0 0
TAOK1 -0.02 0.12 -10000 0 -0.36 37 37
TAOK2 0.017 0.02 -10000 0 -0.35 1 1
TAOK3 0.017 0.019 -10000 0 -0.35 1 1
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 0.029 0.003 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
MAP3K5 0.008 0.11 -10000 0 -0.58 13 13
MAP3K10 0.028 0.007 -10000 0 -10000 0 0
MAP3K3 0.028 0.007 -10000 0 -10000 0 0
TRX/ASK1 0.006 0.075 -10000 0 -0.36 13 13
GADD45/MTK1/MTK1 0.026 0.099 -10000 0 -0.32 21 21
Aurora A signaling

Figure S115.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S115.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.022 0.069 -10000 0 -0.35 10 10
BIRC5 -0.012 0.14 -10000 0 -0.44 32 32
NFKBIA 0.018 0.028 0.25 3 -10000 0 3
CPEB1 -0.042 0.19 -10000 0 -0.56 45 45
AKT1 0.019 0.03 0.25 4 -10000 0 4
NDEL1 0.027 0.007 -10000 0 -10000 0 0
Aurora A/BRCA1 0.029 0.026 -10000 0 -10000 0 0
NDEL1/TACC3 0.045 0.033 -10000 0 -10000 0 0
GADD45A 0.009 0.1 -10000 0 -0.49 14 14
GSK3B 0.03 0.012 -10000 0 -10000 0 0
PAK1/Aurora A 0.034 0.028 -10000 0 -10000 0 0
MDM2 0.028 0.006 -10000 0 -10000 0 0
JUB 0 0 -10000 0 -10000 0 0
TPX2 0.005 0.07 0.23 2 -0.42 7 9
TP53 0.029 0.016 -10000 0 -10000 0 0
DLG7 0.015 0.018 -10000 0 -10000 0 0
AURKAIP1 0.027 0.022 -10000 0 -0.26 2 2
ARHGEF7 0.028 0.006 -10000 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.048 0.035 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle 0.029 0.026 -10000 0 -10000 0 0
AURKA 0.024 0.024 -10000 0 -10000 0 0
AURKB -0.003 0.081 -10000 0 -0.33 19 19
CDC25B 0.022 0.032 -10000 0 -0.48 1 1
G2/M transition checkpoint 0.012 0.022 -10000 0 -10000 0 0
mRNA polyadenylation -0.009 0.12 -10000 0 -0.32 42 42
Aurora A/CPEB -0.009 0.12 -10000 0 -0.32 42 42
Aurora A/TACC1/TRAP/chTOG 0.06 0.036 -10000 0 -10000 0 0
BRCA1 0.027 0.016 -10000 0 -0.26 1 1
centrosome duplication 0.034 0.028 -10000 0 -10000 0 0
regulation of centrosome cycle 0.044 0.033 -10000 0 -10000 0 0
spindle assembly 0.059 0.035 -10000 0 -10000 0 0
TDRD7 0.027 0.008 -10000 0 -10000 0 0
Aurora A/RasGAP/Survivin 0.037 0.083 -10000 0 -0.3 13 13
CENPA 0.003 0.078 -10000 0 -0.35 15 15
Aurora A/PP2A 0.034 0.028 -10000 0 -10000 0 0
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process 0.025 0.02 -10000 0 -10000 0 0
negative regulation of DNA binding 0.029 0.016 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.04 0.013 -10000 0 -10000 0 0
RASA1 0.028 0.006 -10000 0 -10000 0 0
Ajuba/Aurora A 0.012 0.022 -10000 0 -10000 0 0
mitotic prometaphase 0.003 0.024 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.024 0.024 -10000 0 -10000 0 0
TACC1 0.029 0.004 -10000 0 -10000 0 0
TACC3 0.026 0.03 -10000 0 -0.26 4 4
Aurora A/Antizyme1 0.049 0.029 -10000 0 -10000 0 0
Aurora A/RasGAP 0.034 0.029 -10000 0 -10000 0 0
OAZ1 0.027 0.008 -10000 0 -10000 0 0
RAN 0.028 0.006 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA 0.027 0.013 -10000 0 -10000 0 0
GIT1 0.028 0.007 -10000 0 -10000 0 0
GIT1/beta-PIX/PAK1 0.054 0.018 -10000 0 -10000 0 0
Importin alpha/Importin beta/TPX2 0.005 0.07 0.22 2 -0.42 7 9
PPP2R5D 0.029 0.003 -10000 0 -10000 0 0
Aurora A/TPX2 0.016 0.06 -10000 0 -0.33 7 7
PAK1 0.028 0.005 -10000 0 -10000 0 0
CKAP5 0.028 0.005 -10000 0 -10000 0 0
mTOR signaling pathway

Figure S116.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S116.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0 0 -10000 0 -10000 0 0
MKNK1 0.028 0.006 -10000 0 -10000 0 0
mol:PIP3 0.006 0.042 -10000 0 -0.31 6 6
FRAP1 0.017 0.029 0.27 1 -10000 0 1
AKT1 0.004 0.04 -10000 0 -0.29 6 6
INSR 0.027 0.008 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.018 0.005 -10000 0 -10000 0 0
mol:GTP 0.032 0.047 0.26 1 -0.31 2 3
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit 0.019 0.018 -10000 0 -10000 0 0
TSC2 0.027 0.016 -10000 0 -0.26 1 1
RHEB/GDP 0.023 0.037 -10000 0 -0.29 2 2
TSC1 0.027 0.009 -10000 0 -10000 0 0
Insulin Receptor/IRS1 0.022 0.044 -10000 0 -0.32 5 5
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.031 0.023 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0.029 0.005 -10000 0 -10000 0 0
RPS6KB1 0.037 0.085 0.36 17 -0.28 2 19
MAP3K5 -0.007 0.075 0.17 1 -0.33 18 19
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
apoptosis -0.007 0.075 0.17 1 -0.33 18 19
mol:LY294002 0 0.001 0.001 1 -0.004 18 19
EIF4B 0.042 0.11 0.44 19 -0.25 2 21
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.046 0.053 0.36 5 -0.25 1 6
eIF4E/eIF4G1/eIF4A1 0.023 0.014 -10000 0 -10000 0 0
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K 0.037 0.051 -10000 0 -0.32 6 6
mTOR/RHEB/GTP/Raptor/GBL 0.014 0.035 0.24 3 -0.2 1 4
FKBP1A 0.029 0.005 -10000 0 -10000 0 0
RHEB/GTP 0.037 0.042 -10000 0 -0.29 2 2
mol:Amino Acids 0 0.001 0.001 1 -0.004 18 19
FKBP12/Rapamycin 0.021 0.005 -10000 0 -10000 0 0
PDPK1 0.001 0.048 -10000 0 -0.32 7 7
EIF4E 0.029 0.004 -10000 0 -10000 0 0
ASK1/PP5C 0.012 0.14 -10000 0 -0.57 18 18
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.019 0.007 -10000 0 -10000 0 0
TSC1/TSC2 0.036 0.05 0.28 1 -0.34 2 3
tumor necrosis factor receptor activity 0 0.001 0.004 18 -0.001 1 19
RPS6 0.027 0.008 -10000 0 -10000 0 0
PPP5C 0.028 0.007 -10000 0 -10000 0 0
EIF4G1 0.029 0.004 -10000 0 -10000 0 0
IRS1 0.002 0.049 -10000 0 -0.25 11 11
INS 0 0 -10000 0 -10000 0 0
PTEN 0.027 0.008 -10000 0 -10000 0 0
PDK2 0.003 0.042 0.23 2 -0.29 6 8
EIF4EBP1 0.017 0.1 -10000 0 -0.98 4 4
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
PPP2R5D 0.029 0.073 0.4 11 -10000 0 11
peptide biosynthetic process 0.018 0.005 -10000 0 -10000 0 0
RHEB 0.028 0.007 -10000 0 -10000 0 0
EIF4A1 0.027 0.007 -10000 0 -10000 0 0
mol:Rapamycin 0.001 0.002 0.009 16 -0.003 1 17
EEF2 0.018 0.005 -10000 0 -10000 0 0
eIF4E/4E-BP1 0.032 0.097 -10000 0 -0.9 4 4
Class I PI3K signaling events mediated by Akt

Figure S117.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S117.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.018 0.005 -10000 0 -10000 0 0
BAD/BCL-XL/YWHAZ 0.048 0.016 -10000 0 -10000 0 0
CDKN1B 0.024 0.031 -10000 0 -0.43 1 1
CDKN1A 0.017 0.053 -10000 0 -0.43 1 1
FRAP1 0 0 -10000 0 -10000 0 0
PRKDC 0.027 0.032 -10000 0 -0.58 1 1
FOXO3 0.023 0.031 -10000 0 -0.43 1 1
AKT1 0.023 0.031 -10000 0 -0.45 1 1
BAD 0.028 0.005 -10000 0 -10000 0 0
AKT3 0.014 0.027 -10000 0 -0.35 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
FOXO4 0.024 0.033 -10000 0 -0.43 1 1
AKT1/ASK1 0.031 0.07 -10000 0 -0.69 1 1
BAD/YWHAZ 0.054 0.017 -10000 0 -10000 0 0
RICTOR 0.028 0.007 -10000 0 -10000 0 0
RAF1 0.029 0.004 -10000 0 -10000 0 0
JNK cascade -0.03 0.068 0.66 1 -10000 0 1
TSC1 0.022 0.031 -10000 0 -0.43 1 1
YWHAZ 0.029 0.005 -10000 0 -10000 0 0
AKT1/RAF1 0.043 0.044 0.27 1 -0.43 1 2
EP300 0.02 0.033 -10000 0 -0.58 1 1
mol:GDP 0.023 0.031 -10000 0 -0.45 1 1
mol:PI-3-4-5-P3 0 0 -10000 0 -10000 0 0
TSC2 0.022 0.03 -10000 0 -0.43 1 1
YWHAQ 0.028 0.005 -10000 0 -10000 0 0
TBC1D4 0.008 0.03 -10000 0 -0.26 3 3
MAP3K5 0.008 0.11 -10000 0 -0.58 13 13
MAPKAP1 0.027 0.008 -10000 0 -10000 0 0
negative regulation of cell cycle 0.015 0.11 0.4 13 -0.34 5 18
YWHAH 0.022 0.013 -10000 0 -10000 0 0
AKT1S1 0.025 0.037 -10000 0 -0.43 1 1
CASP9 0.025 0.036 -10000 0 -0.43 1 1
YWHAB 0.028 0.005 -10000 0 -10000 0 0
p27Kip1/KPNA1 0.047 0.056 0.41 5 -0.41 1 6
GBL 0 0 -10000 0 -10000 0 0
PDK1/Src/Hsp90 0.052 0.038 -10000 0 -0.36 2 2
YWHAE 0.027 0.008 -10000 0 -10000 0 0
SRC 0.026 0.035 -10000 0 -0.42 2 2
AKT2/p21CIP1 0.018 0.053 -10000 0 -0.34 2 2
KIAA1303 0 0 -10000 0 -10000 0 0
mTOR/RHEB/GTP/Raptor/GBL 0.018 0.013 -10000 0 -10000 0 0
CHUK 0.023 0.031 -10000 0 -0.43 1 1
BAD/BCL-XL 0.049 0.04 0.27 1 -0.41 1 2
mTORC2 0.033 0.012 -10000 0 -10000 0 0
AKT2 0.015 0.028 -10000 0 -0.35 2 2
FOXO1-3a-4/14-3-3 family -0.01 0.12 0.36 5 -0.51 6 11
PDPK1 0.024 0.045 -10000 0 -0.58 2 2
MDM2 0.024 0.032 -10000 0 -0.43 1 1
MAPKKK cascade -0.043 0.043 0.42 1 -0.27 1 2
MDM2/Cbp/p300 0.041 0.043 -10000 0 -0.4 1 1
TSC1/TSC2 0.024 0.044 0.3 4 -0.42 1 5
proteasomal ubiquitin-dependent protein catabolic process 0.039 0.041 -10000 0 -0.38 1 1
glucose import -0.017 0.078 0.2 1 -0.32 18 19
mTOR/RHEB/GDP/Raptor/GBL/PRAS40 0.026 0.028 0.21 2 -0.25 1 3
response to stress 0 0 -10000 0 -10000 0 0
SLC2A4 -0.017 0.078 0.2 1 -0.32 18 19
GSK3A 0.025 0.036 -10000 0 -0.43 1 1
FOXO1 0.022 0.031 -10000 0 -0.43 1 1
GSK3B 0.024 0.031 -10000 0 -0.43 1 1
SFN -0.13 0.25 -10000 0 -0.47 123 123
G1/S transition of mitotic cell cycle 0.027 0.042 0.34 1 -0.42 1 2
p27Kip1/14-3-3 family -0.023 0.12 -10000 0 -0.36 23 23
PRKACA 0.027 0.008 -10000 0 -10000 0 0
KPNA1 0.029 0.004 -10000 0 -10000 0 0
HSP90AA1 0.028 0.006 -10000 0 -10000 0 0
YWHAG 0.028 0.007 -10000 0 -10000 0 0
RHEB 0.028 0.007 -10000 0 -10000 0 0
CREBBP 0.028 0.007 -10000 0 -10000 0 0
Signaling mediated by p38-gamma and p38-delta

Figure S118.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S118.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K 0.009 0.019 -10000 0 -0.36 1 1
SNTA1 0.019 0.051 -10000 0 -0.26 12 12
response to hypoxia 0 0 -10000 0 -10000 0 0
STMN1 0.009 0.021 -10000 0 -0.36 1 1
MAPK12 0 0.046 0.2 1 -0.32 6 7
CCND1 0.007 0.045 -10000 0 -0.36 4 4
p38 gamma/SNTA1 0.02 0.062 0.39 1 -0.3 6 7
MAP2K3 0.027 0.007 -10000 0 -10000 0 0
PKN1 0.027 0.008 -10000 0 -10000 0 0
G2/M transition checkpoint 0.002 0.05 0.21 4 -0.32 6 10
MAP2K6 0.005 0.048 0.22 1 -0.33 6 7
MAPT 0.01 0.053 0.31 5 -0.34 3 8
MAPK13 0.017 0.023 -10000 0 -0.42 1 1
hyperosmotic response 0 0 -10000 0 -10000 0 0
ZAK 0.015 0.028 -10000 0 -0.35 2 2
Insulin Pathway

Figure S119.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S119.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP 0.038 0.051 -10000 0 -0.29 6 6
TC10/GTP 0.043 0.038 -10000 0 -0.29 2 2
Insulin Receptor/Insulin/IRS1/Shp2 0.048 0.046 -10000 0 -0.34 4 4
HRAS 0.027 0.022 -10000 0 -0.26 2 2
APS homodimer 0.027 0.016 -10000 0 -0.26 1 1
GRB14 0.017 0.075 -10000 0 -0.44 9 9
FOXO3 0.018 0.095 -10000 0 -0.61 8 8
AKT1 0.02 0.072 0.34 6 -0.52 1 7
INSR 0.029 0.009 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.046 0.014 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
GRB10 0.026 0.032 -10000 0 -0.58 1 1
SORBS1 0.021 0.055 -10000 0 -0.35 7 7
CRK 0.027 0.008 -10000 0 -10000 0 0
PTPN1 0.022 0.021 -10000 0 -10000 0 0
CAV1 0.008 0.069 0.19 1 -0.32 13 14
CBL/APS/CAP/Crk-II/C3G 0.068 0.049 -10000 0 -0.31 2 2
Insulin Receptor/Insulin/IRS1/NCK2 0.048 0.046 -10000 0 -0.34 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.039 0.047 -10000 0 -0.3 6 6
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.023 0.059 -10000 0 -0.33 3 3
RPS6KB1 0.011 0.062 0.31 4 -0.47 1 5
PARD6A 0.027 0.016 -10000 0 -0.26 1 1
CBL 0.028 0.006 -10000 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -10000 0 -10000 0 0
DOK1 0.019 0.029 -10000 0 -0.5 1 1
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/Shc 0.028 0.054 -10000 0 -0.46 1 1
HRAS/GTP 0.008 0.042 -10000 0 -0.27 6 6
Insulin Receptor 0.029 0.009 -10000 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.056 0.048 -10000 0 -0.32 4 4
PRKCI 0.031 0.055 -10000 0 -10000 0 0
Insulin Receptor/Insulin/GRB14/PDK1 0.019 0.059 -10000 0 -0.31 10 10
SHC1 0.027 0.008 -10000 0 -10000 0 0
negative regulation of MAPKKK cascade 0.048 0.045 -10000 0 -0.4 1 1
PI3K 0.048 0.05 -10000 0 -0.3 6 6
NCK2 0.028 0.005 -10000 0 -10000 0 0
RHOQ 0.028 0.005 -10000 0 -10000 0 0
mol:H2O2 0.001 0.004 -10000 0 -10000 0 0
HRAS/GDP 0.02 0.015 -10000 0 -0.17 2 2
AKT2 0.018 0.077 0.38 7 -0.52 1 8
PRKCZ 0.031 0.051 -10000 0 -0.34 1 1
SH2B2 0.027 0.016 -10000 0 -0.26 1 1
SHC/SHIP 0.028 0.055 -10000 0 -0.3 6 6
F2RL2 -0.074 0.2 -10000 0 -0.41 88 88
TRIP10 0.027 0.008 -10000 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0.035 0.015 -10000 0 -10000 0 0
TC10/GTP/CIP4/Exocyst 0.036 0.011 -10000 0 -10000 0 0
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.061 0.027 -10000 0 -10000 0 0
RAPGEF1 0.027 0.008 -10000 0 -10000 0 0
RASA1 0.028 0.006 -10000 0 -10000 0 0
NCK1 0.029 0.004 -10000 0 -10000 0 0
CBL/APS/CAP/Crk-II 0.061 0.045 -10000 0 -0.33 2 2
TC10/GDP 0.021 0.004 -10000 0 -10000 0 0
Insulin Receptor/Insulin/SHC/GRB10 0.049 0.029 -10000 0 -0.34 1 1
INPP5D 0.014 0.054 0.18 2 -0.32 6 8
SOS1 0.028 0.006 -10000 0 -10000 0 0
SGK1 -0.001 0.12 -10000 0 -0.78 9 9
mol:cAMP 0 0 -10000 0 -10000 0 0
PTPN11 0.028 0.006 -10000 0 -10000 0 0
IRS1 0.019 0.069 -10000 0 -0.42 8 8
p62DOK/RasGAP 0.049 0.046 -10000 0 -0.41 1 1
INS 0.002 0.007 -10000 0 -10000 0 0
mol:PI-3-4-P2 0.014 0.054 0.18 2 -0.31 6 8
GRB2 0.028 0.007 -10000 0 -10000 0 0
EIF4EBP1 0.012 0.065 0.34 4 -0.47 1 5
PTPRA 0.031 0.006 -10000 0 -10000 0 0
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
TC10/GTP/CIP4 0.036 0.011 -10000 0 -10000 0 0
PDPK1 0.024 0.045 -10000 0 -0.58 2 2
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0.026 0.032 -10000 0 -0.26 4 4
Insulin Receptor/Insulin/IRS1 0.032 0.043 -10000 0 -0.34 4 4
Insulin Receptor/Insulin/IRS3 0.023 0.009 -10000 0 -10000 0 0
Par3/Par6 0 0.12 -10000 0 -0.31 40 40
Signaling events mediated by HDAC Class II

Figure S120.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S120.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G beta1gamma2/HDAC5 0.067 0.028 -9999 0 -10000 0 0
HDAC3 0.028 0.006 -9999 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.008 0.006 -9999 0 -10000 0 0
GATA1/HDAC4 0.036 0.017 -9999 0 -10000 0 0
GATA1/HDAC5 0.036 0.013 -9999 0 -10000 0 0
GATA2/HDAC5 0.037 0.038 -9999 0 -0.42 2 2
HDAC5/BCL6/BCoR 0.052 0.028 -9999 0 -0.36 1 1
HDAC9 0.006 0.1 -9999 0 -0.41 19 19
Glucocorticoid receptor/Hsp90/HDAC6 0.054 0.018 -9999 0 -10000 0 0
HDAC4/ANKRA2 0.04 0.015 -9999 0 -10000 0 0
HDAC5/YWHAB 0.041 0.011 -9999 0 -10000 0 0
NPC/RanGAP1/SUMO1/Ubc9 0.015 0.009 -9999 0 -10000 0 0
GATA2 0.023 0.051 -9999 0 -0.39 5 5
HDAC4/RFXANK 0.039 0.02 -9999 0 -10000 0 0
BCOR 0.027 0.008 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
HDAC10 0.021 0.013 -9999 0 -10000 0 0
HDAC5 0.028 0.007 -9999 0 -10000 0 0
GNB1/GNG2 0.039 0.022 -9999 0 -10000 0 0
Histones 0.004 0.067 -9999 0 -0.39 3 3
ADRBK1 0.028 0.005 -9999 0 -10000 0 0
HDAC4 0.028 0.016 -9999 0 -0.26 1 1
XPO1 0.028 0.005 -9999 0 -10000 0 0
HDAC5/ANKRA2 0.04 0.011 -9999 0 -10000 0 0
HDAC4/Ubc9 0.04 0.016 -9999 0 -10000 0 0
HDAC7 0.028 0.006 -9999 0 -10000 0 0
HDAC5/14-3-3 E 0.04 0.011 -9999 0 -10000 0 0
TUBA1B 0.028 0.006 -9999 0 -10000 0 0
HDAC6 0.027 0.008 -9999 0 -10000 0 0
HDAC5/RFXANK 0.039 0.017 -9999 0 -10000 0 0
CAMK4 -0.012 0.13 -9999 0 -0.36 39 39
Tubulin/HDAC6 0.047 0.049 -9999 0 -0.36 3 3
SUMO1 0.028 0.005 -9999 0 -10000 0 0
EntrezGene:9972 0 0 -9999 0 -10000 0 0
YWHAB 0.028 0.005 -9999 0 -10000 0 0
GATA1 0.023 0.009 -9999 0 -10000 0 0
EntrezGene:8021 0 0 -9999 0 -10000 0 0
YWHAE 0.027 0.008 -9999 0 -10000 0 0
NR3C1 0.028 0.006 -9999 0 -10000 0 0
SUMO1/HDAC4 0.018 0.059 -9999 0 -0.24 3 3
SRF 0.027 0.026 -9999 0 -0.26 3 3
HDAC4/YWHAB 0.041 0.015 -9999 0 -10000 0 0
Tubulin 0.033 0.055 -9999 0 -0.42 4 4
HDAC4/14-3-3 E 0.039 0.016 -9999 0 -10000 0 0
GNB1 0.028 0.006 -9999 0 -10000 0 0
RANGAP1 0.022 0.013 -9999 0 -10000 0 0
BCL6/BCoR 0.039 0.027 -9999 0 -0.42 1 1
HDAC4/HDAC3/SMRT (N-CoR2) 0.055 0.019 -9999 0 -10000 0 0
HDAC4/SRF 0.026 0.09 -9999 0 -0.36 12 12
HDAC4/ER alpha -0.023 0.14 -9999 0 -0.42 33 33
EntrezGene:23225 0 0 -9999 0 -10000 0 0
positive regulation of chromatin silencing 0.004 0.067 -9999 0 -0.39 3 3
cell motility 0.047 0.048 -9999 0 -0.36 3 3
EntrezGene:23636 0 0 -9999 0 -10000 0 0
UBE2I 0.027 0.007 -9999 0 -10000 0 0
HDAC7/HDAC3 0.041 0.01 -9999 0 -10000 0 0
BCL6 0.027 0.031 -9999 0 -0.58 1 1
HDAC4/CaMK II delta B 0.028 0.016 -9999 0 -0.26 1 1
Hsp90/HDAC6 0.039 0.013 -9999 0 -10000 0 0
ESR1 -0.056 0.18 -9999 0 -0.4 74 74
HDAC6/HDAC11 0.04 0.012 -9999 0 -10000 0 0
Ran/GTP/Exportin 1 0.022 0.052 -9999 0 -0.21 1 1
NPC 0.017 0.003 -9999 0 -10000 0 0
MEF2C 0.028 0.006 -9999 0 -10000 0 0
RAN 0.028 0.006 -9999 0 -10000 0 0
HDAC4/MEF2C 0.079 0.028 -9999 0 -10000 0 0
GNG2 0.026 0.026 -9999 0 -0.26 3 3
NCOR2 0.028 0.006 -9999 0 -10000 0 0
TUBB2A 0.017 0.073 -9999 0 -0.37 11 11
HDAC11 0.029 0.004 -9999 0 -10000 0 0
HSP90AA1 0.028 0.006 -9999 0 -10000 0 0
RANBP2 0.028 0.005 -9999 0 -10000 0 0
ANKRA2 0.028 0.006 -9999 0 -10000 0 0
RFXANK 0.026 0.017 -9999 0 -0.26 1 1
nuclear import -0.039 0.013 -9999 0 -10000 0 0
EPO signaling pathway

Figure S121.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S121.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.051 0.061 -10000 0 -10000 0 0
CRKL 0.021 0.047 0.45 3 -10000 0 3
mol:DAG 0.039 0.036 -10000 0 -0.33 1 1
HRAS 0.04 0.058 0.41 3 -10000 0 3
MAPK8 0.02 0.052 -10000 0 -0.33 5 5
RAP1A 0.033 0.065 0.48 6 -10000 0 6
GAB1 0.03 0.054 0.45 4 -10000 0 4
MAPK14 0.025 0.036 -10000 0 -0.31 1 1
EPO 0.024 0.018 -10000 0 -0.26 1 1
PLCG1 0.039 0.037 -10000 0 -0.34 1 1
EPOR/TRPC2/IP3 Receptors 0.025 0.044 -10000 0 -0.32 5 5
RAPGEF1 0.027 0.008 -10000 0 -10000 0 0
EPO/EPOR (dimer)/SOCS3 0.03 0.083 -10000 0 -0.38 9 9
GAB1/SHC/GRB2/SOS1 0.057 0.038 -10000 0 -10000 0 0
EPO/EPOR (dimer) 0.035 0.037 -10000 0 -0.42 1 1
IRS2 0.024 0.074 0.46 5 -0.29 6 11
STAT1 0.04 0.062 -10000 0 -0.35 5 5
STAT5B 0.042 0.038 -10000 0 -0.34 1 1
cell proliferation 0.017 0.062 0.34 5 -0.31 5 10
GAB1/SHIP/PIK3R1/SHP2/SHC 0.04 0.045 -10000 0 -0.33 1 1
TEC 0.03 0.054 0.45 4 -10000 0 4
SOCS3 -0.003 0.12 -10000 0 -0.41 26 26
STAT1 (dimer) 0.04 0.061 -10000 0 -0.34 5 5
JAK2 0.03 0.013 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
EPO/EPOR (dimer)/JAK2 0.072 0.043 -10000 0 -0.28 1 1
EPO/EPOR 0.035 0.037 -10000 0 -0.42 1 1
LYN 0.03 0.007 -10000 0 -10000 0 0
TEC/VAV2 0.04 0.034 -10000 0 -10000 0 0
elevation of cytosolic calcium ion concentration 0.025 0.044 -10000 0 -0.32 5 5
SHC1 0.027 0.008 -10000 0 -10000 0 0
EPO/EPOR (dimer)/LYN 0.055 0.038 -10000 0 -0.35 1 1
mol:IP3 0.039 0.036 -10000 0 -0.33 1 1
PI3K regualtory subunit polypeptide 1/IRS2/SHIP 0.041 0.068 -10000 0 -0.35 1 1
SH2B3 0.03 0.008 -10000 0 -10000 0 0
NFKB1 0.024 0.034 -10000 0 -0.31 1 1
EPO/EPOR (dimer)/JAK2/SOCS3 0.003 0.05 -10000 0 -0.25 9 9
PTPN6 0.029 0.04 0.31 1 -0.28 1 2
TEC/VAV2/GRB2 0.051 0.038 -10000 0 -10000 0 0
EPOR 0.025 0.045 -10000 0 -0.32 5 5
INPP5D 0.017 0.064 -10000 0 -0.31 12 12
mol:GDP 0.056 0.038 -10000 0 -10000 0 0
SOS1 0.028 0.006 -10000 0 -10000 0 0
PLCG2 0.025 0.026 -10000 0 -0.26 3 3
CRKL/CBL/C3G 0.039 0.038 -10000 0 -10000 0 0
VAV2 0.032 0.062 0.45 6 -10000 0 6
CBL 0.029 0.053 0.44 4 -10000 0 4
SHC/Grb2/SOS1 0.044 0.033 -10000 0 -10000 0 0
STAT5A 0.042 0.038 -10000 0 -0.34 1 1
GRB2 0.028 0.007 -10000 0 -10000 0 0
STAT5 (dimer) 0.064 0.048 -10000 0 -10000 0 0
LYN/PLCgamma2 0.04 0.024 -10000 0 -10000 0 0
PTPN11 0.028 0.006 -10000 0 -10000 0 0
BTK -0.005 0.087 -10000 0 -0.3 22 22
BCL2 0.043 0.11 0.34 1 -0.82 4 5
Signaling events mediated by HDAC Class I

Figure S122.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S122.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NF kappa B/RelA 0.014 0.14 -10000 0 -0.38 41 41
Ran/GTP/Exportin 1/HDAC1 0.008 0.002 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha -0.016 0.12 -10000 0 -0.35 40 40
SUMO1 0.028 0.005 -10000 0 -10000 0 0
ZFPM1 0.023 0.034 -10000 0 -0.26 5 5
NPC/RanGAP1/SUMO1/Ubc9 0.015 0.009 -10000 0 -10000 0 0
FKBP3 0.028 0.005 -10000 0 -10000 0 0
Histones 0.041 0.075 -10000 0 -10000 0 0
YY1/LSF 0.01 0.063 -10000 0 -0.33 4 4
SMG5 0.027 0.008 -10000 0 -10000 0 0
RAN 0.028 0.006 -10000 0 -10000 0 0
I kappa B alpha/HDAC3 -0.008 0.095 -10000 0 -0.27 39 39
I kappa B alpha/HDAC1 0.009 0.073 -10000 0 -10000 0 0
SAP18 0.028 0.006 -10000 0 -10000 0 0
RELA -0.019 0.11 -10000 0 -0.44 12 12
HDAC1/Smad7 0.054 0.017 -10000 0 -10000 0 0
RANGAP1 0.022 0.013 -10000 0 -10000 0 0
HDAC3/TR2 0.01 0.073 -10000 0 -10000 0 0
NuRD/MBD3 Complex 0.034 0.031 -10000 0 -0.33 1 1
NF kappa B1 p50/RelA -0.023 0.11 0.31 1 -0.4 13 14
EntrezGene:23225 0 0 -10000 0 -10000 0 0
GATA2 0.023 0.051 -10000 0 -0.39 5 5
GATA1 0.023 0.009 -10000 0 -10000 0 0
Mad/Max 0.042 0.009 -10000 0 -10000 0 0
NuRD/MBD3 Complex/GATA1/Fog1 0.037 0.067 -10000 0 -0.45 4 4
RBBP7 0.027 0.008 -10000 0 -10000 0 0
NPC 0.017 0.003 -10000 0 -10000 0 0
RBBP4 0.025 0.044 -10000 0 -0.58 2 2
MAX 0.028 0.005 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
FBXW11 0.028 0.006 -10000 0 -10000 0 0
NFKBIA -0.004 0.074 -10000 0 -10000 0 0
KAT2B 0.029 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
SIN3/HDAC complex 0.033 0.026 -10000 0 -10000 0 0
SIN3 complex 0.066 0.032 -10000 0 -0.33 1 1
SMURF1 0.028 0.007 -10000 0 -10000 0 0
CHD3 0.027 0.007 -10000 0 -10000 0 0
SAP30 0.027 0.032 -10000 0 -0.58 1 1
EntrezGene:23636 0 0 -10000 0 -10000 0 0
NCOR1 0.027 0.007 -10000 0 -10000 0 0
YY1/HDAC3 -0.008 0.075 -10000 0 -0.37 1 1
YY1/HDAC2 0.011 0.056 -10000 0 -0.26 2 2
YY1/HDAC1 0.012 0.055 -10000 0 -0.26 2 2
NuRD/MBD2 Complex (MeCP1) 0.035 0.028 -10000 0 -10000 0 0
PPARG -0.018 0.12 -10000 0 -0.34 39 39
HDAC8/hEST1B 0.049 0.023 -10000 0 -10000 0 0
UBE2I 0.027 0.007 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.028 0.006 -10000 0 -10000 0 0
TNFRSF1A 0.028 0.006 -10000 0 -10000 0 0
HDAC3/SMRT (N-CoR2) 0.01 0.073 -10000 0 -10000 0 0
MBD3L2 0 0 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.054 0.017 -10000 0 -10000 0 0
CREBBP 0.028 0.007 -10000 0 -10000 0 0
NuRD/MBD3/MBD3L2 Complex 0.041 0.048 -10000 0 -0.48 1 1
HDAC1 0.028 0.006 -10000 0 -10000 0 0
HDAC3 -0.004 0.074 -10000 0 -10000 0 0
HDAC2 0.029 0.004 -10000 0 -10000 0 0
YY1 0.02 0.02 -10000 0 -0.28 1 1
HDAC8 0.027 0.008 -10000 0 -10000 0 0
SMAD7 0.029 0.005 -10000 0 -10000 0 0
NCOR2 0.028 0.006 -10000 0 -10000 0 0
MXD1 0.028 0.005 -10000 0 -10000 0 0
STAT3 0.019 0.023 -10000 0 -0.34 1 1
NFKB1 0.029 0.004 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.028 0.005 -10000 0 -10000 0 0
YY1/LSF/HDAC1 0.023 0.063 -10000 0 -0.34 3 3
YY1/SAP30/HDAC1 0.024 0.059 -10000 0 -10000 0 0
EP300 0.02 0.033 -10000 0 -0.58 1 1
STAT3 (dimer non-phopshorylated) 0.019 0.023 -10000 0 -0.34 1 1
proteasomal ubiquitin-dependent protein catabolic process -0.004 0.074 -10000 0 -10000 0 0
histone deacetylation 0.04 0.031 -10000 0 -10000 0 0
STAT3 (dimer non-phopshorylated)/HDAC3 0 0.072 -10000 0 -0.42 1 1
nuclear export -0.049 0.023 -10000 0 -10000 0 0
PRKACA 0.027 0.008 -10000 0 -10000 0 0
GATAD2B 0.027 0.008 -10000 0 -10000 0 0
GATAD2A 0.027 0.008 -10000 0 -10000 0 0
GATA2/HDAC3 0.007 0.077 -10000 0 -0.32 2 2
GATA1/HDAC1 0.036 0.013 -10000 0 -10000 0 0
GATA1/HDAC3 0.007 0.072 -10000 0 -10000 0 0
CHD4 0.028 0.006 -10000 0 -10000 0 0
TNF-alpha/TNFR1A -0.033 0.15 -10000 0 -0.42 41 41
SIN3/HDAC complex/Mad/Max 0.034 0.045 -10000 0 -0.67 1 1
NuRD Complex 0.045 0.051 -10000 0 -0.55 1 1
positive regulation of chromatin silencing 0.039 0.073 -10000 0 -10000 0 0
SIN3B 0.027 0.008 -10000 0 -10000 0 0
MTA2 0.028 0.005 -10000 0 -10000 0 0
SIN3A 0.029 0.004 -10000 0 -10000 0 0
XPO1 0.028 0.005 -10000 0 -10000 0 0
SUMO1/HDAC1 0.017 0.059 -10000 0 -0.25 3 3
HDAC complex 0.066 0.037 -10000 0 -0.33 2 2
GATA1/Fog1 0.033 0.028 -10000 0 -0.18 2 2
FKBP25/HDAC1/HDAC2 0.056 0.015 -10000 0 -10000 0 0
TNF -0.07 0.2 -10000 0 -0.42 83 83
negative regulation of cell growth 0.036 0.046 -10000 0 -0.66 1 1
NuRD/MBD2/PRMT5 Complex 0.035 0.028 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.022 0.052 -10000 0 -0.21 1 1
NF kappa B/RelA/I kappa B alpha -0.027 0.12 -10000 0 -0.36 40 40
SIN3/HDAC complex/NCoR1 0.032 0.05 -10000 0 -0.63 1 1
TFCP2 0.023 0.054 -10000 0 -0.58 3 3
NR2C1 0.028 0.006 -10000 0 -10000 0 0
MBD3 0.027 0.008 -10000 0 -10000 0 0
MBD2 0.029 0.005 -10000 0 -10000 0 0
E-cadherin signaling in the nascent adherens junction

Figure S123.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S123.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.032 0.039 -10000 0 -0.42 1 1
KLHL20 0.015 0.064 -10000 0 -0.28 3 3
CYFIP2 0.026 0.032 -10000 0 -0.58 1 1
Rac1/GDP 0.04 0.046 -10000 0 -10000 0 0
ENAH 0.03 0.028 -10000 0 -10000 0 0
AP1M1 0.027 0.008 -10000 0 -10000 0 0
RAP1B 0.028 0.006 -10000 0 -10000 0 0
RAP1A 0.028 0.006 -10000 0 -10000 0 0
CTNNB1 0.029 0.004 -10000 0 -10000 0 0
CDC42/GTP 0.038 0.021 -10000 0 -10000 0 0
ABI1/Sra1/Nap1 -0.015 0.037 -10000 0 -0.17 5 5
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.033 0.1 -10000 0 -0.33 22 22
RAPGEF1 0.028 0.046 0.34 1 -0.37 1 2
CTNND1 0.028 0.005 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion 0.034 0.04 -10000 0 -0.45 1 1
CRK 0.027 0.04 -10000 0 -0.41 1 1
E-cadherin/gamma catenin/alpha catenin 0.054 0.02 -10000 0 -10000 0 0
alphaE/beta7 Integrin 0 0.12 -10000 0 -0.4 24 24
IQGAP1 0.029 0.004 -10000 0 -10000 0 0
NCKAP1 0.029 0.005 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.052 0.016 -10000 0 -10000 0 0
DLG1 0.031 0.039 -10000 0 -0.44 1 1
ChemicalAbstracts:7440-70-2 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.009 0.017 -10000 0 -10000 0 0
MLLT4 0.029 0.004 -10000 0 -10000 0 0
ARF6/GTP/NME1/Tiam1 0.015 0.11 -10000 0 -0.33 32 32
PI3K 0.018 0.023 -10000 0 -10000 0 0
ARF6 0.028 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
E-cadherin/gamma catenin 0.039 0.016 -10000 0 -10000 0 0
TIAM1 -0.035 0.18 -10000 0 -0.53 42 42
E-cadherin(dimer)/Ca2+ 0.065 0.02 -10000 0 -10000 0 0
AKT1 0.021 0.024 -10000 0 -10000 0 0
PIK3R1 0.028 0.006 -10000 0 -10000 0 0
CDH1 0.028 0.007 -10000 0 -10000 0 0
RhoA/GDP 0.053 0.082 0.48 8 -10000 0 8
actin cytoskeleton organization 0.013 0.049 0.14 1 -0.2 3 4
CDC42/GDP 0.053 0.087 0.5 9 -10000 0 9
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.025 0.008 -10000 0 -10000 0 0
ITGB7 -0.024 0.16 -10000 0 -0.43 42 42
RAC1 0.028 0.007 -10000 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.07 0.022 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin 0.048 0.016 -10000 0 -10000 0 0
mol:GDP 0.04 0.089 0.56 7 -10000 0 7
CDC42/GTP/IQGAP1 0.038 0.009 -10000 0 -10000 0 0
JUP 0.028 0.007 -10000 0 -10000 0 0
p120 catenin/RhoA/GDP 0.049 0.05 -10000 0 -10000 0 0
RAC1/GTP/IQGAP1 0.037 0.01 -10000 0 -10000 0 0
PIP5K1C/AP1M1 0.04 0.012 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
CDC42 0.028 0.006 -10000 0 -10000 0 0
CTNNA1 0.028 0.006 -10000 0 -10000 0 0
positive regulation of S phase of mitotic cell cycle 0.013 0.042 0.19 2 -0.21 3 5
NME1 0.028 0.007 -10000 0 -10000 0 0
clathrin coat assembly 0 0 -10000 0 -10000 0 0
TJP1 0.031 0.039 -10000 0 -0.44 1 1
regulation of cell-cell adhesion 0.026 0.017 -10000 0 -10000 0 0
WASF2 0.009 0.027 -10000 0 -10000 0 0
Rap1/GTP 0.044 0.032 0.25 1 -10000 0 1
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.044 0.1 -10000 0 -0.31 21 21
CCND1 0.014 0.05 0.22 1 -0.27 3 4
VAV2 0.013 0.14 -10000 0 -0.54 19 19
RAP1/GDP 0.051 0.043 0.31 3 -10000 0 3
adherens junction assembly 0.031 0.039 -10000 0 -0.42 1 1
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
ABI1 0.029 0.005 -10000 0 -10000 0 0
PIP5K1C 0.027 0.008 -10000 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.033 0.094 -10000 0 -0.3 21 21
E-cadherin/beta catenin 0.017 0.007 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
SRC 0.031 0.043 -10000 0 -0.44 1 1
PIK3CA 0.026 0.044 -10000 0 -0.58 2 2
Rac1/GTP -0.031 0.084 -10000 0 -0.42 6 6
E-cadherin/beta catenin/alpha catenin 0.055 0.018 -10000 0 -10000 0 0
ITGAE 0.026 0.022 -10000 0 -0.26 2 2
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.035 0.041 -10000 0 -0.46 1 1
E-cadherin signaling in keratinocytes

Figure S124.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S124.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation 0.031 0.036 0.28 2 -0.31 2 4
adherens junction organization 0.02 0.041 0.22 2 -0.31 1 3
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.03 0.065 -10000 0 -10000 0 0
FMN1 0.007 0.08 -10000 0 -0.28 26 26
mol:IP3 0.03 0.029 -10000 0 -0.27 2 2
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.03 0.03 -10000 0 -0.28 2 2
CTNNB1 0.028 0.005 -10000 0 -10000 0 0
AKT1 0.036 0.034 0.21 1 -0.26 2 3
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.036 0.045 -10000 0 -0.39 2 2
CTNND1 0.03 0.007 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.026 0.027 -10000 0 -0.36 1 1
VASP 0.027 0.025 -10000 0 -0.28 1 1
ZYX 0.027 0.028 -10000 0 -0.28 1 1
JUB 0.026 0.028 -10000 0 -0.26 2 2
EGFR(dimer) 0.032 0.07 -10000 0 -0.27 17 17
E-cadherin/beta catenin-gamma catenin 0.053 0.019 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.052 0.036 -10000 0 -0.28 2 2
PIK3CA 0.027 0.045 -10000 0 -0.58 2 2
PI3K 0.053 0.037 -10000 0 -0.28 2 2
FYN 0.025 0.046 0.28 2 -0.33 3 5
mol:Ca2+ 0.03 0.029 -10000 0 -0.26 2 2
JUP 0.027 0.007 -10000 0 -10000 0 0
PIK3R1 0.029 0.006 -10000 0 -10000 0 0
mol:DAG 0.03 0.029 -10000 0 -0.27 2 2
CDH1 0.027 0.007 -10000 0 -10000 0 0
RhoA/GDP 0.031 0.066 -10000 0 -10000 0 0
establishment of polarity of embryonic epithelium 0.027 0.024 -10000 0 -0.28 1 1
SRC 0.026 0.035 -10000 0 -0.42 2 2
RAC1 0.028 0.007 -10000 0 -10000 0 0
RHOA 0.029 0.004 -10000 0 -10000 0 0
EGFR 0.002 0.12 -10000 0 -0.54 17 17
CASR 0.018 0.032 -10000 0 -0.26 2 2
RhoA/GTP 0.043 0.029 -10000 0 -0.25 2 2
AKT2 0.034 0.031 -10000 0 -0.26 2 2
actin cable formation 0.006 0.075 -10000 0 -0.33 3 3
apoptosis -0.031 0.035 0.28 2 -0.36 1 3
CTNNA1 0.029 0.006 -10000 0 -10000 0 0
mol:GDP 0.015 0.064 -10000 0 -0.26 17 17
PIP5K1A 0.026 0.027 -10000 0 -0.36 1 1
PLCG1 0.031 0.03 -10000 0 -0.28 2 2
Rac1/GTP 0.041 0.069 -10000 0 -0.25 16 16
homophilic cell adhesion 0.001 0.005 -10000 0 -10000 0 0
Regulation of cytoplasmic and nuclear SMAD2/3 signaling

Figure S125.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S125.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SMAD4 0.029 0.005 -9999 0 -10000 0 0
SMAD2 -0.013 0.044 -9999 0 -0.24 1 1
SMAD3 0.023 0.017 -9999 0 -10000 0 0
SMAD3/SMAD4 0.038 0.042 -9999 0 -0.45 2 2
SMAD4/Ubc9/PIASy 0.052 0.02 -9999 0 -10000 0 0
SMAD2/SMAD2/SMAD4 0.032 0.064 -9999 0 -0.31 1 1
PPM1A 0.028 0.005 -9999 0 -10000 0 0
CALM1 0.028 0.005 -9999 0 -10000 0 0
SMAD2/SMAD4 0 0.057 -9999 0 -0.32 3 3
MAP3K1 0.027 0.032 -9999 0 -0.58 1 1
TRAP-1/SMAD4 0.014 0.11 -9999 0 -0.42 22 22
MAPK3 0.028 0.007 -9999 0 -10000 0 0
MAPK1 0.022 0.013 -9999 0 -10000 0 0
NUP214 0.027 0.008 -9999 0 -10000 0 0
CTDSP1 0.028 0.005 -9999 0 -10000 0 0
CTDSP2 0.028 0.006 -9999 0 -10000 0 0
CTDSPL 0.029 0.004 -9999 0 -10000 0 0
KPNB1 0.028 0.007 -9999 0 -10000 0 0
TGFBRAP1 -0.007 0.14 -9999 0 -0.58 22 22
UBE2I 0.027 0.007 -9999 0 -10000 0 0
NUP153 0.029 0.003 -9999 0 -10000 0 0
KPNA2 0.028 0.007 -9999 0 -10000 0 0
PIAS4 0.027 0.008 -9999 0 -10000 0 0
PLK2 and PLK4 events

Figure S126.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S126.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 0.025 0.03 -9999 0 -0.26 4 4
PLK4 0.027 0.032 -9999 0 -0.58 1 1
regulation of centriole replication 0.015 0.03 -9999 0 -0.42 1 1
Arf6 trafficking events

Figure S127.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S127.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SLC2A4 -0.023 0.14 -10000 0 -0.37 48 48
CLTC 0.03 0.019 -10000 0 -10000 0 0
calcium ion-dependent exocytosis 0.022 0.017 0.19 1 -10000 0 1
Dynamin 2/GTP 0.029 0.011 -10000 0 -10000 0 0
EXOC4 0.028 0.007 -10000 0 -10000 0 0
CD59 0.022 0.012 -10000 0 -10000 0 0
CPE -0.002 0.086 -10000 0 -0.36 20 20
CTNNB1 0.029 0.004 -10000 0 -10000 0 0
membrane fusion 0.019 0.007 -10000 0 -10000 0 0
CTNND1 0.021 0.025 0.19 8 -10000 0 8
DNM2 0.027 0.008 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.023 0.028 -10000 0 -10000 0 0
TSHR 0.016 0.028 -10000 0 -0.36 2 2
INS 0.01 0.015 -10000 0 -10000 0 0
BIN1 0.029 0.005 -10000 0 -10000 0 0
mol:Choline 0.019 0.007 -10000 0 -10000 0 0
growth hormone secretagogue receptor activity 0 0 -10000 0 -10000 0 0
mol:GDP 0.018 0.005 -10000 0 -10000 0 0
membrane depolarization 0 0 -10000 0 -10000 0 0
ARF6 0.028 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0.029 0.01 -10000 0 -10000 0 0
JUP 0.023 0.009 -10000 0 -10000 0 0
ASAP2/amphiphysin II 0.052 0.031 -10000 0 -0.33 2 2
ARF6/GTP 0.021 0.004 -10000 0 -10000 0 0
CDH1 0.022 0.012 -10000 0 -10000 0 0
clathrin-independent pinocytosis 0.021 0.004 -10000 0 -10000 0 0
MAPK8IP3 0.028 0.007 -10000 0 -10000 0 0
positive regulation of endocytosis 0.021 0.004 -10000 0 -10000 0 0
EXOC2 0.029 0.004 -10000 0 -10000 0 0
substrate adhesion-dependent cell spreading 0.036 0.014 -10000 0 -10000 0 0
insulin receptor binding 0 0 -10000 0 -10000 0 0
SPAG9 0.028 0.007 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.049 0.023 -10000 0 -10000 0 0
positive regulation of phagocytosis 0.018 0.005 -10000 0 -10000 0 0
ARF6/GTP/JIP3 0.037 0.01 -10000 0 -10000 0 0
ACAP1 0.021 0.028 -10000 0 -0.18 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
CHRM2 0.02 0.009 -10000 0 -10000 0 0
clathrin heavy chain/ACAP1 0.029 0.022 -10000 0 -10000 0 0
JIP4/KLC1 0.052 0.015 -10000 0 -10000 0 0
EXOC1 0.029 0.004 -10000 0 -10000 0 0
exocyst 0.036 0.015 -10000 0 -10000 0 0
RALA/GTP 0.021 0.005 -10000 0 -10000 0 0
ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex 0.037 0.01 -10000 0 -10000 0 0
receptor recycling 0.021 0.004 -10000 0 -10000 0 0
CTNNA1 0.02 0.022 0.19 6 -10000 0 6
NME1 0.018 0.005 -10000 0 -10000 0 0
clathrin coat assembly 0.031 0.024 -10000 0 -10000 0 0
IL2RA -0.005 0.068 -10000 0 -10000 0 0
VAMP3 0.018 0.005 -10000 0 -10000 0 0
GLUT4/clathrin heavy chain/ACAP1 0.019 0.068 -10000 0 -10000 0 0
EXOC6 0.028 0.005 -10000 0 -10000 0 0
PLD1 0.02 0.005 -10000 0 -10000 0 0
PLD2 0.019 0.006 -10000 0 -10000 0 0
EXOC5 0.028 0.005 -10000 0 -10000 0 0
PIP5K1C 0.023 0.015 -10000 0 -10000 0 0
SDC1 0.022 0.015 -10000 0 -10000 0 0
ARF6/GDP 0.027 0.008 -10000 0 -10000 0 0
EXOC7 0.028 0.007 -10000 0 -10000 0 0
E-cadherin/beta catenin 0.053 0.025 -10000 0 -10000 0 0
mol:Phosphatidic acid 0.019 0.007 -10000 0 -10000 0 0
endocytosis -0.05 0.03 0.33 2 -10000 0 2
SCAMP2 0.029 0.004 -10000 0 -10000 0 0
ADRB2 0.028 0.073 0.39 7 -10000 0 7
EXOC3 0.027 0.007 -10000 0 -10000 0 0
ASAP2 0.025 0.044 -10000 0 -0.58 2 2
Dynamin 2/GDP 0.033 0.012 -10000 0 -10000 0 0
KLC1 0.028 0.006 -10000 0 -10000 0 0
AVPR2 0.023 0.086 0.42 7 -10000 0 7
RALA 0.028 0.007 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.048 0.024 -10000 0 -10000 0 0
Sumoylation by RanBP2 regulates transcriptional repression

Figure S128.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S128.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.028 0.006 -9999 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.002 0.014 -9999 0 -10000 0 0
MDM2/SUMO1 0.019 0.054 -9999 0 -0.22 1 1
HDAC4 0.028 0.016 -9999 0 -0.26 1 1
Ran/GTP/Exportin 1/HDAC1 0.002 0.013 -9999 0 -10000 0 0
SUMO1 0.028 0.005 -9999 0 -10000 0 0
NPC/RanGAP1/SUMO1 0.007 0.039 -9999 0 -0.25 8 8
mol:GTP 0 0 -9999 0 -10000 0 0
XPO1 0.013 0.008 -9999 0 -10000 0 0
EntrezGene:23636 0 0 -9999 0 -10000 0 0
RAN 0.028 0.006 -9999 0 -10000 0 0
EntrezGene:8021 0 0 -9999 0 -10000 0 0
RANBP2 0.028 0.005 -9999 0 -10000 0 0
SUMO1/HDAC4 0.018 0.059 -9999 0 -0.24 3 3
SUMO1/HDAC1 0.017 0.059 -9999 0 -0.25 3 3
RANGAP1 0.022 0.013 -9999 0 -10000 0 0
MDM2/SUMO1/SUMO1 0.071 0.019 -9999 0 -10000 0 0
NPC/RanGAP1/SUMO1/RanBP2/Ubc9 0.015 0.009 -9999 0 -10000 0 0
Ran/GTP 0.01 0.047 -9999 0 -0.23 1 1
EntrezGene:23225 0 0 -9999 0 -10000 0 0
MDM2 0.028 0.006 -9999 0 -10000 0 0
UBE2I 0.027 0.007 -9999 0 -10000 0 0
Ran/GTP/Exportin 1 0.01 0.045 -9999 0 -0.21 1 1
NPC 0.017 0.003 -9999 0 -10000 0 0
PIAS2 0.029 0.005 -9999 0 -10000 0 0
PIAS1 0.029 0.004 -9999 0 -10000 0 0
EntrezGene:9972 0 0 -9999 0 -10000 0 0
E-cadherin signaling events

Figure S129.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S129.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.054 0.02 -9999 0 -9999 0 0
E-cadherin/beta catenin 0.04 0.015 -9999 0 -9999 0 0
CTNNB1 0.029 0.004 -9999 0 -9999 0 0
JUP 0.028 0.007 -9999 0 -9999 0 0
CDH1 0.028 0.007 -9999 0 -9999 0 0
Arf1 pathway

Figure S130.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S130.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
coatomer protein complex 0.013 0.02 0.17 4 -10000 0 4
EntrezGene:79658 0 0 -10000 0 -10000 0 0
ARF1/GDP/Membrin/GBF1/p115/Brefeldin A 0.024 0.03 -10000 0 -0.22 1 1
AP2 0.041 0.011 -10000 0 -10000 0 0
mol:DAG 0 0 -10000 0 -10000 0 0
Arfaptin 2/Rac/GTP 0.038 0.012 -10000 0 -10000 0 0
CLTB 0.027 0.016 -10000 0 -0.26 1 1
coatomer protein complex/ARF1/GTP/ER cargo protein 0.023 0.01 -10000 0 -10000 0 0
CD4 0.016 0.071 -10000 0 -0.33 13 13
CLTA 0.027 0.008 -10000 0 -10000 0 0
mol:GTP -0.001 0.002 -10000 0 -10000 0 0
ARFGAP1 0.01 0.002 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.008 0.018 -10000 0 -0.33 1 1
ARF1/GTP 0.031 0.016 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1/ER cargo protein 0.016 0.008 -10000 0 -10000 0 0
mol:Choline 0.008 0.02 -10000 0 -0.33 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
ARF1 0.028 0.009 -10000 0 -10000 0 0
DDEF1 0.008 0.02 -10000 0 -0.34 1 1
ARF1/GDP 0.006 0.016 -10000 0 -10000 0 0
AP2M1 0.029 0.004 -10000 0 -10000 0 0
EntrezGene:1313 0 0 -10000 0 -10000 0 0
actin filament polymerization 0.015 0.006 -10000 0 -10000 0 0
Rac/GTP 0.022 0.007 -10000 0 -10000 0 0
ARF1/GTP/GGA3/ARF-GAP1 0.039 0.016 -10000 0 -10000 0 0
ARFIP2 0.023 0.013 -10000 0 -10000 0 0
COPA 0.027 0.008 -10000 0 -10000 0 0
RAC1 0.028 0.007 -10000 0 -10000 0 0
ARF1/GTP/coatomer protein complex 0.015 0.036 -10000 0 -0.49 1 1
ARF1/GTP/ARHGAP10 0.019 0.007 -10000 0 -10000 0 0
GGA3 0.028 0.007 -10000 0 -10000 0 0
ARF1/GTP/Membrin 0.027 0.017 -10000 0 -10000 0 0
AP2A1 0.028 0.007 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1 0.021 0.009 -10000 0 -10000 0 0
ARF1/GDP/Membrin 0.028 0.019 -10000 0 -0.2 1 1
Arfaptin 2/Rac/GDP 0.036 0.011 -10000 0 -10000 0 0
CYTH2 0.03 0.01 -10000 0 -10000 0 0
ARF1/GTP/GGA3 0.035 0.014 -10000 0 -10000 0 0
mol:ATP 0 0 -10000 0 -10000 0 0
Rac/GDP 0.021 0.005 -10000 0 -10000 0 0
mol:Brefeldin A 0 0 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex/Coatomer protein complex/ARF1/GTP 0.023 0.032 -10000 0 -0.21 3 3
PLD2 0.007 0.018 -10000 0 -0.33 1 1
ARF-GAP1/v-SNARE 0.01 0.002 -10000 0 -10000 0 0
PIP5K1A 0.008 0.018 -10000 0 -0.34 1 1
ARF1/GTP/Membrin/GBF1/p115 0.025 0.018 -10000 0 -10000 0 0
mol:Phosphatic acid 0 0 -10000 0 -10000 0 0
mol:Phosphatidic acid 0.007 0.018 -10000 0 -0.33 1 1
KDEL Receptor/Ligand/ARF-GAP1 0.01 0.002 -10000 0 -10000 0 0
GOSR2 0.015 0.011 -10000 0 -10000 0 0
USO1 0.015 0.011 -10000 0 -10000 0 0
GBF1 0.013 0.026 -10000 0 -0.31 2 2
ARF1/GTP/Arfaptin 2 0.037 0.015 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex 0.046 0.051 -10000 0 -0.36 3 3
Alternative NF-kappaB pathway

Figure S131.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S131.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.038 0.036 -9999 0 -0.42 2 2
FBXW11 0.028 0.006 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0 0 -9999 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.028 0.006 -9999 0 -10000 0 0
CHUK 0.029 0.005 -9999 0 -10000 0 0
NF kappa B2 p100/RelB 0.075 0.046 -9999 0 -0.34 3 3
NFKB1 0.029 0.004 -9999 0 -10000 0 0
MAP3K14 0.024 0.045 -9999 0 -0.58 2 2
NF kappa B1 p50/RelB 0.04 0.026 -9999 0 -0.42 1 1
RELB 0.026 0.032 -9999 0 -0.58 1 1
NFKB2 0.029 0.005 -9999 0 -10000 0 0
NF kappa B2 p52/RelB 0.036 0.029 -9999 0 -0.48 1 1
regulation of B cell activation 0.035 0.029 -9999 0 -0.48 1 1
Inferred Pathway Levels Matrix

Table 3.  Get Full Table First 10 out of 7202 rows and 4 out of 375 columns in the PARADIGM inferred pathway levels matrix.

pid_entity TCGA.J8.A3YH TCGA.J8.A3YG TCGA.J8.A3YE TCGA.J8.A3YD
109_MAP3K5 0.057 0.057 0.044 0.057
47_PPARGC1A -0.58 0.029 -0.26 0.029
105_BMP4 -0.26 0 -0.58 0.029
105_BMP6 0.029 0.029 0.029 0.029
105_BMP7 0.029 0.029 0.029 0.029
105_BMP2 0.029 0.029 0.029 0.029
131_RELN/VLDLR 0.076 -0.11 -0.33 -0.13
30_TGFB1/TGF beta receptor Type II 0.029 0.029 0.029 0.029
84_STAT5B 0.044 -0.14 -0.076 0.044
84_STAT5A 0.044 -0.14 -0.076 0.044
Methods & Data
Input

  • Expression Data Normalization = Expression data was not used in this analysis.

  • mRNASeq Expression File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/mRNAseq_preprocessor/THCA-TP/2284143/0.mRNAseq_preprocessor.Finished/THCA-TP.uncv2.mRNAseq_RSEM_normalized_log2.txt

  • Copy Number File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Gistic2_Pipeline/THCA-TP/2284137/1.Gistic2_Analysis.Finished/all_data_by_genes.txt

Data Sets and Pathway Interactions

Both copy number and expression data are incorporated into PARADIGM's inference. Whenever normal tissue controls are available for analysis in the expression data, each patient's gene-value is normalized by subtracting the gene's median level observed in the normal control. Copy number data is also normalized to reflect the difference in copy number between a gene's levels detected in tumor versus control (e.g. blood normal). The collection of pathways used by PARADIGM includes those from NCI-PID on September 15, 2009 containing 131 pathways, 11,563 interactions, and 7,204 entities. All gene identifiers were translated into HUGO standard identifiers wherever possible. We refer to molecular entities as "concepts," which include gene products such as proteins and miRNAs, small molecules, protein complexes, and abstract concepts. Each concept is represented as "node" in PARADIGM's graphical model. The abstract concepts correspond to general cellular processes (such as "apoptosis" or "DNA damage response") and families of genes that share functional activity such as the RAS family of signal transducers. Various types of concept-concept interactions are included in the pathways including protein-protein interactions, transcriptional regulatory interactions, and protein modifications such as phosphorylation and ubiquitinylation interactions.

Pathway Inference Method

The PARADIGM algorithm (described in PMID: 20529912) assigns an integrated pathway level (IPL) reflecting the activity of a concept determined through a belief propagation strategy. The belief propagation is given the copy number and gene expression measurements of all of the genes and iteratively updates hidden states reflecting the activities of all of the genes in a pathway so as to maximize the likelihood of the observed data given the interactions in the pathway. In the end, the inferred level of a concept reflects both the data observed for the concept and the neighborhood of activity surrounding the concept.

Determining significantly altered levels

The significance of the IPL obtained for each concept in each patient sample is assessed using a permutation analysis. Importantly, the permutation analysis preserves data tuples so as to preserve any implicit correlations between the different data modalities. For example, genes that are deleted have concomitantly lower expression levels. Preserving the copy number and expression pairs therefore retains this data property. The simulation therefore makes "null samples" by permuting data tuples across all of the genes in the genome so that each gene in a null sample is associated with a random tuple of another gene with equal probability. This approach has the added benefit of preserving the pathway structure so that every observed IPL can be compared to a distribution of random IPLs derived from exactly the same interaction context. PARADIGM inferences are then obtained for 1000 "null" patients and serve as a background distribution to contrast the observed IPLs against. Pathway concepts are excluded from further analysis if they did not obtain a minimum IPL of 0.5 in any patient sample both observed or simulated.

An IPL I(i,j) for concept i in sample j, is considered to be deviated if its absolute level is two standard deviations from the average level observed for concept i in the 1000 null samples. The degree to which a concept has significantly altered levels across a patient cohort is summarized in the proportion of deviated samples (PDS) score. For example, a protein with a PDS of 0.10 reflects that the protein's level of activity was inferred to be significantly higher or lower in tumors compared to normal in 10% of the patient samples. An average PDS for a pathway is also reported by computing the mean PDS over all concepts in the pathway.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[2] Charles J. Vaske, Stephen C. Benz, J. Zachary Sanborn, Dent Earl, Christopher Szeto, Jingchun Zhu, David Haussler, and Joshua M. Stuart, Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, Bioinformatics 12(26):237-245 (2010)
Copyright © 2013 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle